data_2n1h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1h _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 107.035 -1.469 . . . . 74.44 107.035 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.42 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.14 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.02 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.625 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 75.04 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.21 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.13 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.31 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.625 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.54 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.15 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 73.24 109.037 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.55 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.15 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.12 112.399 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 71.24 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.21 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 75.03 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.494 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.2 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.43 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.12 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 70.43 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.494 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.05 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 74.41 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 72.34 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.41 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.641 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.53 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 72.0 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.52 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 65.44 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 74.01 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 71.22 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.44 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 71.21 108.324 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.54 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 71.34 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.564 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.52 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.641 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.51 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 404' ' ' ASN . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.31 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 403' ' ' GLU . 50.9 m-80 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 64.21 111.335 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.22 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 64.31 106.326 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.14 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.41 110.217 -179.506 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 . . . . . 0 C--O 1.267 1.989 0 N-CA-C 108.661 -0.866 . . . . 73.11 108.661 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.33 108.397 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 73.43 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 72.32 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.425 HG11 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.3 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.44 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.425 ' H ' HG11 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.42 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.35 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.21 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 74.4 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 64.14 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 73.5 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.446 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 72.41 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 72.4 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.4 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.44 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.55 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 49.3 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.34 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 70.23 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.05 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 75.13 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.43 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.21 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 72.03 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.32 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.45 111.645 178.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.424 -1.753 0 CA-C-O 120.889 0.376 . . . . 74.0 111.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.11 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.32 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 65.32 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 74.34 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.4 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.55 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 75.4 111.241 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 61.53 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.562 ' CE2' HD12 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.41 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 65.33 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.494 HG23 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 74.44 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.22 110.67 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.51 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.11 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.43 109.829 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.11 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.11 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 74.01 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.32 109.524 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.41 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.13 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.44 109.822 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.42 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.562 HD12 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.34 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.03 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 72.0 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.35 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.3 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.11 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.3 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 75.52 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 71.34 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.12 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.55 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 74.21 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.54 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.3 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 74.52 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 63.3 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.41 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.03 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.33 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.401 ' HA ' ' NH2' ' A' ' 414' ' ' ARG . 28.5 p . . . . . 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.11 110.595 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.401 ' NH2' ' HA ' ' A' ' 408' ' ' CYS . 45.0 ttm105 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.12 109.178 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.54 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.43 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 74.35 109.797 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 401' ' ' LYS . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.31 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.44 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 74.3 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 73.3 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.23 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.462 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 74.23 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 37.37 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 75.13 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.32 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 51.04 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.42 107.429 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.55 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 74.01 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.22 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.52 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.34 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.42 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.33 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.21 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.546 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 72.44 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.02 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 74.14 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 74.54 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.11 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 72.3 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.51 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 73.31 112.688 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.589 0.233 . . . . 71.13 111.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 72.24 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 73.51 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.43 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 74.15 110.305 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 62.22 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.53 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 75.43 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 72.14 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.42 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 75.41 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.22 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 74.21 106.992 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.4 112.836 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.32 112.254 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.23 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.441 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.12 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.1 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 62.33 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.1 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.1 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 73.31 110.75 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.52 HD11 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 74.22 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.446 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 75.22 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 36.51 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.11 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.11 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 74.53 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.43 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.42 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.22 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 73.25 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 74.53 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.43 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.589 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.12 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 401' ' ' LYS . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 74.23 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.411 ' HB3' ' CE ' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 75.45 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.3 m120 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.3 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.31 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.21 110.838 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.34 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.21 109.544 -177.171 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 121.288 0.566 . . . . 75.02 111.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.02 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 74.34 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.24 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.33 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.13 108.789 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.55 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.31 112.971 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.4 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.42 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.23 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.456 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.22 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 70.35 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 74.22 107.889 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 74.35 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.12 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.44 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.04 109.289 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.21 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.41 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 64.22 108.181 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.11 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.41 107.427 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.443 HG23 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.24 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.13 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.11 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 65.24 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 72.21 111.367 177.039 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 54.23 106.976 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 71.11 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 74.33 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.52 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 71.22 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 37.89 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.22 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.12 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 75.21 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 63.32 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.43 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.548 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 72.14 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.548 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 74.14 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.14 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.2 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.0 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 74.24 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.45 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 60.12 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.431 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.35 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.12 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.494 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.35 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.12 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 72.2 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 64.03 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.24 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.42 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.12 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.34 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.45 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.22 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.44 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 75.4 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.694 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 73.15 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.43 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.45 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.21 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.42 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.33 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.14 110.939 -174.465 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 105.489 -2.041 . . . . 73.03 105.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.694 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.44 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 61.24 108.787 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 74.04 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.14 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.21 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 443' ' ' MET . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.22 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 73.02 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.42 114.339 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.22 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.14 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.1 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.4 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.42 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.42 108.103 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.45 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.52 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.496 HG13 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 73.42 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.31 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.33 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 74.43 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.3 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.2 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 64.03 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.432 ' CD1' HD21 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.23 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 75.15 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 75.05 110.366 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 74.22 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.21 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 75.22 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.52 111.006 174.211 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.42 107.621 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.21 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.413 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.32 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.4 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.505 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 75.32 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.42 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.24 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.31 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.23 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.43 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.21 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 74.25 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' A' ' 380' ' ' GLU . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 72.31 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.35 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.34 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.458 ' OE1' HG13 ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.22 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.33 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 74.01 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.44 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.472 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 74.32 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 74.44 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.472 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 72.15 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.52 HD23 HD22 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 74.22 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 61.5 109.907 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.42 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 64.13 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.42 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 75.02 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.22 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.35 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 75.45 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.41 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.42 109.106 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 75.41 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.34 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.532 ' CE ' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.43 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 64.34 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 65.43 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.34 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.12 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.21 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.21 110.409 -177.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.44 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 72.24 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.14 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 75.4 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.2 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 75.51 109.275 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.13 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.23 111.157 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.44 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 54.32 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.23 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.12 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 64.24 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.31 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 64.53 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.13 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.13 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.02 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.41 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 45.3 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.4 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.42 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.04 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.02 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.43 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 64.42 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 64.42 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.41 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 75.12 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.32 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.34 108.667 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 75.34 111.211 176.07 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.944 -0.391 . . . . 71.41 109.944 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 75.32 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.24 106.104 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.54 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 75.02 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.42 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.15 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.45 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.31 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.11 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.41 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.44 108.767 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.521 HG12 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.01 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.51 110.192 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 73.05 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.521 ' OE2' HG12 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.35 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.581 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 74.54 112.13 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.51 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.51 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.03 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.54 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.45 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.408 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.03 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.14 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.43 110.276 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.417 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.11 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.33 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 75.54 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 72.32 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.35 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 74.35 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.45 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 38.67 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 71.11 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.35 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 73.21 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.507 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.44 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.05 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.32 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.21 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.23 108.382 -177.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.21 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.44 109.08 176.034 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.412 -0.588 . . . . 74.41 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.43 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 74.41 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 64.35 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 72.12 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.52 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.41 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.478 ' H ' HG11 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 74.22 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.32 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.3 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 73.15 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.01 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.15 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 71.03 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.41 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 75.24 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 73.24 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 73.5 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.11 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.51 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.479 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 74.13 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.13 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.44 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.42 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.23 112.126 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 62.35 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 72.53 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.14 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.463 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.24 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.32 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.05 111.97 178.517 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 107.129 -1.434 . . . . 73.14 107.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.54 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.01 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.42 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.15 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.21 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.41 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.55 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.1 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.23 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.51 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 72.03 109.208 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 74.35 107.297 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.484 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.22 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 72.24 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.54 111.676 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.542 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.32 112.076 -176.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.33 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.23 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 71.2 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.4 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 74.43 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 391' ' ' ASN . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 73.13 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.402 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.11 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 52.45 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 64.25 110.077 -177.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.54 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 62.15 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.45 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 71.23 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.2 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.41 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.53 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 74.12 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.01 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.483 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 74.43 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.31 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.05 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.01 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.03 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.54 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.35 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.31 110.84 -175.601 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.53 109.018 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.483 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.11 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 62.43 110.048 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 440' ' ' LEU . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.01 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 75.31 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 74.43 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.11 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.33 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.21 112.536 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 71.15 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 65.24 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.23 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 70.41 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 72.4 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.48 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.53 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 74.3 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.42 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.13 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.32 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.4 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.42 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 73.45 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.15 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.22 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.33 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 64.14 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 74.2 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 74.44 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 73.15 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.15 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 74.0 111.046 177.308 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 120.569 0.223 . . . . 72.21 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.22 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 75.43 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.33 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.557 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 72.31 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.01 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 52.45 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.23 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 74.44 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.649 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.41 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 72.42 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 73.42 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 380' ' ' GLU . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.21 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 63.14 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.52 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.22 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.42 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 75.41 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 74.43 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.474 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.8 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.45 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.44 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.24 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.474 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.4 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.44 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 74.44 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.53 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.3 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 73.34 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.13 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.41 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.404 ' HB3' HD11 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.53 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 71.34 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.45 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 75.41 110.928 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.42 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 395' ' ' GLN . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 61.1 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 74.14 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.52 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.33 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.44 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 73.34 106.498 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.44 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 72.03 110.269 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 106.596 -1.631 . . . . 74.44 106.596 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.21 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 74.34 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 73.41 110.566 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 74.03 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 422' ' ' CYS . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.43 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.35 111.771 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.42 ' H ' HG11 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.24 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.34 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 72.32 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.54 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.24 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.34 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.44 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.21 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.11 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.22 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 75.44 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.25 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.1 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.14 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.505 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.45 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 75.21 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 75.22 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.14 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.43 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.412 HG21 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.14 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 71.04 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 73.54 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.33 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.42 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.45 111.294 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.13 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 75.24 109.571 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.42 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.21 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.55 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.24 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.42 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 431' ' ' VAL . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 75.21 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 73.33 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 74.31 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.421 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.12 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.41 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.22 110.544 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.575 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.22 111.438 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 73.23 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.04 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.45 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.33 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 74.13 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 75.41 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.485 HD23 HD22 ' A' ' 391' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 74.22 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.45 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.41 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.41 109.552 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.51 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 72.44 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.23 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.14 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.21 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.14 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.14 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 74.34 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 72.34 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 75.52 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.32 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 64.32 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.51 113.928 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.45 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 75.35 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.24 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.4 109.858 -177.284 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 . . . . . 0 C--O 1.254 1.307 0 CA-C-O 121.487 0.661 . . . . 71.1 111.615 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.435 ' HG ' ' C ' ' A' ' 414' ' ' ARG . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.13 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.4 109.527 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 71.04 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 74.43 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 65.41 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 75.11 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.43 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.427 ' H ' HG13 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 62.33 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.21 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.34 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 74.1 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.35 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.02 106.935 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.34 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 74.23 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 72.22 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 72.44 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.22 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.42 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 22.7 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.44 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 74.41 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 61.45 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 64.4 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.506 ' CD1' HD21 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 75.52 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 74.01 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.52 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.11 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.13 109.534 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 75.45 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 71.45 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.45 111.461 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.41 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 73.03 106.721 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.53 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 72.11 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.14 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 65.13 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 75.02 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 70.4 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.33 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.41 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.35 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.14 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 74.1 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.23 111.253 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.24 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.55 110.857 -176.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.13 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.15 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.14 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 71.04 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 73.24 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.552 HD22 HD22 ' A' ' 391' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.54 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.23 109.253 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.13 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.9 m-80 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 73.11 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 72.32 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.15 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 75.4 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.14 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.44 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.32 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.31 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.429 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.4 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 75.43 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 74.21 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.13 110.308 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.14 111.197 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.405 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 73.35 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.31 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.4 111.65 -175.196 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 112.416 0.525 . . . . 72.45 112.416 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.45 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 72.24 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.4 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.35 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 422' ' ' CYS . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 73.42 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.33 111.351 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.475 ' H ' HG13 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.32 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.11 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 75.55 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.55 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.14 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.421 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.04 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.52 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 70.44 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 75.15 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 72.15 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.523 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 65.01 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 75.11 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.25 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 75.31 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.523 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 71.12 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.15 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.31 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 75.23 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 74.54 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.54 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.41 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 72.22 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 72.43 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.13 111.296 176.132 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 120.466 0.174 . . . . 74.54 110.806 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.52 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.23 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.22 109.633 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 75.01 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.51 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.54 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.31 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.45 111.757 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.14 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.54 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 71.51 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.522 HG12 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.01 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 75.4 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 73.13 110.678 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.522 ' OE2' HG12 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.52 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.11 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.24 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.513 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.4 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.41 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 75.22 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 74.33 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.513 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.43 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 62.01 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.584 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.55 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 74.53 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 74.44 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.31 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 71.15 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 64.3 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.33 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.54 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.31 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.14 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 74.3 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 75.45 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.411 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.4 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.24 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 74.52 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.44 108.448 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 73.31 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.407 ' HA ' ' NH2' ' A' ' 414' ' ' ARG . 42.3 t . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.15 110.979 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 408' ' ' CYS . 13.1 ttm180 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 109.519 -0.548 . . . . 73.45 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.02 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 73.55 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.414 ' CG2' HD21 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.42 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.42 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 74.34 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.2 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.45 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 74.25 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.14 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 75.1 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.52 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.02 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.13 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.456 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.43 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.21 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.24 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.12 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 74.22 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.04 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.32 109.674 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.44 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.32 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 73.31 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.533 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 74.41 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 74.22 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 73.2 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 74.35 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.34 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 74.41 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.51 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.33 111.567 178.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 107.131 -1.433 . . . . 72.14 107.131 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.01 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 74.53 107.718 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.33 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 65.43 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.3 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 74.12 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 71.03 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 73.33 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.05 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 74.23 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.31 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.13 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.12 112.089 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.34 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.488 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 72.13 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 73.02 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.31 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.33 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.24 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.5 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.45 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.487 HD21 HD22 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.13 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 75.51 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.21 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 65.43 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.33 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 64.54 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.22 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.35 105.057 174.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.54 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 65.34 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.22 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.32 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 72.43 110.541 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 75.23 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.21 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.54 110.684 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.32 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 38.29 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 72.31 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.1 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.43 109.538 -176.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.412 ' C ' ' HG ' ' A' ' 415' ' ' SER . 69.7 mtt180 . . . . . 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 74.12 111.611 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.434 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.42 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.32 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.34 109.139 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 73.31 110.173 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 72.42 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.476 HG11 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 74.41 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.31 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.476 ' H ' HG11 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 72.33 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 38.29 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 73.3 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 74.12 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 74.44 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.14 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.498 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.42 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 73.35 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.41 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.31 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.41 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.05 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.23 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.466 ' OE1' HD23 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 74.33 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.521 ' HZ2' ' CD ' ' A' ' 438' ' ' GLU . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 75.43 116.377 -177.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.453 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.51 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.521 ' CD ' ' HZ2' ' A' ' 436' ' ' LYS . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.24 109.114 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 71.13 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.42 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 61.22 106.856 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.31 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.498 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.43 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.34 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.14 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 74.31 111.615 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.44 107.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 71.25 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 75.24 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.23 112.018 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.457 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.53 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 74.33 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.05 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.1 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 74.15 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 75.01 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.22 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 74.24 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 73.11 110.21 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 72.41 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 70.44 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.55 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 73.43 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.23 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.451 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.43 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 75.24 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.53 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.451 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.45 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.492 HD21 HD22 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 75.43 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 74.13 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 75.3 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 74.01 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.1 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.44 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 73.1 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 75.12 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 71.12 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.21 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.21 109.047 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.1 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 51.21 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.3 107.557 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 65.21 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 64.02 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 65.15 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.42 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.41 111.23 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.03 108.962 -179.389 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.171 0.51 . . . . 64.31 110.576 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.24 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.34 107.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.409 ' CG2' HD21 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.14 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.43 110.199 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 75.51 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.456 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.14 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.44 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 75.32 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.11 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.23 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.55 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 74.31 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 75.1 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.03 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 72.44 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.31 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.546 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.34 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.24 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.441 HE21 HD23 ' A' ' 440' ' ' LEU . 48.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.35 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.31 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.546 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 74.22 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 73.42 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 74.54 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.43 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.41 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 70.34 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.41 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.1 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.31 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.11 112.051 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 107.686 -1.228 . . . . 75.13 107.686 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 75.55 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.14 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.21 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 71.45 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 74.33 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.11 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.21 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.3 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.21 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.14 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.53 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 74.11 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 72.33 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.32 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.31 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 63.22 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.14 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.54 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.491 ' CD ' HD22 ' A' ' 389' ' ' LEU . 10.4 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 74.41 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.31 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.42 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 73.22 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.508 HD23 HD22 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.14 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.491 HD22 ' CD ' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.23 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.495 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 37.67 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.34 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.04 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 54.45 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.52 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.04 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 73.03 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 61.22 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.15 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.14 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 74.44 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.42 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.42 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.41 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 74.41 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.43 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.32 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 75.51 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.2 111.145 -174.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.08 -0.711 . . . . 75.21 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.41 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 37.67 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.443 HD11 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 64.12 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 65.35 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 73.52 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.04 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.15 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.458 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.51 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.14 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.22 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.45 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.8 OUTLIER -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.24 109.468 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.12 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 74.35 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.33 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 73.24 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 73.12 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.21 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.15 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 75.32 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.51 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 74.2 115.915 -178.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.13 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.13 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 433' ' ' GLU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.44 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 73.31 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 73.12 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.22 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.15 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.42 108.587 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 75.35 112.109 178.464 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 111.646 0.239 . . . . 74.11 111.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 71.12 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 72.43 106.677 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 74.5 111.768 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.01 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.53 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 73.52 110.976 -171.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 74.13 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 73.22 107.487 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.13 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 75.04 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.23 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.24 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.498 ' OE1' HG13 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.4 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.45 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.23 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.14 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.23 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.42 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 74.1 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 74.44 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.21 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.44 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 52.04 112.048 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 71.34 108.532 -178.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 73.51 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 61.41 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.51 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.34 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.33 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.3 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.43 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 62.54 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.52 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.42 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 70.22 114.052 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.33 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 60.0 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 72.21 111.673 -174.774 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 109.251 -0.648 . . . . 71.44 109.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.31 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.22 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.34 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.04 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 75.11 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.5 HG11 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 64.42 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 74.41 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.5 ' H ' HG11 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.2 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.04 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.01 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.34 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 74.23 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.31 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 71.31 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.23 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 72.04 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.35 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 74.53 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 62.03 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.32 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 75.41 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 72.21 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.444 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.42 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 74.55 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.35 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.33 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.42 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.15 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.432 HG21 HG13 ' A' ' 428' ' ' ILE . 3.7 m . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.983 0.42 . . . . 73.42 110.809 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.12 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.42 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.45 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.442 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.34 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 44.22 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 70.1 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 73.32 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.14 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.696 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.43 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.55 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.497 HG23 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 72.43 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.544 HG12 ' OE2' ' A' ' 380' ' ' GLU . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 74.42 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.55 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.33 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.544 ' OE2' HG12 ' A' ' 377' ' ' VAL . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 54.24 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.566 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 70.53 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.03 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.24 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.5 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.22 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.11 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.04 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 74.34 110.57 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.51 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 72.31 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.468 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.04 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.43 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.41 111.208 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 71.2 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.34 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.44 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 72.44 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.22 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.23 108.588 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.2 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.33 108.779 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.44 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.34 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 74.32 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.44 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.45 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.14 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.05 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 70.23 106.442 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.34 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.53 110.129 -178.047 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.281 -0.637 . . . . 75.2 109.281 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.14 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.54 109.513 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.45 HG21 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.42 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.34 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.11 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 74.34 109.642 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.31 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.54 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.22 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.23 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 71.54 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.13 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 74.0 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.34 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.44 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.4 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.437 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.21 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 74.41 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 71.01 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.437 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.11 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 75.33 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.426 HG23 ' HG3' ' A' ' 443' ' ' MET . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.45 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.52 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 376' ' ' VAL . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 72.12 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 63.04 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 73.52 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.53 110.434 174.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.43 107.51 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.12 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.421 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 74.34 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 72.25 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 74.31 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.24 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 51.14 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 53.22 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.35 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 70.42 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.44 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 74.55 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.494 HG11 ' OE2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 72.3 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.5 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.12 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.5 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.01 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.494 ' OE2' HG11 ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.2 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.34 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.44 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.13 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.52 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.33 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.1 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 71.14 110.892 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.469 HD21 HD22 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.43 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.41 HD21 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.43 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 75.22 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 73.3 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.34 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.21 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.23 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.53 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.24 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.404 ' OD1' ' HB ' ' A' ' 420' ' ' VAL . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.11 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.2 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.496 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.14 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.24 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.44 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.529 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.23 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.32 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 70.15 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.11 110.2 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.42 109.546 -176.323 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 109.437 -0.579 . . . . 73.52 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 71.42 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.11 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 73.24 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.3 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.33 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.417 ' CG ' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.43 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.23 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.31 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 72.55 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.23 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.4 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.13 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.31 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.11 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 50.44 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 75.04 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.44 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.22 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.31 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.21 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.31 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 64.33 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.41 ' CD1' HD21 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 75.51 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.52 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 75.53 108.024 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.32 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.479 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.54 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.34 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.41 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.12 111.213 174.39 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.982 -0.748 . . . . 64.23 108.982 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.33 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 75.52 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.33 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 64.44 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 74.33 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.53 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 61.21 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 65.14 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.13 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.22 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.1 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.548 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 74.33 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.548 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 72.11 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.01 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.51 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 72.23 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 75.35 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.51 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.43 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.43 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.21 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 74.15 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.42 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.13 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.2 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 75.34 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 52.43 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.22 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.44 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.21 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 420' ' ' VAL . 62.3 t30 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.14 108.425 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.439 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.33 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 75.41 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.42 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.446 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 74.12 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 74.01 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.22 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.43 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.42 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.44 110.707 -176.121 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 74.45 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 73.13 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.408 HD12 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.11 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.11 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.02 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.15 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.15 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.43 114.224 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.34 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 64.13 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 75.42 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.41 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.12 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.409 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 61.14 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.12 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.44 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.14 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 72.01 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.14 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 73.53 109.376 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 74.43 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.31 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 70.3 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 75.25 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 71.22 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 75.42 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.05 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.13 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.24 106.13 173.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.01 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.23 112.413 178.209 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 113.23 0.826 . . . . 74.12 113.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.22 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 74.12 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 64.4 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.01 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.52 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 61.55 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 74.32 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.3 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.54 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.62 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.11 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.24 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.15 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.62 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.12 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.79 -177.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.01 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.44 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.11 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.32 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.24 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.487 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 75.01 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 72.43 111.836 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.05 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.2 110.64 -177.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.52 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 74.44 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.04 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 74.13 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 65.34 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.42 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.44 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.03 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 75.22 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.521 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 73.42 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.634 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.13 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.2 110.363 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.44 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.44 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.33 106.407 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.35 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 63.13 109.395 -177.392 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.187 -1.042 . . . . 75.05 108.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.521 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.41 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.42 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 75.41 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.43 111.109 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.14 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 72.3 113.202 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.54 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 75.45 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 72.05 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.15 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.44 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 70.15 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 75.01 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.14 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 75.44 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 75.4 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 64.11 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.54 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.411 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.34 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.13 108.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.23 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.32 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.22 107.913 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 61.31 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.23 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 73.31 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.54 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.35 110.537 176.304 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 107.913 -1.143 . . . . 74.32 107.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 70.45 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.42 107.07 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 75.05 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.53 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.14 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.35 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 60.03 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.31 106.623 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 73.33 106.697 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 72.13 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.02 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.22 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 378' ' ' PHE . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.21 111.264 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.14 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 64.25 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.34 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.01 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.24 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.34 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.41 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.564 HD22 HD22 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.54 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 74.13 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.51 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.564 HD22 HD22 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.33 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.35 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 71.21 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 74.55 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 75.02 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.14 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.33 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 72.23 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.14 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.3 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 -177.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.53 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.424 ' HG3' ' HE3' ' A' ' 401' ' ' LYS . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 62.43 111.044 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 72.34 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 38.23 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.35 106.726 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 62.01 113.656 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.12 108.991 -176.706 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 121.473 0.654 . . . . 74.53 111.899 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 73.32 108.275 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.33 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.41 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 74.31 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 73.41 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 74.43 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.41 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.02 114.325 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.42 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 70.04 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.41 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.41 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 71.14 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 74.32 107.48 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 74.35 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 73.22 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.31 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 73.34 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.51 109.687 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.54 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.34 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 75.31 109.2 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 73.15 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 74.41 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.42 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.31 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 60.14 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 73.53 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.51 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 64.34 110.177 175.326 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.649 0.261 . . . . 74.23 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -107.33 132.62 52.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.404 -0.591 . . . . 73.41 109.404 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -75.38 140.08 42.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.872 0.367 . . . . 75.42 110.107 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 12.3 tt -94.21 131.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.439 -0.578 . . . . 73.33 109.439 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HB3' ' OE2' ' A' ' 380' ' ' GLU . 64.7 pttt -96.85 156.26 16.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.868 -0.733 . . . . 74.54 111.631 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -83.49 -120.8 0.76 Allowed Glycine 0 N--CA 1.423 -2.187 0 CA-C-N 115.46 -0.791 . . . . 72.25 112.285 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -14.15 15.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 112.57 0.581 . . . . 74.11 112.57 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 63.3 92.98 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.527 0.68 . . . . 71.13 111.275 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 9.8 m -100.62 129.12 46.5 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.035 -1.469 . . . . 74.44 107.035 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.42 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.14 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.02 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.625 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 75.04 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.21 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.13 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.31 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.625 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.54 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.15 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 73.24 109.037 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.55 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.15 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.483 ' OE2' ' HB3' ' A' ' 361' ' ' LYS . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.12 112.399 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 71.24 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.21 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 75.03 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.494 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.2 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.43 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.12 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 70.43 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.494 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.05 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 74.41 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 72.34 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.41 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.641 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.53 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 72.0 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.52 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 65.44 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 74.01 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 71.22 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.44 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.406 HD22 ' HB2' ' A' ' 448' ' ' ALA . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 71.21 108.324 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.54 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 71.34 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.564 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.52 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.641 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.51 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 404' ' ' ASN . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.31 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 403' ' ' GLU . 50.9 m-80 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 64.21 111.335 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.22 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 64.31 106.326 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.14 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 410' ' ' ASN . 43.4 t -94.65 -21.71 18.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.41 110.217 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.27 -36.37 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.232 1.413 . . . . 62.35 112.687 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 408' ' ' CYS . 38.0 m-80 -101.46 10.03 40.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.653 0.74 . . . . 72.43 109.736 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -171.61 -153.19 8.88 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.562 -1.015 . . . . 60.31 110.562 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.8 -162.24 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.593 2.195 . . . . 73.42 110.779 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -57.4 142.39 43.96 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.267 -0.424 . . . . 72.22 110.55 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -71.1 156.39 39.65 Favored 'General case' 0 C--O 1.267 1.989 0 C-N-CA 119.464 -0.894 . . . . 73.11 108.661 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.33 108.397 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 73.43 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 72.32 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.425 HG11 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.3 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.44 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.425 ' H ' HG11 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.42 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.35 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.21 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 74.4 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 64.14 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 73.5 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.446 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 72.41 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 72.4 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.4 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.44 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.55 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 74.21 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 49.3 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.34 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 70.23 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.05 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 75.13 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.43 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.21 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.446 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 72.03 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.32 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.22 -27.89 48.26 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.45 111.645 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.28 -10.67 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.822 -0.627 . . . . 74.43 110.918 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' A' ' 398' ' ' ASN . . . -83.86 -24.44 30.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.124 -0.489 . . . . 63.12 110.915 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 55.5 m -67.86 132.56 47.6 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 109.801 -0.444 . . . . 65.54 109.801 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.411 -0.959 . . . . 65.55 108.411 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.49 ' HA ' ' CD ' ' A' ' 380' ' ' GLU . 79.2 m-85 . . . . . 0 CA--C 1.501 -0.935 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -90.85 89.67 7.58 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.13 -0.941 . . . . 70.2 113.084 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 66.19 -72.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.119 1.367 . . . . 61.12 113.08 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.26 115.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.583 -0.895 . . . . 73.55 108.583 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.48 ' HD2' ' O ' ' A' ' 361' ' ' LYS . 1.8 pptp? -123.82 130.97 53.45 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.235 -0.586 . . . . 74.54 109.728 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.5 -87.97 1.95 Allowed Glycine 0 C--N 1.294 -1.762 0 C-N-CA 120.041 -1.076 . . . . 55.35 111.905 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.475 ' HB2' HG13 ' A' ' 377' ' ' VAL . 50.8 ttm 60.04 81.38 0.18 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.866 0.866 . . . . 72.1 110.873 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.18 -38.39 0.11 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.385 -0.969 . . . . 72.14 108.385 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.4 m -90.56 124.96 35.44 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 118.845 -1.142 . . . . 74.0 111.398 -170.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.11 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.32 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 65.32 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 74.34 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.4 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.55 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 75.4 111.241 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 61.53 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.562 ' CE2' HD12 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.41 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 65.33 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.494 HG23 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 74.44 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 363' ' ' MET . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.22 110.67 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.51 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.11 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 357' ' ' TYR . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.43 109.829 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.11 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.11 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.478 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 74.01 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.32 109.524 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.41 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.13 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.44 109.822 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.42 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.562 HD12 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.34 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.03 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 72.0 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.35 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.3 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.11 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.3 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 75.52 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 71.34 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.12 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.55 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 74.21 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.54 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.3 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 74.52 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 63.3 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.41 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.03 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.33 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.401 ' HA ' ' NH2' ' A' ' 414' ' ' ARG . 28.5 p -106.18 -16.86 14.48 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.11 110.595 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 62.81 23.67 14.11 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.513 0.725 . . . . 75.31 111.528 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.444 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 23.8 t-20 -128.84 -54.02 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.765 -0.652 . . . . 75.13 109.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.87 -156.11 10.03 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 109.199 -1.56 . . . . 63.23 109.199 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.19 -68.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.597 2.198 . . . . 53.13 112.173 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -143.98 157.62 44.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.997 -1.112 . . . . 73.11 107.997 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.401 ' NH2' ' HA ' ' A' ' 408' ' ' CYS . 45.0 ttm105 -71.16 147.26 48.52 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.12 109.178 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.54 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.43 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 74.35 109.797 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 401' ' ' LYS . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.31 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.44 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 74.3 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 73.3 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.23 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.462 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 74.23 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 37.37 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 75.13 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.32 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 51.04 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.42 107.429 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.55 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 74.01 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.22 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.52 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.34 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.42 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.33 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.21 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.546 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 72.44 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.02 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 74.14 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 74.54 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.11 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 72.3 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.51 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.72 -29.98 42.17 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 73.31 112.688 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.18 -18.35 63.19 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.215 0.531 . . . . 73.43 111.152 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.29 65.31 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.669 -0.696 . . . . 72.32 111.676 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 65.6 m -68.34 -37.35 80.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.376 -0.53 . . . . 73.54 109.952 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 123.963 0.905 . . . . 71.4 112.167 177.637 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 109.488 -0.56 . . . . 75.44 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -154.04 155.8 36.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.022 -1.473 . . . . 71.3 107.022 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.71 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.254 0.346 . . . . 70.34 110.616 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.84 116.35 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.353 -0.98 . . . . 72.44 108.353 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.5 121.52 30.04 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.458 -0.792 . . . . 71.14 110.784 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -103.79 64.69 0.36 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.615 -0.802 . . . . 43.11 111.38 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 24.5 ptm -84.27 37.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.045 0.938 . . . . 72.21 111.213 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -20.52 39.33 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.262 1.208 . . . . 63.21 114.262 -170.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 6.1 m -122.21 135.24 54.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 118.456 -1.297 . . . . 71.13 111.56 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 72.24 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 73.51 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.43 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 74.15 110.305 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 62.22 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.53 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 75.43 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 72.14 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.66 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.42 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 75.41 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.22 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 363' ' ' MET . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 74.21 106.992 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.4 112.836 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.32 112.254 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.23 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.441 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.12 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.1 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 62.33 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.1 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.1 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 73.31 110.75 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.52 HD11 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 74.22 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.446 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 75.22 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 36.51 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.11 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.11 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 74.53 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.43 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.42 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.22 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 73.25 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 74.53 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.43 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.589 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.12 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 401' ' ' LYS . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 74.23 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.411 ' HB3' ' CE ' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 75.45 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.3 m120 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.3 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.31 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.21 110.838 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.34 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.69 -34.06 34.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.21 109.544 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.17 -164.95 0.44 Allowed 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.83 -2.656 . . . . 75.3 103.83 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -76.68 82.59 3.32 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.799 -0.76 . . . . 72.42 109.868 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 164.08 -99.56 0.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.524 -0.762 . . . . 72.22 111.78 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.99 -178.5 4.43 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.186 1.924 . . . . 74.44 113.82 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -116.42 165.31 13.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.047 -0.979 . . . . 64.31 109.71 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -85.16 166.33 16.68 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.288 0.566 . . . . 75.02 111.488 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.02 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 74.34 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.24 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.33 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 448' ' ' ALA . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.13 108.789 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.55 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 449' ' ' CYS . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.31 112.971 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.4 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.42 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.23 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.456 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.22 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 70.35 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 74.22 107.889 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 74.35 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.12 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.44 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.04 109.289 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.21 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.41 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 64.22 108.181 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.11 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.41 107.427 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.443 HG23 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 75.13 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.24 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.13 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.11 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 65.24 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.43 -29.73 24.98 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 72.21 111.367 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.45 -11.54 58.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.323 0.583 . . . . 74.12 112.186 -175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.418 ' HB3' HG12 ' A' ' 420' ' ' VAL . . . -110.17 -1.72 17.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.673 0.749 . . . . 71.51 108.984 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 36.2 t -70.58 -32.84 70.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.664 -1.153 . . . . 73.31 110.661 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 108.982 -0.747 . . . . 70.21 108.982 179.034 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.948 -1.13 . . . . 63.21 107.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -52.45 2.82 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 104.936 -2.246 . . . . 74.13 104.936 170.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -124.61 157.11 36.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.092 -1.818 . . . . 71.03 106.092 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 10.9 tt -125.08 140.35 48.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 120.2 -0.6 . . . . 70.44 111.542 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -78.76 121.32 24.61 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.356 -0.979 . . . . 74.15 108.356 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.17 -66.98 1.6 Allowed Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.757 -0.735 . . . . 62.03 112.8 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.641 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 24.6 mmt -129.78 178.9 6.17 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.251 -1.389 . . . . 70.45 107.251 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.61 69.11 1.08 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 122.584 1.183 . . . . 74.14 109.178 166.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m -76.51 131.75 39.18 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 54.23 106.976 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 71.11 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 74.33 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.52 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 71.22 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 37.89 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.22 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.12 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 75.21 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 63.32 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 363' ' ' MET . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.43 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.548 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 72.14 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.548 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 74.14 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.14 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.2 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.0 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 74.24 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.45 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 60.12 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.431 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.35 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.12 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.494 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.35 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.12 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 72.2 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 64.03 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.24 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.42 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.12 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.34 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.45 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.22 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.44 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 75.4 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.694 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 73.15 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.43 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.45 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.21 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.42 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.33 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.92 -28.03 11.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.14 110.939 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . 71.15 135.08 0.04 OUTLIER 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.361 1.064 . . . . 64.52 109.218 -172.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 54.2 t30 74.74 -33.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.145 0.978 . . . . 71.1 110.612 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -117.47 104.12 1.14 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.878 -1.689 . . . . 74.53 108.878 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.79 113.75 1.65 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 123.305 2.67 . . . . 73.4 112.62 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.0 m170 69.01 128.34 0.03 OUTLIER 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.502 1.521 . . . . 70.15 112.108 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -84.75 148.53 26.3 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.489 -2.041 . . . . 73.03 105.489 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.694 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.44 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 61.24 108.787 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 74.04 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.14 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.21 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 443' ' ' MET . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.22 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 73.02 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.42 114.339 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.22 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.14 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.1 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.4 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.42 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.42 108.103 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.45 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.52 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.496 HG13 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 73.42 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.31 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.33 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 74.43 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.3 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.2 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 64.03 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.432 ' CD1' HD21 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.23 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 75.15 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 75.05 110.366 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 74.22 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.21 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 75.22 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.19 -23.81 20.72 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.52 111.006 174.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.86 63.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 73.01 112.386 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.423 ' HB1' HG12 ' A' ' 420' ' ' VAL . . . -104.94 -2.29 24.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.782 . . . . 74.34 109.189 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.22 93.41 6.49 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.955 -1.021 . . . . 64.05 109.28 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.797 -1.186 . . . . 75.33 107.797 179.184 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 112.361 0.504 . . . . 72.42 112.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.64 73.41 1.43 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.482 -1.673 . . . . 72.44 106.482 171.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 65.43 -173.5 0.18 Allowed 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.816 -1.083 . . . . 64.43 109.189 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.59 114.81 27.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.091 -1.044 . . . . 74.4 110.344 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.39 137.68 51.52 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.516 -1.22 . . . . 73.24 107.74 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.34 -58.36 1.02 Allowed Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 119.41 -1.376 . . . . 54.32 110.742 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 57.1 mtm -143.58 169.98 16.69 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.034 -2.21 . . . . 62.31 105.034 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -136.13 75.18 1.53 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.217 1.008 . . . . 73.14 108.901 170.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m -76.32 121.42 22.96 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.42 107.621 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.21 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.413 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.32 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.4 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.505 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 75.32 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.42 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.24 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.31 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.23 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.43 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.21 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 74.25 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 363' ' ' MET . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 72.31 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.35 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.34 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.458 ' OE1' HG13 ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.22 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.33 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 74.01 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.44 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.472 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 74.32 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 74.44 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.472 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 72.15 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.52 HD23 HD22 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 74.22 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 61.5 109.907 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.42 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 64.13 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.42 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 75.02 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.22 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.35 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 75.45 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.41 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 448' ' ' ALA . 63.9 t30 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.42 109.106 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 75.41 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.34 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.532 ' CE ' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.43 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 64.34 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 65.43 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.34 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.12 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.21 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.64 -45.07 31.45 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.21 110.409 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.67 124.33 0.67 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.901 -1.148 . . . . 73.11 107.901 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.84 -49.25 0.67 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.132 0.973 . . . . 64.43 113.31 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -159.43 -61.18 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.922 -0.932 . . . . 71.43 114.413 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -44.94 147.44 1.96 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.02 3.147 . . . . 71.14 115.414 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -69.48 146.05 52.24 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.854 1.428 . . . . 64.51 114.854 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -91.09 165.02 13.73 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 162.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.44 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 72.24 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.14 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 75.4 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.2 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 75.51 109.275 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.13 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.23 111.157 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.44 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 54.32 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.23 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.12 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 64.24 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.31 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 64.53 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.13 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.13 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.02 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.41 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 45.3 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.4 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.42 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.04 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.02 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.43 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 64.42 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 64.42 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.41 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.489 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 75.12 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.32 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.34 108.667 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -28.86 51.74 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 75.34 111.211 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.75 -5.24 47.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.38 -0.827 . . . . 73.43 111.665 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.446 ' HB3' HD22 ' A' ' 398' ' ' ASN . . . -84.65 -31.15 24.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.273 -0.422 . . . . 60.02 111.822 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 66.5 m -67.46 85.45 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.624 0.726 . . . . 51.41 112.262 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 107.359 -1.349 . . . . 71.42 107.359 177.863 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.065 -0.346 . . . . 74.34 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -55.38 -56.36 21.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.515 0.561 . . . . 75.22 112.515 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -115.25 156.95 24.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.095 -0.502 . . . . 74.11 111.798 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 11.1 tt -83.24 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -117.23 147.94 42.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.955 0.407 . . . . 74.34 111.444 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -120.18 -145.21 7.36 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 120.815 -0.707 . . . . 73.22 113.205 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.477 ' HE2' ' HA ' ' A' ' 363' ' ' MET . 10.8 mmt -66.88 153.37 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.799 0.84 . . . . 74.51 111.888 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.56 99.24 7.02 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.077 -1.082 . . . . 75.42 108.077 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.431 -0.508 . . . . 71.41 109.944 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 75.32 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.24 106.104 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.54 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 75.02 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.42 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.15 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.45 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.31 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.11 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.41 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.44 108.767 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.521 HG12 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.01 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.51 110.192 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 73.05 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.521 ' OE2' HG12 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.35 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.581 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 74.54 112.13 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.51 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.51 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.03 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.54 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.45 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.408 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.03 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.14 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.43 110.276 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.417 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.11 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.33 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 75.54 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 72.32 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.35 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 74.35 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.45 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 38.67 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 71.11 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.35 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 73.21 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.507 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.44 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.05 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.32 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.21 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.23 108.382 -177.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.21 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t -89.26 -35.51 16.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.44 109.08 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -138.53 -87.02 0.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.448 -0.575 . . . . 75.25 109.448 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -139.62 -2.3 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.444 -0.502 . . . . 75.21 111.699 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.4 -84.45 0.56 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.062 -0.815 . . . . 53.41 111.062 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.58 158.18 38.15 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 122.504 2.136 . . . . 55.25 112.949 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -106.97 170.34 8.01 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.719 -1.128 . . . . 71.3 109.105 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -85.3 168.01 15.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.412 -0.588 . . . . 74.41 109.412 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.43 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 74.41 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 64.35 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 72.12 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.52 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.41 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.478 ' H ' HG11 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 74.22 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.32 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.3 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 73.15 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.01 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.15 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 71.03 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.41 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 75.24 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 73.24 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 73.5 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.11 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.51 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.479 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 74.13 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.13 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.44 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.42 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.23 112.126 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 62.35 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 72.53 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.14 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.463 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.24 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.32 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.98 -28.84 23.7 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.05 111.97 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.28 -11.08 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.825 -0.625 . . . . 71.11 111.244 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -76.52 -35.83 58.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.653 -0.703 . . . . 71.22 111.257 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 59.5 m -64.64 98.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.216 0.531 . . . . 64.35 110.923 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.411 -2.389 0 N-CA-C 106.709 -1.589 . . . . 72.41 106.709 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 121.163 0.506 . . . . 70.3 112.34 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.55 -13.65 15.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.432 -0.951 . . . . 74.02 108.432 168.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -148.95 -172.82 4.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.93 -1.032 . . . . 62.42 108.606 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 69.2 mt -105.45 130.72 56.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.121 -1.066 . . . . 72.24 108.121 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.87 134.66 33.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.903 -1.119 . . . . 74.31 109.877 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -88.13 -115.71 1.24 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.721 -0.752 . . . . 74.33 111.398 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -107.67 155.99 19.56 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.239 -1.023 . . . . 72.01 108.239 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 376' ' ' VAL . 10.5 pt-20 -120.18 95.03 4.58 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.712 0.768 . . . . 74.35 111.219 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 20.4 m -79.7 140.7 36.91 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.129 -1.434 . . . . 73.14 107.129 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.54 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.01 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.42 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.15 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.21 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.41 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.55 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.1 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.23 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.51 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 364' ' ' GLU . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 72.03 109.208 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 74.35 107.297 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.484 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.22 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 72.24 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.54 111.676 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.542 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.32 112.076 -176.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.33 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.23 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 71.2 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.4 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 74.43 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 391' ' ' ASN . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 73.13 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.402 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.11 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 52.45 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 64.25 110.077 -177.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.54 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 62.15 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.45 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 71.23 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.2 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.41 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.53 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 74.12 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.01 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.483 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 74.43 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.31 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.05 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.01 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.03 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.54 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.35 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 412' ' ' PRO . 41.3 t -77.51 -26.07 50.87 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.31 110.84 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.11 -42.84 0.53 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.054 . . . . 72.53 112.626 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.58 -32.96 74.83 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.183 -0.673 . . . . 72.33 109.183 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.93 -137.53 3.17 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.196 -1.561 . . . . 75.43 109.196 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.581 ' O ' ' HB3' ' A' ' 408' ' ' CYS . 8.1 Cg_exo -75.67 -161.67 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.51 2.14 . . . . 74.42 110.561 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -70.99 149.25 46.84 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.662 -0.649 . . . . 75.44 109.277 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -64.2 154.73 33.98 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.53 109.018 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.483 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.11 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 62.43 110.048 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 440' ' ' LEU . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.01 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 75.31 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 74.43 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.11 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.33 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 448' ' ' ALA . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.21 112.536 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 71.15 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 65.24 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.23 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 70.41 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 72.4 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.48 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.53 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 74.3 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.42 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.13 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.32 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.4 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.42 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 73.45 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.15 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.22 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.33 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 64.14 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 74.2 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 74.44 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 73.15 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.15 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.07 -26.55 50.4 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 74.0 111.046 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.42 62.41 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.254 -0.884 . . . . 72.44 110.958 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 422' ' ' CYS . . . -76.22 -21.77 56.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.078 -0.51 . . . . 65.22 111.029 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.75 -23.84 52.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.158 -0.473 . . . . 37.44 111.463 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 118.498 -0.763 . . . . 74.22 110.382 179.599 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 51.2 t80 . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.683 -1.229 . . . . 72.11 107.683 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.47 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 1.1 tpm_? 67.74 15.0 9.62 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.568 0.699 . . . . 74.05 111.131 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -96.91 117.13 30.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.8 -0.563 . . . . 64.33 110.487 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 6.5 tt -88.73 128.18 41.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.018 -0.537 . . . . 72.12 109.983 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.465 ' HG3' ' CG ' ' A' ' 380' ' ' GLU . 2.9 mppt? -93.69 121.06 34.73 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.505 -0.316 . . . . 73.34 110.813 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.552 ' O ' HG11 ' A' ' 377' ' ' VAL . . . -121.99 -146.89 7.43 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.772 -1.204 . . . . 65.25 111.874 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 24.7 ptt? 177.95 38.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.504 -2.036 . . . . 71.33 105.504 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.51 -46.11 73.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.657 -2.065 . . . . 73.43 113.384 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m -122.44 143.33 49.75 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.647 -0.821 . . . . 72.21 110.997 -176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.22 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 75.43 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.33 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.557 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 72.31 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.01 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 52.45 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.23 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 74.44 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.649 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.41 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 72.42 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 73.42 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 362' ' ' GLY . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.21 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 63.14 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.52 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.465 ' CG ' ' HG3' ' A' ' 361' ' ' LYS . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.22 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.42 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 75.41 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 74.43 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.474 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.8 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.45 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.44 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.24 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.474 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.4 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.44 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 74.44 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.53 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.3 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 73.34 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.13 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.41 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.404 ' HB3' HD11 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.53 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 71.34 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.45 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 448' ' ' ALA . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 75.41 110.928 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.42 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 395' ' ' GLN . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 61.1 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 74.14 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.52 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.33 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.44 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 73.34 106.498 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.44 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t -97.47 -19.97 18.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 72.03 110.269 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 71.29 -37.86 0.4 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.945 1.298 . . . . 53.31 112.699 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -72.8 -55.35 6.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.202 0.601 . . . . 53.54 109.926 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.2 172.1 26.3 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 110.26 -1.136 . . . . 42.03 110.26 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.93 -56.69 2.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 122.646 2.231 . . . . 74.45 111.433 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -136.38 157.74 46.08 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.464 -1.68 . . . . 75.42 106.464 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 -85.37 145.83 27.29 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.596 -1.631 . . . . 74.44 106.596 171.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.21 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 74.34 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 73.41 110.566 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 74.03 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 448' ' ' ALA . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.43 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.35 111.771 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.42 ' H ' HG11 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.24 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.34 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 72.32 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.54 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.24 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.34 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.44 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.21 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.11 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.22 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 75.44 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.25 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.1 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.14 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.505 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.45 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 75.21 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 75.22 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.14 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.43 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.412 HG21 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.14 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 71.04 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 73.54 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.33 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.42 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.32 -25.71 15.27 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.45 111.294 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.25 61.01 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.59 -0.732 . . . . 63.2 111.531 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 420' ' ' VAL . . . -107.43 -2.3 20.65 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.571 -0.9 . . . . 60.3 108.571 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.5 t -72.74 -30.5 64.22 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.118 -1.067 . . . . 75.02 108.118 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.666 -1.605 . . . . 72.14 106.666 177.478 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 121.082 0.468 . . . . 74.43 110.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -172.91 177.44 2.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.927 -1.509 . . . . 74.53 106.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.87 149.6 47.68 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.128 0.489 . . . . 64.32 110.084 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 9.5 tt -117.2 139.45 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.08 120.42 26.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.077 -0.649 . . . . 73.31 110.455 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.32 -72.57 1.04 Allowed Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 107.941 -2.063 . . . . 55.44 107.941 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.62 81.09 0.14 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.042 1.337 . . . . 71.42 110.31 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.77 -27.04 6.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.474 -0.785 . . . . 70.12 111.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m -122.42 136.27 54.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.23 -0.988 . . . . 72.53 112.811 -172.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.13 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 75.24 109.571 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.42 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.21 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.55 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.24 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.42 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 431' ' ' VAL . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 75.21 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 73.33 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 74.31 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.421 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.12 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.41 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.22 110.544 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.575 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.22 111.438 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 73.23 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.04 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.45 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.33 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 74.13 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 75.41 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.485 HD23 HD22 ' A' ' 391' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 74.22 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.45 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.41 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.41 109.552 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.51 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 72.44 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.23 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.14 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.21 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.14 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.14 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 74.34 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 72.34 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 75.52 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.32 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 64.32 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.51 113.928 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.45 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 75.35 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.24 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.44 1.16 56.92 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.4 109.858 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . 73.37 108.03 0.07 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.183 1.393 . . . . 63.41 111.224 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 72.49 -34.3 0.29 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.639 1.175 . . . . 55.23 112.363 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -97.81 -143.34 14.7 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 112.237 -0.345 . . . . 63.5 112.237 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.41 -151.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.839 3.026 . . . . 51.24 112.731 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.37 159.36 24.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.474 -0.565 . . . . 73.32 109.474 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 -67.86 155.9 38.34 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.487 0.661 . . . . 71.1 111.615 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.435 ' HG ' ' C ' ' A' ' 414' ' ' ARG . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.13 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.4 109.527 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 71.04 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 74.43 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 65.41 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 75.11 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.43 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.427 ' H ' HG13 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 62.33 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.21 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.34 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 74.1 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.35 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.02 106.935 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.34 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 74.23 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 72.22 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 72.44 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.22 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.42 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 22.7 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.44 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 74.41 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 61.45 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 64.4 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.506 ' CD1' HD21 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 75.52 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 74.01 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.52 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.11 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.13 109.534 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 75.45 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 71.45 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.2 -29.81 55.36 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.45 111.461 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.12 -5.39 43.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.448 -0.796 . . . . 73.35 111.388 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -91.48 -14.66 30.07 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 120.76 0.315 . . . . 73.33 111.339 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.4 m -69.67 -4.67 20.54 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.212 0.449 . . . . 61.4 112.212 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.077 -0.712 . . . . 74.2 109.077 176.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.164 0.507 . . . . 72.4 110.092 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 115.56 17.9 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.571 -1.64 . . . . 74.41 106.571 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.12 153.4 19.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.563 -0.903 . . . . 61.42 108.563 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 8.9 tp -100.71 137.26 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.066 0.46 . . . . 75.34 110.982 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -79.73 139.53 37.29 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.509 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 379' ' ' TYR . . . -114.64 -98.7 2.25 Favored Glycine 0 N--CA 1.426 -2.012 0 C-N-CA 120.128 -1.034 . . . . 74.4 110.843 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 363' ' ' MET . 6.2 mmt -97.19 86.08 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.063 -1.088 . . . . 71.52 108.063 176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.36 106.64 13.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.008 -0.738 . . . . 73.24 109.008 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m -116.4 149.97 38.54 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.41 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 73.03 106.721 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.53 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 72.11 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.14 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 65.13 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 75.02 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 70.4 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.33 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.41 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.35 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.14 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 74.1 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.508 ' CD2' ' HA3' ' A' ' 362' ' ' GLY . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.23 111.253 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.24 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.55 110.857 -176.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.13 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.15 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.14 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 71.04 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 73.24 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.552 HD22 HD22 ' A' ' 391' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.54 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.23 109.253 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.13 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.9 m-80 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 73.11 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 72.32 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.15 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 75.4 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.14 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.44 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.32 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.31 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.429 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.4 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 75.43 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 74.21 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.13 110.308 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.14 111.197 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.405 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 73.35 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.31 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t -72.87 -18.57 61.42 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.4 111.65 -175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.25 -52.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.499 1.12 . . . . 51.55 110.973 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -65.11 -35.64 81.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.942 -0.762 . . . . 73.42 108.942 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -131.31 -155.66 8.22 Favored Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.338 -1.505 . . . . 74.44 109.338 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.28 -153.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.917 2.411 . . . . 74.52 110.75 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -62.5 135.21 57.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.736 -1.209 . . . . 71.44 107.736 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 -78.08 172.74 13.08 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.621 -0.832 . . . . 72.45 112.416 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.45 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 72.24 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.4 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.35 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 448' ' ' ALA . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 73.42 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.33 111.351 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.475 ' H ' HG13 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.32 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.11 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 75.55 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.55 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.14 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.421 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.04 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.52 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 70.44 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 75.15 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 72.15 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.523 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 65.01 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 75.11 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.25 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 75.31 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.523 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 71.12 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.15 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.31 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 75.23 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 74.54 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.54 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.41 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 72.22 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 72.43 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.68 -25.41 34.07 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.13 111.296 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.51 -16.63 60.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.917 -0.583 . . . . 73.44 112.317 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 420' ' ' VAL . . . -116.67 -1.41 12.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.757 0.789 . . . . 75.21 109.03 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.5 t -73.35 115.67 12.98 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.275 -0.875 . . . . 72.44 109.179 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 107.655 -1.239 . . . . 74.44 107.655 177.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 109.573 -0.528 . . . . 73.54 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -110.81 120.11 41.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.237 -1.024 . . . . 72.35 108.237 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 60.44 -165.42 0.21 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.927 0.767 . . . . 64.23 110.225 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.578 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 66.4 mt -115.31 120.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.786 -1.19 . . . . 73.35 107.786 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -94.66 120.27 34.63 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.697 -0.853 . . . . 75.34 108.697 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -114.65 -67.31 0.45 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.538 -1.315 . . . . 71.24 113.035 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 52.6 mtm 68.22 81.84 0.18 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.696 -1.224 . . . . 71.31 107.696 -172.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -101.32 -59.98 1.6 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.034 0.753 . . . . 75.55 113.034 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m -121.79 150.88 41.24 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.385 -0.526 . . . . 74.54 110.806 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.52 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.23 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.22 109.633 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 75.01 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.51 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.54 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.31 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.45 111.757 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.14 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.54 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 71.51 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.522 HG12 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.01 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 75.4 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.578 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 73.13 110.678 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.522 ' OE2' HG12 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.52 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.11 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.24 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.513 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.4 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.41 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 75.22 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 74.33 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.513 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.43 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 62.01 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.584 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.55 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 74.53 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 74.44 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.31 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 71.15 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 65.43 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 64.3 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.33 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.54 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.31 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.14 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 74.3 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 75.45 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.411 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.4 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.24 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 74.52 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.44 108.448 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 73.31 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.407 ' HA ' ' NH2' ' A' ' 414' ' ' ARG . 42.3 t -112.95 -11.34 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.15 110.979 -173.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 66.72 13.77 9.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.569 1.148 . . . . 74.52 111.013 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -96.14 -41.33 8.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.412 -0.958 . . . . 74.1 108.412 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.16 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.924 -0.655 . . . . 65.23 111.55 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.0 -171.9 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.9 2.4 . . . . 75.11 112.153 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -83.63 144.44 29.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.517 -0.549 . . . . 71.24 109.517 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 408' ' ' CYS . 13.1 ttm180 -68.96 152.88 44.7 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.757 -0.656 . . . . 73.45 109.519 -174.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.02 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 73.55 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.414 ' CG2' HD21 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.42 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.467 HG21 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.42 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 74.34 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.2 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.45 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 74.25 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.14 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 75.1 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.52 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.02 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.13 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.456 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.43 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.21 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.24 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.12 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 74.22 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.04 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.32 109.674 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.44 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.32 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 73.31 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.533 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 74.41 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 74.22 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 73.2 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 74.35 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.34 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 74.41 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.51 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.73 -28.96 51.51 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.33 111.567 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.08 62.24 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.911 -0.586 . . . . 70.13 111.313 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -74.87 -30.63 61.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.987 -0.552 . . . . 74.32 111.635 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.92 104.69 0.21 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.45 0.643 . . . . 63.23 110.483 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.416 -2.139 0 CA-C-N 114.905 -1.043 . . . . 74.12 110.295 -175.727 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.739 -0.837 . . . . 71.11 108.739 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 65.64 103.3 0.04 OUTLIER 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.892 1.277 . . . . 71.11 112.315 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.429 ' HB3' ' HG2' ' A' ' 380' ' ' GLU . . . -88.87 -165.14 1.26 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.751 -0.658 . . . . 65.43 109.474 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.0 mp -82.68 124.54 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.551 -0.537 . . . . 71.32 109.551 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.61 120.74 30.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.628 -1.249 . . . . 74.13 107.628 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -96.85 -83.09 1.66 Allowed Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 110.272 -1.131 . . . . 73.41 110.272 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 1.9 mpt? -122.86 175.13 6.72 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.083 -1.081 . . . . 73.41 108.083 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.88 97.18 3.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.706 -0.85 . . . . 74.04 108.706 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m -97.43 134.96 39.99 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.131 -1.433 . . . . 72.14 107.131 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.01 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 74.53 107.718 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.33 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.511 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 65.43 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.3 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 74.12 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 71.03 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 73.33 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.05 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 74.23 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 363' ' ' MET . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.31 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.13 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.12 112.089 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.34 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.488 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 72.13 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 73.02 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.31 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.33 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.24 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.5 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.45 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.487 HD21 HD22 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.13 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 75.51 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.21 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 65.43 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.33 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 64.54 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.22 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.35 105.057 174.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.54 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 65.34 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.22 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.32 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 72.43 110.541 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 75.23 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.21 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.54 110.684 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.32 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 38.29 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 72.31 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.1 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t -69.54 -39.09 77.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.43 109.538 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -164.64 -66.28 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.392 -1.336 . . . . 60.44 107.392 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.5 98.72 1.13 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.72 0.771 . . . . 73.52 109.52 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.14 -79.88 0.33 Allowed Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.354 -1.098 . . . . 62.41 110.354 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.19 147.69 26.96 Favored 'Trans proline' 0 C--O 1.256 1.392 0 C-N-CA 122.755 2.303 . . . . 64.35 112.735 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.39 128.51 55.57 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.488 -1.233 . . . . 73.44 110.149 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.412 ' C ' ' HG ' ' A' ' 415' ' ' SER . 69.7 mtt180 -68.05 152.75 45.03 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 74.12 111.611 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.434 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.42 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.32 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.34 109.139 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 73.31 110.173 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 72.42 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.476 HG11 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 74.41 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.31 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.476 ' H ' HG11 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 72.33 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 38.29 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 73.3 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 74.12 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 74.44 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.14 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.498 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.42 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 73.35 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.41 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.31 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.41 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.05 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.23 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.466 ' OE1' HD23 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 74.33 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.521 ' HZ2' ' CD ' ' A' ' 438' ' ' GLU . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 75.43 116.377 -177.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.453 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.51 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.521 ' CD ' ' HZ2' ' A' ' 436' ' ' LYS . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.24 109.114 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 71.13 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.42 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 61.22 106.856 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.31 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.498 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.43 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.34 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.14 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.2 -28.86 47.74 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 74.31 111.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.56 -12.59 61.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.56 -0.746 . . . . 71.21 111.457 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -86.79 -15.62 38.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.482 -0.326 . . . . 71.5 111.353 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 31.2 m -70.64 90.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.456 0.646 . . . . 72.23 111.378 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.128 -1.434 . . . . 70.12 107.128 177.43 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.783 -0.821 . . . . 72.01 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 65.67 90.1 0.09 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.671 0.788 . . . . 63.44 112.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -176.91 158.66 1.62 Allowed 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.809 -1.552 . . . . 61.4 106.809 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 35.4 pt -85.86 127.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.944 -0.702 . . . . 73.13 109.776 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 55.3 pttt -123.02 150.35 43.16 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 119.253 -0.979 . . . . 72.23 109.405 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -90.55 -72.56 1.25 Allowed Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 108.631 -1.788 . . . . 73.43 108.631 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.3 tpp -165.37 130.75 2.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.382 -1.71 . . . . 74.43 106.382 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.35 95.69 4.46 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.3 -0.96 . . . . 75.51 111.403 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m -74.59 134.62 42.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.44 107.477 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 71.25 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 75.24 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.23 112.018 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.457 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.53 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 74.33 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.05 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.1 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 74.15 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 75.01 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.22 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 74.24 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 73.11 110.21 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 72.41 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 70.44 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.55 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 73.43 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.23 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.451 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.43 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 75.24 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.53 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.451 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.45 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.492 HD21 HD22 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 75.43 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 74.13 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 75.3 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 74.01 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.1 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.44 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 73.1 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 75.12 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 71.12 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.21 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.21 109.047 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.1 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 51.21 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.3 107.557 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 65.21 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 64.02 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 65.15 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.42 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.41 111.23 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.12 -26.51 18.24 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.03 108.962 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . -167.19 -170.12 1.42 Allowed 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.095 -2.187 . . . . 72.5 105.095 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -77.86 22.72 0.27 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.526 0.679 . . . . 74.41 110.072 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -139.12 -79.56 0.07 OUTLIER Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 111.798 -0.521 . . . . 51.22 111.798 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -71.32 148.86 56.02 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.985 1.79 . . . . 75.04 113.94 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.9 2.57 32.7 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.07 -1.423 . . . . 70.23 110.685 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 75.32 150.51 0.11 Allowed 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.712 1.205 . . . . 64.31 110.576 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.24 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.34 107.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.409 ' CG2' HD21 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.14 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.43 110.199 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 75.51 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.456 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.14 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.44 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 75.32 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.11 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.23 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.55 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 74.31 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 75.1 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.03 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 72.44 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.31 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.546 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.34 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.24 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.441 HE21 HD23 ' A' ' 440' ' ' LEU . 48.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.35 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.31 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.546 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 74.22 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 73.42 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 74.54 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.43 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.41 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 70.34 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.41 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.1 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.31 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.74 -28.08 44.08 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.11 112.051 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.95 -16.07 62.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.792 -0.64 . . . . 65.54 111.141 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -77.05 -29.29 55.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.069 -0.514 . . . . 70.12 111.319 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 51.9 m -61.64 102.81 0.28 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.185 0.517 . . . . 61.22 111.643 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.419 -1.997 0 N-CA-C 107.151 -1.425 . . . . 62.31 107.151 178.242 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 359' ' ' ALA . 78.8 m-85 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.824 0.345 . . . . 74.52 111.78 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -80.37 -24.28 39.89 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.853 -0.795 . . . . 75.2 108.853 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 357' ' ' TYR . . . -143.05 -166.18 2.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.26 -1.385 . . . . 70.32 107.26 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.71 136.62 51.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.511 -0.552 . . . . 75.54 109.511 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.8 135.15 36.41 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.831 -0.804 . . . . 74.25 108.831 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.63 -106.8 3.15 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.673 -1.251 . . . . 72.54 112.17 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -90.79 108.84 20.09 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.0 -0.741 . . . . 72.54 109.0 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.19 93.81 6.45 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.978 -0.749 . . . . 75.24 108.978 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m -103.49 141.37 36.11 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.686 -1.228 . . . . 75.13 107.686 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 75.55 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.14 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.21 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 71.45 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 74.33 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.11 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.21 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.3 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.21 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.14 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.53 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 74.11 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 72.33 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.32 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.31 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 63.22 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.14 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.54 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.491 ' CD ' HD22 ' A' ' 389' ' ' LEU . 10.4 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 74.41 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.31 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.42 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 73.22 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.508 HD23 HD22 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.14 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.491 HD22 ' CD ' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.23 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.495 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 37.67 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.34 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.04 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 54.45 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.52 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.445 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.04 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 73.03 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 61.22 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.15 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.14 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 74.44 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.42 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.42 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.41 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 74.41 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.43 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.32 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 75.51 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.55 -16.45 27.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.2 111.145 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.54 73.42 0.48 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.528 -0.916 . . . . 74.54 108.528 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -169.88 -43.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.292 -1.322 . . . . 74.43 108.236 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.96 -73.87 0.27 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.656 -0.783 . . . . 61.31 111.71 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.79 179.48 3.68 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.432 2.088 . . . . 74.41 112.368 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -87.22 145.64 26.31 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.725 -0.843 . . . . 74.22 108.725 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 -75.82 145.84 40.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.08 -0.711 . . . . 75.21 109.08 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.41 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 37.67 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.443 HD11 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 64.12 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 65.35 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 73.52 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.04 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.15 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.458 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.51 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.14 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.22 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.45 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.8 OUTLIER -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.24 109.468 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.12 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 74.35 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.33 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 73.24 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 73.12 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.21 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.15 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 75.32 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.51 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 74.2 115.915 -178.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.13 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.13 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 433' ' ' GLU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.44 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 73.31 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 73.12 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.22 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.15 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.42 108.587 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.49 -27.8 46.24 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 75.35 112.109 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.33 64.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.817 -0.629 . . . . 64.24 111.492 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -73.54 -28.15 61.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.766 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 33.2 m -64.96 108.68 1.86 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.23 0.538 . . . . 64.54 111.073 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.424 -1.764 0 N-CA-C 107.361 -1.348 . . . . 73.0 107.361 176.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.485 -0.561 . . . . 71.2 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -86.76 110.41 19.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 106.499 -1.667 . . . . 65.04 106.499 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.4 -168.9 2.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 110.224 -0.287 . . . . 71.44 110.224 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.54 129.44 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.812 -1.551 . . . . 74.12 106.812 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -121.66 121.39 37.25 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.172 -1.011 . . . . 73.42 112.971 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -116.09 65.37 0.32 Allowed Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.639 -1.384 . . . . 63.32 109.639 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 60.5 ttp -93.0 107.3 19.11 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.008 0.523 . . . . 74.1 110.274 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -147.49 -7.55 0.45 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.685 -0.806 . . . . 71.34 110.598 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m -121.78 133.43 54.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.466 -1.293 . . . . 74.11 111.646 -174.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 71.12 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 72.43 106.677 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 74.5 111.768 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.01 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.53 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 73.52 110.976 -171.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 74.13 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 73.22 107.487 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.13 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 75.04 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.23 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.24 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.498 ' OE1' HG13 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.4 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.535 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.45 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.23 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.14 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.23 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.42 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 74.1 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 74.44 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.21 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.44 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 52.04 112.048 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 71.34 108.532 -178.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 73.51 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 61.41 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.51 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.34 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.33 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.3 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.43 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 74.13 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 62.54 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.52 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.42 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 70.22 114.052 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.33 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 60.0 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -124.35 0.15 8.29 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 72.21 111.673 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.11 70.77 0.62 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.955 0.883 . . . . 75.02 109.87 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -153.25 -47.88 0.1 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.518 -1.219 . . . . 72.55 108.921 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.6 -80.24 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.949 -1.26 . . . . 64.4 109.949 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.88 -166.25 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.492 2.128 . . . . 70.33 111.241 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -88.65 165.52 14.72 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.119 -0.491 . . . . 74.53 110.058 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -76.03 159.57 30.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 71.44 109.251 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.31 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.22 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.34 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.04 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 75.11 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.5 HG11 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 64.42 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 74.41 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.5 ' H ' HG11 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.2 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.04 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.01 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.34 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 74.23 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.31 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 71.31 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.23 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 72.04 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.35 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 74.53 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 62.03 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.32 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 75.41 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 72.21 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.444 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.42 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 74.55 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.35 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.33 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.42 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.15 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.48 -28.99 45.43 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.737 -0.665 . . . . 75.12 111.862 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.81 58.36 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.342 -0.39 . . . . 72.21 111.426 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.94 109.83 1.18 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 54.33 111.34 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.617 -0.883 . . . . 75.04 108.617 177.001 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 120.594 0.235 . . . . 71.51 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -130.25 73.99 1.57 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.3 -1.0 . . . . 74.22 108.3 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -170.59 113.6 0.44 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.741 0.305 . . . . 75.22 111.484 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 70.9 mt -82.37 120.02 33.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.128 -1.434 . . . . 75.43 107.128 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.56 ' HD2' ' OE2' ' A' ' 380' ' ' GLU . 20.5 pttp -79.27 136.93 37.18 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.845 -0.342 . . . . 73.44 110.687 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.71 -78.67 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.482 -0.866 . . . . 55.23 112.851 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.501 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 12.2 tmm? 67.39 97.48 0.06 Allowed 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.689 1.196 . . . . 72.5 109.194 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.03 -35.15 0.33 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.656 -0.702 . . . . 70.43 110.586 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.432 HG21 HG13 ' A' ' 428' ' ' ILE . 3.7 m -95.17 132.79 39.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.477 -0.889 . . . . 73.42 110.809 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.12 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.42 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.45 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.442 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.34 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 44.22 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 70.1 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 73.32 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.14 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.696 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.43 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.55 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.497 HG23 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 72.43 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.544 HG12 ' OE2' ' A' ' 380' ' ' GLU . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 74.42 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.55 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.33 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 361' ' ' LYS . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 54.24 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.566 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 70.53 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.03 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.24 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.5 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.22 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.11 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.04 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 74.34 110.57 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.51 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 72.31 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.468 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.04 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.43 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.41 111.208 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 71.2 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.34 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.44 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 72.44 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.22 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.23 108.588 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.2 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.33 108.779 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.44 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.34 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 74.32 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.44 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.45 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.14 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.05 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 70.23 106.442 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.34 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.12 -44.96 8.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.53 110.129 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -156.64 -83.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.49 -0.323 . . . . 74.52 110.487 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -146.38 12.06 1.18 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.206 0.527 . . . . 61.45 110.694 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.55 -120.73 2.27 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.148 -1.181 . . . . 63.24 110.148 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.79 167.69 13.27 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.203 1.935 . . . . 62.43 111.986 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -94.17 -175.21 3.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.546 -0.909 . . . . 73.13 108.546 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -83.04 152.25 25.46 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.281 -0.637 . . . . 75.2 109.281 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.14 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.54 109.513 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.45 HG21 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.42 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.34 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.11 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 74.34 109.642 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.31 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.54 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.22 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.23 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 71.54 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.13 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 74.0 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.34 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.44 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.4 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.437 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.21 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 74.41 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 71.01 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.437 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.11 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 75.33 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.426 HG23 ' HG3' ' A' ' 443' ' ' MET . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.45 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.52 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 376' ' ' VAL . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 72.12 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 63.04 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 73.52 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.85 -27.36 43.82 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.53 110.434 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.11 -15.81 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 53.3 110.804 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -72.69 -40.98 65.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.624 -0.716 . . . . 75.45 110.598 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.46 110.61 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.141 -0.689 . . . . 64.33 109.141 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.415 -2.184 0 N-CA-C 108.765 -0.828 . . . . 63.12 108.765 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 109.579 -0.526 . . . . 74.4 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -88.13 82.97 7.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.11 0.957 . . . . 63.1 111.594 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -145.68 140.67 27.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.521 -1.659 . . . . 53.33 106.521 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.595 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.4 mp -83.2 123.88 39.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.075 0.464 . . . . 75.11 110.179 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.75 121.97 42.57 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 73.41 108.914 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -110.17 50.77 0.75 Allowed Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.913 -0.66 . . . . 53.22 112.941 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.493 ' HE3' ' N ' ' A' ' 363' ' ' MET . 0.0 OUTLIER 70.9 100.49 0.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.237 1.015 . . . . 75.01 110.535 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.11 95.42 0.4 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.814 0.816 . . . . 71.2 110.714 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m -85.77 127.68 34.61 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.43 107.51 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.12 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.421 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 74.34 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 72.25 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 74.31 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.24 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 51.14 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 53.22 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.35 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 70.42 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.44 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 74.55 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.494 HG11 ' OE2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 72.3 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.5 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.12 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.01 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.494 ' OE2' HG11 ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.2 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.34 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.44 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.13 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.52 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.33 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.1 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 71.14 110.892 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.469 HD21 HD22 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.43 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.41 HD21 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.43 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 75.22 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 73.3 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.34 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.21 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.23 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.53 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.24 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 448' ' ' ALA . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.11 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.2 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.496 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.14 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.24 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.44 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.529 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.23 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.32 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 70.15 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.11 110.2 174.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.79 -45.01 25.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.42 109.546 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -159.78 93.67 1.1 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.749 -1.114 . . . . 73.23 107.994 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 69.85 -49.25 0.63 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.758 1.223 . . . . 71.13 114.134 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -113.98 -97.58 2.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.476 -0.869 . . . . 65.34 114.124 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -49.95 155.98 3.82 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.522 2.815 . . . . 73.44 113.731 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 22.6 m-70 -96.28 159.44 14.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.181 -0.918 . . . . 73.05 110.934 -171.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -78.55 163.06 25.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.056 -0.975 . . . . 73.52 109.437 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 71.42 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.11 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 73.24 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.3 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.33 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.417 ' CG ' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.43 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.23 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.31 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 72.55 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.23 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.4 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.13 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.31 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.11 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 50.44 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 75.04 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.44 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.22 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.31 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.21 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.31 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 64.33 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.41 ' CD1' HD21 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 75.51 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.52 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 75.53 108.024 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.32 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.479 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.54 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.34 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.41 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.56 -18.76 48.85 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.12 111.213 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.41 85.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.306 -0.861 . . . . 72.43 112.078 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.427 ' HB2' ' OD1' ' A' ' 398' ' ' ASN . . . -100.78 -8.08 23.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.789 0.804 . . . . 72.0 109.429 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.9 t -78.61 -13.98 59.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.679 -1.146 . . . . 75.24 110.202 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 115.57 -0.741 . . . . 73.31 109.587 -179.367 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.141 0.496 . . . . 72.12 111.848 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -95.65 95.8 8.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.753 -1.203 . . . . 75.52 107.753 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 57.11 -165.52 0.15 Allowed 'General case' 0 C--O 1.256 1.417 0 O-C-N 123.859 0.724 . . . . 52.32 110.558 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.14 116.16 31.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.849 -1.167 . . . . 74.34 107.849 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.448 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 21.9 pttp -117.95 155.71 29.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.368 -0.378 . . . . 64.31 110.467 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.42 -130.1 6.46 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 120.636 -0.793 . . . . 73.32 111.514 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 65.7 mtt -94.7 90.44 6.1 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.656 0.741 . . . . 74.03 111.09 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.94 110.79 1.27 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.938 -1.483 . . . . 73.42 111.636 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m -121.94 144.83 48.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.982 -0.748 . . . . 64.23 108.982 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.33 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 75.52 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.33 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 64.44 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 74.33 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.53 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 61.21 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 65.14 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.13 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.22 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.1 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.548 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 74.33 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.548 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 72.11 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.01 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.51 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 72.23 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 75.35 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.51 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.43 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.43 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.44 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.21 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 74.15 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.42 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.13 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.2 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 75.34 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 52.43 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.22 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.44 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.21 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 420' ' ' VAL . 62.3 t30 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.14 108.425 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.439 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.33 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 75.41 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.42 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.446 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 74.12 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 74.01 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.22 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.43 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.42 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t -116.78 -31.42 5.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.44 110.707 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 173.03 -144.28 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.403 -2.073 . . . . 62.33 105.403 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.08 -2.97 33.41 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.358 0.599 . . . . 71.15 110.053 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.13 175.79 45.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.309 -0.472 . . . . 52.31 112.366 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.55 47.52 2.54 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.511 2.807 . . . . 72.34 112.735 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 66.59 -178.44 0.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.496 1.118 . . . . 73.51 110.793 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -84.32 157.5 21.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 74.45 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 73.13 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.408 HD12 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.11 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.11 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.02 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.15 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.15 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.43 114.224 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.34 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 64.13 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 75.42 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.41 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.12 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.409 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 61.14 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.12 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.44 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.14 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 72.01 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.14 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 73.53 109.376 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 74.43 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.31 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 70.3 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 75.25 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 71.22 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 75.42 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.05 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.13 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.24 106.13 173.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.01 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.05 -29.25 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.23 112.413 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.47 60.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.624 0.602 . . . . 72.51 112.624 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -92.95 -2.23 55.98 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.911 0.863 . . . . 74.44 109.054 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 15.3 t -70.96 -27.94 64.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.514 -1.221 . . . . 74.1 109.0 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 108.542 -0.91 . . . . 61.2 108.542 177.755 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.138 0.018 . . . . 73.43 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 55.81 93.54 0.02 OUTLIER 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.634 1.573 . . . . 73.32 112.194 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -87.27 120.91 29.04 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.412 -0.813 . . . . 72.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 360' ' ' ILE . 2.2 mp -82.42 124.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.047 -1.834 . . . . 74.11 106.047 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.454 ' HD2' ' OE1' ' A' ' 380' ' ' GLU . 48.6 mtmt -104.78 156.57 17.88 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.929 0.395 . . . . 73.2 111.612 -174.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -125.49 57.49 0.69 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.812 -0.915 . . . . 64.12 110.812 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.442 ' HB2' HG12 ' A' ' 377' ' ' VAL . 56.1 ttp -79.58 81.23 5.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.931 -1.137 . . . . 65.14 107.931 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -125.11 -32.58 2.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.641 -0.708 . . . . 71.32 112.841 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 1.9 m -119.64 137.41 53.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 118.729 -1.188 . . . . 74.12 113.23 -169.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.22 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 74.12 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 64.4 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.01 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.52 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 61.55 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 74.32 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.3 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.54 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.62 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.11 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.24 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.15 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.62 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.12 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.79 -177.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.01 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.44 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.11 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.32 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.24 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.487 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 75.01 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 72.43 111.836 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.05 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.2 110.64 -177.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.52 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 74.44 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.04 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 74.13 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 65.34 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.42 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.44 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.03 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 75.22 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.521 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 73.42 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.634 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.13 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.2 110.363 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.44 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.44 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.33 106.407 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.35 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t -73.7 -40.29 63.72 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 63.13 109.395 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -160.79 -69.47 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.36 -1.348 . . . . 62.31 107.36 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -167.11 97.59 0.52 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.035 -0.984 . . . . 71.14 108.571 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 162.02 -116.62 0.72 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.649 -1.38 . . . . 55.23 109.649 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.65 -176.82 3.18 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.917 1.744 . . . . 55.41 110.946 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -101.68 163.78 12.08 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.378 -0.374 . . . . 75.03 110.085 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -75.76 157.93 32.89 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.187 -1.042 . . . . 75.05 108.187 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.521 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.41 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.42 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 75.41 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.43 111.109 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 443' ' ' MET . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.14 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 72.3 113.202 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.54 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 75.45 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 72.05 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.15 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.44 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 70.15 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 75.01 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.14 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 75.44 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 75.4 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 64.11 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.411 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.54 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.411 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.34 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.13 108.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.23 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.32 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.22 107.913 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 61.31 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.23 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 73.31 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.54 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.35 -28.9 39.01 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.35 110.537 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.18 -10.22 59.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.599 -0.728 . . . . 72.13 111.403 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 420' ' ' VAL . . . -116.74 -2.18 11.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.825 -0.805 . . . . 74.45 108.825 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.3 t -74.03 -31.94 63.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.827 -1.079 . . . . 64.01 108.844 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.429 -1.5 0 CA-C-N 115.573 -0.74 . . . . 61.01 110.247 179.611 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.864 -0.421 . . . . 75.3 109.864 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.4 ' N ' ' HD2' ' A' ' 358' ' ' ARG . 5.3 mpt_? 65.43 112.29 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.913 1.285 . . . . 73.14 113.164 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -106.64 112.92 26.12 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.507 -0.77 . . . . 73.22 109.894 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.47 116.01 49.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.836 -1.172 . . . . 72.42 107.836 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -86.06 136.03 33.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.418 -0.913 . . . . 74.43 111.683 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -82.37 -88.03 0.7 Allowed Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.584 -1.006 . . . . 74.21 110.584 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.13 103.02 6.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.182 -0.673 . . . . 74.31 109.182 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 376' ' ' VAL . 40.8 tt0 -79.27 106.59 11.41 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.303 -0.862 . . . . 72.33 110.2 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m -113.18 145.73 40.48 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.913 -1.143 . . . . 74.32 107.913 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 70.45 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.42 107.07 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 75.05 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.53 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.14 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.35 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 60.03 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.31 106.623 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 364' ' ' GLU . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 73.33 106.697 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 72.13 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.02 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.22 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 378' ' ' PHE . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.21 111.264 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.551 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.14 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 64.25 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.34 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.01 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.24 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.34 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.41 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.564 HD22 HD22 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.54 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 74.13 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.51 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.564 HD22 HD22 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.33 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.35 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 71.21 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 74.55 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 75.02 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.14 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.33 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 72.23 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.14 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.3 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 -177.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.53 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.424 ' HG3' ' HE3' ' A' ' 401' ' ' LYS . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 62.43 111.044 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 72.34 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 38.23 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.35 106.726 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 62.01 113.656 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.36 -11.13 41.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.12 108.991 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 75.1 118.16 0.05 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.215 1.406 . . . . 64.1 110.263 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 75.76 -38.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.456 1.103 . . . . 63.33 112.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.42 -159.67 30.03 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.833 -0.907 . . . . 74.41 110.833 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.74 -179.86 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.263 1.975 . . . . 64.05 111.596 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -90.76 30.04 1.24 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.438 0.637 . . . . 75.4 110.408 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 72.3 162.44 0.26 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 126.459 1.904 . . . . 74.53 111.899 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 73.32 108.275 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.33 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.41 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 74.31 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 73.41 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 74.43 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.41 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 448' ' ' ALA . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.02 114.325 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.42 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 70.04 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.41 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.41 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 71.14 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 74.32 107.48 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 74.35 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 73.22 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.31 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 73.34 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.51 109.687 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.54 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.34 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 75.31 109.2 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 73.15 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 74.41 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.42 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.31 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 60.14 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 73.53 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.51 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.81 -25.95 60.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 64.34 110.177 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.56 -5.1 34.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.983 -1.008 . . . . 74.23 110.877 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 422' ' ' CYS . . . -91.36 -27.23 18.49 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.049 -0.523 . . . . 74.42 110.102 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 62.8 m -79.38 -30.13 42.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.147 -0.479 . . . . 73.43 109.922 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 109.197 -0.668 . . . . 75.43 109.197 179.128 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.444 HG22 HG13 ' A' ' 428' ' ' ILE . 9.8 m . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 107.035 -1.469 . . . . 64.150000000000006 107.035 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.420000000000002 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.140000000000001 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.020000000000003 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.631 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 73.140000000000001 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.209999999999994 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.129999999999995 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.310000000000002 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.631 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.540000000000006 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.150000000000006 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 54.130000000000003 109.037 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.549999999999997 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.150000000000006 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.120000000000005 112.399 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 60.409999999999997 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.209999999999994 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 64.319999999999993 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.9 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.430000000000007 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.120000000000005 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 65.340000000000003 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.567 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.049999999999997 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.588 HD21 HD21 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 71.209999999999994 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 64.219999999999999 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.409999999999997 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.530000000000001 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 65.340000000000003 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.520000000000003 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 64.420000000000002 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 62.25 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 62.539999999999999 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.439999999999998 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 61.049999999999997 108.324 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.540000000000006 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 63.229999999999997 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.519999999999996 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.510000000000005 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.310000000000002 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 24.0 m120 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 54.299999999999997 111.335 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.219999999999999 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.439 HE21 HG23 ' A' ' 387' ' ' ILE . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 63.109999999999999 106.326 -177.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.140000000000001 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.409999999999997 110.217 -179.506 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 . . . . . 0 C--O 1.267 1.989 0 N-CA-C 108.661 -0.866 . . . . 73.109999999999999 108.661 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.537 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.409999999999997 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.329999999999998 108.397 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 62.049999999999997 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 62.200000000000003 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.299999999999997 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.430000000000007 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.420000000000002 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.349999999999994 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 71.140000000000001 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 50.43 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 60.350000000000001 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.515 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 64.109999999999999 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 70.030000000000001 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.400000000000006 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.549999999999997 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 72.25 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 55.8 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.420000000000002 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.340000000000003 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 35.399999999999999 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.049999999999997 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 73.109999999999999 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.430000000000007 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.430000000000007 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.209999999999994 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 70.040000000000006 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.319999999999993 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.109999999999999 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.450000000000003 111.645 178.562 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 428' ' ' ILE . 7.4 m . . . . . 0 N--CA 1.424 -1.753 0 CA-C-O 120.889 0.376 . . . . 74.0 111.398 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.319999999999993 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 64.510000000000005 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 61.530000000000001 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.399999999999999 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.549999999999997 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 374' ' ' TYR . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 74.519999999999996 111.241 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 53.329999999999998 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.409999999999997 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 64.019999999999996 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.507 HG21 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 73.040000000000006 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.219999999999999 110.67 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.510000000000005 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.109999999999999 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.430000000000007 109.829 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.109999999999999 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.109999999999999 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.488 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 63.130000000000003 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.445 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.319999999999993 109.524 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.409999999999997 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.129999999999995 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.445 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 109.822 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.420000000000002 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.340000000000003 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.030000000000001 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 62.43 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.349999999999994 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.299999999999997 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.109999999999999 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.299999999999997 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 74.010000000000005 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 45.030000000000001 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.120000000000005 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.549999999999997 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 63.140000000000001 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.534 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.299999999999997 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 73.409999999999997 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 62.240000000000002 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.409999999999997 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.030000000000001 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.209999999999994 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.329999999999998 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 414' ' ' ARG . 28.5 p . . . . . 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.109999999999999 110.595 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 408' ' ' CYS . 45.0 ttm105 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.120000000000005 109.178 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.534 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.430000000000007 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 71.329999999999998 109.797 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 440' ' ' LEU . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.439999999999998 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 62.409999999999997 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 72.219999999999999 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.230000000000004 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.569 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 71.239999999999995 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 35.130000000000003 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 71.209999999999994 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.319999999999993 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.329999999999998 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 43.020000000000003 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 365' ' ' THR . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.420000000000002 107.429 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.549999999999997 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 41.310000000000002 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.219999999999999 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.519999999999996 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.340000000000003 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.420000000000002 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.329999999999998 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.209999999999994 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.55 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 70.310000000000002 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.019999999999996 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 73.450000000000003 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 65.140000000000001 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.109999999999999 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.507 ' SD ' HG21 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 64.310000000000002 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.510000000000005 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.310000000000002 107.134 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 60.109999999999999 112.688 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.445 HG22 HG13 ' A' ' 428' ' ' ILE . 6.1 m . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.589 0.233 . . . . 70.140000000000001 111.56 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 64.400000000000006 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 64.439999999999998 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.430000000000007 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 72.140000000000001 110.305 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 51.130000000000003 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.530000000000001 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 74.109999999999999 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 71.040000000000006 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.672 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.420000000000002 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 71.239999999999995 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.219999999999999 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 65.129999999999995 106.992 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.4 ' HB3' ' HD1' ' A' ' 379' ' ' TYR . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.400000000000006 112.836 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.4 ' HD1' ' HB3' ' A' ' 378' ' ' PHE . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.319999999999993 112.254 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.230000000000004 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HB2' HD11 ' A' ' 388' ' ' LEU . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.120000000000005 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.099999999999994 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 373' ' ' THR . 8.5 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 61.219999999999999 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.099999999999994 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.099999999999994 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 65.409999999999997 110.75 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 63.130000000000003 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 74.239999999999995 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 32.310000000000002 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.109999999999999 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.109999999999999 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 72.420000000000002 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.430000000000007 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.420000000000002 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.219999999999999 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 71.109999999999999 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 63.340000000000003 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.430000000000007 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.120000000000005 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 73.209999999999994 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 64.329999999999998 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.299999999999997 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.310000000000002 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 388' ' ' LEU . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 110.838 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.340000000000003 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.209999999999994 109.544 -177.171 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 121.288 0.566 . . . . 75.019999999999996 111.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.019999999999996 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 70.040000000000006 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.239999999999995 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.329999999999998 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 422' ' ' CYS . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.129999999999995 108.789 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.549999999999997 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.484 ' H ' HG12 ' A' ' 420' ' ' VAL . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.310000000000002 112.971 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.399999999999999 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.420000000000002 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.229999999999997 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.219999999999999 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 64.109999999999999 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 54.119999999999997 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.120000000000005 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.439999999999998 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.039999999999999 109.289 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.209999999999994 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.409999999999997 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 61.25 108.181 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.109999999999999 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.409999999999997 107.427 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 74.439999999999998 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.239999999999995 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.129999999999995 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.109999999999999 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 41.049999999999997 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 71.239999999999995 111.367 177.039 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 53.100000000000001 106.976 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 63.43 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 72.409999999999997 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.519999999999996 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.491 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 65.129999999999995 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 34.530000000000001 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.219999999999999 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.120000000000005 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 71.209999999999994 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.109999999999999 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.450000000000003 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 25.420000000000002 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.430000000000007 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 62.539999999999999 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 72.230000000000004 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.420000000000002 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.140000000000001 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.200000000000003 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.8 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 71.510000000000005 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.450000000000003 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 52.350000000000001 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.349999999999994 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.512 HD13 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.349999999999994 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.120000000000005 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 54.340000000000003 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 63.130000000000003 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.239999999999995 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.420000000000002 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.119999999999997 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.340000000000003 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.450000000000003 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.140000000000001 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.439999999999998 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.665 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 71.230000000000004 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.744 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 60.130000000000003 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.430000000000007 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.519999999999996 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.450000000000003 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.209999999999994 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.420000000000002 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.329999999999998 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.140000000000001 110.939 -174.465 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 105.489 -2.041 . . . . 73.030000000000001 105.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.744 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.439999999999998 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 41.310000000000002 108.787 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 72.049999999999997 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.140000000000001 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.209999999999994 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 443' ' ' MET . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.219999999999999 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 70.209999999999994 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.415 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.420000000000002 114.339 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.219999999999999 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.140000000000001 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.099999999999994 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.329999999999998 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.420000000000002 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.239999999999995 108.103 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.450000000000003 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.520000000000003 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 71.099999999999994 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.239999999999995 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.329999999999998 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 71.230000000000004 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.299999999999997 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.200000000000003 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 61.340000000000003 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.443 ' CD1' HD22 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.120000000000005 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 72.530000000000001 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.366 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 73.439999999999998 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 70.230000000000004 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.439999999999998 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.519999999999996 111.006 174.211 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.420000000000002 107.621 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.209999999999994 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.424 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.319999999999993 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.400000000000006 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 73.299999999999997 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.420000000000002 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.239999999999995 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.310000000000002 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.230000000000004 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.430000000000007 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.209999999999994 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 65.319999999999993 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 23.43 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.040000000000006 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.340000000000003 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.219999999999999 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.329999999999998 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 62.009999999999998 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.439999999999998 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.526 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 8.6 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 62.210000000000001 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 60.140000000000001 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 53.539999999999999 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.526 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 55.340000000000003 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 73.5 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 374' ' ' TYR . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 53.539999999999999 109.907 175.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.420000000000002 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 52.009999999999998 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.420000000000002 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 51.030000000000001 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.219999999999999 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.349999999999994 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 74.519999999999996 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.409999999999997 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.420000000000002 109.106 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 70.530000000000001 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.448 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.340000000000003 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.599 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.430000000000007 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 51.039999999999999 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.599 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 52.299999999999997 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.340000000000003 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.120000000000005 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.420000000000002 106.407 -178.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.209999999999994 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.209999999999994 110.409 -177.474 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 62.240000000000002 107.76 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.561 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.439999999999998 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 63.109999999999999 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.140000000000001 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 73.040000000000006 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.200000000000003 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 71.310000000000002 109.275 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.129999999999995 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.422 ' H ' HG12 ' A' ' 420' ' ' VAL . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.229999999999997 111.157 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.439999999999998 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 43.219999999999999 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.230000000000004 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.0 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 62.32 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.310000000000002 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 54.340000000000003 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.129999999999995 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.528 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.129999999999995 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.019999999999996 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.409999999999997 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.120000000000005 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 50.0 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.420000000000002 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.039999999999999 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.019999999999996 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.430000000000007 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 43.340000000000003 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 61.530000000000001 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.409999999999997 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 73.010000000000005 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.319999999999993 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.340000000000003 108.667 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 55.149999999999999 111.211 176.07 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.944 -0.391 . . . . 71.409999999999997 109.944 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 74.209999999999994 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.239999999999995 106.104 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.540000000000006 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 71.150000000000006 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.420000000000002 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.149999999999999 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.450000000000003 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.310000000000002 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.109999999999999 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.409999999999997 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.4 HG11 ' SD ' ' A' ' 443' ' ' MET . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.439999999999998 108.767 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.53 HG11 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.010000000000005 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.403 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.510000000000005 110.192 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 70.439999999999998 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' HG11 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.349999999999994 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.566 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.4 p-10 -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 72.329999999999998 112.13 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.430000000000007 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.510000000000005 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.030000000000001 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.539999999999999 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.450000000000003 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.030000000000001 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 439' ' ' TYR . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.019999999999996 110.276 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.109999999999999 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.329999999999998 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 74.450000000000003 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 43.509999999999998 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.349999999999994 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 63.32 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.450000000000003 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 22.449999999999999 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 64.030000000000001 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.349999999999994 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 60.219999999999999 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.439999999999998 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.049999999999997 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.319999999999993 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.209999999999994 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 20.3 tm0? -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.209999999999994 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.439999999999998 109.08 176.034 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.412 -0.588 . . . . 62.25 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.430000000000007 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 40.229999999999997 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.109999999999999 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.518 HG22 HD12 ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 61.109999999999999 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 71.549999999999997 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.594 HG12 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.520000000000003 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.409999999999997 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.594 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 72.340000000000003 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.319999999999993 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.299999999999997 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 64.310000000000002 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.010000000000005 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.150000000000006 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.509 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 51.509999999999998 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.409999999999997 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 63.219999999999999 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.446 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 70.040000000000006 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 63.25 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.109999999999999 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.409999999999997 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 70.340000000000003 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.533 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.109999999999999 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.439999999999998 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.420000000000002 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.413 ' CD1' HD22 ' A' ' 389' ' ' LEU . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.230000000000004 112.126 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.491 ' HA ' HG23 ' A' ' 417' ' ' ILE . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 50.439999999999998 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 63.310000000000002 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.140000000000001 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 441' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.239999999999995 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.299999999999997 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.319999999999993 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.049999999999997 111.97 178.517 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 428' ' ' ILE . 20.4 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 107.129 -1.434 . . . . 63.439999999999998 107.129 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.540000000000006 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.010000000000005 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.420000000000002 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.150000000000006 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.210000000000001 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.409999999999997 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.549999999999997 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.099999999999994 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.230000000000004 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.430000000000007 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 382' ' ' VAL . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 60.350000000000001 109.208 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 43.119999999999997 107.297 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.495 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.219999999999999 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 70.239999999999995 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.540000000000006 111.676 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 16.2 p-10 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.319999999999993 112.076 -176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 389' ' ' LEU . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.329999999999998 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.230000000000004 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 64.319999999999993 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.399999999999999 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.455 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 72.420000000000002 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 383' ' ' PHE . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 70.040000000000006 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 382' ' ' VAL . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.109999999999999 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 50.420000000000002 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 7.8 m-20 -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 52.439999999999998 110.077 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.540000000000006 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 52.299999999999997 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.450000000000003 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 65.120000000000005 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.200000000000003 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.409999999999997 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.530000000000001 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 72.409999999999997 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.010000000000005 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.665 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 55.030000000000001 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.310000000000002 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.569 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.049999999999997 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.010000000000005 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.030000000000001 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.540000000000006 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.350000000000001 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.310000000000002 110.84 -175.601 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.530000000000001 109.018 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.452 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.109999999999999 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 441' ' ' ILE . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 43.530000000000001 110.048 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 401' ' ' LYS . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.010000000000005 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 71.040000000000006 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 71.340000000000003 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.109999999999999 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.329999999999998 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.209999999999994 112.536 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 42.310000000000002 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.230000000000004 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 61.219999999999999 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 54.520000000000003 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.530000000000001 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 54.109999999999999 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.420000000000002 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.129999999999995 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.319999999999993 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.230000000000004 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.400000000000006 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.420000000000002 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 64.329999999999998 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.0 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.219999999999999 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 417' ' ' ILE . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.329999999999998 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.422 ' CD1' HG11 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 61.039999999999999 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 73.129999999999995 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 71.329999999999998 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 72.439999999999998 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.150000000000006 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 53.210000000000001 111.046 177.308 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 120.569 0.223 . . . . 65.420000000000002 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.109999999999999 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 70.099999999999994 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.329999999999998 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.556 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 63.049999999999997 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.010000000000005 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 45.009999999999998 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.230000000000004 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 62.509999999999998 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.409999999999997 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 64.200000000000003 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 62.420000000000002 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 380' ' ' GLU . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.209999999999994 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 62.119999999999997 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.519999999999996 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.219999999999999 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.109999999999999 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 50.340000000000003 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 73.349999999999994 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.509 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.2 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.450000000000003 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.439999999999998 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.239999999999995 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.509 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.400000000000006 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.439999999999998 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.602 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 73.420000000000002 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.530000000000001 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.299999999999997 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 70.400000000000006 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.129999999999995 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.409999999999997 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.409999999999997 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 62.450000000000003 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.450000000000003 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 73.519999999999996 110.928 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.420000000000002 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.49 ' H ' HG12 ' A' ' 418' ' ' VAL . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 53.119999999999997 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 63.350000000000001 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.519999999999996 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.329999999999998 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.439999999999998 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 63.100000000000001 106.498 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.439999999999998 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 63.43 110.269 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 106.596 -1.631 . . . . 74.019999999999996 106.596 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.209999999999994 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 71.230000000000004 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 400' ' ' LEU . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 64.200000000000003 110.566 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 71.430000000000007 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 422' ' ' CYS . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.430000000000007 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.349999999999994 111.771 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.448 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.240000000000002 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.340000000000003 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 71.430000000000007 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.540000000000006 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.589 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.239999999999995 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.340000000000003 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.613 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.439999999999998 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.210000000000001 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.109999999999999 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.219999999999999 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 72.439999999999998 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.099999999999994 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.100000000000001 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.140000000000001 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.450000000000003 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 44.310000000000002 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 74.230000000000004 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.140000000000001 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.430000000000007 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.140000000000001 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 45.32 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.613 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 65.129999999999995 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.329999999999998 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.420000000000002 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.450000000000003 111.294 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.485 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 112.811 0.671 . . . . 72.530000000000001 112.811 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.129999999999995 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 72.120000000000005 109.571 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.420000000000002 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.510000000000005 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.209999999999994 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.549999999999997 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.239999999999995 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.420000000000002 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.430000000000007 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 71.129999999999995 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 54.140000000000001 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 60.020000000000003 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.406 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.120000000000005 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.409999999999997 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.219999999999999 110.544 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.553 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.5 p-10 -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.219999999999999 111.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 71.420000000000002 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.040000000000006 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 8.3 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.450000000000003 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.329999999999998 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 60.149999999999999 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 73.230000000000004 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.535 ' CD1' HD21 ' A' ' 381' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 73.420000000000002 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.450000000000003 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.409999999999997 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 5.2 m-20 -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.409999999999997 109.552 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.510000000000005 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 50.32 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.230000000000004 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.140000000000001 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.210000000000001 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.140000000000001 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.140000000000001 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 72.439999999999998 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 62.43 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 65.420000000000002 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.319999999999993 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.594 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 63.049999999999997 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.510000000000005 113.928 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.450000000000003 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.484 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 71.420000000000002 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.239999999999995 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.400000000000006 109.858 -177.284 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.515 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 . . . . . 0 C--O 1.254 1.307 0 CA-C-O 121.487 0.661 . . . . 64.420000000000002 111.615 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.496 ' HB2' ' HG3' ' A' ' 438' ' ' GLU . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.129999999999995 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.399999999999999 109.527 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 53.210000000000001 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 70.219999999999999 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 44.219999999999999 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 61.020000000000003 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.430000000000007 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.512 ' H ' HG12 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 52.210000000000001 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.209999999999994 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.340000000000003 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 73.439999999999998 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.349999999999994 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 365' ' ' THR . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.019999999999996 106.935 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.340000000000003 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 53.149999999999999 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 70.049999999999997 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 64.129999999999995 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.219999999999999 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.420000000000002 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 97.6 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.439999999999998 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 72.430000000000007 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 53.140000000000001 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 54.450000000000003 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.516 ' CD1' HD22 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 63.32 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 73.299999999999997 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.519999999999996 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.109999999999999 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.129999999999995 109.534 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 74.299999999999997 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 65.319999999999993 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.450000000000003 111.461 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.535 -0.913 . . . . 72.450000000000003 108.535 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.409999999999997 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 71.329999999999998 106.721 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.530000000000001 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 71.219999999999999 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.140000000000001 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 62.25 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 74.230000000000004 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 60.340000000000003 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.329999999999998 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.409999999999997 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.349999999999994 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.140000000000001 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 65.200000000000003 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.230000000000004 111.253 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.239999999999995 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 390' ' ' GLY . 19.6 p-10 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.519999999999996 110.857 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.129999999999995 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 373' ' ' THR . 8.9 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.150000000000006 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.140000000000001 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 51.340000000000003 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.451 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 60.299999999999997 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 381' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.540000000000006 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 374' ' ' TYR . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.230000000000004 109.253 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.129999999999995 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 20.2 m120 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 62.140000000000001 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 60.530000000000001 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.150000000000006 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 72.319999999999993 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.140000000000001 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.439999999999998 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.239999999999995 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.310000000000002 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.400000000000006 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 64.200000000000003 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 70.450000000000003 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.129999999999995 110.308 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.140000000000001 111.197 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 72.129999999999995 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.019999999999996 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.399999999999999 111.65 -175.196 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 112.416 0.525 . . . . 72.450000000000003 112.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.519999999999996 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.450000000000003 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 71.430000000000007 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.400000000000006 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.350000000000001 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 422' ' ' CYS . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 72.030000000000001 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.329999999999998 111.351 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.537 ' H ' HG12 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.319999999999993 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.109999999999999 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 50.340000000000003 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.549999999999997 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.239999999999995 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.140000000000001 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.040000000000006 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.520000000000003 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 41.530000000000001 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 71.299999999999997 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 65.420000000000002 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 60.43 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 50.240000000000002 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.150000000000006 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 74.25 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.512 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 62.329999999999998 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.150000000000006 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.310000000000002 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 72.030000000000001 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 64.340000000000003 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.540000000000006 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.409999999999997 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 64.439999999999998 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 42.140000000000001 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.129999999999995 111.296 176.132 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 120.466 0.174 . . . . 74.540000000000006 110.806 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.519999999999996 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.230000000000004 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.219999999999999 109.633 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 63.509999999999998 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.509999999999998 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.539999999999999 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.040000000000006 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.450000000000003 111.757 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.140000000000001 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.540000000000006 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.434 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 63.210000000000001 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.524 HG11 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.010000000000005 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 63.240000000000002 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 64.5 110.678 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.524 ' OE2' HG11 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.519999999999996 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.109999999999999 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.519999999999996 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.239999999999995 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.6 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.409999999999997 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 71.439999999999998 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 71.409999999999997 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.614 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.430000000000007 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.562 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 60.219999999999999 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.549999999999997 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 44.549999999999997 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 61.119999999999997 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.310000000000002 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 61.119999999999997 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 52.329999999999998 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 62.43 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.329999999999998 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.299999999999997 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.310000000000002 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.140000000000001 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.573 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 71.310000000000002 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 65.239999999999995 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.56 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.400000000000006 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.239999999999995 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 65.129999999999995 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.439999999999998 108.448 -175.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 54.140000000000001 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.150000000000006 110.979 -173.848 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 13.1 ttm180 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 109.519 -0.548 . . . . 73.450000000000003 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.020000000000003 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 62.310000000000002 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.43 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.420000000000002 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.420000000000002 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 65.299999999999997 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.200000000000003 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.450000000000003 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 420' ' ' VAL . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 53.030000000000001 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.140000000000001 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 73.129999999999995 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.519999999999996 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.019999999999996 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.129999999999995 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.522 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.430000000000007 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.209999999999994 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.239999999999995 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.120000000000005 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 73.109999999999999 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.040000000000006 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 98.6 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.319999999999993 109.674 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.439999999999998 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.319999999999993 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 64.209999999999994 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.542 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 65.329999999999998 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 73.439999999999998 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 62.219999999999999 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 55.420000000000002 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.522 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.340000000000003 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 71.319999999999993 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.510000000000005 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.329999999999998 111.567 178.369 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 107.131 -1.433 . . . . 72.140000000000001 107.131 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 64.129999999999995 107.718 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.329999999999998 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 64.319999999999993 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.299999999999997 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 71.409999999999997 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 62.25 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 71.329999999999998 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.040000000000006 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 52.420000000000002 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.310000000000002 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.129999999999995 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.120000000000005 112.089 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.340000000000003 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.496 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 63.520000000000003 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 61.200000000000003 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.56 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.4 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.310000000000002 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.329999999999998 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.239999999999995 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.450000000000003 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.129999999999995 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 71.310000000000002 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.209999999999994 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 62.340000000000003 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.329999999999998 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 53.5 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.219999999999999 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.541 ' HG2' ' HG ' ' A' ' 400' ' ' LEU . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.349999999999994 105.057 174.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.540000000000006 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 62.520000000000003 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.219999999999999 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.319999999999993 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.541 ' HG ' ' HG2' ' A' ' 395' ' ' GLN . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 54.549999999999997 110.541 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.536 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 72.239999999999995 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.209999999999994 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.536 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.540000000000006 110.684 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.319999999999993 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 32.350000000000001 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 71.129999999999995 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.099999999999994 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.430000000000007 109.538 -176.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 . . . . . 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 72.430000000000007 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.420000000000002 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.319999999999993 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.340000000000003 109.139 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.452 HG22 HD12 ' A' ' 441' ' ' ILE . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 61.310000000000002 110.173 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 64.040000000000006 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 71.530000000000001 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.310000000000002 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.565 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 64.120000000000005 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 25.52 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 72.530000000000001 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 64.209999999999994 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 64.230000000000004 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.140000000000001 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.420000000000002 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 62.100000000000001 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.409999999999997 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.310000000000002 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.310000000000002 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.049999999999997 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.230000000000004 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 71.420000000000002 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 73.109999999999999 116.377 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.510000000000005 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.239999999999995 109.114 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 55.329999999999998 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.420000000000002 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 443' ' ' MET . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 54.200000000000003 106.856 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.310000000000002 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.340000000000003 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.140000000000001 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 62.420000000000002 111.615 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.439999999999998 107.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 61.100000000000001 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.461 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 74.310000000000002 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.229999999999997 112.018 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.530000000000001 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 65.310000000000002 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.099999999999994 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 65.349999999999994 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 74.310000000000002 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.219999999999999 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 72.310000000000002 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 64.209999999999994 110.21 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 71.140000000000001 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 62.009999999999998 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.549999999999997 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 61.439999999999998 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.230000000000004 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.230000000000004 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 70.430000000000007 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.530000000000001 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.450000000000003 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.531 HD21 HD21 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 44.32 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 71.319999999999993 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 51.310000000000002 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 63.5 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.099999999999994 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.439999999999998 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 33.399999999999999 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 73.450000000000003 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 70.519999999999996 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.209999999999994 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.209999999999994 109.047 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.099999999999994 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 50.539999999999999 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.299999999999997 107.557 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 63.329999999999998 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 63.119999999999997 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 51.399999999999999 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.420000000000002 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.409999999999997 111.23 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.030000000000001 108.962 -179.389 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.171 0.51 . . . . 64.310000000000002 110.576 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.239999999999995 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.340000000000003 107.841 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.140000000000001 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 441' ' ' ILE . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.430000000000007 110.199 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.329999999999998 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 71.109999999999999 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 62.520000000000003 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.544 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.140000000000001 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.439999999999998 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 53.530000000000001 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.109999999999999 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.230000000000004 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.549999999999997 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 63.420000000000002 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 53.530000000000001 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.030000000000001 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 64.209999999999994 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.040000000000006 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.559 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.340000000000003 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.239999999999995 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 51.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.349999999999994 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.219999999999999 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.559 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 65.140000000000001 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 54.420000000000002 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 64.519999999999996 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.329999999999998 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 64.109999999999999 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.561 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.409999999999997 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.099999999999994 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.310000000000002 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.109999999999999 112.051 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 107.686 -1.228 . . . . 75.129999999999995 107.686 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 52.32 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.140000000000001 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.209999999999994 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 65.310000000000002 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 52.420000000000002 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.109999999999999 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.209999999999994 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.299999999999997 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.210000000000001 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.140000000000001 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.530000000000001 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 60.229999999999997 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.415 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 65.519999999999996 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.319999999999993 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.310000000000002 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 60.149999999999999 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.140000000000001 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.540000000000006 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.597 ' NE2' HD21 ' A' ' 389' ' ' LEU . 61.2 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 73.040000000000006 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.310000000000002 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.420000000000002 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 71.310000000000002 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.651 HD21 HD21 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.140000000000001 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.597 HD21 ' NE2' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.230000000000004 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.508 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 5.4400000000000004 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.651 HD21 HD21 ' A' ' 388' ' ' LEU . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.340000000000003 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.040000000000006 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 43.219999999999999 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.519999999999996 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.040000000000006 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 64.099999999999994 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 54.219999999999999 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.150000000000006 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.140000000000001 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 73.209999999999994 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.546 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.420000000000002 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.420000000000002 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.409999999999997 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 71.230000000000004 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.430000000000007 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.319999999999993 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 43.32 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.200000000000003 111.145 -174.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.08 -0.711 . . . . 74.340000000000003 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 34.520000000000003 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 63.229999999999997 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 45.340000000000003 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 63.039999999999999 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.040000000000006 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.150000000000006 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.485 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.510000000000005 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.140000000000001 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.219999999999999 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.450000000000003 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 2.4 m-20 -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.239999999999995 109.468 177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.119999999999997 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 72.319999999999993 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.329999999999998 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 50.409999999999997 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 62.32 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.209999999999994 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.150000000000006 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 63.109999999999999 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.510000000000005 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 73.109999999999999 115.915 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.129999999999995 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.129999999999995 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 389' ' ' LEU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.439999999999998 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 64.409999999999997 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 72.140000000000001 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.219999999999999 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.150000000000006 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.420000000000002 108.587 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 72.25 112.109 178.464 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 111.646 0.239 . . . . 74.109999999999999 111.646 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 32.219999999999999 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 62.229999999999997 106.677 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 71.010000000000005 111.768 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.475 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.340000000000003 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.009999999999998 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.530000000000001 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 72.530000000000001 110.976 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 71.519999999999996 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 63.210000000000001 107.487 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.129999999999995 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.513 HG11 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 65.450000000000003 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.230000000000004 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.239999999999995 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.513 ' OE1' HG11 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.399999999999999 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.542 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.450000000000003 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.230000000000004 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.140000000000001 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.230000000000004 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.420000000000002 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 52.119999999999997 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 64.319999999999993 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.209999999999994 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.455 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.439999999999998 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 30.210000000000001 112.048 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 6.9 m-20 -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 70.239999999999995 108.532 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 63.240000000000002 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 54.130000000000003 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.510000000000005 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.340000000000003 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.329999999999998 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.299999999999997 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 65.400000000000006 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 33.210000000000001 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.738 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.519999999999996 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.420000000000002 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 65.209999999999994 114.052 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.329999999999998 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 34.299999999999997 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.210000000000001 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 63.350000000000001 111.673 -174.774 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 12.0 ttm180 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 109.251 -0.648 . . . . 60.030000000000001 109.251 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.461 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.310000000000002 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.219999999999999 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.340000000000003 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.040000000000006 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 65.420000000000002 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 63.539999999999999 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 73.129999999999995 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.619 ' H ' HG12 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.200000000000003 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.039999999999999 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.010000000000005 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.340000000000003 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 71.420000000000002 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.310000000000002 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 53.329999999999998 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.230000000000004 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 62.329999999999998 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.349999999999994 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 41.32 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 54.109999999999999 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.319999999999993 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 63.420000000000002 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 71.439999999999998 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.420000000000002 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 64.329999999999998 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.349999999999994 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.329999999999998 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.420000000000002 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.150000000000006 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.219999999999999 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.542 HG22 HG13 ' A' ' 428' ' ' ILE . 3.7 m . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.983 0.42 . . . . 73.420000000000002 110.809 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.120000000000005 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.420000000000002 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.450000000000003 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.449 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.340000000000003 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 34.549999999999997 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 61.439999999999998 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 64.409999999999997 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.140000000000001 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.430000000000007 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.549999999999997 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.509 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 70.239999999999995 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.532 HG11 ' OE2' ' A' ' 380' ' ' GLU . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 65.340000000000003 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.549999999999997 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.329999999999998 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.532 ' OE2' HG11 ' A' ' 377' ' ' VAL . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 50.299999999999997 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 61.32 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.030000000000001 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.239999999999995 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 373' ' ' THR . 6.1 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.219999999999999 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.109999999999999 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.040000000000006 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.409 HG23 HE21 ' A' ' 406' ' ' GLN . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 110.57 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.446 HD21 HD21 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.512 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 65.120000000000005 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.040000000000006 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.430000000000007 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 400' ' ' LEU . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.409999999999997 111.208 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 63.5 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.340000000000003 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.439999999999998 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 54.439999999999998 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.219999999999999 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.230000000000004 108.588 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.200000000000003 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 392' ' ' PHE . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.329999999999998 108.779 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.340000000000003 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 54.509999999999998 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.450000000000003 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.140000000000001 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.049999999999997 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.409 HE21 HG23 ' A' ' 387' ' ' ILE . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 62.210000000000001 106.442 -177.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.229999999999997 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.530000000000001 110.129 -178.047 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.281 -0.637 . . . . 65.209999999999994 109.281 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.140000000000001 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.130000000000003 109.513 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.340000000000003 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.340000000000003 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.109999999999999 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 444' ' ' LYS . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 73.540000000000006 109.642 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.310000000000002 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.540000000000006 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.219999999999999 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.230000000000004 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 64.200000000000003 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.129999999999995 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 365' ' ' THR . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 70.340000000000003 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.340000000000003 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.439999999999998 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.400000000000006 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.209999999999994 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 73.519999999999996 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.420000000000002 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 70.310000000000002 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.436 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.109999999999999 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 61.329999999999998 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.319999999999993 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.519999999999996 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 64.5 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 44.229999999999997 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 65.209999999999994 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.530000000000001 110.434 174.858 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.430000000000007 107.51 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.120000000000005 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.44 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 73.040000000000006 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 54.240000000000002 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 62.530000000000001 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.239999999999995 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 50.399999999999999 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 51.539999999999999 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.349999999999994 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 64.430000000000007 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.439999999999998 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 72.400000000000006 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 55.25 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.120000000000005 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.010000000000005 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.200000000000003 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.340000000000003 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.439999999999998 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.129999999999995 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 373' ' ' THR . 7.7 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.519999999999996 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.329999999999998 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.099999999999994 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 64.439999999999998 110.892 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.219999999999999 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 72.530000000000001 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.430000000000007 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 72.540000000000006 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 61.329999999999998 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.340000000000003 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.209999999999994 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.230000000000004 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.530000000000001 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.240000000000002 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 420' ' ' VAL . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.109999999999999 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.200000000000003 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.5 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.140000000000001 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.239999999999995 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.439999999999998 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.661 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.229999999999997 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.319999999999993 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 55.210000000000001 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.109999999999999 110.2 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.420000000000002 109.546 -176.323 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 109.437 -0.579 . . . . 70.310000000000002 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 65.329999999999998 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.109999999999999 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 65.519999999999996 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.299999999999997 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.329999999999998 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 61.100000000000001 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.430000000000007 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.571 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.230000000000004 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.310000000000002 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 64.129999999999995 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.230000000000004 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.400000000000006 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.129999999999995 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.310000000000002 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.109999999999999 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 43.140000000000001 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 72.140000000000001 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.239999999999995 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.219999999999999 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.310000000000002 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.439999999999998 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.209999999999994 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.310000000000002 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 60.109999999999999 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 64.200000000000003 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.519999999999996 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 74.310000000000002 108.024 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.319999999999993 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.540000000000006 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.340000000000003 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.409999999999997 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.120000000000005 111.213 174.39 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.982 -0.748 . . . . 63.310000000000002 108.982 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.329999999999998 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.427 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 52.130000000000003 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.329999999999998 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 62.439999999999998 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 63.109999999999999 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.530000000000001 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 60.200000000000003 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 63.509999999999998 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.129999999999995 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.219999999999999 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.099999999999994 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 73.25 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 55.340000000000003 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.010000000000005 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.509999999999998 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 71.439999999999998 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 72.409999999999997 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.3 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.510000000000005 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.430000000000007 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.430000000000007 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.209999999999994 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 73.519999999999996 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.420000000000002 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.129999999999995 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.200000000000003 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 64.129999999999995 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 42.210000000000001 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.219999999999999 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.439999999999998 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.209999999999994 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.140000000000001 108.425 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.329999999999998 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 62.530000000000001 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.420000000000002 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 73.030000000000001 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 61.0 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.219999999999999 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.430000000000007 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.420000000000002 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.439999999999998 110.707 -176.121 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.905 -0.776 . . . . 71.340000000000003 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 55.530000000000001 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 72.519999999999996 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.109999999999999 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.109999999999999 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.019999999999996 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.150000000000006 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.150000000000006 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.430000000000007 114.224 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.340000000000003 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 53.0 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.349999999999994 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.119999999999997 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 55.32 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.439999999999998 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.120000000000005 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.439999999999998 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.140000000000001 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 50.240000000000002 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.140000000000001 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 55.229999999999997 109.376 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 70.209999999999994 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.310000000000002 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 63.0 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 52.509999999999998 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 73.120000000000005 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.049999999999997 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.129999999999995 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.239999999999995 106.13 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.009999999999998 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.230000000000004 112.413 178.209 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.443 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 113.23 0.826 . . . . 74.120000000000005 113.23 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.464 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 60.299999999999997 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.219999999999999 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 71.030000000000001 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 61.32 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.010000000000005 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.519999999999996 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 41.409999999999997 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 72.109999999999999 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.299999999999997 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.539999999999999 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.625 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.039999999999999 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.417 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.239999999999995 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.150000000000006 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.625 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.120000000000005 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.628 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 14.5 p-10 -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 111.79 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.010000000000005 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.439999999999998 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 6.6 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.109999999999999 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.319999999999993 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.239999999999995 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 74.299999999999997 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.435 HD11 HD21 ' A' ' 381' ' ' ASN . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 64.540000000000006 111.836 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.544 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.049999999999997 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 8.1 m-20 -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.200000000000003 110.64 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.439999999999998 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 52.420000000000002 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.040000000000006 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 63.119999999999997 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 55.450000000000003 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.420000000000002 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.230000000000004 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.030000000000001 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 73.230000000000004 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 61.310000000000002 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.129999999999995 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.200000000000003 110.363 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.439999999999998 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.439999999999998 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.329999999999998 106.407 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.349999999999994 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 55.509999999999998 109.395 -177.392 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.187 -1.042 . . . . 75.049999999999997 108.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.409999999999997 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.420000000000002 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 73.140000000000001 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.504 HG23 ' HE2' ' A' ' 402' ' ' TYR . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.430000000000007 111.109 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 53.520000000000003 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.140000000000001 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.436 ' H ' HG12 ' A' ' 420' ' ' VAL . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 70.439999999999998 113.202 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.539999999999999 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 70.140000000000001 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 63.200000000000003 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.150000000000006 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.439999999999998 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 63.32 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 52.539999999999999 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.52 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.140000000000001 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 74.010000000000005 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 72.400000000000006 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 61.200000000000003 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.47 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.540000000000006 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.47 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.340000000000003 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.129999999999995 108.752 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.230000000000004 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.319999999999993 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 418' ' ' VAL . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.219999999999999 107.913 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 60.520000000000003 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.230000000000004 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 71.310000000000002 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.539999999999999 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.349999999999994 110.537 176.304 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 107.913 -1.143 . . . . 43.140000000000001 107.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 61.329999999999998 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.120000000000005 107.07 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 71.140000000000001 109.174 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 74.319999999999993 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.530000000000001 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.140000000000001 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.349999999999994 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 51.0 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HE2' ' HE2' ' A' ' 366' ' ' LYS . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.310000000000002 106.623 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 61.5 106.697 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 71.109999999999999 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.433 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.019999999999996 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.219999999999999 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.209999999999994 111.264 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.557 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.140000000000001 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 63.299999999999997 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.340000000000003 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.009999999999998 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.239999999999995 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.239999999999995 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.540000000000006 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 62.310000000000002 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.510000000000005 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.625 HD21 HD21 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.329999999999998 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.349999999999994 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 61.130000000000003 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 73.319999999999993 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 70.510000000000005 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.140000000000001 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.329999999999998 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 70.230000000000004 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.140000000000001 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.299999999999997 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 63.43 108.438 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.557 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.530000000000001 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 60.509999999999998 111.044 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 60.240000000000002 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 31.510000000000002 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.0 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.349999999999994 106.726 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 51.200000000000003 113.656 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.119999999999997 108.991 -176.706 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 121.473 0.654 . . . . 74.530000000000001 111.899 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 402' ' ' TYR . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 54.140000000000001 108.275 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.329999999999998 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.409999999999997 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.486 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 62.020000000000003 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 72.400000000000006 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 72.329999999999998 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.409999999999997 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.019999999999996 114.325 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.420000000000002 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 62.229999999999997 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.409999999999997 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.409999999999997 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 64.209999999999994 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 72.420000000000002 107.48 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 63.200000000000003 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 51.130000000000003 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.310000000000002 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.129999999999995 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 55.420000000000002 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.510000000000005 109.687 -177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.539999999999999 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.340000000000003 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 72.099999999999994 109.2 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 71.349999999999994 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 73.230000000000004 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.420000000000002 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.109999999999999 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 54.350000000000001 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 71.230000000000004 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.509999999999998 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 63.200000000000003 110.177 175.326 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.649 0.261 . . . . 62.0 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -107.33 132.62 52.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.404 -0.591 . . . . 70.319999999999993 109.404 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -75.38 140.08 42.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.872 0.367 . . . . 75.329999999999998 110.107 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 12.3 tt -94.21 131.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.439 -0.578 . . . . 71.030000000000001 109.439 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HB3' ' OE2' ' A' ' 380' ' ' GLU . 64.7 pttt -96.85 156.26 16.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.868 -0.733 . . . . 74.540000000000006 111.631 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -83.49 -120.8 0.76 Allowed Glycine 0 N--CA 1.423 -2.187 0 CA-C-N 115.46 -0.791 . . . . 64.329999999999998 112.285 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -14.15 15.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 112.57 0.581 . . . . 71.230000000000004 112.57 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 63.3 92.98 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.527 0.68 . . . . 71.129999999999995 111.275 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.444 HG22 HG13 ' A' ' 428' ' ' ILE . 9.8 m -100.62 129.12 46.5 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.035 -1.469 . . . . 64.150000000000006 107.035 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.420000000000002 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.140000000000001 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.020000000000003 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.631 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 73.140000000000001 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.209999999999994 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.129999999999995 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.310000000000002 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.631 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.540000000000006 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.150000000000006 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 54.130000000000003 109.037 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.549999999999997 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.150000000000006 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 361' ' ' LYS . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.120000000000005 112.399 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 60.409999999999997 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.209999999999994 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 64.319999999999993 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.9 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.430000000000007 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.120000000000005 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 65.340000000000003 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.567 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.049999999999997 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.588 HD21 HD21 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 71.209999999999994 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 64.219999999999999 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.409999999999997 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.530000000000001 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 65.340000000000003 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.520000000000003 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 64.420000000000002 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 62.25 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 62.539999999999999 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.439999999999998 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.482 HD21 ' HB1' ' A' ' 448' ' ' ALA . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 61.049999999999997 108.324 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.540000000000006 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 63.229999999999997 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.519999999999996 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.510000000000005 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.310000000000002 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 24.0 m120 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 54.299999999999997 111.335 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.219999999999999 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.439 HE21 HG23 ' A' ' 387' ' ' ILE . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 63.109999999999999 106.326 -177.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.140000000000001 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 412' ' ' PRO . 43.4 t -94.65 -21.71 18.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.409999999999997 110.217 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.27 -36.37 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.232 1.413 . . . . 52.5 112.687 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 408' ' ' CYS . 38.0 m-80 -101.46 10.03 40.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.653 0.74 . . . . 72.430000000000007 109.736 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -171.61 -153.19 8.88 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.562 -1.015 . . . . 60.310000000000002 110.562 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 408' ' ' CYS . 95.0 Cg_endo -81.8 -162.24 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.593 2.195 . . . . 70.439999999999998 110.779 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -57.4 142.39 43.96 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.267 -0.424 . . . . 72.219999999999999 110.55 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -71.1 156.39 39.65 Favored 'General case' 0 C--O 1.267 1.989 0 C-N-CA 119.464 -0.894 . . . . 73.109999999999999 108.661 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.537 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.409999999999997 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.329999999999998 108.397 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 62.049999999999997 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 62.200000000000003 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.299999999999997 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.430000000000007 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.420000000000002 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.349999999999994 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 71.140000000000001 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 50.43 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 60.350000000000001 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.515 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 64.109999999999999 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 70.030000000000001 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.400000000000006 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.549999999999997 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 72.25 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 55.8 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.420000000000002 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.340000000000003 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 35.399999999999999 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.049999999999997 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 73.109999999999999 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.430000000000007 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.430000000000007 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.209999999999994 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 70.040000000000006 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.319999999999993 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.109999999999999 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.22 -27.89 48.26 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.450000000000003 111.645 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.28 -10.67 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.822 -0.627 . . . . 73.299999999999997 110.918 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -83.86 -24.44 30.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.124 -0.489 . . . . 63.119999999999997 110.915 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 55.5 m -67.86 132.56 47.6 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 109.801 -0.444 . . . . 64.540000000000006 109.801 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.411 -0.959 . . . . 44.340000000000003 108.411 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.45 ' HA ' ' CD ' ' A' ' 380' ' ' GLU . 79.2 m-85 . . . . . 0 CA--C 1.501 -0.935 0 N-CA-C 109.245 -0.65 . . . . 74.230000000000004 109.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -90.85 89.67 7.58 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.13 -0.941 . . . . 62.32 113.084 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 66.19 -72.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.119 1.367 . . . . 55.299999999999997 113.08 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.26 115.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.583 -0.895 . . . . 73.549999999999997 108.583 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 361' ' ' LYS . 1.8 pptp? -123.82 130.97 53.45 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.235 -0.586 . . . . 73.299999999999997 109.728 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.5 -87.97 1.95 Allowed Glycine 0 C--N 1.294 -1.762 0 C-N-CA 120.041 -1.076 . . . . 55.350000000000001 111.905 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.539 ' HB2' HG13 ' A' ' 377' ' ' VAL . 50.8 ttm 60.04 81.38 0.18 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.866 0.866 . . . . 64.430000000000007 110.873 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.18 -38.39 0.11 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.385 -0.969 . . . . 72.140000000000001 108.385 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 428' ' ' ILE . 7.4 m -90.56 124.96 35.44 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 118.845 -1.142 . . . . 74.0 111.398 -170.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.319999999999993 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 64.510000000000005 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 61.530000000000001 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.399999999999999 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.549999999999997 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 374' ' ' TYR . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 74.519999999999996 111.241 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 53.329999999999998 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.409999999999997 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 64.019999999999996 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.507 HG21 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 73.040000000000006 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 363' ' ' MET . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.219999999999999 110.67 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.510000000000005 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.109999999999999 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.45 ' CD ' ' HA ' ' A' ' 357' ' ' TYR . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.430000000000007 109.829 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.109999999999999 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.109999999999999 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.488 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 63.130000000000003 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.445 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.319999999999993 109.524 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.409999999999997 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.129999999999995 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.445 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 109.822 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.420000000000002 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.340000000000003 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.030000000000001 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 62.43 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.349999999999994 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.299999999999997 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.109999999999999 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.299999999999997 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 74.010000000000005 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 45.030000000000001 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.120000000000005 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.549999999999997 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 63.140000000000001 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.534 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.299999999999997 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 73.409999999999997 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 62.240000000000002 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.409999999999997 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.030000000000001 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.209999999999994 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.329999999999998 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 414' ' ' ARG . 28.5 p -106.18 -16.86 14.48 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.109999999999999 110.595 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 62.81 23.67 14.11 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.513 0.725 . . . . 75.310000000000002 111.528 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.447 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 23.8 t-20 -128.84 -54.02 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.765 -0.652 . . . . 75.129999999999995 109.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.87 -156.11 10.03 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 109.199 -1.56 . . . . 32.130000000000003 109.199 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.19 -68.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.597 2.198 . . . . 53.130000000000003 112.173 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -143.98 157.62 44.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.997 -1.112 . . . . 61.100000000000001 107.997 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 408' ' ' CYS . 45.0 ttm105 -71.16 147.26 48.52 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.120000000000005 109.178 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.534 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.430000000000007 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 71.329999999999998 109.797 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 440' ' ' LEU . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.439999999999998 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 62.409999999999997 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 72.219999999999999 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.230000000000004 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.569 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 71.239999999999995 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 35.130000000000003 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 71.209999999999994 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.319999999999993 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.329999999999998 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 43.020000000000003 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 365' ' ' THR . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.420000000000002 107.429 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.549999999999997 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 41.310000000000002 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.219999999999999 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.519999999999996 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.340000000000003 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.420000000000002 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.329999999999998 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.209999999999994 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.55 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 70.310000000000002 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.019999999999996 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 73.450000000000003 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 65.140000000000001 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.109999999999999 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.507 ' SD ' HG21 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 64.310000000000002 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.510000000000005 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.310000000000002 107.134 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.72 -29.98 42.17 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 60.109999999999999 112.688 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.18 -18.35 63.19 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.215 0.531 . . . . 73.430000000000007 111.152 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.29 65.31 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.669 -0.696 . . . . 63.109999999999999 111.676 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 65.6 m -68.34 -37.35 80.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.376 -0.53 . . . . 73.540000000000006 109.952 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 123.963 0.905 . . . . 71.400000000000006 112.167 177.637 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 109.488 -0.56 . . . . 71.150000000000006 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -154.04 155.8 36.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.022 -1.473 . . . . 71.299999999999997 107.022 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.71 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.254 0.346 . . . . 70.340000000000003 110.616 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.84 116.35 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.353 -0.98 . . . . 62.119999999999997 108.353 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.5 121.52 30.04 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.458 -0.792 . . . . 71.140000000000001 110.784 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -103.79 64.69 0.36 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.615 -0.802 . . . . 43.109999999999999 111.38 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 24.5 ptm -84.27 37.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.045 0.938 . . . . 72.209999999999994 111.213 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -20.52 39.33 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.262 1.208 . . . . 63.210000000000001 114.262 -170.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.445 HG22 HG13 ' A' ' 428' ' ' ILE . 6.1 m -122.21 135.24 54.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 118.456 -1.297 . . . . 70.140000000000001 111.56 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 64.400000000000006 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 64.439999999999998 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.430000000000007 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 72.140000000000001 110.305 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 51.130000000000003 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.530000000000001 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 74.109999999999999 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 71.040000000000006 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.672 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.420000000000002 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 71.239999999999995 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.219999999999999 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 363' ' ' MET . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 65.129999999999995 106.992 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.4 ' HB3' ' HD1' ' A' ' 379' ' ' TYR . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.400000000000006 112.836 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.4 ' HD1' ' HB3' ' A' ' 378' ' ' PHE . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.319999999999993 112.254 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.230000000000004 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HB2' HD11 ' A' ' 388' ' ' LEU . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.120000000000005 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.099999999999994 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 373' ' ' THR . 8.5 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 61.219999999999999 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.099999999999994 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.099999999999994 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 65.409999999999997 110.75 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 63.130000000000003 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 74.239999999999995 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 32.310000000000002 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.109999999999999 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.109999999999999 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 72.420000000000002 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.430000000000007 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.420000000000002 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.219999999999999 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 71.109999999999999 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 63.340000000000003 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.430000000000007 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.120000000000005 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 73.209999999999994 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 64.329999999999998 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.299999999999997 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.310000000000002 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 388' ' ' LEU . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 110.838 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.340000000000003 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.69 -34.06 34.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.209999999999994 109.544 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.17 -164.95 0.44 Allowed 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.83 -2.656 . . . . 55.539999999999999 103.83 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -76.68 82.59 3.32 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.799 -0.76 . . . . 72.420000000000002 109.868 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 164.08 -99.56 0.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.524 -0.762 . . . . 72.219999999999999 111.78 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.99 -178.5 4.43 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.186 1.924 . . . . 74.439999999999998 113.82 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -116.42 165.31 13.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.047 -0.979 . . . . 52.32 109.71 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -85.16 166.33 16.68 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.288 0.566 . . . . 75.019999999999996 111.488 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.019999999999996 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 70.040000000000006 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.239999999999995 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.329999999999998 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.51 HG11 ' HB3' ' A' ' 448' ' ' ALA . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.129999999999995 108.789 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.549999999999997 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.484 ' H ' HG12 ' A' ' 420' ' ' VAL . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.310000000000002 112.971 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.399999999999999 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.140000000000001 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.420000000000002 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.229999999999997 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.219999999999999 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 64.109999999999999 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 54.119999999999997 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.120000000000005 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.439999999999998 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.039999999999999 109.289 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.209999999999994 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.409999999999997 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 61.25 108.181 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.109999999999999 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.409999999999997 107.427 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 74.439999999999998 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.239999999999995 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.129999999999995 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.109999999999999 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 41.049999999999997 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.43 -29.73 24.98 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 71.239999999999995 111.367 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.45 -11.54 58.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.323 0.583 . . . . 74.120000000000005 112.186 -175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.51 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -110.17 -1.72 17.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.673 0.749 . . . . 64.25 108.984 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 36.2 t -70.58 -32.84 70.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.664 -1.153 . . . . 73.310000000000002 110.661 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 108.982 -0.747 . . . . 65.430000000000007 108.982 179.034 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.948 -1.13 . . . . 63.210000000000001 107.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -52.45 2.82 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 104.936 -2.246 . . . . 63.229999999999997 104.936 170.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -124.61 157.11 36.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.092 -1.818 . . . . 71.030000000000001 106.092 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 10.9 tt -125.08 140.35 48.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 120.2 -0.6 . . . . 60.109999999999999 111.542 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -78.76 121.32 24.61 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.356 -0.979 . . . . 74.150000000000006 108.356 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.17 -66.98 1.6 Allowed Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.757 -0.735 . . . . 62.030000000000001 112.8 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.666 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 24.6 mmt -129.78 178.9 6.17 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.251 -1.389 . . . . 52.32 107.251 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.61 69.11 1.08 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 122.584 1.183 . . . . 74.140000000000001 109.178 166.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m -76.51 131.75 39.18 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 53.100000000000001 106.976 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 63.43 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 72.409999999999997 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.519999999999996 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.491 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 65.129999999999995 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 34.530000000000001 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.219999999999999 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.120000000000005 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 71.209999999999994 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.109999999999999 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.450000000000003 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 25.420000000000002 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 363' ' ' MET . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.430000000000007 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 62.539999999999999 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 72.230000000000004 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.420000000000002 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.140000000000001 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.200000000000003 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.8 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 71.510000000000005 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.450000000000003 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 52.350000000000001 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.349999999999994 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.512 HD13 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.349999999999994 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.120000000000005 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 54.340000000000003 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 63.130000000000003 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.239999999999995 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.420000000000002 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.119999999999997 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.340000000000003 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.450000000000003 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.140000000000001 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.439999999999998 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.665 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 71.230000000000004 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.744 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 60.130000000000003 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.430000000000007 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.519999999999996 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.450000000000003 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.209999999999994 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.420000000000002 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.329999999999998 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.92 -28.03 11.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.140000000000001 110.939 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . 71.15 135.08 0.04 OUTLIER 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.361 1.064 . . . . 52.32 109.218 -172.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 54.2 t30 74.74 -33.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.145 0.978 . . . . 64.510000000000005 110.612 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -117.47 104.12 1.14 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.878 -1.689 . . . . 74.530000000000001 108.878 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.79 113.75 1.65 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 123.305 2.67 . . . . 71.140000000000001 112.62 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.0 m170 69.01 128.34 0.03 OUTLIER 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.502 1.521 . . . . 70.150000000000006 112.108 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -84.75 148.53 26.3 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.489 -2.041 . . . . 73.030000000000001 105.489 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.744 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.439999999999998 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 41.310000000000002 108.787 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 72.049999999999997 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.140000000000001 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.209999999999994 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 448' ' ' ALA . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.219999999999999 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 70.209999999999994 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.415 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.420000000000002 114.339 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.219999999999999 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.140000000000001 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.099999999999994 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.329999999999998 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.420000000000002 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.239999999999995 108.103 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.450000000000003 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.520000000000003 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 71.099999999999994 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.239999999999995 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.329999999999998 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 71.230000000000004 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.299999999999997 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.200000000000003 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 61.340000000000003 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.443 ' CD1' HD22 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.120000000000005 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 72.530000000000001 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.366 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 73.439999999999998 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 70.230000000000004 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.439999999999998 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.19 -23.81 20.72 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.519999999999996 111.006 174.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.86 63.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 61.340000000000003 112.386 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.561 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -104.94 -2.29 24.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.782 . . . . 70.129999999999995 109.189 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.22 93.41 6.49 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.955 -1.021 . . . . 63.030000000000001 109.28 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.797 -1.186 . . . . 75.329999999999998 107.797 179.184 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 112.361 0.504 . . . . 72.420000000000002 112.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.401 ' O ' ' HE2' ' A' ' 361' ' ' LYS . 98.5 mtt180 -138.64 73.41 1.43 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.482 -1.673 . . . . 72.439999999999998 106.482 171.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 65.43 -173.5 0.18 Allowed 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.816 -1.083 . . . . 43.140000000000001 109.189 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.59 114.81 27.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.091 -1.044 . . . . 74.400000000000006 110.344 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 358' ' ' ARG . 68.1 mttm -114.39 137.68 51.52 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.516 -1.22 . . . . 73.239999999999995 107.74 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.34 -58.36 1.02 Allowed Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 119.41 -1.376 . . . . 54.32 110.742 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 57.1 mtm -143.58 169.98 16.69 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.034 -2.21 . . . . 62.310000000000002 105.034 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -136.13 75.18 1.53 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.217 1.008 . . . . 73.140000000000001 108.901 170.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m -76.32 121.42 22.96 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.420000000000002 107.621 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.209999999999994 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.424 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.319999999999993 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.400000000000006 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 73.299999999999997 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.420000000000002 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.239999999999995 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.310000000000002 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.230000000000004 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.430000000000007 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.209999999999994 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 65.319999999999993 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 363' ' ' MET . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 23.43 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.040000000000006 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.340000000000003 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.219999999999999 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.329999999999998 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 62.009999999999998 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.439999999999998 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.526 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 8.6 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 62.210000000000001 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 60.140000000000001 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 53.539999999999999 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.526 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 55.340000000000003 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 73.5 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 374' ' ' TYR . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 53.539999999999999 109.907 175.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.420000000000002 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 52.009999999999998 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.420000000000002 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 51.030000000000001 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.219999999999999 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.349999999999994 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 74.519999999999996 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.409999999999997 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.420000000000002 109.106 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 70.530000000000001 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.448 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.340000000000003 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.599 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.430000000000007 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 51.039999999999999 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.599 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 52.299999999999997 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.340000000000003 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.120000000000005 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.420000000000002 106.407 -178.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.209999999999994 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.64 -45.07 31.45 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.209999999999994 110.409 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.67 124.33 0.67 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.901 -1.148 . . . . 73.109999999999999 107.901 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.84 -49.25 0.67 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.132 0.973 . . . . 64.430000000000007 113.31 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -159.43 -61.18 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.922 -0.932 . . . . 71.430000000000007 114.413 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -44.94 147.44 1.96 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.02 3.147 . . . . 64.120000000000005 115.414 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -69.48 146.05 52.24 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.854 1.428 . . . . 54.549999999999997 114.854 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -91.09 165.02 13.73 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 62.240000000000002 107.76 162.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.561 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.439999999999998 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 63.109999999999999 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.140000000000001 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 73.040000000000006 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.200000000000003 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 71.310000000000002 109.275 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.129999999999995 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.422 ' H ' HG12 ' A' ' 420' ' ' VAL . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.229999999999997 111.157 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.439999999999998 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 43.219999999999999 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.230000000000004 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.0 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 62.32 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.310000000000002 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 54.340000000000003 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.129999999999995 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.528 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.129999999999995 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.019999999999996 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.409999999999997 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.120000000000005 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 50.0 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.420000000000002 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.039999999999999 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.019999999999996 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.430000000000007 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 43.340000000000003 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 61.530000000000001 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.409999999999997 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 73.010000000000005 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.319999999999993 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.340000000000003 108.667 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -28.86 51.74 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 55.149999999999999 111.211 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.75 -5.24 47.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.38 -0.827 . . . . 62.130000000000003 111.665 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.15 24.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.273 -0.422 . . . . 43.130000000000003 111.822 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 66.5 m -67.46 85.45 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.624 0.726 . . . . 45.420000000000002 112.262 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 107.359 -1.349 . . . . 71.420000000000002 107.359 177.863 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.065 -0.346 . . . . 74.340000000000003 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -55.38 -56.36 21.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -115.25 156.95 24.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.095 -0.502 . . . . 74.109999999999999 111.798 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 11.1 tt -83.24 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.63 -0.878 . . . . 73.239999999999995 108.63 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -117.23 147.94 42.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.955 0.407 . . . . 74.340000000000003 111.444 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -120.18 -145.21 7.36 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 120.815 -0.707 . . . . 73.219999999999999 113.205 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 10.8 mmt -66.88 153.37 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.799 0.84 . . . . 74.140000000000001 111.888 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.56 99.24 7.02 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.077 -1.082 . . . . 75.420000000000002 108.077 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.431 -0.508 . . . . 71.409999999999997 109.944 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 74.209999999999994 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.239999999999995 106.104 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.540000000000006 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 71.150000000000006 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.420000000000002 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.149999999999999 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.450000000000003 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.310000000000002 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.109999999999999 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.409999999999997 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.4 HG11 ' SD ' ' A' ' 443' ' ' MET . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.439999999999998 108.767 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.53 HG11 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.010000000000005 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.403 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.510000000000005 110.192 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 70.439999999999998 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' HG11 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.349999999999994 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.566 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.4 p-10 -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 72.329999999999998 112.13 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.430000000000007 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.510000000000005 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.030000000000001 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.539999999999999 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.450000000000003 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.030000000000001 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 439' ' ' TYR . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.019999999999996 110.276 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.109999999999999 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.329999999999998 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 74.450000000000003 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 43.509999999999998 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.349999999999994 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 63.32 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.450000000000003 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 22.449999999999999 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 64.030000000000001 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.349999999999994 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 60.219999999999999 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.439999999999998 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.049999999999997 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.319999999999993 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.209999999999994 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 20.3 tm0? -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.209999999999994 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t -89.26 -35.51 16.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.439999999999998 109.08 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -138.53 -87.02 0.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.448 -0.575 . . . . 75.25 109.448 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -139.62 -2.3 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.444 -0.502 . . . . 75.209999999999994 111.699 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.4 -84.45 0.56 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.062 -0.815 . . . . 52.149999999999999 111.062 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.58 158.18 38.15 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 122.504 2.136 . . . . 55.25 112.949 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -106.97 170.34 8.01 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.719 -1.128 . . . . 71.299999999999997 109.105 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -85.3 168.01 15.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.412 -0.588 . . . . 62.25 109.412 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.430000000000007 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 40.229999999999997 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.109999999999999 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.518 HG22 HD12 ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 61.109999999999999 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 71.549999999999997 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.594 HG12 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.520000000000003 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.409999999999997 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.594 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 72.340000000000003 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.319999999999993 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.299999999999997 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 64.310000000000002 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.010000000000005 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.150000000000006 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.509 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 51.509999999999998 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.409999999999997 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 63.219999999999999 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.446 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 70.040000000000006 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 63.25 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.109999999999999 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.409999999999997 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 70.340000000000003 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.533 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.109999999999999 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.439999999999998 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.420000000000002 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.413 ' CD1' HD22 ' A' ' 389' ' ' LEU . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.230000000000004 112.126 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.491 ' HA ' HG23 ' A' ' 417' ' ' ILE . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 50.439999999999998 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 63.310000000000002 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.140000000000001 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 441' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.239999999999995 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.299999999999997 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.319999999999993 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.98 -28.84 23.7 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.049999999999997 111.97 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.28 -11.08 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.825 -0.625 . . . . 64.420000000000002 111.244 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' A' ' 420' ' ' VAL . . . -76.52 -35.83 58.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.653 -0.703 . . . . 71.219999999999999 111.257 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 59.5 m -64.64 98.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.216 0.531 . . . . 64.25 110.923 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.411 -2.389 0 N-CA-C 106.709 -1.589 . . . . 72.340000000000003 106.709 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 121.163 0.506 . . . . 70.299999999999997 112.34 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.55 -13.65 15.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.432 -0.951 . . . . 53.329999999999998 108.432 168.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -148.95 -172.82 4.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.93 -1.032 . . . . 62.420000000000002 108.606 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 69.2 mt -105.45 130.72 56.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.121 -1.066 . . . . 70.099999999999994 108.121 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.87 134.66 33.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.903 -1.119 . . . . 65.409999999999997 109.877 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -88.13 -115.71 1.24 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.721 -0.752 . . . . 74.329999999999998 111.398 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -107.67 155.99 19.56 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.239 -1.023 . . . . 72.010000000000005 108.239 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.453 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.5 pt-20 -120.18 95.03 4.58 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.712 0.768 . . . . 74.349999999999994 111.219 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 428' ' ' ILE . 20.4 m -79.7 140.7 36.91 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.129 -1.434 . . . . 63.439999999999998 107.129 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.540000000000006 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.010000000000005 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.420000000000002 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.150000000000006 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.210000000000001 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.409999999999997 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.549999999999997 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.099999999999994 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.230000000000004 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.430000000000007 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 382' ' ' VAL . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 60.350000000000001 109.208 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 364' ' ' GLU . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 43.119999999999997 107.297 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.495 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.219999999999999 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 70.239999999999995 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.540000000000006 111.676 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 16.2 p-10 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.319999999999993 112.076 -176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 389' ' ' LEU . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.329999999999998 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.230000000000004 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 64.319999999999993 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.399999999999999 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.455 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 72.420000000000002 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 383' ' ' PHE . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 70.040000000000006 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 382' ' ' VAL . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.109999999999999 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 50.420000000000002 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 7.8 m-20 -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 52.439999999999998 110.077 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.540000000000006 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 52.299999999999997 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.450000000000003 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 65.120000000000005 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.200000000000003 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.409999999999997 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.530000000000001 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 72.409999999999997 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.010000000000005 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.665 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 55.030000000000001 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.310000000000002 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.569 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.049999999999997 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.010000000000005 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.030000000000001 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.540000000000006 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.350000000000001 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 412' ' ' PRO . 41.3 t -77.51 -26.07 50.87 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.310000000000002 110.84 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.11 -42.84 0.53 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.054 . . . . 70.439999999999998 112.626 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.58 -32.96 74.83 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.183 -0.673 . . . . 72.329999999999998 109.183 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.93 -137.53 3.17 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.196 -1.561 . . . . 75.430000000000007 109.196 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 408' ' ' CYS . 8.1 Cg_exo -75.67 -161.67 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.51 2.14 . . . . 74.420000000000002 110.561 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -70.99 149.25 46.84 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.662 -0.649 . . . . 75.439999999999998 109.277 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -64.2 154.73 33.98 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.530000000000001 109.018 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.452 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.109999999999999 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 441' ' ' ILE . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 43.530000000000001 110.048 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 401' ' ' LYS . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.010000000000005 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 71.040000000000006 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 71.340000000000003 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.109999999999999 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.329999999999998 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 448' ' ' ALA . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.209999999999994 112.536 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 42.310000000000002 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.230000000000004 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 61.219999999999999 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 54.520000000000003 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.530000000000001 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 54.109999999999999 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.420000000000002 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.129999999999995 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.319999999999993 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.230000000000004 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.400000000000006 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.420000000000002 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 64.329999999999998 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.0 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.219999999999999 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 417' ' ' ILE . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.329999999999998 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.422 ' CD1' HG11 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 61.039999999999999 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 73.129999999999995 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 71.329999999999998 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 72.439999999999998 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.150000000000006 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.07 -26.55 50.4 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 53.210000000000001 111.046 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.42 62.41 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.254 -0.884 . . . . 72.439999999999998 110.958 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 422' ' ' CYS . . . -76.22 -21.77 56.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.078 -0.51 . . . . 65.219999999999999 111.029 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.75 -23.84 52.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.158 -0.473 . . . . 34.520000000000003 111.463 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 118.498 -0.763 . . . . 74.219999999999999 110.382 179.599 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 51.2 t80 . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.683 -1.229 . . . . 64.319999999999993 107.683 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 1.1 tpm_? 67.74 15.0 9.62 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.568 0.699 . . . . 54.140000000000001 111.131 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -96.91 117.13 30.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.8 -0.563 . . . . 61.009999999999998 110.487 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 6.5 tt -88.73 128.18 41.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.018 -0.537 . . . . 72.120000000000005 109.983 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HG3' ' CG ' ' A' ' 380' ' ' GLU . 2.9 mppt? -93.69 121.06 34.73 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.505 -0.316 . . . . 73.340000000000003 110.813 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 377' ' ' VAL . . . -121.99 -146.89 7.43 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.772 -1.204 . . . . 65.25 111.874 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 24.7 ptt? 177.95 38.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.504 -2.036 . . . . 61.32 105.504 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.51 -46.11 73.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.657 -2.065 . . . . 73.430000000000007 113.384 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m -122.44 143.33 49.75 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.647 -0.821 . . . . 65.420000000000002 110.997 -176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.109999999999999 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 70.099999999999994 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.329999999999998 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.556 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 63.049999999999997 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.010000000000005 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 45.009999999999998 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.230000000000004 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 62.509999999999998 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.409999999999997 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 64.200000000000003 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 62.420000000000002 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 362' ' ' GLY . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.209999999999994 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 62.119999999999997 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.519999999999996 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 361' ' ' LYS . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.219999999999999 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.109999999999999 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 50.340000000000003 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 73.349999999999994 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.509 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.2 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.450000000000003 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.439999999999998 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.239999999999995 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.509 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.400000000000006 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.439999999999998 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.602 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 73.420000000000002 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.530000000000001 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.299999999999997 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 70.400000000000006 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.129999999999995 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.409999999999997 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.409999999999997 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 62.450000000000003 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.450000000000003 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.448 ' HB2' ' HB1' ' A' ' 448' ' ' ALA . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 73.519999999999996 110.928 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.420000000000002 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.49 ' H ' HG12 ' A' ' 418' ' ' VAL . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 53.119999999999997 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 63.350000000000001 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.519999999999996 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.329999999999998 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.439999999999998 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 63.100000000000001 106.498 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.439999999999998 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t -97.47 -19.97 18.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 63.43 110.269 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 71.29 -37.86 0.4 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.945 1.298 . . . . 32.229999999999997 112.699 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -72.8 -55.35 6.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.202 0.601 . . . . 53.539999999999999 109.926 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.2 172.1 26.3 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 110.26 -1.136 . . . . 35.43 110.26 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.93 -56.69 2.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 122.646 2.231 . . . . 74.450000000000003 111.433 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -136.38 157.74 46.08 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.464 -1.68 . . . . 74.109999999999999 106.464 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 -85.37 145.83 27.29 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.596 -1.631 . . . . 74.019999999999996 106.596 171.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.209999999999994 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 71.230000000000004 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 400' ' ' LEU . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 64.200000000000003 110.566 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 71.430000000000007 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 448' ' ' ALA . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.430000000000007 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.349999999999994 111.771 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.448 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.240000000000002 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.340000000000003 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 71.430000000000007 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.540000000000006 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.589 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.239999999999995 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.340000000000003 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.613 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.439999999999998 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.210000000000001 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.109999999999999 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.219999999999999 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 72.439999999999998 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.099999999999994 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.100000000000001 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.140000000000001 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.450000000000003 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 44.310000000000002 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 74.230000000000004 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.140000000000001 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.430000000000007 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.140000000000001 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 45.32 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.613 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 65.129999999999995 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.329999999999998 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.420000000000002 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.32 -25.71 15.27 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.450000000000003 111.294 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.25 61.01 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.59 -0.732 . . . . 63.200000000000003 111.531 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.609 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -107.43 -2.3 20.65 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.571 -0.9 . . . . 43.509999999999998 108.571 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.5 t -72.74 -30.5 64.22 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.118 -1.067 . . . . 75.019999999999996 108.118 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.666 -1.605 . . . . 64.109999999999999 106.666 177.478 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 121.082 0.468 . . . . 74.430000000000007 110.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -172.91 177.44 2.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.927 -1.509 . . . . 74.530000000000001 106.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.87 149.6 47.68 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.128 0.489 . . . . 63.409999999999997 110.084 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 9.5 tt -117.2 139.45 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 109.162 -0.681 . . . . 75.319999999999993 109.162 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.08 120.42 26.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.077 -0.649 . . . . 73.310000000000002 110.455 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.32 -72.57 1.04 Allowed Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 107.941 -2.063 . . . . 55.439999999999998 107.941 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.62 81.09 0.14 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.042 1.337 . . . . 71.420000000000002 110.31 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.77 -27.04 6.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.474 -0.785 . . . . 51.329999999999998 111.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.485 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -122.42 136.27 54.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.23 -0.988 . . . . 72.530000000000001 112.811 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.129999999999995 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 72.120000000000005 109.571 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.420000000000002 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.510000000000005 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.209999999999994 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.549999999999997 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.239999999999995 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.420000000000002 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.430000000000007 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 71.129999999999995 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 54.140000000000001 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 60.020000000000003 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.406 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.120000000000005 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.409999999999997 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.219999999999999 110.544 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.553 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.5 p-10 -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.219999999999999 111.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 71.420000000000002 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.040000000000006 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 8.3 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.450000000000003 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.329999999999998 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 60.149999999999999 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 73.230000000000004 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.535 ' CD1' HD21 ' A' ' 381' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 73.420000000000002 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.450000000000003 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.409999999999997 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 5.2 m-20 -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.409999999999997 109.552 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.510000000000005 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 50.32 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.230000000000004 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.140000000000001 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.210000000000001 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.140000000000001 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.140000000000001 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 72.439999999999998 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 62.43 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 65.420000000000002 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.319999999999993 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.594 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 63.049999999999997 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.510000000000005 113.928 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.450000000000003 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.484 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 71.420000000000002 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.239999999999995 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.44 1.16 56.92 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.400000000000006 109.858 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 73.37 108.03 0.07 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.183 1.393 . . . . 54.32 111.224 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 72.49 -34.3 0.29 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.639 1.175 . . . . 51.530000000000001 112.363 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -97.81 -143.34 14.7 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 112.237 -0.345 . . . . 63.5 112.237 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.41 -151.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.839 3.026 . . . . 51.240000000000002 112.731 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.37 159.36 24.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.474 -0.565 . . . . 73.319999999999993 109.474 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.515 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 -67.86 155.9 38.34 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.487 0.661 . . . . 64.420000000000002 111.615 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.496 ' HB2' ' HG3' ' A' ' 438' ' ' GLU . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.129999999999995 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.399999999999999 109.527 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 53.210000000000001 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 70.219999999999999 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 44.219999999999999 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 61.020000000000003 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.430000000000007 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.512 ' H ' HG12 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 52.210000000000001 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.209999999999994 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.340000000000003 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 73.439999999999998 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.349999999999994 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 365' ' ' THR . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.019999999999996 106.935 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.340000000000003 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 53.149999999999999 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 70.049999999999997 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 64.129999999999995 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.219999999999999 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.420000000000002 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 97.6 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.439999999999998 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 72.430000000000007 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 53.140000000000001 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 54.450000000000003 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.516 ' CD1' HD22 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 63.32 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 73.299999999999997 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.519999999999996 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.109999999999999 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.129999999999995 109.534 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 74.299999999999997 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 65.319999999999993 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.2 -29.81 55.36 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.450000000000003 111.461 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.12 -5.39 43.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.448 -0.796 . . . . 73.349999999999994 111.388 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -91.48 -14.66 30.07 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 120.76 0.315 . . . . 73.329999999999998 111.339 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.4 m -69.67 -4.67 20.54 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.212 0.449 . . . . 61.399999999999999 112.212 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.077 -0.712 . . . . 62.100000000000001 109.077 176.914 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.164 0.507 . . . . 72.400000000000006 110.092 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 115.56 17.9 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.571 -1.64 . . . . 73.209999999999994 106.571 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.12 153.4 19.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.563 -0.903 . . . . 61.420000000000002 108.563 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 8.9 tp -100.71 137.26 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.066 0.46 . . . . 75.340000000000003 110.982 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -79.73 139.53 37.29 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.509 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.51 ' HA3' ' CD2' ' A' ' 379' ' ' TYR . . . -114.64 -98.7 2.25 Favored Glycine 0 N--CA 1.426 -2.012 0 C-N-CA 120.128 -1.034 . . . . 74.400000000000006 110.843 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 6.2 mmt -97.19 86.08 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.063 -1.088 . . . . 71.519999999999996 108.063 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 42.3 tt0 -81.36 106.64 13.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.008 -0.738 . . . . 73.239999999999995 109.008 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m -116.4 149.97 38.54 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.535 -0.913 . . . . 72.450000000000003 108.535 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.409999999999997 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 71.329999999999998 106.721 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.530000000000001 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 71.219999999999999 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.140000000000001 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 62.25 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 74.230000000000004 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 60.340000000000003 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.329999999999998 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.409999999999997 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.349999999999994 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.140000000000001 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 65.200000000000003 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.51 ' CD2' ' HA3' ' A' ' 362' ' ' GLY . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.230000000000004 111.253 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.239999999999995 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 390' ' ' GLY . 19.6 p-10 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.519999999999996 110.857 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.129999999999995 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 373' ' ' THR . 8.9 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.150000000000006 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.140000000000001 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 51.340000000000003 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.451 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 60.299999999999997 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 381' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.540000000000006 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 374' ' ' TYR . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.230000000000004 109.253 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.129999999999995 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 20.2 m120 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 62.140000000000001 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 60.530000000000001 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.150000000000006 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 72.319999999999993 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.140000000000001 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.439999999999998 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.239999999999995 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.310000000000002 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.400000000000006 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 64.200000000000003 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 70.450000000000003 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.129999999999995 110.308 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.140000000000001 111.197 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 72.129999999999995 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.019999999999996 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t -72.87 -18.57 61.42 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.399999999999999 111.65 -175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.25 -52.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.499 1.12 . . . . 43.0 110.973 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -65.11 -35.64 81.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.942 -0.762 . . . . 73.420000000000002 108.942 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -131.31 -155.66 8.22 Favored Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.338 -1.505 . . . . 74.439999999999998 109.338 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.28 -153.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.917 2.411 . . . . 71.0 110.75 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -62.5 135.21 57.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.736 -1.209 . . . . 55.310000000000002 107.736 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 -78.08 172.74 13.08 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.621 -0.832 . . . . 72.450000000000003 112.416 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.519999999999996 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.450000000000003 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 71.430000000000007 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.400000000000006 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.350000000000001 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 448' ' ' ALA . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 72.030000000000001 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.329999999999998 111.351 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.537 ' H ' HG12 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.319999999999993 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.109999999999999 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 50.340000000000003 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.549999999999997 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.239999999999995 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.140000000000001 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.040000000000006 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.520000000000003 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 41.530000000000001 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 71.299999999999997 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 65.420000000000002 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 60.43 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 50.240000000000002 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.150000000000006 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 74.25 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.512 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 62.329999999999998 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.150000000000006 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.310000000000002 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 72.030000000000001 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 64.340000000000003 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.540000000000006 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.409999999999997 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 64.439999999999998 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 42.140000000000001 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.68 -25.41 34.07 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.129999999999995 111.296 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.51 -16.63 60.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.917 -0.583 . . . . 72.439999999999998 112.317 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.646 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -116.67 -1.41 12.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.757 0.789 . . . . 75.209999999999994 109.03 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.5 t -73.35 115.67 12.98 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.275 -0.875 . . . . 72.439999999999998 109.179 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 107.655 -1.239 . . . . 72.140000000000001 107.655 177.795 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 109.573 -0.528 . . . . 73.540000000000006 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -110.81 120.11 41.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.237 -1.024 . . . . 72.349999999999994 108.237 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 60.44 -165.42 0.21 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.927 0.767 . . . . 62.109999999999999 110.225 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 66.4 mt -115.31 120.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.786 -1.19 . . . . 71.030000000000001 107.786 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -94.66 120.27 34.63 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.697 -0.853 . . . . 75.340000000000003 108.697 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -114.65 -67.31 0.45 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.538 -1.315 . . . . 71.239999999999995 113.035 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 52.6 mtm 68.22 81.84 0.18 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.696 -1.224 . . . . 71.310000000000002 107.696 -172.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -101.32 -59.98 1.6 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.034 0.753 . . . . 75.549999999999997 113.034 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m -121.79 150.88 41.24 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.385 -0.526 . . . . 74.540000000000006 110.806 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.519999999999996 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.230000000000004 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.219999999999999 109.633 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 63.509999999999998 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.509999999999998 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.539999999999999 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.040000000000006 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.450000000000003 111.757 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.140000000000001 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.540000000000006 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.434 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 63.210000000000001 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.524 HG11 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.010000000000005 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 63.240000000000002 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.594 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 64.5 110.678 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.524 ' OE2' HG11 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.519999999999996 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.109999999999999 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.519999999999996 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.239999999999995 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.6 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.409999999999997 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 71.439999999999998 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 71.409999999999997 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.614 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.430000000000007 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.562 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 60.219999999999999 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.549999999999997 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 44.549999999999997 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 61.119999999999997 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.310000000000002 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 61.119999999999997 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 52.329999999999998 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 62.43 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.329999999999998 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.299999999999997 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.310000000000002 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.140000000000001 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.573 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 71.310000000000002 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 65.239999999999995 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.56 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.400000000000006 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.239999999999995 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 65.129999999999995 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.439999999999998 108.448 -175.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 54.140000000000001 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.95 -11.34 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.150000000000006 110.979 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 66.72 13.77 9.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.569 1.148 . . . . 74.519999999999996 111.013 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -96.14 -41.33 8.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.412 -0.958 . . . . 65.540000000000006 108.412 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.16 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.924 -0.655 . . . . 65.230000000000004 111.55 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.0 -171.9 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.9 2.4 . . . . 74.400000000000006 112.153 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -83.63 144.44 29.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.517 -0.549 . . . . 71.239999999999995 109.517 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 13.1 ttm180 -68.96 152.88 44.7 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.757 -0.656 . . . . 73.450000000000003 109.519 -174.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.020000000000003 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 62.310000000000002 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.43 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.420000000000002 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.420000000000002 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 65.299999999999997 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.200000000000003 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.450000000000003 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 420' ' ' VAL . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 53.030000000000001 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.140000000000001 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 73.129999999999995 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.519999999999996 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.019999999999996 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.129999999999995 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.522 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.430000000000007 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.209999999999994 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.239999999999995 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.120000000000005 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 73.109999999999999 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.040000000000006 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 98.6 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.319999999999993 109.674 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.439999999999998 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.319999999999993 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 64.209999999999994 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.542 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 65.329999999999998 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 73.439999999999998 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 62.219999999999999 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 55.420000000000002 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.522 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.340000000000003 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 71.319999999999993 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.510000000000005 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.73 -28.96 51.51 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.329999999999998 111.567 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.08 62.24 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.911 -0.586 . . . . 70.129999999999995 111.313 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -74.87 -30.63 61.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.987 -0.552 . . . . 73.400000000000006 111.635 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.92 104.69 0.21 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.45 0.643 . . . . 63.229999999999997 110.483 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.416 -2.139 0 CA-C-N 114.905 -1.043 . . . . 74.120000000000005 110.295 -175.727 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.739 -0.837 . . . . 71.109999999999999 108.739 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 65.64 103.3 0.04 OUTLIER 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.892 1.277 . . . . 65.420000000000002 112.315 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.464 ' HB3' ' HG2' ' A' ' 380' ' ' GLU . . . -88.87 -165.14 1.26 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.751 -0.658 . . . . 65.430000000000007 109.474 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.0 mp -82.68 124.54 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.551 -0.537 . . . . 71.319999999999993 109.551 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.61 120.74 30.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.628 -1.249 . . . . 72.530000000000001 107.628 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -96.85 -83.09 1.66 Allowed Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 110.272 -1.131 . . . . 73.409999999999997 110.272 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 1.9 mpt? -122.86 175.13 6.72 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.083 -1.081 . . . . 73.409999999999997 108.083 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.88 97.18 3.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.706 -0.85 . . . . 74.040000000000006 108.706 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m -97.43 134.96 39.99 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.131 -1.433 . . . . 72.140000000000001 107.131 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 64.129999999999995 107.718 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.329999999999998 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 64.319999999999993 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.299999999999997 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 71.409999999999997 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 62.25 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 71.329999999999998 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.040000000000006 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 52.420000000000002 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.310000000000002 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.129999999999995 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.120000000000005 112.089 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.340000000000003 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.496 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 63.520000000000003 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 61.200000000000003 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.56 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.4 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.310000000000002 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.329999999999998 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.239999999999995 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.450000000000003 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.129999999999995 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 71.310000000000002 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.209999999999994 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 62.340000000000003 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.329999999999998 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 53.5 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.219999999999999 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.541 ' HG2' ' HG ' ' A' ' 400' ' ' LEU . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.349999999999994 105.057 174.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.540000000000006 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 62.520000000000003 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.219999999999999 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.319999999999993 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.541 ' HG ' ' HG2' ' A' ' 395' ' ' GLN . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 54.549999999999997 110.541 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.536 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 72.239999999999995 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.209999999999994 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.536 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.540000000000006 110.684 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.319999999999993 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 32.350000000000001 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 71.129999999999995 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.099999999999994 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t -69.54 -39.09 77.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.430000000000007 109.538 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -164.64 -66.28 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.392 -1.336 . . . . 60.439999999999998 107.392 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.5 98.72 1.13 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.72 0.771 . . . . 73.329999999999998 109.52 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.14 -79.88 0.33 Allowed Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.354 -1.098 . . . . 62.409999999999997 110.354 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.19 147.69 26.96 Favored 'Trans proline' 0 C--O 1.256 1.392 0 C-N-CA 122.755 2.303 . . . . 60.539999999999999 112.735 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.39 128.51 55.57 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.488 -1.233 . . . . 73.439999999999998 110.149 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -68.05 152.75 45.03 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 72.430000000000007 111.611 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.420000000000002 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.319999999999993 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.340000000000003 109.139 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.452 HG22 HD12 ' A' ' 441' ' ' ILE . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 61.310000000000002 110.173 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 64.040000000000006 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 71.530000000000001 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.310000000000002 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.565 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 64.120000000000005 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 25.52 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 72.530000000000001 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 64.209999999999994 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 64.230000000000004 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.140000000000001 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.420000000000002 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 62.100000000000001 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.409999999999997 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.310000000000002 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.310000000000002 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.049999999999997 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.230000000000004 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 71.420000000000002 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 73.109999999999999 116.377 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.510000000000005 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.239999999999995 109.114 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 55.329999999999998 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.420000000000002 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 443' ' ' MET . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 54.200000000000003 106.856 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.310000000000002 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.340000000000003 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.140000000000001 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.2 -28.86 47.74 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 62.420000000000002 111.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.56 -12.59 61.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.56 -0.746 . . . . 71.209999999999994 111.457 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -86.79 -15.62 38.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.482 -0.326 . . . . 71.5 111.353 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 31.2 m -70.64 90.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.456 0.646 . . . . 72.230000000000004 111.378 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.128 -1.434 . . . . 70.120000000000005 107.128 177.43 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.783 -0.821 . . . . 72.010000000000005 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 65.67 90.1 0.09 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.671 0.788 . . . . 63.439999999999998 112.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -176.91 158.66 1.62 Allowed 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.809 -1.552 . . . . 44.200000000000003 106.809 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 35.4 pt -85.86 127.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.944 -0.702 . . . . 61.119999999999997 109.776 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 55.3 pttt -123.02 150.35 43.16 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 119.253 -0.979 . . . . 72.230000000000004 109.405 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -90.55 -72.56 1.25 Allowed Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 108.631 -1.788 . . . . 73.430000000000007 108.631 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.3 tpp -165.37 130.75 2.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.382 -1.71 . . . . 74.430000000000007 106.382 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 375' ' ' LYS . 1.4 pm0 -77.35 95.69 4.46 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.3 -0.96 . . . . 75.510000000000005 111.403 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m -74.59 134.62 42.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.439999999999998 107.477 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 61.100000000000001 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.461 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 74.310000000000002 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.229999999999997 112.018 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.530000000000001 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 65.310000000000002 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.099999999999994 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 65.349999999999994 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 74.310000000000002 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.219999999999999 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 72.310000000000002 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 64.209999999999994 110.21 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 71.140000000000001 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 62.009999999999998 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.549999999999997 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 61.439999999999998 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.230000000000004 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 7.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.230000000000004 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 70.430000000000007 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.530000000000001 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.450000000000003 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.531 HD21 HD21 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 44.32 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 71.319999999999993 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 51.310000000000002 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 63.5 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.099999999999994 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.439999999999998 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 33.399999999999999 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 73.450000000000003 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 70.519999999999996 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.209999999999994 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.408 HD21 ' HB1' ' A' ' 448' ' ' ALA . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.209999999999994 109.047 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.099999999999994 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 50.539999999999999 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.299999999999997 107.557 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 63.329999999999998 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 63.119999999999997 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 51.399999999999999 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.420000000000002 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.409999999999997 111.23 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.12 -26.51 18.24 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.030000000000001 108.962 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . -167.19 -170.12 1.42 Allowed 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.095 -2.187 . . . . 64.329999999999998 105.095 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -77.86 22.72 0.27 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.526 0.679 . . . . 74.409999999999997 110.072 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -139.12 -79.56 0.07 OUTLIER Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 111.798 -0.521 . . . . 31.300000000000001 111.798 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 409' ' ' ALA . 2.9 Cg_exo -71.32 148.86 56.02 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.985 1.79 . . . . 75.040000000000006 113.94 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.9 2.57 32.7 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.07 -1.423 . . . . 70.230000000000004 110.685 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 75.32 150.51 0.11 Allowed 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.712 1.205 . . . . 64.310000000000002 110.576 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.239999999999995 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.340000000000003 107.841 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.140000000000001 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 441' ' ' ILE . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.430000000000007 110.199 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.329999999999998 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 71.109999999999999 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 62.520000000000003 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.544 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.140000000000001 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.439999999999998 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 53.530000000000001 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.109999999999999 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.230000000000004 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.549999999999997 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 63.420000000000002 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 53.530000000000001 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.030000000000001 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 64.209999999999994 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.040000000000006 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.559 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.340000000000003 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.239999999999995 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 51.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.349999999999994 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.219999999999999 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.559 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 65.140000000000001 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 54.420000000000002 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 64.519999999999996 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.329999999999998 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 64.109999999999999 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.561 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.409999999999997 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.099999999999994 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.310000000000002 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.74 -28.08 44.08 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.109999999999999 112.051 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.95 -16.07 62.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.792 -0.64 . . . . 65.540000000000006 111.141 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -77.05 -29.29 55.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.069 -0.514 . . . . 64.109999999999999 111.319 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 51.9 m -61.64 102.81 0.28 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.185 0.517 . . . . 61.219999999999999 111.643 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.419 -1.997 0 N-CA-C 107.151 -1.425 . . . . 62.310000000000002 107.151 178.242 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 359' ' ' ALA . 78.8 m-85 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.824 0.345 . . . . 74.519999999999996 111.78 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -80.37 -24.28 39.89 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.853 -0.795 . . . . 72.430000000000007 108.853 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 357' ' ' TYR . . . -143.05 -166.18 2.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.26 -1.385 . . . . 70.319999999999993 107.26 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.71 136.62 51.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.511 -0.552 . . . . 65.340000000000003 109.511 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.8 135.15 36.41 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.831 -0.804 . . . . 63.100000000000001 108.831 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.63 -106.8 3.15 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.673 -1.251 . . . . 62.340000000000003 112.17 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.573 ' HG2' HD22 ' A' ' 426' ' ' ASN . 1.7 mpt? -90.79 108.84 20.09 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.0 -0.741 . . . . 53.310000000000002 109.0 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.19 93.81 6.45 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.978 -0.749 . . . . 75.239999999999995 108.978 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m -103.49 141.37 36.11 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.686 -1.228 . . . . 75.129999999999995 107.686 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 52.32 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.140000000000001 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.209999999999994 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 65.310000000000002 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 52.420000000000002 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.109999999999999 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.209999999999994 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.299999999999997 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.210000000000001 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.140000000000001 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.530000000000001 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 60.229999999999997 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.415 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 65.519999999999996 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.319999999999993 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.310000000000002 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 60.149999999999999 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.140000000000001 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.540000000000006 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.597 ' NE2' HD21 ' A' ' 389' ' ' LEU . 61.2 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 73.040000000000006 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.310000000000002 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.420000000000002 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 71.310000000000002 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.651 HD21 HD21 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.140000000000001 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.597 HD21 ' NE2' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.230000000000004 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.508 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 5.4400000000000004 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.651 HD21 HD21 ' A' ' 388' ' ' LEU . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.340000000000003 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.040000000000006 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 43.219999999999999 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.519999999999996 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.040000000000006 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 64.099999999999994 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 54.219999999999999 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.150000000000006 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.140000000000001 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 73.209999999999994 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.546 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.420000000000002 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.420000000000002 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.409999999999997 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 71.230000000000004 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.430000000000007 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.319999999999993 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 43.32 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.55 -16.45 27.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.200000000000003 111.145 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.54 73.42 0.48 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.528 -0.916 . . . . 74.540000000000006 108.528 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -169.88 -43.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.292 -1.322 . . . . 61.030000000000001 108.236 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.96 -73.87 0.27 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.656 -0.783 . . . . 61.310000000000002 111.71 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.79 179.48 3.68 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.432 2.088 . . . . 74.409999999999997 112.368 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -87.22 145.64 26.31 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.725 -0.843 . . . . 74.219999999999999 108.725 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 -75.82 145.84 40.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.08 -0.711 . . . . 74.340000000000003 109.08 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 34.520000000000003 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 63.229999999999997 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 45.340000000000003 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 63.039999999999999 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.040000000000006 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.150000000000006 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.485 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.510000000000005 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.140000000000001 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.219999999999999 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.450000000000003 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.573 HD22 ' HG2' ' A' ' 363' ' ' MET . 2.4 m-20 -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.239999999999995 109.468 177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.119999999999997 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 72.319999999999993 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.329999999999998 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 50.409999999999997 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 62.32 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.209999999999994 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.150000000000006 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 63.109999999999999 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.510000000000005 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 73.109999999999999 115.915 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.129999999999995 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.129999999999995 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 389' ' ' LEU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.439999999999998 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 64.409999999999997 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 72.140000000000001 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.219999999999999 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.150000000000006 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.420000000000002 108.587 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.49 -27.8 46.24 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 72.25 112.109 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.33 64.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.817 -0.629 . . . . 64.239999999999995 111.492 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -73.54 -28.15 61.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.204 -0.453 . . . . 75.420000000000002 111.766 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 33.2 m -64.96 108.68 1.86 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.23 0.538 . . . . 64.540000000000006 111.073 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.424 -1.764 0 N-CA-C 107.361 -1.348 . . . . 73.0 107.361 176.278 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.485 -0.561 . . . . 70.510000000000005 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -86.76 110.41 19.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 106.499 -1.667 . . . . 65.040000000000006 106.499 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.4 -168.9 2.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 110.224 -0.287 . . . . 71.439999999999998 110.224 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 360' ' ' ILE . 2.4 mp -89.54 129.44 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.812 -1.551 . . . . 61.039999999999999 106.812 176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -121.66 121.39 37.25 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.172 -1.011 . . . . 73.420000000000002 112.971 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -116.09 65.37 0.32 Allowed Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.639 -1.384 . . . . 63.32 109.639 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.467 ' HB2' HG13 ' A' ' 377' ' ' VAL . 60.5 ttp -93.0 107.3 19.11 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.008 0.523 . . . . 74.099999999999994 110.274 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -147.49 -7.55 0.45 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.685 -0.806 . . . . 71.340000000000003 110.598 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -121.78 133.43 54.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.466 -1.293 . . . . 74.109999999999999 111.646 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 32.219999999999999 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 62.229999999999997 106.677 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 71.010000000000005 111.768 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.475 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.340000000000003 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.009999999999998 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.530000000000001 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 72.530000000000001 110.976 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 71.519999999999996 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.402 ' HD2' ' SD ' ' A' ' 363' ' ' MET . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 63.210000000000001 107.487 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.129999999999995 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.513 HG11 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 65.450000000000003 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.230000000000004 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.239999999999995 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.513 ' OE1' HG11 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.399999999999999 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.542 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.450000000000003 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.230000000000004 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.140000000000001 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.230000000000004 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.420000000000002 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 52.119999999999997 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 64.319999999999993 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.209999999999994 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.455 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.439999999999998 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 30.210000000000001 112.048 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 6.9 m-20 -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 70.239999999999995 108.532 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 63.240000000000002 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 54.130000000000003 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.510000000000005 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.340000000000003 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.329999999999998 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.299999999999997 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 65.400000000000006 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 33.210000000000001 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.738 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.519999999999996 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.420000000000002 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 413' ' ' HIS . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 65.209999999999994 114.052 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.329999999999998 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 34.299999999999997 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.210000000000001 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -124.35 0.15 8.29 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 63.350000000000001 111.673 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.11 70.77 0.62 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.955 0.883 . . . . 75.019999999999996 109.87 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -153.25 -47.88 0.1 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.518 -1.219 . . . . 70.299999999999997 108.921 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.6 -80.24 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.949 -1.26 . . . . 64.400000000000006 109.949 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.88 -166.25 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.492 2.128 . . . . 70.329999999999998 111.241 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 404' ' ' ASN . 21.8 m-70 -88.65 165.52 14.72 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.119 -0.491 . . . . 70.329999999999998 110.058 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 12.0 ttm180 -76.03 159.57 30.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 60.030000000000001 109.251 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.461 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.310000000000002 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.219999999999999 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.340000000000003 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.040000000000006 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 65.420000000000002 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 63.539999999999999 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 73.129999999999995 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.619 ' H ' HG12 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.200000000000003 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.039999999999999 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.010000000000005 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.340000000000003 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 71.420000000000002 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.310000000000002 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 53.329999999999998 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.230000000000004 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 62.329999999999998 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.349999999999994 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 41.32 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 54.109999999999999 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.319999999999993 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 63.420000000000002 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 71.439999999999998 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.420000000000002 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 64.329999999999998 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.349999999999994 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.329999999999998 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.420000000000002 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.150000000000006 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.219999999999999 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.48 -28.99 45.43 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.737 -0.665 . . . . 75.120000000000005 111.862 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 420' ' ' VAL . . . -76.62 -33.81 58.36 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.342 -0.39 . . . . 72.209999999999994 111.426 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.94 109.83 1.18 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 54.329999999999998 111.34 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.617 -0.883 . . . . 75.040000000000006 108.617 177.001 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 120.594 0.235 . . . . 64.519999999999996 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -130.25 73.99 1.57 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.3 -1.0 . . . . 70.219999999999999 108.3 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -170.59 113.6 0.44 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.741 0.305 . . . . 75.219999999999999 111.484 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 70.9 mt -82.37 120.02 33.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.128 -1.434 . . . . 75.430000000000007 107.128 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.576 ' HD2' ' OE2' ' A' ' 380' ' ' GLU . 20.5 pttp -79.27 136.93 37.18 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.845 -0.342 . . . . 73.439999999999998 110.687 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.71 -78.67 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.482 -0.866 . . . . 55.229999999999997 112.851 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 12.2 tmm? 67.39 97.48 0.06 Allowed 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.689 1.196 . . . . 72.5 109.194 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.03 -35.15 0.33 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.656 -0.702 . . . . 70.430000000000007 110.586 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.542 HG22 HG13 ' A' ' 428' ' ' ILE . 3.7 m -95.17 132.79 39.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.477 -0.889 . . . . 73.420000000000002 110.809 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.120000000000005 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.420000000000002 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.450000000000003 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.449 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.340000000000003 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 34.549999999999997 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 61.439999999999998 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 64.409999999999997 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.140000000000001 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.430000000000007 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.549999999999997 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.509 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 70.239999999999995 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 363' ' ' MET . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 65.340000000000003 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.549999999999997 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.329999999999998 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 361' ' ' LYS . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 50.299999999999997 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 61.32 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.030000000000001 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.239999999999995 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 373' ' ' THR . 6.1 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.219999999999999 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.109999999999999 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.040000000000006 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.409 HG23 HE21 ' A' ' 406' ' ' GLN . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 110.57 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.446 HD21 HD21 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.512 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 65.120000000000005 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.040000000000006 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.430000000000007 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 400' ' ' LEU . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.409999999999997 111.208 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 63.5 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.340000000000003 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.439999999999998 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 54.439999999999998 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.219999999999999 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.413 HD21 ' HB1' ' A' ' 448' ' ' ALA . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.230000000000004 108.588 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.200000000000003 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 392' ' ' PHE . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.329999999999998 108.779 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.340000000000003 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 54.509999999999998 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.450000000000003 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.140000000000001 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.049999999999997 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.409 HE21 HG23 ' A' ' 387' ' ' ILE . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 62.210000000000001 106.442 -177.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.229999999999997 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.12 -44.96 8.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.530000000000001 110.129 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -156.64 -83.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.49 -0.323 . . . . 74.519999999999996 110.487 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -146.38 12.06 1.18 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.206 0.527 . . . . 61.450000000000003 110.694 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.55 -120.73 2.27 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.148 -1.181 . . . . 63.240000000000002 110.148 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.79 167.69 13.27 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.203 1.935 . . . . 31.25 111.986 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -94.17 -175.21 3.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.546 -0.909 . . . . 73.129999999999995 108.546 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -83.04 152.25 25.46 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.281 -0.637 . . . . 65.209999999999994 109.281 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.140000000000001 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.130000000000003 109.513 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.340000000000003 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.340000000000003 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.109999999999999 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 444' ' ' LYS . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 73.540000000000006 109.642 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.310000000000002 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.540000000000006 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.219999999999999 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.230000000000004 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 64.200000000000003 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.129999999999995 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 365' ' ' THR . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 70.340000000000003 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.340000000000003 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.439999999999998 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.400000000000006 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.209999999999994 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 73.519999999999996 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.420000000000002 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 70.310000000000002 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.436 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.109999999999999 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 61.329999999999998 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.319999999999993 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.519999999999996 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 64.5 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 44.229999999999997 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 65.209999999999994 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.85 -27.36 43.82 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.530000000000001 110.434 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.11 -15.81 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 51.149999999999999 110.804 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.413 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -72.69 -40.98 65.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.624 -0.716 . . . . 75.450000000000003 110.598 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.46 110.61 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.141 -0.689 . . . . 64.329999999999998 109.141 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.415 -2.184 0 N-CA-C 108.765 -0.828 . . . . 61.549999999999997 108.765 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 109.579 -0.526 . . . . 74.400000000000006 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -88.13 82.97 7.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.11 0.957 . . . . 61.329999999999998 111.594 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -145.68 140.67 27.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.521 -1.659 . . . . 53.329999999999998 106.521 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.4 mp -83.2 123.88 39.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.075 0.464 . . . . 71.209999999999994 110.179 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.75 121.97 42.57 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 73.409999999999997 108.914 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -110.17 50.77 0.75 Allowed Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.913 -0.66 . . . . 53.219999999999999 112.941 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.9 100.49 0.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.237 1.015 . . . . 75.010000000000005 110.535 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.11 95.42 0.4 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.814 0.816 . . . . 65.129999999999995 110.714 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m -85.77 127.68 34.61 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.430000000000007 107.51 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.120000000000005 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.44 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 73.040000000000006 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 54.240000000000002 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 62.530000000000001 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.239999999999995 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 50.399999999999999 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 51.539999999999999 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.349999999999994 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 64.430000000000007 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.439999999999998 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 72.400000000000006 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 55.25 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.120000000000005 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.010000000000005 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.200000000000003 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.340000000000003 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.439999999999998 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.129999999999995 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 373' ' ' THR . 7.7 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.519999999999996 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.329999999999998 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.099999999999994 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 64.439999999999998 110.892 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.219999999999999 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 72.530000000000001 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.430000000000007 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 72.540000000000006 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 61.329999999999998 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.340000000000003 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.209999999999994 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.230000000000004 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.530000000000001 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.240000000000002 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 420' ' ' VAL . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.109999999999999 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.200000000000003 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.5 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.140000000000001 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.239999999999995 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.439999999999998 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.661 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.229999999999997 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.319999999999993 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 55.210000000000001 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.109999999999999 110.2 174.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.79 -45.01 25.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.420000000000002 109.546 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -159.78 93.67 1.1 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.749 -1.114 . . . . 73.230000000000004 107.994 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 69.85 -49.25 0.63 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.758 1.223 . . . . 71.129999999999995 114.134 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -113.98 -97.58 2.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.476 -0.869 . . . . 65.340000000000003 114.124 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -49.95 155.98 3.82 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.522 2.815 . . . . 73.439999999999998 113.731 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 22.6 m-70 -96.28 159.44 14.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.181 -0.918 . . . . 71.219999999999999 110.934 -171.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -78.55 163.06 25.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.056 -0.975 . . . . 70.310000000000002 109.437 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 65.329999999999998 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.109999999999999 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 65.519999999999996 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.299999999999997 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.329999999999998 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 61.100000000000001 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.430000000000007 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.571 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.230000000000004 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.310000000000002 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 64.129999999999995 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.230000000000004 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.400000000000006 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.129999999999995 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.310000000000002 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.109999999999999 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 43.140000000000001 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 72.140000000000001 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.239999999999995 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.219999999999999 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.310000000000002 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.439999999999998 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.209999999999994 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.310000000000002 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 60.109999999999999 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 64.200000000000003 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.519999999999996 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 74.310000000000002 108.024 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.319999999999993 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.540000000000006 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.340000000000003 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.409999999999997 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.56 -18.76 48.85 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.120000000000005 111.213 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.41 85.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.306 -0.861 . . . . 61.109999999999999 112.078 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.49 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -100.78 -8.08 23.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.789 0.804 . . . . 54.25 109.429 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.9 t -78.61 -13.98 59.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.679 -1.146 . . . . 75.239999999999995 110.202 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 115.57 -0.741 . . . . 73.310000000000002 109.587 -179.367 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.141 0.496 . . . . 72.120000000000005 111.848 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -95.65 95.8 8.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.753 -1.203 . . . . 75.519999999999996 107.753 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 57.11 -165.52 0.15 Allowed 'General case' 0 C--O 1.256 1.417 0 O-C-N 123.859 0.724 . . . . 22.420000000000002 110.558 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.14 116.16 31.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.849 -1.167 . . . . 71.0 107.849 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.475 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 21.9 pttp -117.95 155.71 29.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.368 -0.378 . . . . 64.310000000000002 110.467 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.42 -130.1 6.46 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 120.636 -0.793 . . . . 73.319999999999993 111.514 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 65.7 mtt -94.7 90.44 6.1 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.656 0.741 . . . . 74.030000000000001 111.09 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.94 110.79 1.27 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.938 -1.483 . . . . 73.420000000000002 111.636 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m -121.94 144.83 48.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.982 -0.748 . . . . 63.310000000000002 108.982 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.329999999999998 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.427 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 52.130000000000003 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.329999999999998 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 62.439999999999998 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 63.109999999999999 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.530000000000001 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 60.200000000000003 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 63.509999999999998 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.129999999999995 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.219999999999999 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.099999999999994 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 73.25 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 55.340000000000003 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.010000000000005 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.509999999999998 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 71.439999999999998 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 72.409999999999997 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 9.3 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.510000000000005 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.430000000000007 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.430000000000007 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.209999999999994 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 73.519999999999996 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.420000000000002 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.129999999999995 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.200000000000003 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 64.129999999999995 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 42.210000000000001 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.219999999999999 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.439999999999998 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.209999999999994 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 420' ' ' VAL . 62.3 t30 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.140000000000001 108.425 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.329999999999998 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 62.530000000000001 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.420000000000002 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 73.030000000000001 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 61.0 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.219999999999999 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.430000000000007 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.420000000000002 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t -116.78 -31.42 5.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.439999999999998 110.707 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 173.03 -144.28 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.403 -2.073 . . . . 62.329999999999998 105.403 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.08 -2.97 33.41 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.358 0.599 . . . . 63.240000000000002 110.053 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.13 175.79 45.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.309 -0.472 . . . . 52.310000000000002 112.366 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.55 47.52 2.54 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.511 2.807 . . . . 71.200000000000003 112.735 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 66.59 -178.44 0.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.496 1.118 . . . . 71.129999999999995 110.793 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -84.32 157.5 21.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.905 -0.776 . . . . 71.340000000000003 108.905 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 55.530000000000001 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 72.519999999999996 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.109999999999999 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.109999999999999 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.019999999999996 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.150000000000006 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.150000000000006 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.430000000000007 114.224 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.340000000000003 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 53.0 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.349999999999994 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.119999999999997 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 55.32 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.439999999999998 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.120000000000005 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.439999999999998 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.140000000000001 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 50.240000000000002 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.140000000000001 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 55.229999999999997 109.376 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 70.209999999999994 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.310000000000002 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 63.0 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 52.509999999999998 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 73.120000000000005 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.049999999999997 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.129999999999995 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.239999999999995 106.13 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.009999999999998 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.05 -29.25 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.230000000000004 112.413 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.47 60.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.624 0.602 . . . . 51.299999999999997 112.624 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -92.95 -2.23 55.98 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.911 0.863 . . . . 74.439999999999998 109.054 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 15.3 t -70.96 -27.94 64.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.514 -1.221 . . . . 74.099999999999994 109.0 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 108.542 -0.91 . . . . 61.200000000000003 108.542 177.755 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.138 0.018 . . . . 73.430000000000007 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 55.81 93.54 0.02 OUTLIER 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.634 1.573 . . . . 73.109999999999999 112.194 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -87.27 120.91 29.04 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.412 -0.813 . . . . 72.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 360' ' ' ILE . 2.2 mp -82.42 124.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.047 -1.834 . . . . 74.109999999999999 106.047 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.467 ' HD2' ' OE1' ' A' ' 380' ' ' GLU . 48.6 mtmt -104.78 156.57 17.88 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.929 0.395 . . . . 54.200000000000003 111.612 -174.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -125.49 57.49 0.69 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.812 -0.915 . . . . 64.120000000000005 110.812 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.522 ' HB2' HG13 ' A' ' 377' ' ' VAL . 56.1 ttp -79.58 81.23 5.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.931 -1.137 . . . . 63.329999999999998 107.931 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -125.11 -32.58 2.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.641 -0.708 . . . . 71.319999999999993 112.841 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.443 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -119.64 137.41 53.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 118.729 -1.188 . . . . 74.120000000000005 113.23 -169.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.464 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 60.299999999999997 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.219999999999999 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 71.030000000000001 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 61.32 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.010000000000005 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.519999999999996 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 41.409999999999997 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 72.109999999999999 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.299999999999997 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.539999999999999 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.625 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.039999999999999 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.417 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.239999999999995 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.150000000000006 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.625 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.120000000000005 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.628 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 14.5 p-10 -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 111.79 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.010000000000005 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.439999999999998 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 6.6 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.109999999999999 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.319999999999993 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.239999999999995 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 74.299999999999997 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.435 HD11 HD21 ' A' ' 381' ' ' ASN . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 64.540000000000006 111.836 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.544 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.049999999999997 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 8.1 m-20 -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.200000000000003 110.64 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.439999999999998 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 52.420000000000002 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.040000000000006 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 63.119999999999997 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 55.450000000000003 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.420000000000002 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.230000000000004 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.030000000000001 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 73.230000000000004 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 61.310000000000002 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.129999999999995 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.200000000000003 110.363 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.439999999999998 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.439999999999998 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.329999999999998 106.407 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.349999999999994 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t -73.7 -40.29 63.72 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 55.509999999999998 109.395 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -160.79 -69.47 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.36 -1.348 . . . . 60.350000000000001 107.36 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -167.11 97.59 0.52 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.035 -0.984 . . . . 70.140000000000001 108.571 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 162.02 -116.62 0.72 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.649 -1.38 . . . . 55.229999999999997 109.649 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.65 -176.82 3.18 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.917 1.744 . . . . 55.409999999999997 110.946 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -101.68 163.78 12.08 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.378 -0.374 . . . . 75.030000000000001 110.085 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -75.76 157.93 32.89 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.187 -1.042 . . . . 75.049999999999997 108.187 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.409999999999997 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.420000000000002 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 73.140000000000001 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.504 HG23 ' HE2' ' A' ' 402' ' ' TYR . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.430000000000007 111.109 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 448' ' ' ALA . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 53.520000000000003 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.140000000000001 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.436 ' H ' HG12 ' A' ' 420' ' ' VAL . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 70.439999999999998 113.202 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.539999999999999 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 70.140000000000001 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 63.200000000000003 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.150000000000006 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.439999999999998 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 63.32 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 52.539999999999999 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.52 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.140000000000001 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 74.010000000000005 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 72.400000000000006 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 61.200000000000003 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.47 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.540000000000006 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.47 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.340000000000003 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.129999999999995 108.752 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.230000000000004 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.319999999999993 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 418' ' ' VAL . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.219999999999999 107.913 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 60.520000000000003 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.230000000000004 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 71.310000000000002 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.539999999999999 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.35 -28.9 39.01 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.349999999999994 110.537 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.18 -10.22 59.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.599 -0.728 . . . . 72.129999999999995 111.403 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.495 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -116.74 -2.18 11.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.825 -0.805 . . . . 73.329999999999998 108.825 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.3 t -74.03 -31.94 63.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.827 -1.079 . . . . 64.010000000000005 108.844 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.429 -1.5 0 CA-C-N 115.573 -0.74 . . . . 39.479999999999997 110.247 179.611 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.864 -0.421 . . . . 75.299999999999997 109.864 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 358' ' ' ARG . 5.3 mpt_? 65.43 112.29 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.913 1.285 . . . . 73.140000000000001 113.164 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -106.64 112.92 26.12 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.507 -0.77 . . . . 72.409999999999997 109.894 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.47 116.01 49.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.836 -1.172 . . . . 70.519999999999996 107.836 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 361' ' ' LYS . 18.4 ptpt -86.06 136.03 33.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.418 -0.913 . . . . 64.530000000000001 111.683 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -82.37 -88.03 0.7 Allowed Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.584 -1.006 . . . . 70.329999999999998 110.584 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.13 103.02 6.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.182 -0.673 . . . . 74.310000000000002 109.182 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 376' ' ' VAL . 40.8 tt0 -79.27 106.59 11.41 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.303 -0.862 . . . . 72.329999999999998 110.2 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m -113.18 145.73 40.48 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.913 -1.143 . . . . 43.140000000000001 107.913 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 61.329999999999998 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.120000000000005 107.07 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 71.140000000000001 109.174 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 74.319999999999993 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.530000000000001 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.140000000000001 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.349999999999994 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 51.0 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HE2' ' HE2' ' A' ' 366' ' ' LYS . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.310000000000002 106.623 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 364' ' ' GLU . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 61.5 106.697 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 71.109999999999999 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.433 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.019999999999996 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.219999999999999 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.209999999999994 111.264 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.557 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.140000000000001 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 63.299999999999997 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.340000000000003 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.009999999999998 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.239999999999995 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.340000000000003 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.239999999999995 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.540000000000006 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 62.310000000000002 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.510000000000005 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.625 HD21 HD21 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.329999999999998 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.349999999999994 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 61.130000000000003 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 73.319999999999993 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 70.510000000000005 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.140000000000001 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.329999999999998 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 70.230000000000004 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.140000000000001 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.299999999999997 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 63.43 108.438 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.557 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.530000000000001 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 60.509999999999998 111.044 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 60.240000000000002 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 31.510000000000002 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.0 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.349999999999994 106.726 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 51.200000000000003 113.656 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.36 -11.13 41.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.119999999999997 108.991 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 75.1 118.16 0.05 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.215 1.406 . . . . 64.099999999999994 110.263 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 75.76 -38.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.456 1.103 . . . . 63.329999999999998 112.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.42 -159.67 30.03 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.833 -0.907 . . . . 74.409999999999997 110.833 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.74 -179.86 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.263 1.975 . . . . 64.049999999999997 111.596 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 44.7 m-70 -90.76 30.04 1.24 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.438 0.637 . . . . 61.240000000000002 110.408 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 72.3 162.44 0.26 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 126.459 1.904 . . . . 74.530000000000001 111.899 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 402' ' ' TYR . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 54.140000000000001 108.275 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.329999999999998 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.409999999999997 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.486 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 62.020000000000003 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 72.400000000000006 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 72.329999999999998 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.409999999999997 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 448' ' ' ALA . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.019999999999996 114.325 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.420000000000002 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 62.229999999999997 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.409999999999997 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.409999999999997 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 64.209999999999994 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 72.420000000000002 107.48 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 63.200000000000003 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 51.130000000000003 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.310000000000002 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.129999999999995 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 55.420000000000002 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.510000000000005 109.687 -177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.539999999999999 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.340000000000003 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 72.099999999999994 109.2 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 71.349999999999994 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 73.230000000000004 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.420000000000002 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.109999999999999 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 54.350000000000001 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 71.230000000000004 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.509999999999998 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.81 -25.95 60.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 63.200000000000003 110.177 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.56 -5.1 34.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.983 -1.008 . . . . 70.310000000000002 110.877 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 422' ' ' CYS . . . -91.36 -27.23 18.49 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.049 -0.523 . . . . 72.019999999999996 110.102 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 62.8 m -79.38 -30.13 42.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.147 -0.479 . . . . 73.430000000000007 109.922 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 109.197 -0.668 . . . . 72.430000000000007 109.197 179.128 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.444 HG22 HG13 ' A' ' 428' ' ' ILE . 9.8 m . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 107.035 -1.469 . . . . 64.15 107.035 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.42 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.14 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.02 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.631 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 73.14 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.21 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.13 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.31 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.631 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.54 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.15 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 54.13 109.037 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.55 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.15 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.12 112.399 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 60.41 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.21 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 64.32 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.2 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.43 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.12 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 65.34 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.567 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.05 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.588 HD21 HD21 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 71.21 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 64.22 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.41 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.53 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 65.34 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.52 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 64.42 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 62.25 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 62.54 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.44 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 61.05 108.324 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.54 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 63.23 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.52 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.51 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.31 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 403' ' ' GLU . 50.9 m-80 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 54.3 111.335 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.22 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.439 HE21 HG23 ' A' ' 387' ' ' ILE . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 63.11 106.326 -177.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.14 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.41 110.217 -179.506 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 . . . . . 0 C--O 1.267 1.989 0 N-CA-C 108.661 -0.866 . . . . 73.11 108.661 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.537 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.33 108.397 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 62.05 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 62.2 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.3 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.43 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.42 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.35 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.21 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 50.43 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 60.35 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.515 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 64.11 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 70.03 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.4 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.44 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.55 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 72.25 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 49.3 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.34 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 35.4 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.05 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 73.11 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.43 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.21 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 70.04 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.32 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.45 111.645 178.562 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 428' ' ' ILE . 7.4 m . . . . . 0 N--CA 1.424 -1.753 0 CA-C-O 120.889 0.376 . . . . 74.0 111.398 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.11 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.32 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 64.51 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 61.53 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.4 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.55 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 374' ' ' TYR . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 74.52 111.241 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 53.33 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.41 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 64.02 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.507 HG21 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 73.04 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.22 110.67 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.51 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.11 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.43 109.829 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.11 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.11 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.488 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 63.13 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.445 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.32 109.524 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.41 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.13 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.445 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.44 109.822 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.42 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.34 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.03 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 62.43 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.35 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.3 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.11 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.3 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 74.01 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 45.03 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.12 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.55 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 63.14 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.534 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.3 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 73.41 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 62.24 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.41 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.03 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.33 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 414' ' ' ARG . 28.5 p . . . . . 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.11 110.595 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 408' ' ' CYS . 45.0 ttm105 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.12 109.178 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.534 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.43 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 71.33 109.797 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 440' ' ' LEU . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.31 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.44 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 62.41 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 72.22 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.23 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.569 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 71.24 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 35.13 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 71.21 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.32 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 43.02 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 365' ' ' THR . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.42 107.429 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.55 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 41.31 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.22 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.52 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.34 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.42 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.33 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.21 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.55 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 70.31 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.02 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 73.45 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 65.14 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.11 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.507 ' SD ' HG21 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 64.31 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.51 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 60.11 112.688 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.445 HG22 HG13 ' A' ' 428' ' ' ILE . 6.1 m . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.589 0.233 . . . . 70.14 111.56 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 64.4 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 64.44 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.43 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 72.14 110.305 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 51.13 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.53 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 74.11 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 71.04 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.672 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.42 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 71.24 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.22 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 65.13 106.992 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.4 ' HB3' ' HD1' ' A' ' 379' ' ' TYR . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.4 112.836 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.4 ' HD1' ' HB3' ' A' ' 378' ' ' PHE . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.32 112.254 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.23 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HB2' HD11 ' A' ' 388' ' ' LEU . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.12 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.1 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 61.22 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.1 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.1 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 65.41 110.75 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 63.13 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 74.24 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 32.31 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.11 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.11 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 72.42 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.43 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.42 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.22 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 71.11 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 63.34 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.43 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.12 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 73.21 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 64.33 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.3 m120 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.3 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.31 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 388' ' ' LEU . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.21 110.838 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.34 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.21 109.544 -177.171 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 121.288 0.566 . . . . 75.02 111.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.02 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 70.04 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.24 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.33 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 422' ' ' CYS . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.13 108.789 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.55 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.484 ' H ' HG12 ' A' ' 420' ' ' VAL . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.31 112.971 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.4 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.42 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.23 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.22 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 64.11 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 73.41 107.889 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 54.12 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.12 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.44 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.04 109.289 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.21 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.41 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 61.25 108.181 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.11 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.41 107.427 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 74.44 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.24 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.13 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.11 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 41.05 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 71.24 111.367 177.039 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 53.1 106.976 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 63.43 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 72.41 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.52 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.491 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 65.13 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 34.53 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.22 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.12 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 71.21 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 25.42 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.43 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 62.54 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 72.23 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.14 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.2 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.0 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 71.51 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.45 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 52.35 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.35 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.512 HD13 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.12 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.35 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.12 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 54.34 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 63.13 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.24 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.42 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.12 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.34 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.45 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.14 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.44 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.665 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 71.23 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.744 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 60.13 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.43 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.45 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.21 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.42 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.33 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.14 110.939 -174.465 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 105.489 -2.041 . . . . 73.03 105.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.744 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.44 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 41.31 108.787 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 72.05 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.14 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.21 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 443' ' ' MET . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.22 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 70.21 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.415 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.42 114.339 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.22 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.14 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.1 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.33 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.42 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.24 108.103 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.45 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.52 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 71.1 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.24 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.33 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 71.23 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.3 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.2 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 61.34 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.443 ' CD1' HD22 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.12 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 72.53 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 74.33 110.366 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 73.44 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.21 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 70.23 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.52 111.006 174.211 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.42 107.621 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.21 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.424 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.32 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.4 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 73.3 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.42 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.24 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.31 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.23 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.43 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.21 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 65.32 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 23.43 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.04 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.34 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.22 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.33 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 62.01 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.44 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.526 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 62.21 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 60.14 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 53.54 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.526 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 55.34 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 73.5 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 374' ' ' TYR . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 53.54 109.907 175.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.42 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 52.01 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.42 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 51.03 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.22 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.35 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 74.52 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.41 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.42 109.106 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 70.53 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.448 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.34 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.599 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.43 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 51.04 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.599 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 52.3 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.34 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.12 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 -178.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.21 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.21 110.409 -177.474 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 62.24 107.76 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.561 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.44 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 63.11 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.14 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 73.04 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.2 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 71.31 109.275 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.13 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.422 ' H ' HG12 ' A' ' 420' ' ' VAL . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.23 111.157 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.44 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 43.22 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.23 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.0 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 62.32 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.31 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 54.34 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.13 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.528 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.13 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.02 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.41 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 45.3 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.4 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.42 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.04 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.02 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.43 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 43.34 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 61.53 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.41 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 73.01 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.32 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.34 108.667 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 55.15 111.211 176.07 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.944 -0.391 . . . . 71.41 109.944 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 74.21 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.24 106.104 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.54 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 71.15 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.42 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.15 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.45 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.31 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.11 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.41 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.4 HG11 ' SD ' ' A' ' 443' ' ' MET . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.44 108.767 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.53 HG11 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.01 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.403 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.51 110.192 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 70.44 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' HG11 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.35 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 72.33 112.13 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.43 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.51 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.03 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.54 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.45 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.03 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.14 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 439' ' ' TYR . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.02 110.276 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.11 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.33 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 74.45 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 43.51 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.35 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 63.32 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.45 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 22.45 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 64.03 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.35 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 60.22 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.44 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.05 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.32 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.21 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.23 108.382 -177.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.21 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.44 109.08 176.034 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 109.412 -0.588 . . . . 62.25 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.43 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 40.23 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.518 HG22 HD12 ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 61.11 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 71.55 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.594 HG12 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.52 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.41 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.594 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 72.34 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.32 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.3 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 64.31 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.01 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.15 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.509 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 51.51 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.41 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 63.22 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.446 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 70.04 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 63.25 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.11 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.41 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 70.34 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.533 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.11 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.44 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.42 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.413 ' CD1' HD22 ' A' ' 389' ' ' LEU . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.23 112.126 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.491 ' HA ' HG23 ' A' ' 417' ' ' ILE . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 50.44 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 63.31 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.14 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 441' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.24 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.32 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.05 111.97 178.517 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 428' ' ' ILE . 20.4 m . . . . . 0 N--CA 1.433 -1.322 0 N-CA-C 107.129 -1.434 . . . . 63.44 107.129 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.54 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.01 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.42 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.15 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.21 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.41 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.55 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.1 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.23 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.43 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 382' ' ' VAL . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 60.35 109.208 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 43.12 107.297 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.495 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.22 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 70.24 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 381' ' ' ASN . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.54 111.676 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.32 112.076 -176.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 389' ' ' LEU . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.33 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.23 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 64.32 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.4 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.455 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 72.42 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 391' ' ' ASN . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 70.04 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 382' ' ' VAL . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.11 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 50.42 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 52.44 110.077 -177.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.54 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 52.3 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.45 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 65.12 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.2 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.41 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.53 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 72.41 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.01 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.665 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 55.03 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.31 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.569 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.05 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.01 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.03 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.54 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.35 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.31 110.84 -175.601 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.53 109.018 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.452 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.11 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 441' ' ' ILE . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 43.53 110.048 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 401' ' ' LYS . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.01 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 71.04 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 71.34 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.11 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.33 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.21 112.536 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 42.31 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 62.14 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.23 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 61.22 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 54.52 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.53 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 54.11 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.42 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.13 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.32 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.4 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.42 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 64.33 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.0 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.22 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 417' ' ' ILE . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.33 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.422 ' CD1' HG11 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 61.04 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 73.13 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 71.33 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 72.44 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.15 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 53.21 111.046 177.308 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m . . . . . 0 N--CA 1.432 -1.358 0 CA-C-O 120.569 0.223 . . . . 65.42 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.11 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.33 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.556 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 63.05 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.01 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 45.01 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.23 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 62.51 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.41 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 64.2 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 62.42 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 380' ' ' GLU . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.21 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 62.12 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.52 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.22 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.11 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 50.34 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 73.35 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.509 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.8 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.45 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.44 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.24 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.509 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.4 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.44 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.602 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 73.42 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.53 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.3 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 70.4 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.13 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.41 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 62.45 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.45 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 73.52 110.928 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.42 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.49 ' H ' HG12 ' A' ' 418' ' ' VAL . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 53.12 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 63.35 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.52 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.33 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.44 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 63.1 106.498 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.44 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 63.43 110.269 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 106.596 -1.631 . . . . 74.02 106.596 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.21 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 71.23 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 400' ' ' LEU . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 64.2 110.566 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 71.43 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 422' ' ' CYS . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.43 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.35 111.771 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.448 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.24 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.34 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 71.43 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.54 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.589 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.24 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.34 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.613 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.44 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.21 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.11 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.22 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 72.44 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.1 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.1 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.14 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.45 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 44.31 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 74.23 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.14 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.43 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.14 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 45.32 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.613 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 65.13 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.33 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.42 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.45 111.294 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.485 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.13 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 72.12 109.571 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.42 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.21 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.55 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.24 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.42 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 71.13 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 54.14 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 60.02 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.406 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.12 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.41 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.439 ' HB3' HD22 ' A' ' 381' ' ' ASN . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.22 110.544 169.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.22 111.438 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 71.42 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.04 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.45 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.33 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 60.15 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.597 HD21 HD21 ' A' ' 391' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 73.42 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.45 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.41 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.597 HD21 HD21 ' A' ' 388' ' ' LEU . 0.9 OUTLIER -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.41 109.552 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.51 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 50.32 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.23 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.14 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.21 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.14 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.14 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 72.44 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 62.43 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 65.42 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.32 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.594 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 63.05 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.51 113.928 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.45 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.484 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 71.42 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.24 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.4 109.858 -177.284 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.515 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 . . . . . 0 C--O 1.254 1.307 0 CA-C-O 121.487 0.661 . . . . 64.42 111.615 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.496 ' HB2' ' HG3' ' A' ' 438' ' ' GLU . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.13 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.4 109.527 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 53.21 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 70.22 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 44.22 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 61.02 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.43 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.512 ' H ' HG12 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 52.21 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.21 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.34 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 73.44 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.35 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 365' ' ' THR . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.02 106.935 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.34 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 53.15 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 70.05 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 64.13 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.22 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.42 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 22.7 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.44 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 72.43 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 53.14 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 54.45 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.516 ' CD1' HD22 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 63.32 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 73.3 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.52 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.11 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.13 109.534 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 74.3 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 65.32 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.45 111.461 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.41 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 71.33 106.721 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.53 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 71.22 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.14 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 62.25 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 74.23 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 60.34 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.33 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.41 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.35 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.14 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 65.2 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.23 111.253 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.24 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.52 110.857 -176.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.13 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.15 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.14 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 51.34 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.451 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 60.3 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 391' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.54 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 374' ' ' TYR . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.23 109.253 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.13 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.9 m-80 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 62.14 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 60.53 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.15 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 72.32 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.14 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.44 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.24 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.31 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.4 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 64.2 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 70.45 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.13 110.308 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.14 111.197 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 72.13 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.02 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.4 111.65 -175.196 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 112.416 0.525 . . . . 72.45 112.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.45 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 71.43 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.4 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.35 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 422' ' ' CYS . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 72.03 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.33 111.351 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.537 ' H ' HG12 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.32 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.11 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 50.34 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.55 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.14 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.04 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.52 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 41.53 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 71.3 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 65.42 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 60.43 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 50.24 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.15 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 74.25 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.512 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 62.33 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.15 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.31 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 72.03 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 64.34 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.54 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.41 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 64.44 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 42.14 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.13 111.296 176.132 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 120.466 0.174 . . . . 74.54 110.806 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.52 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.23 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.22 109.633 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 63.51 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.51 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.54 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.04 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.45 111.757 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.14 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.54 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.434 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 63.21 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.524 HG11 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.01 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 63.24 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 64.5 110.678 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.524 ' OE2' HG11 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.52 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.11 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.24 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.4 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.41 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 71.44 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 71.41 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.614 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.43 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.562 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 60.22 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.55 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 44.55 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 61.12 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.31 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 61.12 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 52.33 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 62.43 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.33 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.3 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.31 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.14 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.573 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 71.31 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 65.24 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.56 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.4 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.24 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 65.13 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.44 108.448 -175.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 54.14 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.15 110.979 -173.848 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 13.1 ttm180 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 109.519 -0.548 . . . . 73.45 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.02 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 62.31 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.43 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.42 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.42 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 65.3 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.2 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.45 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 420' ' ' VAL . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 53.03 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.14 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 73.13 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.52 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.02 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.13 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.522 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.43 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.21 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.24 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.12 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 73.11 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.04 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.8 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.32 109.674 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.44 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.32 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 64.21 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.542 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 65.33 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 73.44 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 62.22 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 55.42 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.522 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.34 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 71.32 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.51 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.33 111.567 178.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 107.131 -1.433 . . . . 72.14 107.131 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.01 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 64.13 107.718 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.33 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 64.32 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.3 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 71.41 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 62.25 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 71.33 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.04 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 52.42 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.31 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.13 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.12 112.089 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.34 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.496 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 63.52 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 61.2 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.56 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.3 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.31 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.33 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.24 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.45 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.13 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 71.31 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.21 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 62.34 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.33 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 53.5 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.22 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.541 ' HG2' ' HG ' ' A' ' 400' ' ' LEU . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.35 105.057 174.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.54 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 62.52 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.22 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.32 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.541 ' HG ' ' HG2' ' A' ' 395' ' ' GLN . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 54.55 110.541 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.536 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 72.24 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.21 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.536 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.54 110.684 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.32 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 32.35 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 71.13 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.1 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.43 109.538 -176.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 . . . . . 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 72.43 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.42 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.32 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.34 109.139 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.452 HG22 HD12 ' A' ' 441' ' ' ILE . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 61.31 110.173 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 64.04 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 71.53 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.31 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.565 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 64.12 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 25.52 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 72.53 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 64.21 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 64.23 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.14 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.42 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 62.1 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.41 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.31 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.31 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.05 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.23 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 71.42 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 73.11 116.377 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.51 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.24 109.114 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 55.33 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.42 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 443' ' ' MET . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 54.2 106.856 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.31 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.43 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.34 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.14 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 62.42 111.615 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.44 107.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 61.1 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.461 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 74.31 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.23 112.018 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.53 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 65.31 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.05 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.1 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 65.35 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 74.31 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.22 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 72.31 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 64.21 110.21 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 71.14 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 62.01 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.55 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 61.44 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.23 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.23 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 70.43 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.53 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.45 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.531 HD21 HD21 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 44.32 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 71.32 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 51.31 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 63.5 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.1 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.44 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 33.4 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 73.45 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 70.52 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.21 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.21 109.047 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.1 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 50.54 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.3 107.557 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 63.33 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 63.12 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 51.4 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.42 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.41 111.23 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.03 108.962 -179.389 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.171 0.51 . . . . 64.31 110.576 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.24 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.34 107.841 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.14 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 441' ' ' ILE . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.43 110.199 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 71.11 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 62.52 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.544 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.14 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.44 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 53.53 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.11 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.23 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.55 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 63.42 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 53.53 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.03 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 64.21 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.04 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.559 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.34 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.24 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.523 HE21 HD21 ' A' ' 440' ' ' LEU . 48.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.35 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.22 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.559 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 65.14 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 54.42 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.523 HD21 HE21 ' A' ' 435' ' ' GLN . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 64.52 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.33 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 64.11 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.561 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.41 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.1 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.31 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.11 112.051 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 107.686 -1.228 . . . . 75.13 107.686 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 52.32 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.14 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.21 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 65.31 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 52.42 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.11 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.21 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.3 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.21 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.14 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.53 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 60.23 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.415 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 65.52 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.32 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.31 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 60.15 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.14 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.54 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.521 ' CD ' HD21 ' A' ' 389' ' ' LEU . 10.4 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 73.04 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.31 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.42 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 71.31 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.651 HD21 HD21 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.14 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.521 HD21 ' CD ' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.23 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.508 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 5.44 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.651 HD21 HD21 ' A' ' 388' ' ' LEU . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.34 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.04 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 43.22 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.52 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.04 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 64.1 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 54.22 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.15 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.14 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 73.21 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.546 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.42 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.42 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.41 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 71.23 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.43 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.32 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 43.32 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.2 111.145 -174.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.08 -0.711 . . . . 74.34 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.41 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 34.52 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 63.23 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 45.34 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 63.04 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.04 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.15 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.485 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.51 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.14 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.22 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.45 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.8 OUTLIER -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.24 109.468 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.12 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 72.32 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.33 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 50.41 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 62.32 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.21 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.15 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 63.11 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.51 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 73.11 115.915 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.13 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.13 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 389' ' ' LEU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.44 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 64.41 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 72.14 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.22 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.15 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.42 108.587 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 72.25 112.109 178.464 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 111.646 0.239 . . . . 74.11 111.646 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 32.22 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 62.23 106.677 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 71.01 111.768 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.475 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.01 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.53 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 72.53 110.976 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 71.52 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 63.21 107.487 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.13 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.513 HG11 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 65.45 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.23 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.24 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.513 ' OE1' HG11 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.4 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.542 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.45 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.23 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.14 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.23 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.42 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 52.12 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 64.32 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.21 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.455 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.44 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 391' ' ' ASN . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 30.21 112.048 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 70.24 108.532 -178.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 63.24 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 54.13 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.51 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.34 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.33 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.3 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.43 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 65.4 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 33.21 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.738 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.52 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.42 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 65.21 114.052 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.33 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 34.3 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 63.35 111.673 -174.774 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 12.0 ttm180 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 109.251 -0.648 . . . . 60.03 109.251 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.461 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.31 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.22 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.34 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.04 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 65.42 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 63.54 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 73.13 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.619 ' H ' HG12 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.2 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.04 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.01 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.34 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 71.42 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.31 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 53.33 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.23 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.35 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 41.32 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 54.11 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.32 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 63.42 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 71.44 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.42 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 64.33 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.35 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.33 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.42 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.15 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.542 HG22 HG13 ' A' ' 428' ' ' ILE . 3.7 m . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.983 0.42 . . . . 73.42 110.809 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.12 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.42 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.45 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.449 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.34 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 34.55 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 61.44 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 64.41 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.14 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.43 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.55 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.509 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 70.24 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.532 HG11 ' OE2' ' A' ' 380' ' ' GLU . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 65.34 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.55 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.33 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.532 ' OE2' HG11 ' A' ' 377' ' ' VAL . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 50.3 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 61.32 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.03 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.24 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.5 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.22 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.11 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.04 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.409 HG23 HE21 ' A' ' 406' ' ' GLN . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.57 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.446 HD21 HD21 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.512 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 65.12 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.04 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.43 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 400' ' ' LEU . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.41 111.208 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 63.5 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.34 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.44 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 54.44 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.22 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.23 108.588 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.2 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 392' ' ' PHE . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.33 108.779 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.34 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 54.51 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.45 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.14 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.05 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.409 HE21 HG23 ' A' ' 387' ' ' ILE . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 62.21 106.442 -177.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.23 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.53 110.129 -178.047 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.281 -0.637 . . . . 65.21 109.281 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.14 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.13 109.513 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.34 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.34 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.11 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 444' ' ' LYS . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 73.54 109.642 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.31 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.54 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.22 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.23 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 64.2 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.13 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 365' ' ' THR . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 70.34 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.34 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.44 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.4 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.21 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 73.52 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 70.31 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.436 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.11 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 61.33 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.32 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.52 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 64.5 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 44.23 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 65.21 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.53 110.434 174.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.43 107.51 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.12 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.44 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 73.04 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 54.24 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 62.53 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.24 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 50.4 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 51.54 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.35 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 64.43 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.44 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 72.4 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 55.25 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.12 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.503 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.01 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.2 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.34 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.44 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.13 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.52 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.33 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.1 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 64.44 110.892 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.22 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 72.53 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.43 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 72.54 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 61.33 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.34 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.21 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.23 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.53 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.24 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 420' ' ' VAL . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.11 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.2 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.5 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.14 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.24 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.44 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.661 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.23 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.32 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 55.21 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.11 110.2 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.42 109.546 -176.323 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 109.437 -0.579 . . . . 70.31 109.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 65.33 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.11 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 65.52 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.3 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.33 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 61.1 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.43 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.571 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.23 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.31 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 64.13 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.23 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.4 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.13 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.31 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.11 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 43.14 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 72.14 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.24 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.22 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.31 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.21 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.31 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 60.11 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 64.2 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.52 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 74.31 108.024 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.32 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.54 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.34 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.41 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.12 111.213 174.39 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 108.982 -0.748 . . . . 63.31 108.982 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.33 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.427 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 52.13 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.33 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 62.44 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 63.11 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.53 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 60.2 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 63.51 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.13 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.22 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.1 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 73.25 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 55.34 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.01 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.51 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 71.44 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 72.41 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.51 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.43 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.43 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.21 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 73.52 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.42 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.13 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.2 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 64.13 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 42.21 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.22 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.44 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.21 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 420' ' ' VAL . 62.3 t30 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.14 108.425 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.33 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 62.53 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.42 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 73.03 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 61.0 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.22 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.43 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.42 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.44 110.707 -176.121 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 55.53 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 72.52 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.11 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.11 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.02 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.15 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.15 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.43 114.224 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.34 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 53.0 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.35 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.12 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 55.32 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.12 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.44 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.14 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 50.24 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.14 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 55.23 109.376 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 70.21 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.31 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 63.0 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 72.31 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 52.51 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 73.12 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.05 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.13 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.24 106.13 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.01 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.23 112.413 178.209 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.443 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 113.23 0.826 . . . . 74.12 113.23 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.464 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 60.3 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.22 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 71.03 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 61.32 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.01 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.52 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 41.41 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 72.11 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.3 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.54 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.625 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.04 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.417 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.24 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.15 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.625 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.12 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.628 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.79 -177.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.01 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.44 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.11 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.32 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.24 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 74.3 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 64.54 111.836 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.544 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.05 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.2 110.64 -177.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.44 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 52.42 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.04 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 63.12 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 55.45 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.42 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.23 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.03 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 73.23 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 61.31 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.13 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.2 110.363 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.44 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.44 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.33 106.407 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.35 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 55.51 109.395 -177.392 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.187 -1.042 . . . . 75.05 108.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.41 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.42 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 73.14 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.504 HG23 ' HE2' ' A' ' 402' ' ' TYR . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.43 111.109 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 53.52 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.14 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.436 ' H ' HG12 ' A' ' 420' ' ' VAL . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 70.44 113.202 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.54 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 70.14 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 63.2 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.15 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.44 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 63.32 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 52.54 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.52 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.14 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 74.01 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 72.4 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 61.2 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.47 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.54 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.47 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.34 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.13 108.752 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.23 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.32 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 418' ' ' VAL . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.22 107.913 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 60.52 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.23 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 71.31 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.54 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.35 110.537 176.304 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 107.913 -1.143 . . . . 43.14 107.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 61.33 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.12 107.07 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 71.14 109.174 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 74.32 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.53 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.14 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.35 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 51.0 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HE2' ' HE2' ' A' ' 366' ' ' LYS . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.31 106.623 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 61.5 106.697 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 71.11 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.433 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.02 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.22 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.21 111.264 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.557 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.14 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 63.3 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.34 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.01 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.24 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.34 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.24 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.54 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 62.31 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.51 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.625 HD21 HD21 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.33 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.35 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 61.13 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 70.51 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.14 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.33 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 70.23 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.14 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.3 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 63.43 108.438 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.557 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.53 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 60.51 111.044 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 60.24 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 31.51 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 387' ' ' ILE . 0.5 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.35 106.726 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 51.2 113.656 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.12 108.991 -176.706 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 121.473 0.654 . . . . 74.53 111.899 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 402' ' ' TYR . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 54.14 108.275 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.33 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.41 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.486 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 62.02 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 72.4 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 72.33 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.41 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.02 114.325 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.42 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 62.23 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.41 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.41 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 64.21 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 72.42 107.48 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 63.2 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 51.13 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.31 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 55.42 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.51 109.687 -177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.54 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.34 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 72.1 109.2 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 71.35 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 73.23 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.42 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.11 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 54.35 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 71.23 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.51 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 63.2 110.177 175.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.649 0.261 . . . . 62.0 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -107.33 132.62 52.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -75.38 140.08 42.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 120.872 0.367 . . . . 75.33 110.107 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 12.3 tt -94.21 131.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.439 -0.578 . . . . 71.03 109.439 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HB3' ' OE2' ' A' ' 380' ' ' GLU . 64.7 pttt -96.85 156.26 16.42 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.868 -0.733 . . . . 74.54 111.631 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -83.49 -120.8 0.76 Allowed Glycine 0 N--CA 1.423 -2.187 0 CA-C-N 115.46 -0.791 . . . . 64.33 112.285 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -14.15 15.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 112.57 0.581 . . . . 71.23 112.57 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 63.3 92.98 0.06 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.527 0.68 . . . . 71.13 111.275 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.444 HG22 HG13 ' A' ' 428' ' ' ILE . 9.8 m -100.62 129.12 46.5 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.035 -1.469 . . . . 64.15 107.035 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 21.6 pttm -133.99 136.26 44.0 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.78 0.324 . . . . 73.42 111.09 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -150.91 148.68 28.72 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.361 -0.977 . . . . 75.14 108.361 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.22 111.45 23.18 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.924 -0.398 . . . . 53.02 109.924 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.631 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -121.94 131.73 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.794 -1.187 . . . . 73.14 107.794 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.99 20.57 62.6 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 114.866 0.706 . . . . 73.21 114.866 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 98.81 -15.15 61.14 Favored Glycine 0 CA--C 1.505 -0.564 0 C-N-CA 120.847 -0.692 . . . . 72.13 112.728 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -113.95 154.65 27.22 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.381 0.61 . . . . 74.31 112.568 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 39.7 m -94.4 114.19 26.18 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.37 -0.832 . . . . 74.44 110.307 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.631 ' CE1' ' HB ' ' A' ' 369' ' ' ILE . 60.3 m-85 -86.12 126.6 34.33 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.65 -0.871 . . . . 70.54 108.65 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.1 ttmt -120.28 123.63 43.63 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.83 107.69 23.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.224 -1.028 . . . . 74.15 108.224 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.4 t -83.57 -12.76 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 121.92 0.867 . . . . 54.13 109.037 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 5.5 t80 74.56 -55.03 0.66 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.975 1.71 . . . . 70.55 112.148 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 95.2 m-85 -102.4 6.32 40.16 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.705 -0.622 . . . . 74.15 111.284 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 361' ' ' LYS . 36.2 mt-10 -122.25 -71.9 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.539 -0.755 . . . . 73.12 112.399 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 7.6 p30 -172.77 -178.08 1.8 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 112.131 0.419 . . . . 60.41 112.131 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 57.6 t -130.91 136.24 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.719 -0.673 . . . . 73.21 109.338 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.1 m-85 -125.23 162.05 25.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.346 -0.388 . . . . 64.32 110.051 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.2 pt20 -125.23 99.86 6.27 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.346 -1.353 . . . . 75.43 107.346 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 28.2 t70 70.31 -79.41 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 125.209 1.404 . . . . 71.12 109.926 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.3 t -140.55 -1.12 1.5 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.852 -0.613 . . . . 65.34 109.394 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.567 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 48.2 mm -89.99 115.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.05 109.355 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.588 HD21 HD21 ' A' ' 391' ' ' ASN . 41.5 tp -73.76 112.53 9.95 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.212 -0.904 . . . . 71.21 112.57 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.11 -68.19 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.936 0.398 . . . . 64.22 110.451 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -153.17 177.27 30.88 Favored Glycine 0 CA--C 1.492 -1.362 0 C-N-CA 120.25 -0.976 . . . . 61.41 110.973 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 44.8 m-80 -125.68 145.95 49.94 Favored 'General case' 0 CA--C 1.446 -3.042 0 CA-C-N 116.931 0.365 . . . . 74.53 110.88 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.47 115.35 5.06 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.599 1.187 . . . . 65.34 110.664 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.66 -46.28 2.96 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.526 -0.761 . . . . 61.52 110.77 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 40.0 p -150.78 153.25 35.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.243 0.544 . . . . 64.42 111.956 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -109.43 118.77 37.51 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.453 -1.684 . . . . 62.25 106.453 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.93 102.83 10.57 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.98 -0.748 . . . . 62.54 108.98 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.62 -123.73 10.22 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 109.173 -1.571 . . . . 72.44 109.173 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.482 HD21 ' HB1' ' A' ' 448' ' ' ALA . 66.4 t30 -107.45 10.28 29.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.305 1.05 . . . . 61.05 108.324 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 86.7 t -102.75 128.28 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 114.983 -1.008 . . . . 72.54 109.724 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.96 131.55 48.3 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.827 0.346 . . . . 63.23 110.826 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 402' ' ' TYR . 13.3 tptm -108.94 125.21 51.79 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.709 0.766 . . . . 73.52 112.586 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 36.8 m-85 -118.25 120.87 38.96 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.628 -1.169 . . . . 73.51 109.318 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 13.2 pt-20 -139.6 -175.11 4.09 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.436 -0.79 . . . . 74.31 111.25 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 403' ' ' GLU . 50.9 m-80 66.24 27.76 10.17 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.937 0.895 . . . . 54.3 111.335 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -78.87 -139.55 1.67 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.513 -0.851 . . . . 72.22 112.996 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.439 HE21 HG23 ' A' ' 387' ' ' ILE . 0.3 OUTLIER -82.96 146.86 28.56 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.326 -1.731 . . . . 63.11 106.326 -177.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.5 m -57.8 151.01 18.65 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.853 0.835 . . . . 74.14 112.199 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 412' ' ' PRO . 43.4 t -94.65 -21.71 18.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.525 -0.761 . . . . 75.41 110.217 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.27 -36.37 0.35 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.232 1.413 . . . . 52.5 112.687 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 408' ' ' CYS . 38.0 m-80 -101.46 10.03 40.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.653 0.74 . . . . 72.43 109.736 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -171.61 -153.19 8.88 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.562 -1.015 . . . . 60.31 110.562 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 408' ' ' CYS . 95.0 Cg_endo -81.8 -162.24 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.593 2.195 . . . . 70.44 110.779 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -57.4 142.39 43.96 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.267 -0.424 . . . . 72.22 110.55 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -71.1 156.39 39.65 Favored 'General case' 0 C--O 1.267 1.989 0 C-N-CA 119.464 -0.894 . . . . 73.11 108.661 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.537 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 22.8 m -147.29 158.87 44.12 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.329 -0.989 . . . . 73.41 108.329 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.77 133.09 31.69 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.397 -0.964 . . . . 74.33 108.397 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.4 tt -125.52 109.7 22.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-O 121.448 0.642 . . . . 62.05 109.971 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.6 t -93.05 114.16 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.22 0.533 . . . . 62.2 110.292 -176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 24.4 m -97.5 114.69 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.46 -1.311 . . . . 75.0 107.46 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 422' ' ' CYS . 17.6 t -113.59 128.12 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 N-CA-C 109.598 -0.519 . . . . 73.3 109.598 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.82 0.22 23.87 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.835 -0.62 . . . . 75.43 110.315 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.64 155.33 0.14 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.01 -0.995 . . . . 53.42 110.441 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -170.34 -157.22 12.16 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.755 -0.736 . . . . 74.35 111.544 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.56 -34.54 7.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.005 0.431 . . . . 75.21 110.71 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.42 160.32 41.26 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.1 p30 -86.43 132.0 34.05 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.155 -0.683 . . . . 50.43 109.155 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -161.58 141.19 10.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.407 -0.59 . . . . 60.35 109.407 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.515 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.9 mt -83.8 111.19 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.37 -0.974 . . . . 64.11 108.37 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.56 -53.29 14.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.082 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.8 m -157.62 160.99 38.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.218 -0.446 . . . . 70.03 110.318 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.2 t -139.25 129.28 31.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.458 -1.312 . . . . 73.4 107.458 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 67.9 tp -135.41 128.93 32.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.058 0.456 . . . . 73.44 112.164 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -80.3 88.81 5.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.316 -1.364 . . . . 72.55 107.316 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.12 -31.42 7.61 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.076 -0.511 . . . . 72.25 110.571 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 49.3 mt-30 -102.6 167.37 9.96 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.1 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.136 1.902 . . . . 74.34 116.136 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.7 m 55.26 25.76 7.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.988 0.899 . . . . 35.4 110.135 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 41.0 tt0 -113.26 119.92 39.4 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.623 -1.171 . . . . 64.05 108.675 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -95.16 118.92 32.79 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.196 -1.365 . . . . 73.11 111.691 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.5 mt -78.09 118.9 20.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.857 -1.164 . . . . 71.43 107.857 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.5 mt -109.69 124.05 66.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.884 -1.154 . . . . 74.43 107.884 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -106.46 114.92 29.32 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.44 -1.319 . . . . 71.21 107.44 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.8 mtp -142.99 177.43 8.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.072 0.939 . . . . 70.04 112.024 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.698 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 49.3 pttt -156.68 158.87 37.75 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.856 -1.52 . . . . 75.32 108.199 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.2 t -173.51 141.09 0.88 Allowed Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.22 -27.89 48.26 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.786 2.324 . . . . 75.45 111.645 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.28 -10.67 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.822 -0.627 . . . . 73.3 110.918 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -83.86 -24.44 30.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.124 -0.489 . . . . 63.12 110.915 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 55.5 m -67.86 132.56 47.6 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 109.801 -0.444 . . . . 64.54 109.801 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.411 -0.959 . . . . 44.34 108.411 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.45 ' HA ' ' CD ' ' A' ' 380' ' ' GLU . 79.2 m-85 . . . . . 0 CA--C 1.501 -0.935 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -90.85 89.67 7.58 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.13 -0.941 . . . . 62.32 113.084 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 66.19 -72.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.119 1.367 . . . . 55.3 113.08 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.26 115.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.583 -0.895 . . . . 73.55 108.583 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 361' ' ' LYS . 1.8 pptp? -123.82 130.97 53.45 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.235 -0.586 . . . . 73.3 109.728 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.5 -87.97 1.95 Allowed Glycine 0 C--N 1.294 -1.762 0 C-N-CA 120.041 -1.076 . . . . 55.35 111.905 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.539 ' HB2' HG13 ' A' ' 377' ' ' VAL . 50.8 ttm 60.04 81.38 0.18 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.866 0.866 . . . . 64.43 110.873 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.18 -38.39 0.11 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.385 -0.969 . . . . 72.14 108.385 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 428' ' ' ILE . 7.4 m -90.56 124.96 35.44 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 118.845 -1.142 . . . . 74.0 111.398 -170.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.9 mtpt -131.6 144.32 50.99 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 115.163 -0.926 . . . . 71.11 108.79 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -151.28 132.96 14.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 105.931 -1.877 . . . . 75.32 105.931 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.1 112.72 25.49 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.82 -1.152 . . . . 64.51 110.104 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 431' ' ' VAL . 3.1 mp -100.6 120.51 50.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.967 -1.015 . . . . 61.53 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.6 -87.52 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 O-C-N 123.818 0.699 . . . . 63.4 112.672 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.49 17.45 2.05 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.817 -0.913 . . . . 72.55 110.817 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 374' ' ' TYR . 26.5 p90 -126.99 130.06 49.32 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.266 0.555 . . . . 74.52 111.241 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 10.4 m -91.69 115.27 27.91 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.592 -0.731 . . . . 53.33 110.541 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 389' ' ' LEU . 2.0 m-85 -85.88 129.4 34.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.09 -0.505 . . . . 65.41 110.93 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -122.79 123.85 41.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.979 -1.489 . . . . 64.02 106.979 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.507 HG21 ' SD ' ' A' ' 443' ' ' MET . 59.1 t -108.7 111.76 37.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.714 -0.794 . . . . 73.04 110.565 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 363' ' ' MET . 44.2 t -87.45 -28.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 115.876 -0.602 . . . . 74.22 110.67 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 66.66 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.321 0.581 . . . . 73.51 111.235 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 72.58 -33.23 0.26 Allowed 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.663 1.185 . . . . 74.11 112.828 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.45 ' CD ' ' HA ' ' A' ' 357' ' ' TYR . 16.0 mm-40 -77.5 -76.45 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.145 0.497 . . . . 70.43 109.829 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.1 p30 179.15 -174.99 0.21 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 124.047 0.939 . . . . 61.11 111.059 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 84.9 t -132.4 137.71 53.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.831 -0.803 . . . . 72.11 108.831 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.488 ' CE1' HD13 ' A' ' 388' ' ' LEU . 57.2 m-85 -120.27 160.92 22.01 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.131 -0.322 . . . . 63.13 110.131 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.445 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.6 pt20 -129.44 101.15 5.83 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.602 -0.726 . . . . 75.32 109.524 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 69.52 -76.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.794 1.638 . . . . 75.41 110.702 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -142.18 -2.26 1.15 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.33 -0.85 . . . . 70.13 109.491 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.445 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 63.9 mt -99.31 124.81 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 116.078 -0.51 . . . . 74.44 109.822 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 383' ' ' PHE . 34.8 tp -80.3 125.8 30.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.872 -0.604 . . . . 73.42 111.308 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 374' ' ' TYR . 84.0 mt -69.86 -77.88 0.08 Allowed 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.756 -0.656 . . . . 74.34 110.095 175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -145.36 -175.2 18.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.46 -1.056 . . . . 65.03 110.46 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.9 m-80 -131.75 152.79 50.67 Favored 'General case' 0 CA--C 1.446 -3.02 0 N-CA-C 109.546 -0.538 . . . . 62.43 109.546 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -54.45 115.29 2.03 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.063 0.852 . . . . 65.35 111.347 -174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -103.51 -50.54 3.42 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.262 -0.881 . . . . 64.3 109.496 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.1 t -171.01 171.74 5.73 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.129 -1.063 . . . . 74.11 108.129 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.95 140.19 53.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.626 -0.879 . . . . 73.3 108.626 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.04 97.58 5.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.362 -0.977 . . . . 74.01 108.362 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.24 -114.15 5.06 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.081 -0.963 . . . . 45.03 111.001 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -98.45 -9.8 24.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.74 0.781 . . . . 73.12 109.5 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.89 136.5 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.143 -0.935 . . . . 74.55 110.434 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 65.8 mt -112.16 136.19 51.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.889 -0.412 . . . . 63.14 109.889 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.534 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -107.94 130.36 55.04 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 112.612 0.597 . . . . 71.3 112.612 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 89.9 m-85 -119.46 114.07 21.74 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.744 -0.835 . . . . 73.41 108.744 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.12 175.94 9.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.899 -2.26 . . . . 62.24 104.899 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 73.19 28.45 1.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.97 0.804 . . . . 63.41 109.494 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.17 -158.35 20.04 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.08 -0.581 . . . . 73.03 113.344 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.54 146.03 38.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 52.5 m -53.58 137.98 35.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.012 0.434 . . . . 75.33 111.564 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 414' ' ' ARG . 28.5 p -106.18 -16.86 14.48 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 115.932 -0.576 . . . . 64.11 110.595 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 62.81 23.67 14.11 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.513 0.725 . . . . 75.31 111.528 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.447 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 23.8 t-20 -128.84 -54.02 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.765 -0.652 . . . . 75.13 109.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.87 -156.11 10.03 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 109.199 -1.56 . . . . 32.13 109.199 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.19 -68.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.597 2.198 . . . . 53.13 112.173 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -143.98 157.62 44.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.997 -1.112 . . . . 61.1 107.997 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 408' ' ' CYS . 45.0 ttm105 -71.16 147.26 48.52 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.178 -0.675 . . . . 65.12 109.178 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.534 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 42.1 t -144.25 164.7 29.98 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.672 -0.694 . . . . 75.43 109.788 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -146.82 131.8 18.18 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.422 0.689 . . . . 71.33 109.797 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 440' ' ' LEU . 7.0 tp -115.38 108.27 24.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.302 -0.999 . . . . 72.31 108.302 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 72.7 t -93.21 111.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.225 0.536 . . . . 74.44 111.31 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.0 m -105.59 117.97 35.38 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.132 -0.94 . . . . 62.41 108.697 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 422' ' ' CYS . 19.3 t -103.02 132.59 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 N-CA-C 107.606 -1.257 . . . . 72.22 107.606 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.96 10.63 22.22 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.53 0.681 . . . . 72.23 112.252 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.569 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.1 t 62.42 152.75 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.086 1.354 . . . . 71.24 113.349 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -167.75 -159.16 12.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.414 -1.074 . . . . 35.13 110.414 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.86 -17.07 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.649 0.738 . . . . 71.21 109.414 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.03 158.9 43.67 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 108.206 -1.035 . . . . 73.32 108.206 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -92.02 115.8 28.38 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.915 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.06 152.7 33.82 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.229 -0.656 . . . . 43.02 109.229 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 365' ' ' THR . 44.5 mt -89.77 120.66 38.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.429 -1.323 . . . . 72.42 107.429 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.46 -63.22 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.83 -0.433 . . . . 64.55 109.83 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 39.8 m -151.8 160.25 43.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.903 -0.59 . . . . 41.31 109.966 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 14.4 p -142.37 132.78 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.991 -0.744 . . . . 75.22 108.991 175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -137.42 125.68 23.19 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.906 -0.318 . . . . 73.52 111.469 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 41.5 tt0 -80.06 91.84 5.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.093 -1.077 . . . . 54.34 108.093 171.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.42 -26.73 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.512 -0.767 . . . . 73.42 110.641 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 42.1 mt-30 -101.16 174.28 6.07 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.882 -0.784 . . . . 74.33 108.882 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.19 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.693 1.738 . . . . 73.21 115.693 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.55 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 80.0 m 58.19 20.68 7.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.605 0.762 . . . . 74.0 109.717 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 36.3 tt0 -112.16 121.16 44.16 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 114.936 -1.029 . . . . 70.31 110.575 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 52.8 m-85 -94.38 125.3 38.94 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.927 -1.488 . . . . 73.02 112.22 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.1 mt -79.9 107.62 12.82 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.575 -1.269 . . . . 73.45 107.575 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 12.0 mt -105.17 119.6 54.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.188 -0.605 . . . . 65.14 109.536 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -106.7 131.34 53.94 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.928 0.394 . . . . 75.11 111.417 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.507 ' SD ' HG21 ' A' ' 376' ' ' VAL . 81.1 mtp -142.98 171.41 14.09 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.6 -0.727 . . . . 64.31 109.109 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 56.5 pttt -145.6 146.14 31.24 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.723 -1.214 . . . . 71.51 107.723 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 37.5 m -156.05 144.03 14.25 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 107.134 -1.432 . . . . 75.31 107.134 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.72 -29.98 42.17 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.131 1.887 . . . . 60.11 112.688 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.18 -18.35 63.19 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.215 0.531 . . . . 73.43 111.152 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -71.83 -30.29 65.31 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.669 -0.696 . . . . 63.11 111.676 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 65.6 m -68.34 -37.35 80.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.376 -0.53 . . . . 73.54 109.952 173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 123.963 0.905 . . . . 71.4 112.167 177.637 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 109.488 -0.56 . . . . 71.15 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -154.04 155.8 36.16 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.022 -1.473 . . . . 71.3 107.022 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.71 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.254 0.346 . . . . 70.34 110.616 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.4 mm -81.84 116.35 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.353 -0.98 . . . . 62.12 108.353 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.5 121.52 30.04 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.458 -0.792 . . . . 71.14 110.784 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -103.79 64.69 0.36 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.615 -0.802 . . . . 43.11 111.38 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 24.5 ptm -84.27 37.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.045 0.938 . . . . 72.21 111.213 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.68 -20.52 39.33 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.262 1.208 . . . . 63.21 114.262 -170.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.445 HG22 HG13 ' A' ' 428' ' ' ILE . 6.1 m -122.21 135.24 54.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 118.456 -1.297 . . . . 70.14 111.56 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.59 145.67 31.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.353 -0.98 . . . . 64.4 108.353 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -149.03 133.34 17.45 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.236 -1.394 . . . . 64.44 107.236 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 14.1 pt-20 -92.31 110.95 22.35 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 119.23 -0.988 . . . . 74.43 109.231 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.1 122.33 69.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.851 -1.068 . . . . 72.14 110.305 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.01 28.36 70.31 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.724 -0.671 . . . . 51.13 113.588 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.53 81.16 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.623 -0.798 . . . . 61.53 113.327 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -118.25 132.27 56.31 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.409 0.623 . . . . 74.11 111.848 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 71.1 m -84.64 113.83 21.56 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.57 -0.741 . . . . 71.04 112.202 -171.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.672 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.2 m-85 -86.34 125.12 33.41 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.224 -0.898 . . . . 74.42 109.308 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -121.88 125.11 45.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.172 -1.418 . . . . 71.24 107.172 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.33 104.51 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 C-N-CA 120.264 -0.574 . . . . 64.22 110.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 363' ' ' MET . 18.7 t -102.2 97.15 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.668 0 N-CA-C 106.992 -1.484 . . . . 65.13 106.992 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.4 ' HB3' ' HD1' ' A' ' 379' ' ' TYR . 51.5 m-85 -53.16 127.78 25.49 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.25 -0.887 . . . . 73.4 112.836 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.4 ' HD1' ' HB3' ' A' ' 378' ' ' PHE . 62.8 m-85 75.93 4.78 3.85 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.957 1.41 . . . . 75.32 112.254 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -116.77 -71.32 0.74 Allowed 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.53 -0.759 . . . . 75.23 111.908 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HB2' HD11 ' A' ' 388' ' ' LEU . 10.1 p30 177.9 173.73 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.909 0.756 . . . . 65.25 112.132 -174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.1 t -129.41 135.58 61.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.417 -0.957 . . . . 73.12 108.417 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 62.0 m-85 -118.36 163.81 16.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.557 -0.292 . . . . 71.1 110.794 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.3 pt20 -134.03 96.08 3.56 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.54 1.136 . . . . 61.22 108.977 168.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.2 t70 70.37 -75.35 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.058 1.343 . . . . 72.1 110.783 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.8 m -136.48 -16.42 1.58 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.513 -0.767 . . . . 72.1 109.514 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 39.1 mm -86.74 117.53 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.691 0.757 . . . . 65.41 110.75 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 383' ' ' PHE . 40.6 tp -79.2 117.68 20.44 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.748 -1.115 . . . . 63.13 109.917 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 86.7 mt -63.94 -66.93 0.47 Allowed 'General case' 0 C--O 1.201 -1.494 0 O-C-N 123.39 0.431 . . . . 74.24 110.314 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -151.68 -178.66 26.65 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 110.392 -1.083 . . . . 32.31 110.392 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.4 m-80 -131.97 152.35 51.17 Favored 'General case' 0 CA--C 1.46 -2.483 0 CA-C-N 117.276 0.538 . . . . 71.11 111.434 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -51.91 115.75 1.83 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.617 1.198 . . . . 71.11 112.181 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.51 2.66 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.767 -1.106 . . . . 72.42 110.006 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.9 m -148.23 155.11 40.96 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.107 0.48 . . . . 75.43 111.319 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.58 119.42 39.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 103.413 -2.81 . . . . 71.42 103.413 171.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -128.5 109.01 11.0 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.881 -0.415 . . . . 62.22 109.881 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 75.59 -124.52 7.58 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 108.942 -1.663 . . . . 71.11 108.942 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -109.25 13.51 24.31 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.445 -1.317 . . . . 63.34 107.445 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 418' ' ' VAL . 93.8 t -113.56 134.1 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.185 -0.916 . . . . 74.43 111.727 -172.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.631 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 4.1 mm? -96.63 131.31 43.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.876 -0.602 . . . . 72.12 111.59 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.1 tptm -110.62 123.84 50.74 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-N 115.641 -0.708 . . . . 74.5 112.031 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 65.7 m-85 -118.73 122.17 41.83 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.06 -0.973 . . . . 73.21 108.933 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.548 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 10.0 pt-20 -135.4 173.28 11.9 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.041 0.382 . . . . 64.33 110.962 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.3 m120 71.98 39.51 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.157 0.983 . . . . 73.3 111.618 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.62 -150.66 24.81 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.861 -1.161 . . . . 71.31 111.616 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 388' ' ' LEU . 15.9 mm100 -65.32 147.26 53.75 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.402 0.681 . . . . 75.21 110.838 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.2 m -51.36 135.91 26.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.869 0.731 . . . . 73.34 110.077 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.69 -34.06 34.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.747 0.784 . . . . 73.21 109.544 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.17 -164.95 0.44 Allowed 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.83 -2.656 . . . . 55.54 103.83 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -76.68 82.59 3.32 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.799 -0.76 . . . . 72.42 109.868 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 164.08 -99.56 0.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.524 -0.762 . . . . 72.22 111.78 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.99 -178.5 4.43 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.186 1.924 . . . . 74.44 113.82 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -116.42 165.31 13.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.047 -0.979 . . . . 52.32 109.71 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -85.16 166.33 16.68 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.288 0.566 . . . . 75.02 111.488 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 30.8 p -153.53 161.88 41.8 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.056 -0.975 . . . . 75.02 109.107 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -139.59 139.37 36.77 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.78 -0.452 . . . . 70.04 109.78 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.26 118.66 53.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.442 -1.318 . . . . 74.24 107.442 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 13.1 p -98.09 111.0 26.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.012 -1.075 . . . . 72.33 111.378 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 32.5 m -98.97 115.0 27.91 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.51 HG11 ' HB3' ' A' ' 448' ' ' ALA . 29.4 t -108.72 128.39 64.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.789 -0.819 . . . . 73.13 108.789 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.69 14.89 26.34 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.155 0.428 . . . . 73.55 112.155 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.484 ' H ' HG12 ' A' ' 420' ' ' VAL . 8.3 t 68.07 138.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.145 0.974 . . . . 60.31 112.971 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.75 -168.35 19.29 Favored Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.135 -1.586 . . . . 53.4 109.135 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -98.06 -20.95 5.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.779 -0.822 . . . . 74.14 108.779 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.92 147.78 35.83 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.48 -0.933 . . . . 64.42 108.48 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -82.03 123.03 28.56 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.105 0.478 . . . . 63.43 111.883 177.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.7 139.36 17.91 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.278 -1.008 . . . . 63.23 108.278 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 57.7 mt -82.39 117.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.697 -0.853 . . . . 73.22 108.697 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.8 t -79.22 -62.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.663 -0.699 . . . . 64.11 109.819 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 55.6 m -156.39 166.18 34.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.059 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.57 131.82 44.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.889 -1.152 . . . . 73.41 107.889 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.6 tp -129.43 130.06 45.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.85 0.357 . . . . 54.12 111.706 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.96 89.71 8.1 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.563 -1.273 . . . . 71.12 107.563 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -107.83 -33.23 7.31 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.332 0.587 . . . . 64.44 110.476 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.5 mt-30 -100.12 166.69 10.89 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.289 -0.634 . . . . 62.04 109.289 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.844 1.794 . . . . 73.21 115.844 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.09 22.14 5.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.085 0.554 . . . . 74.41 109.999 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 24.9 tt0 -111.62 119.89 40.23 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 108.181 -1.044 . . . . 61.25 108.181 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -94.66 124.39 38.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.274 -1.33 . . . . 65.11 110.785 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.93 105.85 17.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.427 -1.323 . . . . 75.41 107.427 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 443' ' ' MET . 3.2 mp -92.76 128.95 43.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.424 -0.954 . . . . 74.44 108.424 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.75 120.74 43.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.9 -1.148 . . . . 74.24 107.9 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 87.2 mtp -139.86 175.88 9.21 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 121.639 0.733 . . . . 71.13 110.104 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 52.7 pttt -149.27 141.43 24.0 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 107.368 -1.345 . . . . 74.11 107.368 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.2 t -155.37 142.43 13.64 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 109.362 -0.607 . . . . 41.05 109.362 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.43 -29.73 24.98 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.378 2.052 . . . . 71.24 111.367 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.45 -11.54 58.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.323 0.583 . . . . 74.12 112.186 -175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.51 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -110.17 -1.72 17.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.673 0.749 . . . . 64.25 108.984 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 36.2 t -70.58 -32.84 70.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.664 -1.153 . . . . 73.31 110.661 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 108.982 -0.747 . . . . 65.43 108.982 179.034 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.948 -1.13 . . . . 63.21 107.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -52.45 2.82 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 104.936 -2.246 . . . . 63.23 104.936 170.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -124.61 157.11 36.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.092 -1.818 . . . . 71.03 106.092 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 10.9 tt -125.08 140.35 48.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 120.2 -0.6 . . . . 60.11 111.542 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -78.76 121.32 24.61 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.356 -0.979 . . . . 74.15 108.356 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.17 -66.98 1.6 Allowed Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.757 -0.735 . . . . 62.03 112.8 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.666 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 24.6 mmt -129.78 178.9 6.17 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.251 -1.389 . . . . 52.32 107.251 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.61 69.11 1.08 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 122.584 1.183 . . . . 74.14 109.178 166.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.7 m -76.51 131.75 39.18 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.976 -1.491 . . . . 53.1 106.976 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.3 pttt -131.12 137.34 49.01 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.28 0.562 . . . . 63.43 110.509 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -147.48 135.46 21.29 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.773 -1.565 . . . . 72.41 106.773 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.278 0.0 OUTLIER -95.86 110.79 22.91 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 114.066 1.136 . . . . 70.52 114.066 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.491 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -114.32 135.83 52.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.635 -1.166 . . . . 65.13 108.405 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.26 18.96 58.98 Favored Glycine 0 C--O 1.224 -0.526 0 N-CA-C 114.723 0.649 . . . . 34.53 114.723 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 89.4 5.25 72.62 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.428 -0.891 . . . . 65.22 112.567 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -126.35 141.74 51.79 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.379 0.609 . . . . 75.12 112.133 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 88.1 m -87.03 112.85 22.26 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.597 -0.729 . . . . 71.21 111.545 -172.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 61.3 m-85 -86.3 125.32 33.52 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.3 ttmt -118.26 124.0 46.79 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.82 108.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.99 -0.744 . . . . 25.42 108.99 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 363' ' ' MET . 22.4 t -90.71 -10.58 10.06 Favored 'Isoleucine or valine' 0 C--O 1.256 1.397 0 CA-C-O 122.268 1.032 . . . . 71.43 109.234 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE2' ' A' ' 379' ' ' TYR . 4.4 t80 75.07 -61.68 0.48 Allowed 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 125.716 1.607 . . . . 62.54 111.931 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE2' ' HD2' ' A' ' 378' ' ' PHE . 99.0 m-85 -95.37 -2.76 48.42 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.65 -0.656 . . . . 72.23 112.352 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 24.7 mm-40 -108.13 -70.94 0.78 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.936 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 11.4 p30 -178.59 -177.3 0.53 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.357 0.663 . . . . 75.14 111.305 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 60.6 t -131.19 131.67 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.688 0.617 . . . . 71.2 109.411 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 73.1 m-85 -116.76 164.15 15.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.191 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.0 pt20 -129.92 100.29 5.41 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.401 1.08 . . . . 71.51 108.59 168.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 t70 69.99 -76.04 0.07 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.91 1.284 . . . . 72.45 110.782 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.0 t -145.46 5.01 1.05 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.872 -0.604 . . . . 52.35 109.517 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 72.2 mt -102.43 128.78 54.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.552 -0.536 . . . . 74.35 109.552 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.512 HD13 ' CE1' ' A' ' 383' ' ' PHE . 55.9 tp -87.28 123.4 32.23 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 116.243 -0.435 . . . . 74.12 111.579 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.5 mt -69.83 -64.83 0.81 Allowed 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 115.721 -0.672 . . . . 74.35 109.923 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.02 33.75 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 109.97 -1.252 . . . . 74.12 109.97 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.5 m-80 -125.22 148.57 48.58 Favored 'General case' 0 CA--C 1.448 -2.974 0 CA-C-N 117.457 0.629 . . . . 54.34 111.548 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.02 115.18 3.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 124.1 0.875 . . . . 63.13 110.621 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -113.21 -53.58 2.69 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.373 -0.83 . . . . 71.24 110.407 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.1 m -154.85 167.08 31.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 110.033 -0.358 . . . . 70.42 110.033 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -121.24 130.75 53.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.049 -0.723 . . . . 61.12 109.049 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -112.91 98.73 7.37 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.624 -1.25 . . . . 71.34 107.624 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.6 -120.79 7.69 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 109.265 -1.534 . . . . 62.45 109.265 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.36 1.3 30.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.006 0.908 . . . . 71.14 108.613 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 51.5 t -95.92 125.37 48.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.382 -0.826 . . . . 70.44 109.812 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.665 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.3 mp -96.99 139.22 33.33 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.921 0.391 . . . . 71.23 111.826 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.744 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 13.5 tptm -113.89 129.11 56.63 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.535 -0.757 . . . . 60.13 112.369 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 61.5 m-85 -116.33 114.51 24.43 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.1 -1.074 . . . . 75.43 108.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 0.3 OUTLIER -125.96 163.7 22.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 -175.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 66.81 50.48 1.12 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.778 0.831 . . . . 54.45 113.174 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -90.04 -144.38 11.49 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.747 -0.941 . . . . 73.21 110.747 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.9 mt-30 -83.68 147.99 27.36 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.957 -0.386 . . . . 74.42 109.957 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.6 m -64.89 144.73 57.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.168 0.509 . . . . 73.33 110.135 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.92 -28.03 11.35 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.321 -0.4 . . . . 73.14 110.939 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . 71.15 135.08 0.04 OUTLIER 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.361 1.064 . . . . 52.32 109.218 -172.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 54.2 t30 74.74 -33.48 0.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.145 0.978 . . . . 64.51 110.612 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -117.47 104.12 1.14 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.878 -1.689 . . . . 74.53 108.878 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.79 113.75 1.65 Allowed 'Trans proline' 0 C--O 1.249 1.05 0 C-N-CA 123.305 2.67 . . . . 71.14 112.62 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.0 m170 69.01 128.34 0.03 OUTLIER 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.502 1.521 . . . . 70.15 112.108 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -84.75 148.53 26.3 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.489 -2.041 . . . . 73.03 105.489 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.744 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 28.6 t -148.95 167.0 26.93 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 120.943 0.401 . . . . 63.44 111.129 -174.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.61 135.26 26.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.787 -0.82 . . . . 41.31 108.787 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.5 116.11 45.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.167 -1.049 . . . . 72.05 108.167 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.665 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 11.5 p -100.9 113.48 37.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.985 0.898 . . . . 71.14 112.094 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 38.2 m -101.43 114.74 29.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.346 -1.353 . . . . 74.21 107.346 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 448' ' ' ALA . 32.6 t -102.68 124.97 57.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.414 -0.587 . . . . 74.22 109.414 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.43 13.87 27.99 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.159 0.8 . . . . 70.21 113.159 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.415 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.2 t 69.42 136.35 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.339 1.237 . . . . 64.42 114.339 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.29 -168.4 19.05 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.202 -1.559 . . . . 62.22 109.202 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.76 -23.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.069 -1.086 . . . . 74.14 108.069 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.72 160.77 32.36 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.066 -1.425 . . . . 71.1 109.689 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -88.11 109.13 19.64 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 109.076 -0.713 . . . . 74.33 109.076 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.17 150.52 32.79 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 121.142 0.496 . . . . 71.42 110.45 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 51.2 mt -89.12 130.65 38.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.103 -1.073 . . . . 74.24 108.103 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.91 -61.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.199 -0.667 . . . . 72.45 109.199 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.7 m -161.98 164.55 28.3 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 53.52 108.895 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.1 t -131.6 137.66 54.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 106.428 -1.693 . . . . 71.1 106.428 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.74 128.91 31.77 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.54 -0.464 . . . . 74.24 111.945 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.55 106.84 18.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.164 -1.421 . . . . 74.33 107.164 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -145.2 3.76 1.04 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.221 -0.591 . . . . 71.23 110.889 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -144.17 98.39 3.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.593 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.401 0.1 OUTLIER 35.57 59.63 0.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 117.757 2.503 . . . . 74.3 117.757 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.16 16.05 6.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.425 -0.807 . . . . 74.2 112.435 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -102.76 124.32 48.06 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.142 -1.429 . . . . 61.34 107.142 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.443 ' CD1' HD22 ' A' ' 389' ' ' LEU . 73.3 m-85 -94.73 119.36 33.22 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.3 -0.864 . . . . 73.12 111.888 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.78 111.12 14.59 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.961 -1.496 . . . . 72.53 106.961 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 65.4 mt -106.76 130.1 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 120.816 0.341 . . . . 74.33 110.366 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -106.45 128.7 54.27 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.942 -0.572 . . . . 73.44 110.16 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 74.3 mtp -140.28 163.2 33.4 Favored 'General case' 0 CA--C 1.466 -2.251 0 CA-C-N 115.613 -0.721 . . . . 71.21 109.5 175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -142.62 141.29 31.9 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 107.242 -1.392 . . . . 70.23 107.242 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.8 p -161.81 152.82 15.14 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.19 -23.81 20.72 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.22 1.947 . . . . 71.52 111.006 174.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.86 63.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 61.34 112.386 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.561 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -104.94 -2.29 24.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.782 . . . . 70.13 109.189 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.7 t -81.22 93.41 6.49 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.955 -1.021 . . . . 63.03 109.28 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.797 -1.186 . . . . 75.33 107.797 179.184 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 112.361 0.504 . . . . 72.42 112.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.401 ' O ' ' HE2' ' A' ' 361' ' ' LYS . 98.5 mtt180 -138.64 73.41 1.43 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.482 -1.673 . . . . 72.44 106.482 171.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 65.43 -173.5 0.18 Allowed 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.816 -1.083 . . . . 43.14 109.189 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.59 114.81 27.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.091 -1.044 . . . . 74.4 110.344 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 358' ' ' ARG . 68.1 mttm -114.39 137.68 51.52 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.516 -1.22 . . . . 73.24 107.74 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.34 -58.36 1.02 Allowed Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 119.41 -1.376 . . . . 54.32 110.742 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 57.1 mtm -143.58 169.98 16.69 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.034 -2.21 . . . . 62.31 105.034 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -136.13 75.18 1.53 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 122.217 1.008 . . . . 73.14 108.901 170.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.2 m -76.32 121.42 22.96 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.621 -1.251 . . . . 73.42 107.621 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 49.0 mtmt -124.72 133.17 53.28 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 109.708 -0.479 . . . . 73.21 109.708 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.424 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 5.0 tpt180 -150.58 147.15 27.09 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.144 -1.428 . . . . 73.32 107.144 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.87 111.05 23.5 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.133 0.492 . . . . 71.4 111.022 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.38 132.16 71.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.849 -0.797 . . . . 73.3 108.849 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.14 29.59 73.31 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 113.836 0.295 . . . . 71.42 113.836 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.27 58.02 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 121.392 -0.433 . . . . 74.24 113.1 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -115.36 148.0 39.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.043 0.757 . . . . 75.31 113.043 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 86.9 m -90.53 117.05 28.91 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.461 -0.79 . . . . 75.23 111.344 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 52.9 m-85 -86.67 127.17 34.93 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.167 -0.924 . . . . 74.43 109.541 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.2 ttmt -118.45 123.67 45.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.036 -1.098 . . . . 72.21 108.036 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 61.7 t -113.09 106.79 21.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.184 -0.673 . . . . 65.32 109.184 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 363' ' ' MET . 23.1 t -86.92 -14.41 10.21 Favored 'Isoleucine or valine' 0 C--O 1.259 1.579 0 CA-C-O 122.09 0.948 . . . . 23.43 109.142 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 14.8 t80 75.67 -56.22 0.6 Allowed 'General case' 0 C--O 1.205 -1.258 0 C-N-CA 125.502 1.521 . . . . 74.04 111.022 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -91.33 -22.44 20.52 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.874 -0.516 . . . . 71.34 111.818 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 42.7 mt-10 -89.13 -73.26 0.51 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.324 -0.55 . . . . 62.22 110.91 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 15.9 p30 -178.44 -171.11 0.24 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.732 -0.667 . . . . 75.33 110.385 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.4 t -131.25 133.29 62.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 O-C-N 123.734 0.646 . . . . 62.01 109.55 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 58.9 m-85 -119.94 161.86 20.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.849 -0.426 . . . . 72.44 109.849 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.526 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -122.58 97.53 5.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.569 -1.271 . . . . 62.21 107.569 167.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.16 -79.15 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.368 1.467 . . . . 60.14 110.793 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.0 m -138.95 -3.18 1.63 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.43 -0.804 . . . . 53.54 110.086 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.526 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 47.0 mm -94.6 120.4 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-O 121.498 0.666 . . . . 55.34 109.628 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 36.2 tp -77.76 119.51 21.37 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.119 -0.946 . . . . 73.5 112.406 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 374' ' ' TYR . 86.0 mt -70.71 -63.64 1.05 Allowed 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 121.146 0.498 . . . . 53.54 109.907 175.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.5 176.64 37.13 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.507 -1.037 . . . . 73.42 110.507 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 39.2 m-80 -122.33 151.85 40.74 Favored 'General case' 0 CA--C 1.451 -2.85 0 CA-C-N 116.83 0.315 . . . . 52.01 111.651 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -54.24 115.43 2.07 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 124.669 1.231 . . . . 75.42 110.078 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.19 -51.1 2.78 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.369 -0.832 . . . . 51.03 111.047 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 m -145.12 149.23 34.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 116.284 -0.417 . . . . 75.22 110.38 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -119.18 119.28 33.65 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.318 -0.993 . . . . 72.35 108.318 174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.04 99.06 6.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.283 -1.006 . . . . 74.52 108.283 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.66 -119.6 9.26 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.563 -1.015 . . . . 54.41 110.563 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.484 HD21 ' HB1' ' A' ' 448' ' ' ALA . 63.9 t30 -106.09 5.86 30.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.977 0.894 . . . . 72.42 109.106 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.59 121.41 56.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-N 115.704 -0.68 . . . . 70.53 110.569 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.448 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 10.3 mp -109.53 140.11 43.71 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.386 -0.825 . . . . 74.34 111.721 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.599 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 13.0 tptm -117.68 129.55 55.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.272 -0.876 . . . . 73.43 111.711 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 31.9 m-85 -118.68 118.52 31.86 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.139 -0.937 . . . . 51.04 108.895 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.599 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 11.0 pt-20 -139.14 -176.59 4.56 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 121.734 -0.604 . . . . 52.3 111.551 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.56 32.56 18.65 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.035 0.834 . . . . 71.34 110.851 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.66 -138.23 2.1 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.692 -0.685 . . . . 73.12 112.358 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -83.51 145.4 28.94 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 -178.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.9 m -57.55 140.94 49.52 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.714 0.769 . . . . 70.21 112.153 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.64 -45.07 31.45 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.964 -1.016 . . . . 71.21 110.409 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -170.67 124.33 0.67 Allowed 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.901 -1.148 . . . . 73.11 107.901 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.84 -49.25 0.67 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.132 0.973 . . . . 64.43 113.31 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -159.43 -61.18 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.922 -0.932 . . . . 71.43 114.413 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -44.94 147.44 1.96 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.02 3.147 . . . . 64.12 115.414 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -69.48 146.05 52.24 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.854 1.428 . . . . 54.55 114.854 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -91.09 165.02 13.73 Favored 'General case' 0 C--O 1.258 1.533 0 N-CA-C 107.76 -1.2 . . . . 62.24 107.76 162.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.561 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 65.7 m -153.55 163.36 40.1 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.852 0.358 . . . . 74.44 110.696 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.53 134.48 23.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.186 -1.042 . . . . 63.11 108.186 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.39 123.33 64.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 107.664 -1.236 . . . . 75.14 107.664 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.2 p -99.57 121.26 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 119.477 -0.889 . . . . 73.04 110.784 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 m -103.47 113.66 27.33 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 106.8 -1.556 . . . . 73.2 106.8 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.3 t -115.75 130.49 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 109.275 -0.639 . . . . 71.31 109.275 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.61 -4.79 19.21 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.022 -0.536 . . . . 74.13 111.026 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.422 ' H ' HG12 ' A' ' 420' ' ' VAL . 53.2 t 71.81 154.23 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.672 0.789 . . . . 42.23 111.157 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -168.39 -156.94 10.73 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.162 -1.018 . . . . 72.44 112.335 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.7 t -98.73 -19.37 5.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.698 0.761 . . . . 43.22 109.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -142.36 160.65 39.84 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.366 -1.346 . . . . 70.23 107.366 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.1 OUTLIER -100.16 136.49 39.99 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.674 -0.811 . . . . 52.0 109.164 176.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.18 151.09 11.59 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.547 -0.538 . . . . 62.32 109.547 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 59.3 mt -88.58 110.43 21.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.389 -1.337 . . . . 71.31 107.389 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.44 -52.03 16.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.789 -0.641 . . . . 54.34 110.175 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 m -153.56 159.76 42.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.541 -0.54 . . . . 73.13 109.541 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.528 HG11 ' CE2' ' A' ' 374' ' ' TYR . 58.8 t -137.72 125.92 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.58 -1.267 . . . . 72.13 107.58 174.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.1 tp -134.64 120.13 19.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.932 0.396 . . . . 74.02 111.388 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -82.3 87.12 6.59 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.969 -0.752 . . . . 73.41 108.969 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -104.17 -12.22 16.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.98 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 45.3 mt-30 -115.86 173.63 6.46 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.13 -0.486 . . . . 70.4 109.961 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.64 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.432 2.012 . . . . 72.42 116.432 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 74.5 m 57.28 25.28 10.93 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 122.207 1.003 . . . . 63.04 108.914 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 37.9 tt0 -113.76 120.46 40.88 Favored 'General case' 0 N--CA 1.405 -2.692 0 CA-C-N 114.212 -1.358 . . . . 74.02 109.647 -175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.34 122.37 36.83 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.087 -1.415 . . . . 75.43 111.179 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 80.2 mt -80.77 120.49 24.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.588 -1.634 . . . . 43.34 106.588 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 443' ' ' MET . 60.5 mt -107.21 121.23 59.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.14 -1.059 . . . . 61.53 108.14 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -106.17 114.14 28.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.945 -1.502 . . . . 74.41 106.945 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 86.5 mtp -143.52 -179.18 6.27 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.148 0.975 . . . . 73.01 112.837 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 55.9 pttt -162.03 158.42 24.95 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 113.647 -1.615 . . . . 72.32 108.046 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 52.3 p -168.67 149.43 4.32 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.667 -0.864 . . . . 75.34 108.667 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.71 -28.86 51.74 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.422 2.081 . . . . 55.15 111.211 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.75 -5.24 47.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.38 -0.827 . . . . 62.13 111.665 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.484 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -84.65 -31.15 24.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.273 -0.422 . . . . 43.13 111.822 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 66.5 m -67.46 85.45 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.624 0.726 . . . . 45.42 112.262 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 107.359 -1.349 . . . . 71.42 107.359 177.863 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 110.065 -0.346 . . . . 74.34 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -55.38 -56.36 21.04 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.515 0.561 . . . . 75.22 112.515 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -115.25 156.95 24.46 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.095 -0.502 . . . . 74.11 111.798 -173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 11.1 tt -83.24 136.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -117.23 147.94 42.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.955 0.407 . . . . 74.34 111.444 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -120.18 -145.21 7.36 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 120.815 -0.707 . . . . 73.22 113.205 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 10.8 mmt -66.88 153.37 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.799 0.84 . . . . 74.14 111.888 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.56 99.24 7.02 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.077 -1.082 . . . . 75.42 108.077 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 4.9 m -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.431 -0.508 . . . . 71.41 109.944 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -144.27 141.97 30.16 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 120.863 0.363 . . . . 74.21 110.907 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 9.1 tpt180 -152.54 137.74 17.42 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.104 -1.813 . . . . 73.24 106.104 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.311 0.2 OUTLIER -99.56 119.05 37.42 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.813 1.042 . . . . 74.54 113.813 -179.901 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -119.1 132.56 68.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.497 -0.774 . . . . 71.15 109.103 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.47 22.95 64.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 114.636 0.614 . . . . 72.42 114.636 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.7 -11.77 69.5 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.766 -0.731 . . . . 42.15 112.671 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -112.85 137.16 51.61 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.454 0.645 . . . . 72.45 111.949 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.7 m -87.48 116.7 25.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.476 -0.784 . . . . 71.31 110.63 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 54.4 m-85 -86.32 125.52 33.67 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.999 -1.001 . . . . 74.11 108.449 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 38.5 ttmt -117.72 124.05 47.53 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.905 -1.517 . . . . 73.41 106.905 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.4 HG11 ' SD ' ' A' ' 443' ' ' MET . 79.1 t -115.68 102.07 13.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.767 -0.827 . . . . 74.44 108.767 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.53 HG11 ' OE2' ' A' ' 380' ' ' GLU . 27.8 t -102.68 112.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.958 0 N-CA-C 107.351 -1.352 . . . . 72.01 107.351 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.403 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.2 m-85 -56.53 133.91 53.8 Favored 'General case' 0 N--CA 1.427 -1.602 0 O-C-N 123.963 0.79 . . . . 73.51 110.192 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 78.24 -16.93 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.083 0.953 . . . . 70.44 113.285 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' HG11 ' A' ' 377' ' ' VAL . 38.1 mt-10 -97.35 -83.31 0.4 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 120.093 -0.643 . . . . 74.35 111.281 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -179.37 171.8 1.25 Allowed 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 123.503 0.721 . . . . 72.33 112.13 -176.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.6 t -119.81 131.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.803 -0.635 . . . . 64.43 110.483 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 54.8 m-85 -121.7 160.36 24.65 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.093 -0.503 . . . . 73.51 110.067 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.9 pt20 -133.11 101.16 5.1 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.299 -0.864 . . . . 74.03 109.627 169.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 67.69 -78.11 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.956 1.302 . . . . 61.54 110.89 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.5 m -138.31 -0.65 1.99 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 61.45 109.972 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 45.2 mm -101.91 127.09 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 116.137 -0.483 . . . . 75.03 110.377 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 24.3 tp -83.02 124.15 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.975 -0.557 . . . . 73.14 110.442 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 439' ' ' TYR . 82.7 mt -73.87 -77.03 0.12 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.595 -0.442 . . . . 72.02 110.276 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.435 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -137.92 175.71 21.14 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.361 -0.923 . . . . 61.11 111.259 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 7.8 m-20 -125.46 138.18 53.99 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 122.688 0.395 . . . . 70.33 111.319 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.32 115.91 2.75 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.91 0.756 . . . . 74.45 112.472 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.54 -53.32 2.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.465 -0.789 . . . . 43.51 109.815 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 78.1 p -161.95 165.76 27.06 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-N 116.13 -0.486 . . . . 73.35 110.669 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.96 140.25 45.63 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.253 -0.647 . . . . 63.32 109.253 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.92 97.18 5.41 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.974 -1.121 . . . . 74.45 107.974 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.84 -107.25 1.46 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.448 -0.796 . . . . 22.45 112.124 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -106.51 3.13 26.79 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.165 0.983 . . . . 64.03 109.696 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.49 141.45 23.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.402 -0.817 . . . . 70.35 109.459 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.9 138.8 54.26 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.94 -0.475 . . . . 60.22 110.894 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 415' ' ' SER . 0.0 OUTLIER -110.71 130.2 55.63 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 113.574 0.953 . . . . 72.44 113.574 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 75.7 m-85 -119.03 114.0 21.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.938 -1.504 . . . . 74.05 106.938 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.34 169.16 17.64 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.263 -1.384 . . . . 72.0 107.263 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 65.36 34.49 8.17 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.899 0.88 . . . . 71.32 112.639 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.97 -135.69 1.72 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.368 -0.92 . . . . 73.21 112.516 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.0 145.71 31.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.382 -0.97 . . . . 74.23 108.382 -177.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.0 m -50.33 143.38 8.82 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.579 1.152 . . . . 75.21 113.51 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.4 t -89.26 -35.51 16.12 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.08 -0.711 . . . . 64.44 109.08 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -138.53 -87.02 0.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.448 -0.575 . . . . 75.25 109.448 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -139.62 -2.3 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.444 -0.502 . . . . 75.21 111.699 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.4 -84.45 0.56 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.062 -0.815 . . . . 52.15 111.062 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.58 158.18 38.15 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 122.504 2.136 . . . . 55.25 112.949 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -106.97 170.34 8.01 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.719 -1.128 . . . . 71.3 109.105 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -85.3 168.01 15.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.412 -0.588 . . . . 62.25 109.412 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 36.8 t -150.68 162.55 40.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.602 -0.888 . . . . 72.43 108.602 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.11 131.53 18.65 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.805 -0.443 . . . . 40.23 109.805 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 440' ' ' LEU . 6.0 tp -116.27 114.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.518 HG22 HD12 ' A' ' 441' ' ' ILE . 95.4 t -93.13 111.12 24.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 121.953 -0.467 . . . . 61.11 111.162 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 22.4 m -99.32 117.93 34.86 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.337 -1.356 . . . . 71.55 107.337 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.594 HG12 ' H ' ' A' ' 422' ' ' CYS . 4.9 t -120.13 132.55 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 119.409 -0.916 . . . . 63.52 109.182 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.13 2.42 24.85 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.269 0.557 . . . . 74.41 110.67 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.594 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.7 t 70.84 150.87 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.405 1.082 . . . . 72.34 112.045 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -164.91 -153.71 7.62 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.276 -0.73 . . . . 70.32 111.276 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.09 -32.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.322 0.582 . . . . 62.3 110.943 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.14 161.23 37.91 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.086 -0.709 . . . . 64.31 109.086 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 43.6 m-80 -75.63 116.41 16.31 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 123.58 0.55 . . . . 72.01 110.713 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.47 133.15 19.92 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.942 -0.572 . . . . 74.15 111.06 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.509 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 58.7 mt -89.82 126.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.395 -1.335 . . . . 51.51 107.395 173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.33 -55.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.062 0.458 . . . . 71.41 109.925 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 66.8 m -159.88 162.8 34.66 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.073 0.549 . . . . 63.22 109.699 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.446 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -136.22 133.61 50.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 106.623 -1.621 . . . . 70.04 106.623 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.1 tp -136.94 135.63 37.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.419 -0.512 . . . . 63.25 111.615 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -83.25 140.41 32.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.81 -1.182 . . . . 75.11 107.81 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -162.28 -2.75 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.8 -0.76 . . . . 65.41 112.12 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.533 ' HG2' ' HG3' ' A' ' 436' ' ' LYS . 8.4 tt0 -120.11 -86.73 0.65 Allowed 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 118.289 -1.364 . . . . 70.34 112.83 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.533 ' HG3' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -149.73 66.77 0.99 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.54 0.686 . . . . 74.11 112.13 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 55.7 m 67.47 32.15 5.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.571 -1.27 . . . . 55.44 107.571 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -123.01 119.86 31.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.729 -1.123 . . . . 73.42 108.805 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.413 ' CD1' HD22 ' A' ' 389' ' ' LEU . 85.2 m-85 -94.09 121.44 35.58 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.737 -1.119 . . . . 75.23 112.126 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.491 ' HA ' HG23 ' A' ' 417' ' ' ILE . 54.4 mt -79.52 110.7 15.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.54 -1.209 . . . . 50.44 108.35 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 418' ' ' VAL . 11.0 mt -98.3 129.23 48.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.065 -0.717 . . . . 63.31 109.065 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -112.49 114.63 27.4 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.712 -1.588 . . . . 64.14 106.712 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 441' ' ' ILE . 81.2 mtp -144.07 173.27 11.87 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.878 0.847 . . . . 74.24 112.59 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -151.55 143.03 23.53 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.632 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.3 p -156.98 153.74 24.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 123.491 0.716 . . . . 74.32 109.514 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.98 -28.84 23.7 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.544 2.162 . . . . 72.05 111.97 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.28 -11.08 60.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.825 -0.625 . . . . 64.42 111.244 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' A' ' 420' ' ' VAL . . . -76.52 -35.83 58.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.653 -0.703 . . . . 71.22 111.257 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 59.5 m -64.64 98.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.216 0.531 . . . . 64.25 110.923 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.411 -2.389 0 N-CA-C 106.709 -1.589 . . . . 72.34 106.709 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 121.163 0.506 . . . . 70.3 112.34 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.55 -13.65 15.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.432 -0.951 . . . . 53.33 108.432 168.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -148.95 -172.82 4.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.93 -1.032 . . . . 62.42 108.606 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 69.2 mt -105.45 130.72 56.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.121 -1.066 . . . . 70.1 108.121 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.87 134.66 33.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.903 -1.119 . . . . 65.41 109.877 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -88.13 -115.71 1.24 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.721 -0.752 . . . . 74.33 111.398 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -107.67 155.99 19.56 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.239 -1.023 . . . . 72.01 108.239 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.453 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.5 pt-20 -120.18 95.03 4.58 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.712 0.768 . . . . 74.35 111.219 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 428' ' ' ILE . 20.4 m -79.7 140.7 36.91 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.129 -1.434 . . . . 63.44 107.129 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 64.2 pttt -143.86 133.44 23.55 Favored 'General case' 0 CA--C 1.479 -1.752 0 C-N-CA 119.559 -0.856 . . . . 73.54 109.536 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -151.15 153.04 34.23 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 108.995 -0.743 . . . . 73.01 108.995 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -92.17 109.0 20.36 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.698 -0.853 . . . . 71.42 108.698 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 2.7 mp -105.6 122.03 58.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.92 -0.712 . . . . 74.15 109.356 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.93 -89.43 0.06 OUTLIER Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.698 -0.683 . . . . 52.21 111.916 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.73 10.69 1.9 Allowed Glycine 0 C--N 1.31 -0.909 0 N-CA-C 111.065 -0.814 . . . . 72.41 111.065 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -128.05 128.08 44.3 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.241 0.616 . . . . 71.55 111.05 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 87.7 m -86.48 120.84 28.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.774 -0.648 . . . . 73.1 110.896 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 39.2 m-85 -87.04 126.69 34.92 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.93 -1.032 . . . . 73.23 109.881 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 33.6 ttmt -118.27 123.46 45.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.22 -1.77 . . . . 73.43 106.22 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 382' ' ' VAL . 57.9 t -113.59 102.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 N-CA-C 109.208 -0.664 . . . . 60.35 109.208 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 364' ' ' GLU . 16.9 t -99.73 104.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.297 -1.371 . . . . 43.12 107.297 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.495 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 22.0 m-85 -55.14 131.28 44.81 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 123.726 0.642 . . . . 62.22 111.995 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 76.29 -2.17 2.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 70.24 112.955 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 381' ' ' ASN . 5.4 mm-40 -112.05 -80.88 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.004 -0.544 . . . . 74.54 111.676 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER 179.5 169.49 1.08 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 122.734 0.413 . . . . 74.32 112.076 -176.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.428 ' CG1' HD12 ' A' ' 389' ' ' LEU . 61.6 t -121.7 140.08 46.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.559 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 68.7 m-85 -126.22 160.19 30.95 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.02 -0.536 . . . . 75.33 110.473 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.7 pt20 -133.09 99.32 4.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 124.216 1.006 . . . . 75.23 109.596 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.9 t70 66.24 -80.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.89 1.276 . . . . 64.32 111.32 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -135.8 -6.99 2.15 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.782 -0.645 . . . . 54.4 109.724 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.455 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 49.2 mm -95.51 125.4 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.086 -0.709 . . . . 72.42 109.086 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 391' ' ' ASN . 28.6 tp -81.45 131.19 35.27 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.924 -0.58 . . . . 70.04 111.07 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 382' ' ' VAL . 88.5 mt -77.77 -85.87 0.06 Allowed 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.638 -0.505 . . . . 73.11 109.638 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -135.56 -177.04 14.68 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.009 -0.836 . . . . 50.42 111.009 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -127.27 142.82 51.37 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 123.731 0.812 . . . . 52.44 110.077 -177.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -57.79 115.72 3.0 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.351 -0.54 . . . . 74.54 111.818 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -108.87 -50.69 2.98 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.096 -0.956 . . . . 52.3 110.132 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 43.3 m -153.16 158.28 41.57 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.989 0.424 . . . . 70.45 111.412 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -115.04 119.53 36.79 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.88 -1.156 . . . . 65.12 107.88 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -113.68 104.91 12.7 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.918 -1.142 . . . . 73.2 107.918 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.66 -131.54 13.03 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 108.758 -1.737 . . . . 75.41 108.758 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -100.53 8.65 43.36 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 117.72 0.76 . . . . 73.53 109.447 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.7 t -96.68 137.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.007 -0.997 . . . . 72.41 110.599 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.45 132.28 54.28 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.899 -0.591 . . . . 75.01 109.496 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.665 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -117.41 127.92 54.51 Favored 'General case' 0 C--O 1.249 1.059 0 C-N-CA 120.235 -0.586 . . . . 55.03 109.524 178.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 65.7 m-85 -118.87 113.56 21.26 Favored 'General case' 0 C--O 1.196 -1.757 0 N-CA-C 108.769 -0.826 . . . . 75.31 108.769 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.569 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 13.7 pt-20 -133.01 -179.77 5.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 118.379 0.536 . . . . 74.05 109.965 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 69.2 33.18 3.39 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.962 0.789 . . . . 73.01 110.621 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -86.55 -136.65 4.55 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.646 -0.788 . . . . 73.03 112.107 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 128.94 37.37 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.745 -1.205 . . . . 74.54 107.745 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 15.4 m -52.9 119.46 4.65 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.614 0.765 . . . . 63.35 111.251 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 412' ' ' PRO . 41.3 t -77.51 -26.07 50.87 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.351 -0.386 . . . . 62.31 110.84 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.11 -42.84 0.53 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.054 . . . . 70.44 112.626 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.58 -32.96 74.83 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.183 -0.673 . . . . 72.33 109.183 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -144.93 -137.53 3.17 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.196 -1.561 . . . . 75.43 109.196 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 408' ' ' CYS . 8.1 Cg_exo -75.67 -161.67 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.51 2.14 . . . . 74.42 110.561 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -70.99 149.25 46.84 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.662 -0.649 . . . . 75.44 109.277 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -64.2 154.73 33.98 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 109.018 -0.734 . . . . 73.53 109.018 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.452 ' OG ' ' HE3' ' A' ' 401' ' ' LYS . 35.0 t -150.58 169.08 22.4 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 120.886 0.374 . . . . 61.11 110.541 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 441' ' ' ILE . . . -149.33 132.77 16.62 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 123.682 0.793 . . . . 43.53 110.048 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 401' ' ' LYS . 4.4 tp -115.81 112.26 38.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.148 -0.686 . . . . 73.01 109.148 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 399' ' ' VAL . 73.0 t -93.3 110.59 23.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.288 0.566 . . . . 71.04 110.124 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.5 m -108.12 115.37 29.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.106 -0.952 . . . . 71.34 108.892 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.8 m -106.9 134.68 47.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.59 -0.732 . . . . 74.11 112.576 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -106.36 0.28 24.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.308 0.575 . . . . 73.33 109.471 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 448' ' ' ALA . 45.9 t 74.66 148.5 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.463 1.105 . . . . 71.21 112.536 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.1 -160.19 10.09 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.534 -0.757 . . . . 42.31 111.453 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.01 -34.03 5.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.139 0.495 . . . . 62.14 110.077 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.94 162.1 36.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.803 -0.635 . . . . 65.23 109.39 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -74.09 119.23 18.01 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 123.433 0.458 . . . . 61.22 110.429 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.4 142.39 23.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.636 -0.711 . . . . 54.52 109.725 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.8 mt -87.49 120.09 36.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.647 -1.242 . . . . 72.53 107.647 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.32 -62.51 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 120.806 0.336 . . . . 54.11 110.477 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -157.81 161.2 38.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.42 109.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 374' ' ' TYR . 49.0 t -137.64 127.37 36.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.356 -0.609 . . . . 75.13 109.356 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.2 139.01 42.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.543 0.211 . . . . 75.32 111.499 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 439' ' ' TYR . 32.2 tt0 -86.67 108.65 18.73 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.45 -15.71 7.52 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.0 0.428 . . . . 71.4 110.985 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 53.0 mt-30 -118.04 172.65 7.27 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.974 -0.557 . . . . 72.42 110.637 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.375 1.62 . . . . 64.33 115.375 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.1 m 58.26 21.63 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.602 0.715 . . . . 61.0 109.501 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 28.7 tt0 -113.45 120.94 42.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.064 -0.971 . . . . 73.0 108.761 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 433' ' ' GLU . 88.0 m-85 -97.5 128.07 43.96 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.429 -1.259 . . . . 75.22 113.235 -171.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 417' ' ' ILE . 82.4 mt -77.06 112.28 13.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.177 -1.046 . . . . 75.33 108.177 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.422 ' CD1' HG11 ' A' ' 382' ' ' VAL . 14.4 mt -104.48 120.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.177 -1.416 . . . . 61.04 107.177 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -106.32 123.84 48.67 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.054 -1.461 . . . . 73.13 107.054 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -138.23 173.91 11.11 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.652 0.739 . . . . 71.33 110.812 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -153.12 139.86 18.95 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 114.633 -1.167 . . . . 72.44 108.572 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 54.5 p -161.75 158.63 22.15 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.216 -1.031 . . . . 73.15 108.216 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.07 -26.55 50.4 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.33 2.02 . . . . 53.21 111.046 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.42 62.41 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.254 -0.884 . . . . 72.44 110.958 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 422' ' ' CYS . . . -76.22 -21.77 56.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.078 -0.51 . . . . 65.22 111.029 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.75 -23.84 52.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.158 -0.473 . . . . 34.52 111.463 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.433 -1.317 0 CA-C-O 118.498 -0.763 . . . . 74.22 110.382 179.599 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 51.2 t80 . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.683 -1.229 . . . . 64.32 107.683 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 1.1 tpm_? 67.74 15.0 9.62 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.568 0.699 . . . . 54.14 111.131 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -96.91 117.13 30.44 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.8 -0.563 . . . . 61.01 110.487 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 6.5 tt -88.73 128.18 41.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 116.018 -0.537 . . . . 72.12 109.983 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HG3' ' CG ' ' A' ' 380' ' ' GLU . 2.9 mppt? -93.69 121.06 34.73 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.505 -0.316 . . . . 73.34 110.813 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 377' ' ' VAL . . . -121.99 -146.89 7.43 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.772 -1.204 . . . . 65.25 111.874 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 24.7 ptt? 177.95 38.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.504 -2.036 . . . . 61.32 105.504 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.51 -46.11 73.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.657 -2.065 . . . . 73.43 113.384 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 426' ' ' ASN . 2.0 m -122.44 143.33 49.75 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.647 -0.821 . . . . 65.42 110.997 -176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -144.13 140.79 29.61 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.155 -1.054 . . . . 64.11 108.155 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -157.08 151.75 25.59 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.835 -1.172 . . . . 70.1 107.835 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 112.67 25.75 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.721 0.772 . . . . 74.33 112.675 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.556 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.5 mp -110.15 116.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.93 -0.482 . . . . 63.05 110.01 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 27.01 68.13 Favored Glycine 0 C--O 1.222 -0.655 0 CA-C-N 115.973 -0.558 . . . . 71.01 114.163 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.15 -16.24 61.14 Favored Glycine 0 C--N 1.312 -0.778 0 C-N-CA 121.556 -0.354 . . . . 45.01 112.767 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.256 6.0 p90 -104.68 131.73 51.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.732 0.777 . . . . 73.23 111.658 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.6 m -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.749 -1.114 . . . . 62.51 112.06 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 42.0 m-85 -87.17 125.71 34.33 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.952 -1.022 . . . . 72.41 110.223 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttmt -119.8 124.72 46.82 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.799 -1.186 . . . . 64.2 107.799 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.78 104.88 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.205 -0.665 . . . . 62.42 109.205 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 362' ' ' GLY . 39.4 t -83.18 -15.92 11.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 107.498 -1.297 . . . . 72.21 107.498 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 12.3 t80 75.49 -61.17 0.48 Allowed 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 126.001 1.72 . . . . 62.12 112.854 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -89.75 -14.5 34.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 72.52 110.431 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.478 ' CG ' ' HG3' ' A' ' 361' ' ' LYS . 12.9 mm-40 -99.29 -68.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.493 -0.776 . . . . 72.22 112.131 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 12.8 p30 -178.87 -175.73 0.41 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.476 -0.784 . . . . 73.11 111.304 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 59.6 t -131.94 134.48 59.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 N-CA-C 108.273 -1.01 . . . . 50.34 108.273 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 55.6 m-85 -116.45 158.54 23.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.929 -0.397 . . . . 73.35 109.929 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.509 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.8 pt20 -122.37 101.08 7.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.412 -0.958 . . . . 74.45 108.412 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.49 -86.22 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.828 1.251 . . . . 60.44 109.425 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.5 t -132.05 -5.73 3.49 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.289 0.566 . . . . 71.24 109.596 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.509 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 71.5 mt -88.23 120.16 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.142 -0.688 . . . . 73.4 109.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -78.08 124.05 27.58 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.69 -0.686 . . . . 71.44 111.926 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.602 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 89.1 mt -70.69 -71.09 0.26 Allowed 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.37 -0.377 . . . . 73.42 110.724 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -151.16 178.51 28.51 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 109.676 -1.37 . . . . 74.53 109.676 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 52.8 m-80 -127.21 151.26 48.93 Favored 'General case' 0 CA--C 1.449 -2.917 0 CA-C-N 117.489 0.645 . . . . 73.3 111.358 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -53.75 112.84 1.01 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.463 1.102 . . . . 70.4 110.835 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.38 -53.09 2.46 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.398 -0.819 . . . . 75.13 111.561 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.3 m -136.1 154.47 50.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.775 -0.648 . . . . 62.41 109.874 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 400' ' ' LEU . 0.9 OUTLIER -143.63 140.29 30.05 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.38 99.89 3.96 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.055 -0.72 . . . . 62.45 109.055 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.26 -108.03 2.3 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.121 -0.792 . . . . 72.45 111.121 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.448 ' HB2' ' HB1' ' A' ' 448' ' ' ALA . 36.1 p30 -106.53 4.33 28.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.102 0.477 . . . . 73.52 110.928 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.58 122.05 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.377 0.608 . . . . 73.42 110.577 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.49 ' H ' HG12 ' A' ' 418' ' ' VAL . 3.3 mm? -109.98 128.41 55.37 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.889 -1.05 . . . . 53.12 109.401 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 9.5 tptm -109.8 124.99 52.24 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.166 0.507 . . . . 63.35 110.602 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 50.2 m-85 -109.11 113.35 26.14 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.471 -0.786 . . . . 72.52 109.961 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 16.0 mm-40 -112.44 168.08 9.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.906 0.883 . . . . 71.33 110.881 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 55.8 49.9 15.21 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.062 0.851 . . . . 54.43 112.868 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.58 -146.14 5.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.037 -1.078 . . . . 54.44 111.823 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -83.63 127.81 34.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.498 -1.667 . . . . 63.1 106.498 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 16.3 m -40.13 127.55 2.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.576 1.55 . . . . 73.44 114.131 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 414' ' ' ARG . 44.1 t -97.47 -19.97 18.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.683 -0.69 . . . . 63.43 110.269 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 71.29 -37.86 0.4 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.945 1.298 . . . . 32.23 112.699 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -72.8 -55.35 6.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.202 0.601 . . . . 53.54 109.926 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.2 172.1 26.3 Favored Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 110.26 -1.136 . . . . 35.43 110.26 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.93 -56.69 2.38 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 C-N-CA 122.646 2.231 . . . . 74.45 111.433 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -136.38 157.74 46.08 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.464 -1.68 . . . . 74.11 106.464 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 408' ' ' CYS . 38.1 ttm180 -85.37 145.83 27.29 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.596 -1.631 . . . . 74.02 106.596 171.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.531 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 3.7 p -151.11 168.75 23.69 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 112.826 0.676 . . . . 75.25 112.826 -171.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.15 140.93 23.6 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.877 -0.786 . . . . 73.21 108.877 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.6 tp -126.01 130.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.292 -1.003 . . . . 71.23 108.292 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 400' ' ' LEU . 8.5 p -102.5 128.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.769 -1.172 . . . . 64.2 110.566 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 37.2 m -108.32 113.96 27.45 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.961 -1.496 . . . . 71.43 106.961 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 448' ' ' ALA . 65.5 t -112.62 128.79 69.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.689 0.281 . . . . 73.43 110.453 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 10.8 pt-20 -107.64 2.42 23.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.277 -0.42 . . . . 74.35 111.771 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.448 ' H ' HG12 ' A' ' 420' ' ' VAL . 5.7 t 74.39 139.27 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.751 0.657 . . . . 62.24 111.602 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.35 -166.28 14.85 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.152 -0.779 . . . . 70.34 111.152 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 68.8 t -89.77 -37.95 10.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.194 0.521 . . . . 71.43 110.379 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -137.21 162.2 34.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.403 -0.591 . . . . 73.54 109.403 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.589 ' HB3' ' OG1' ' A' ' 365' ' ' THR . 46.6 m-80 -74.03 111.84 9.59 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.519 -0.548 . . . . 74.24 109.519 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -146.01 132.47 19.7 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 61.34 111.147 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.613 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 47.5 mt -85.07 121.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.385 -1.339 . . . . 73.44 107.385 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -87.65 -46.03 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.002 0.429 . . . . 61.21 110.368 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.0 t -162.83 154.46 17.9 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.332 -0.618 . . . . 55.11 109.332 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.7 t -137.76 123.3 25.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 107.419 -1.326 . . . . 74.22 107.419 175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 48.4 tp -134.59 131.01 37.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.427 -0.509 . . . . 72.44 110.852 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -86.69 105.33 16.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.845 -1.169 . . . . 73.1 107.845 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -129.16 8.87 5.62 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.336 0.588 . . . . 62.1 110.57 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 11.3 tt0 -134.61 -169.63 2.38 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.781 -1.563 . . . . 72.14 106.781 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.488 ' H ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -62.24 79.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.853 1.427 . . . . 73.45 114.853 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 78.2 m 56.33 23.77 7.62 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.227 0.611 . . . . 44.31 110.37 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 435' ' ' GLN . 32.1 tt0 -105.11 124.51 49.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.477 -0.934 . . . . 74.23 108.477 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -94.54 119.51 33.34 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.662 -1.154 . . . . 71.14 110.627 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 48.7 mt -80.93 107.94 14.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.346 -1.353 . . . . 74.43 107.346 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 443' ' ' MET . 62.6 mt -97.19 119.25 45.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 108.823 -0.806 . . . . 55.14 108.823 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -106.29 114.24 28.25 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.725 -1.583 . . . . 45.32 106.725 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.613 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.8 mtp -142.11 176.98 8.54 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.523 1.154 . . . . 65.13 112.695 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -157.06 142.46 17.38 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 113.283 -1.78 . . . . 73.33 107.433 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 70.6 p -164.36 152.74 11.07 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 109.711 -0.477 . . . . 72.42 109.711 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.32 -25.71 15.27 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.648 2.232 . . . . 74.45 111.294 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.25 61.01 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.59 -0.732 . . . . 63.2 111.531 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.609 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -107.43 -2.3 20.65 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.571 -0.9 . . . . 43.51 108.571 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.5 t -72.74 -30.5 64.22 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.118 -1.067 . . . . 75.02 108.118 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.666 -1.605 . . . . 64.11 106.666 177.478 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 121.082 0.468 . . . . 74.43 110.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -172.91 177.44 2.81 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.927 -1.509 . . . . 74.53 106.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.87 149.6 47.68 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.128 0.489 . . . . 63.41 110.084 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 9.5 tt -117.2 139.45 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 109.162 -0.681 . . . . 75.32 109.162 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -84.08 120.42 26.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.077 -0.649 . . . . 73.31 110.455 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.32 -72.57 1.04 Allowed Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 107.941 -2.063 . . . . 55.44 107.941 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.62 81.09 0.14 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.042 1.337 . . . . 71.42 110.31 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.77 -27.04 6.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.474 -0.785 . . . . 51.33 111.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.485 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -122.42 136.27 54.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.23 -0.988 . . . . 72.53 112.811 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 62.1 pttt -145.42 139.35 26.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.998 -1.482 . . . . 73.13 106.998 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 59.9 ttt180 -163.88 149.67 11.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.129 -0.629 . . . . 72.12 109.571 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.8 pt-20 -92.46 113.3 25.54 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.53 0.681 . . . . 72.42 112.61 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.42 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.3 mp -121.08 134.39 64.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.29 23.95 64.94 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 114.561 0.584 . . . . 72.21 114.561 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.23 -5.87 71.71 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.501 -0.857 . . . . 42.55 113.254 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.37 150.08 48.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.448 0.536 . . . . 73.24 112.448 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 65.4 m -93.19 116.04 28.64 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.162 0.506 . . . . 70.42 111.007 -173.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 63.5 m-85 -86.98 132.08 33.9 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.124 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 382' ' ' VAL . 36.5 ttmt -118.2 124.65 48.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.966 -1.124 . . . . 71.13 107.966 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.98 107.3 22.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.981 -0.688 . . . . 54.14 109.213 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.73 -28.16 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 115.258 -0.883 . . . . 60.02 111.2 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.406 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 41.5 m-85 67.97 126.92 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.914 0.759 . . . . 71.12 111.419 -173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 71.71 -33.96 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.922 0.889 . . . . 63.41 112.961 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.439 ' HB3' HD22 ' A' ' 381' ' ' ASN . 43.2 mm-40 -74.85 -85.96 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.045 0.45 . . . . 74.22 110.544 169.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -178.7 171.04 1.53 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.895 0.878 . . . . 71.22 111.438 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 375' ' ' LYS . 58.3 t -120.78 140.2 45.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.795 -0.446 . . . . 71.42 109.795 -176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 51.7 m-85 -127.14 161.53 28.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.284 -0.416 . . . . 75.04 110.046 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -127.12 103.06 7.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.045 0.938 . . . . 73.45 108.924 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.6 t70 69.17 -75.53 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.516 1.126 . . . . 73.33 110.148 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.8 p -145.56 -6.14 0.63 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 114.864 -1.062 . . . . 60.15 110.347 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 54.0 mt -94.33 129.33 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.247 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.597 HD21 HD21 ' A' ' 391' ' ' ASN . 32.4 tp -81.26 123.82 28.81 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.664 -0.698 . . . . 73.42 112.319 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 439' ' ' TYR . 58.8 mt -71.6 -70.47 0.32 Allowed 'General case' 0 C--O 1.203 -1.375 0 CA-C-N 116.019 -0.537 . . . . 72.45 109.642 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -159.86 176.02 36.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.798 -0.921 . . . . 61.41 110.798 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.597 HD21 HD21 ' A' ' 388' ' ' LEU . 0.9 OUTLIER -111.02 146.18 37.16 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 109.552 -0.536 . . . . 73.41 109.552 -177.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.97 116.71 5.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.489 -0.885 . . . . 74.51 110.849 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -109.72 -52.37 2.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.754 -0.657 . . . . 50.32 110.406 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 22.7 t -151.49 171.65 17.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.195 -0.668 . . . . 64.23 109.195 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -140.75 136.64 32.73 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.976 0.417 . . . . 71.14 110.388 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -110.74 98.59 7.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.974 -0.751 . . . . 60.21 108.974 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.2 -103.89 0.87 Allowed Glycine 0 C--N 1.31 -0.878 0 C-N-CA 121.086 -0.578 . . . . 72.14 112.265 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -100.55 -9.5 21.96 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.54 0.686 . . . . 71.14 109.958 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 62.2 t -97.59 122.69 49.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.864 -0.607 . . . . 72.44 111.904 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.19 135.03 41.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.368 -0.378 . . . . 62.43 109.997 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.6 OUTLIER -111.22 129.43 55.96 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 109.65 -0.5 . . . . 65.42 109.65 -175.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 70.2 m-85 -118.75 127.51 53.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.566 -0.901 . . . . 73.32 108.566 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.594 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 11.7 pt-20 -133.97 172.3 13.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.614 0.643 . . . . 63.05 112.518 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.92 48.63 8.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.928 1.084 . . . . 74.51 113.928 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -95.33 -137.29 8.99 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 119.761 -1.209 . . . . 51.45 111.126 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.484 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.8 mm100 -65.37 145.64 55.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.827 0.346 . . . . 71.42 111.204 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.2 m -61.7 148.28 43.3 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.817 -0.629 . . . . 74.24 112.203 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.44 1.16 56.92 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.407 -0.815 . . . . 71.4 109.858 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 73.37 108.03 0.07 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.183 1.393 . . . . 54.32 111.224 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 72.49 -34.3 0.29 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.639 1.175 . . . . 51.53 112.363 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -97.81 -143.34 14.7 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 112.237 -0.345 . . . . 63.5 112.237 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.41 -151.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.839 3.026 . . . . 51.24 112.731 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.37 159.36 24.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.474 -0.565 . . . . 73.32 109.474 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.515 ' HG2' ' HB3' ' A' ' 437' ' ' CYS . 59.1 mtt85 -67.86 155.9 38.34 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.487 0.661 . . . . 64.42 111.615 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.496 ' HB2' ' HG3' ' A' ' 438' ' ' GLU . 57.4 m -153.61 167.36 29.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.843 -1.169 . . . . 64.13 107.843 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -143.68 141.59 30.61 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.527 -0.545 . . . . 52.4 109.527 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 108.55 20.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 108.847 -0.797 . . . . 53.21 108.847 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 85.7 t -94.11 111.07 24.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.278 0.561 . . . . 70.22 111.231 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 91.7 m -112.87 117.3 31.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.111 -0.95 . . . . 44.22 108.75 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -102.75 131.59 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.258 -1.015 . . . . 61.02 108.258 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.58 13.76 26.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.108 0.48 . . . . 73.43 112.045 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.512 ' H ' HG12 ' A' ' 420' ' ' VAL . 38.9 t 63.27 153.27 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.09 1.356 . . . . 52.21 112.365 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -173.63 -159.09 19.5 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 119.95 -1.119 . . . . 60.5 112.25 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.81 -32.57 5.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.4 0.619 . . . . 74.21 111.453 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -146.9 159.38 43.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.298 -1.001 . . . . 73.34 108.298 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.3 p30 -77.01 122.31 24.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.174 0.511 . . . . 73.44 110.28 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -153.6 148.58 26.67 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 109.279 -0.637 . . . . 74.35 109.279 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 365' ' ' THR . 47.6 mt -85.63 114.58 25.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.935 -1.506 . . . . 75.02 106.935 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.2 t -79.29 -51.52 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 116.365 -0.38 . . . . 73.34 110.975 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.7 t -156.59 149.73 24.14 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.028 -0.533 . . . . 53.15 109.883 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 48.3 t -137.23 114.54 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.343 -1.355 . . . . 70.05 107.343 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 49.6 tp -120.79 128.8 53.22 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.895 -0.322 . . . . 64.13 111.722 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.83 72.59 6.59 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.772 -0.825 . . . . 74.22 108.772 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -101.38 -15.1 17.33 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.817 0.818 . . . . 73.42 109.904 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 438' ' ' GLU . 22.7 mt-30 -101.14 174.83 5.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.758 -1.11 . . . . 74.44 108.154 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 81.86 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.588 0.709 . . . . 72.43 112.124 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 414' ' ' ARG . 67.1 m 56.95 21.33 6.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.787 0.803 . . . . 53.14 110.914 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 415' ' ' SER . 35.3 tt0 -107.56 120.35 41.95 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.507 -1.664 . . . . 54.45 106.507 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.516 ' CD1' HD22 ' A' ' 389' ' ' LEU . 88.9 m-85 -94.53 124.9 38.83 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.525 -0.762 . . . . 63.32 112.816 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 92.6 mt -78.65 112.45 15.76 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.644 -1.243 . . . . 73.3 107.644 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 14.7 mt -108.78 124.79 65.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.141 -0.624 . . . . 74.52 109.977 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -106.19 131.82 52.99 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-N 115.914 -0.584 . . . . 74.11 110.086 174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.7 mtp -140.01 169.94 16.77 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.533 -0.758 . . . . 73.13 109.534 174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.3 pttt -151.79 141.86 22.19 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 115.282 -0.872 . . . . 74.3 109.027 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 25.4 m -156.52 145.35 14.81 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 107.243 -1.392 . . . . 65.32 107.243 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.2 -29.81 55.36 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 122.19 1.927 . . . . 63.45 111.461 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.12 -5.39 43.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.448 -0.796 . . . . 73.35 111.388 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -91.48 -14.66 30.07 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 120.76 0.315 . . . . 73.33 111.339 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.4 m -69.67 -4.67 20.54 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.212 0.449 . . . . 61.4 112.212 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.077 -0.712 . . . . 62.1 109.077 176.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.164 0.507 . . . . 72.4 110.092 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 115.56 17.9 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.571 -1.64 . . . . 73.21 106.571 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.12 153.4 19.96 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.563 -0.903 . . . . 61.42 108.563 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 8.9 tp -100.71 137.26 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.066 0.46 . . . . 75.34 110.982 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -79.73 139.53 37.29 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.509 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.51 ' HA3' ' CD2' ' A' ' 379' ' ' TYR . . . -114.64 -98.7 2.25 Favored Glycine 0 N--CA 1.426 -2.012 0 C-N-CA 120.128 -1.034 . . . . 74.4 110.843 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 6.2 mmt -97.19 86.08 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.063 -1.088 . . . . 71.52 108.063 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 42.3 tt0 -81.36 106.64 13.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.008 -0.738 . . . . 73.24 109.008 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 19.4 m -116.4 149.97 38.54 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -138.42 150.01 46.08 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.319 -0.553 . . . . 74.41 109.873 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 23.2 tpt180 -156.17 136.97 13.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.721 -1.585 . . . . 71.33 106.721 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . 0.273 0.2 OUTLIER -100.25 118.85 37.39 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 119.272 -0.971 . . . . 71.53 113.029 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -115.15 123.92 71.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.037 -0.983 . . . . 71.22 109.714 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.04 26.48 67.46 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 115.859 -0.61 . . . . 64.14 114.551 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.12 62.63 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.517 -0.849 . . . . 62.25 113.137 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -108.67 137.83 45.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.441 0.639 . . . . 74.23 112.062 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 24.1 m -89.13 115.23 26.5 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.221 -0.899 . . . . 60.34 111.068 -171.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 57.8 m-85 -87.11 128.24 35.12 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 116.009 -0.541 . . . . 71.33 109.771 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.2 ttmt -117.86 123.87 46.95 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.348 -1.353 . . . . 74.41 107.348 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 443' ' ' MET . 64.3 t -116.72 104.97 17.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.061 -1.089 . . . . 74.35 108.061 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 21.3 t -83.25 -16.65 11.2 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.108 -1.071 . . . . 75.14 108.108 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 33.3 t80 74.13 -58.35 0.59 Allowed 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.799 -1.546 . . . . 65.2 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.51 ' CD2' ' HA3' ' A' ' 362' ' ' GLY . 70.7 m-85 -89.02 -12.76 40.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.118 0.485 . . . . 74.23 111.253 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 38.5 mt-10 -103.27 -69.25 0.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.248 0.462 . . . . 71.24 112.248 176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.583 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.0 OUTLIER 178.44 -178.33 0.27 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 122.844 0.458 . . . . 73.52 110.857 -176.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -127.42 136.57 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 O-C-N 123.523 0.514 . . . . 72.13 111.026 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 86.1 m-85 -124.88 166.46 16.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.69 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -129.22 96.35 4.29 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.737 1.215 . . . . 74.15 108.866 169.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.2 -78.25 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.228 1.411 . . . . 74.14 111.294 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.1 m -130.05 -20.14 3.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.306 -0.861 . . . . 51.34 109.742 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.451 HG23 ' HG3' ' A' ' 406' ' ' GLN . 38.9 mt -87.09 128.87 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.434 0.635 . . . . 60.3 111.682 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 391' ' ' ASN . 54.6 tp -83.63 124.36 30.74 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.194 -0.912 . . . . 75.54 111.695 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 374' ' ' TYR . 75.3 mt -76.49 -58.86 3.03 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 109.253 -0.647 . . . . 70.23 109.253 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -168.96 171.67 43.01 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.825 -0.91 . . . . 72.13 110.825 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 46.9 m-80 -116.77 151.8 35.71 Favored 'General case' 0 CA--C 1.447 -3.019 0 C-N-CA 122.63 0.372 . . . . 62.14 110.421 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.01 116.19 2.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 124.765 1.29 . . . . 60.53 110.361 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.62 -48.24 2.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.329 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 64.9 p -141.23 153.08 45.08 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 120.861 0.362 . . . . 73.15 111.241 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -132.04 118.53 19.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.676 -1.231 . . . . 72.32 107.676 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -129.07 98.63 4.98 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.502 -0.925 . . . . 71.14 108.502 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.48 -118.01 6.97 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.587 -1.405 . . . . 61.44 109.587 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -106.6 3.49 26.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.959 0.409 . . . . 70.24 110.455 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.25 126.27 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.183 0.516 . . . . 72.31 109.87 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.0 mp -121.77 143.67 49.25 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.339 -0.846 . . . . 64.4 110.32 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -117.4 132.75 56.52 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 108.03 -1.1 . . . . 64.2 108.03 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 49.4 m-85 -118.93 115.31 24.1 Favored 'General case' 0 C--O 1.198 -1.615 0 C-N-CA 122.614 0.366 . . . . 70.45 110.168 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.621 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 9.7 pt-20 -128.89 -175.28 3.49 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.497 0.589 . . . . 72.25 111.03 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.17 31.5 3.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.636 0.585 . . . . 73.13 110.308 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -84.41 -164.78 38.3 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.012 -1.089 . . . . 75.14 111.197 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 387' ' ' ILE . 15.2 mm-40 -57.5 145.43 33.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.98 0.419 . . . . 72.13 111.493 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 43.7 m -64.29 119.94 11.25 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.541 -0.911 . . . . 71.02 108.541 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 52.9 t -72.87 -18.57 61.42 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.617 -0.719 . . . . 61.4 111.65 -175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 70.25 -52.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.499 1.12 . . . . 43.0 110.973 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -65.11 -35.64 81.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.942 -0.762 . . . . 73.42 108.942 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -131.31 -155.66 8.22 Favored Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.338 -1.505 . . . . 74.44 109.338 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.28 -153.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.917 2.411 . . . . 71.0 110.75 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -62.5 135.21 57.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.736 -1.209 . . . . 55.31 107.736 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 437' ' ' CYS . 7.6 ptm180 -78.08 172.74 13.08 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 119.621 -0.832 . . . . 72.45 112.416 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.0 t -147.65 167.92 23.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.739 -171.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -144.43 139.69 28.52 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.758 -0.831 . . . . 75.45 108.758 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.1 tp -125.44 133.03 70.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.657 -0.868 . . . . 71.43 108.657 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 8.4 p -105.09 125.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 119.204 -0.999 . . . . 75.4 111.173 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 52.3 m -112.96 115.0 27.73 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.945 -1.131 . . . . 63.35 107.945 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 448' ' ' ALA . 64.1 t -105.5 135.12 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.95 -0.568 . . . . 72.03 111.347 -175.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 422' ' ' CYS . 11.8 pt-20 -107.29 -1.08 22.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 111.351 0.13 . . . . 75.33 111.351 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.537 ' H ' HG12 ' A' ' 420' ' ' VAL . 6.0 t 73.93 136.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 72.32 111.899 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -152.19 -178.82 27.27 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.812 -1.315 . . . . 63.11 109.812 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.89 -29.03 5.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.28 0.562 . . . . 50.34 109.49 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.38 160.83 27.25 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.295 -0.866 . . . . 74.55 108.707 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.15 110.23 17.86 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.706 -0.479 . . . . 72.24 109.706 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -145.08 135.7 24.39 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.283 0.563 . . . . 73.14 110.757 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 49.5 mt -85.18 125.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.493 -1.669 . . . . 72.04 106.493 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.52 -63.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.12 0.486 . . . . 63.52 110.409 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.6 m -152.77 162.92 40.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.253 -0.647 . . . . 41.53 109.253 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.2 t -138.09 130.13 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.322 -0.992 . . . . 71.3 108.322 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.06 119.91 17.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 121.113 -0.235 . . . . 65.42 111.129 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.5 tt0 -84.47 87.13 7.22 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.571 -0.9 . . . . 60.43 108.571 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -103.76 -22.82 13.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.407 -0.815 . . . . 50.24 110.402 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.56 167.15 10.32 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.173 -0.677 . . . . 72.15 109.173 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 84.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 115.787 1.773 . . . . 74.25 115.787 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.512 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 62.3 m 54.61 26.1 7.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.657 0.783 . . . . 62.33 109.765 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -117.16 123.73 47.42 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.267 -0.879 . . . . 74.15 108.648 -176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -93.81 122.63 36.48 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.908 -1.042 . . . . 74.31 111.954 -173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 62.1 mt -81.84 107.51 14.62 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.934 -1.506 . . . . 72.03 106.934 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.21 123.84 53.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.726 -0.842 . . . . 64.34 108.726 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -106.76 124.91 50.31 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.369 -1.345 . . . . 72.54 107.369 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.474 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 83.5 mtp -137.86 169.49 17.69 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.758 0.79 . . . . 74.41 110.858 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -146.41 136.74 23.8 Favored 'General case' 0 N--CA 1.406 -2.661 0 N-CA-C 106.995 -1.483 . . . . 64.44 106.995 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 67.9 p -168.26 150.62 5.16 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.444 0.465 . . . . 42.14 109.935 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.68 -25.41 34.07 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.91 2.407 . . . . 74.13 111.296 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.51 -16.63 60.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.917 -0.583 . . . . 72.44 112.317 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.646 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -116.67 -1.41 12.13 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.757 0.789 . . . . 75.21 109.03 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.5 t -73.35 115.67 12.98 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.275 -0.875 . . . . 72.44 109.179 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 107.655 -1.239 . . . . 72.14 107.655 177.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 109.573 -0.528 . . . . 73.54 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -110.81 120.11 41.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.237 -1.024 . . . . 72.35 108.237 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 60.44 -165.42 0.21 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.927 0.767 . . . . 62.11 110.225 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.594 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 66.4 mt -115.31 120.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.786 -1.19 . . . . 71.03 107.786 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -94.66 120.27 34.63 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.697 -0.853 . . . . 75.34 108.697 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -114.65 -67.31 0.45 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.538 -1.315 . . . . 71.24 113.035 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 52.6 mtm 68.22 81.84 0.18 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.696 -1.224 . . . . 71.31 107.696 -172.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -101.32 -59.98 1.6 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.034 0.753 . . . . 75.55 113.034 -172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 3.5 m -121.79 150.88 41.24 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.385 -0.526 . . . . 74.54 110.806 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.7 OUTLIER -142.88 141.03 31.45 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.769 -0.456 . . . . 74.52 109.769 176.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -150.56 143.2 24.52 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.539 -1.282 . . . . 75.23 107.539 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 37.3 tt0 -104.44 110.85 23.27 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.913 -0.715 . . . . 74.22 109.633 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.03 130.98 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.36 -0.978 . . . . 63.51 108.36 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 63.13 -90.97 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.3 -0.72 . . . . 62.51 111.3 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -146.26 15.4 1.68 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.677 -0.969 . . . . 61.54 110.677 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -126.65 134.9 50.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.412 0.625 . . . . 74.04 112.213 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 29.1 m -90.31 114.38 26.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.419 -0.809 . . . . 73.45 111.757 -170.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.0 m-85 -85.66 125.38 33.12 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.886 -0.597 . . . . 74.14 109.473 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.1 ttmt -118.12 123.91 46.72 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.607 -1.256 . . . . 70.54 107.607 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.434 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.8 t -105.47 109.85 29.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 120.276 -0.57 . . . . 63.21 109.723 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.524 HG11 ' OE2' ' A' ' 380' ' ' GLU . 21.7 t -82.12 -17.47 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.611 -0.885 . . . . 74.01 108.611 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 6.9 t80 77.13 -36.76 0.25 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.229 1.812 . . . . 63.24 113.901 170.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.594 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 83.7 m-85 -119.2 -4.1 10.53 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.845 -0.742 . . . . 64.5 110.678 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.524 ' OE2' HG11 ' A' ' 377' ' ' VAL . 33.5 mt-10 -107.4 -66.87 0.99 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.609 -0.723 . . . . 72.52 112.087 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 10.8 p30 -175.94 -178.21 1.01 Allowed 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.249 -0.887 . . . . 64.11 111.39 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 62.0 t -131.73 136.29 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 65.9 m-85 -120.84 158.19 28.15 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.666 -0.494 . . . . 73.24 109.666 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.4 pt20 -117.82 93.99 4.36 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.333 -0.988 . . . . 74.41 108.333 167.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.43 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 126.321 1.849 . . . . 71.44 110.409 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 50.6 m -130.71 -2.4 4.21 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.808 -0.633 . . . . 71.41 110.751 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.614 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 66.1 mt -97.34 119.57 45.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.154 0.502 . . . . 71.43 110.744 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.562 HD21 HD21 ' A' ' 391' ' ' ASN . 31.1 tp -72.82 109.51 6.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.447 -0.797 . . . . 60.22 111.125 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 78.7 mt -62.27 -64.1 1.03 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 123.524 0.515 . . . . 73.55 110.659 178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -160.68 178.96 36.47 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.429 -1.468 . . . . 44.55 109.429 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 43.8 m-80 -129.11 151.36 49.87 Favored 'General case' 0 CA--C 1.455 -2.695 0 CA-C-N 117.419 0.609 . . . . 61.12 111.257 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.28 114.67 3.3 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.495 1.122 . . . . 75.31 110.27 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.79 -52.99 2.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.247 -0.888 . . . . 61.12 110.703 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 20.2 m -146.12 144.46 30.0 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.949 -0.569 . . . . 52.33 110.078 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -115.15 134.08 55.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.16 -1.052 . . . . 62.43 108.16 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -138.44 108.98 6.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.256 -0.646 . . . . 73.33 109.256 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.19 -131.26 10.49 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 107.839 -2.105 . . . . 73.25 107.839 -173.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -106.99 13.19 27.86 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.502 1.144 . . . . 75.3 108.002 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.78 131.3 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 114.783 -1.099 . . . . 74.31 109.603 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.86 123.03 48.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.798 -0.637 . . . . 62.14 109.364 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.573 ' HE3' ' HB2' ' A' ' 415' ' ' SER . 13.6 tptm -103.45 124.57 48.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.635 0.731 . . . . 71.31 112.404 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.0 m-85 -116.51 123.3 47.09 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 114.906 -1.043 . . . . 65.24 108.97 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.56 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.1 pt-20 -137.17 -178.75 5.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 119.423 -0.323 . . . . 75.4 110.902 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 69.69 28.99 4.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.995 -0.743 . . . . 71.24 108.995 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.3 170.62 54.84 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.403 -0.817 . . . . 65.13 112.586 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.5 OUTLIER -61.36 131.3 49.83 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 124.413 1.085 . . . . 72.44 108.448 -175.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.0 m -42.3 146.62 0.3 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.887 1.275 . . . . 54.14 113.253 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.95 -11.34 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.438 -0.801 . . . . 64.15 110.979 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 66.72 13.77 9.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.569 1.148 . . . . 74.52 111.013 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -96.14 -41.33 8.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.412 -0.958 . . . . 65.54 108.412 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.16 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.924 -0.655 . . . . 65.23 111.55 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.0 -171.9 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.9 2.4 . . . . 74.4 112.153 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -83.63 144.44 29.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.517 -0.549 . . . . 71.24 109.517 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 13.1 ttm180 -68.96 152.88 44.7 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.757 -0.656 . . . . 73.45 109.519 -174.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.573 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 10.0 p -153.29 169.35 23.28 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.131 0.491 . . . . 63.02 111.923 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -145.34 138.53 26.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.021 -0.733 . . . . 62.31 109.021 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.43 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.6 tt -125.67 108.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 121.133 0.492 . . . . 74.42 109.68 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 441' ' ' ILE . 57.9 t -94.34 113.38 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.093 0.473 . . . . 72.42 110.398 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.6 m -97.96 114.15 26.19 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 107.139 -1.43 . . . . 65.3 107.139 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.7 t -108.36 133.52 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 108.872 -0.788 . . . . 75.2 108.872 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.3 -3.3 21.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.02 0.438 . . . . 73.45 110.777 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 420' ' ' VAL . 45.6 t 71.92 155.31 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.755 1.222 . . . . 53.03 110.963 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.28 -162.78 17.16 Favored Glycine 0 CA--C 1.483 -1.949 0 N-CA-C 110.66 -0.976 . . . . 74.14 110.66 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 62.0 t -99.47 -21.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 122.109 0.957 . . . . 73.13 108.954 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 160.46 37.64 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.394 -1.275 . . . . 74.52 109.107 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.8 p30 -97.9 128.71 44.67 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.107 -0.637 . . . . 71.02 109.979 174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.09 143.82 18.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.539 -0.911 . . . . 72.13 108.539 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.522 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 62.2 mt -85.75 112.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.196 -1.409 . . . . 73.43 107.196 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.0 t -78.28 -56.73 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.403 -0.817 . . . . 72.21 110.69 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -154.11 161.02 42.18 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.803 0.335 . . . . 71.24 111.058 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 60.9 t -142.3 130.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.315 -1.365 . . . . 74.12 107.315 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 56.0 tp -135.84 128.99 31.7 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.479 -0.488 . . . . 73.11 111.297 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -92.99 84.91 4.97 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.079 -1.082 . . . . 74.04 108.079 175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -113.7 4.68 16.12 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.896 0.855 . . . . 70.0 110.206 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 26.8 mt-30 -127.6 -175.63 3.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.819 -1.082 . . . . 64.32 109.674 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -66.91 70.55 0.08 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.725 0.774 . . . . 74.44 112.394 -177.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 79.5 m 60.58 20.38 10.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.802 -0.636 . . . . 64.32 109.786 -175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -98.12 119.98 37.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 106.975 -1.491 . . . . 64.21 106.975 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.542 ' CD1' HD22 ' A' ' 389' ' ' LEU . 91.4 m-85 -94.25 120.57 34.68 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.38 -0.827 . . . . 65.33 111.856 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 71.0 mt -78.62 110.42 13.73 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.315 -1.735 . . . . 73.44 106.315 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 418' ' ' VAL . 22.1 mt -108.03 134.81 48.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.935 . . . . 62.22 108.477 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.44 127.23 53.46 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.513 -0.551 . . . . 55.42 109.513 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.522 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.1 mtp -143.32 176.14 9.38 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.845 0.831 . . . . 74.34 111.237 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 58.8 pttt -156.64 148.86 23.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.328 -1.305 . . . . 71.32 107.695 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.7 p -165.43 151.68 8.8 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.323 -1.362 . . . . 75.51 107.323 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.73 -28.96 51.51 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.098 1.865 . . . . 72.33 111.567 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.08 62.24 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.911 -0.586 . . . . 70.13 111.313 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -74.87 -30.63 61.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.987 -0.552 . . . . 73.4 111.635 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 39.3 m -57.92 104.69 0.21 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.45 0.643 . . . . 63.23 110.483 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.416 -2.139 0 CA-C-N 114.905 -1.043 . . . . 74.12 110.295 -175.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.739 -0.837 . . . . 71.11 108.739 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 65.64 103.3 0.04 OUTLIER 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.892 1.277 . . . . 65.42 112.315 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.464 ' HB3' ' HG2' ' A' ' 380' ' ' GLU . . . -88.87 -165.14 1.26 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.751 -0.658 . . . . 65.43 109.474 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.0 mp -82.68 124.54 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.551 -0.537 . . . . 71.32 109.551 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.61 120.74 30.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.628 -1.249 . . . . 72.53 107.628 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -96.85 -83.09 1.66 Allowed Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 110.272 -1.131 . . . . 73.41 110.272 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 377' ' ' VAL . 1.9 mpt? -122.86 175.13 6.72 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.083 -1.081 . . . . 73.41 108.083 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.88 97.18 3.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.706 -0.85 . . . . 74.04 108.706 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.3 m -97.43 134.96 39.99 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.131 -1.433 . . . . 72.14 107.131 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -128.12 138.02 52.35 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.177 -0.675 . . . . 62.01 109.177 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 7.3 tpt180 -153.79 136.26 15.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.718 -1.215 . . . . 64.13 107.718 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -97.23 110.45 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 120.274 -0.57 . . . . 60.33 110.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.2 mp -116.66 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.506 -0.924 . . . . 64.32 108.506 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.18 22.69 63.26 Favored Glycine 0 C--N 1.321 -0.261 0 O-C-N 123.106 0.254 . . . . 71.3 113.493 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.04 -10.09 75.15 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.869 -0.681 . . . . 61.32 113.006 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.276 1.1 p90 -112.19 145.64 39.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.577 0.955 . . . . 71.41 113.577 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 20.7 m -87.62 110.89 20.72 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.593 -1.185 . . . . 62.25 110.862 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 62.1 m-85 -86.33 125.27 33.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.015 -0.539 . . . . 71.33 109.56 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.4 ttmt -118.23 124.22 47.35 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.439 -0.948 . . . . 73.04 108.439 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.73 109.74 29.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.576 -0.898 . . . . 52.42 108.576 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 23.2 t -85.49 -11.37 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.366 1.079 . . . . 74.31 109.822 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 5.7 t80 74.5 -25.98 0.2 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.985 1.714 . . . . 75.13 112.916 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 90.0 m-85 -131.76 -6.26 3.61 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 121.509 -0.745 . . . . 72.12 112.089 177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 36.2 mt-10 -100.73 -73.18 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.388 0.613 . . . . 74.34 111.306 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.496 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 7.1 p30 -174.34 -179.81 1.67 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.281 -0.872 . . . . 63.52 110.767 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 56.5 t -128.26 134.14 65.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.171 -0.677 . . . . 61.2 109.171 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 70.9 m-85 -121.19 162.7 19.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.432 -0.349 . . . . 72.0 110.143 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.56 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.3 pt20 -124.4 88.32 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.624 -1.621 . . . . 71.31 106.624 166.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 62.0 -90.96 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.929 -1.487 . . . . 71.33 113.116 -171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.0 p -112.77 -13.47 13.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.191 0.52 . . . . 72.24 111.435 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.56 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.8 mm -91.03 120.92 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 109.233 -0.654 . . . . 64.45 109.233 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.526 HD21 HD21 ' A' ' 391' ' ' ASN . 30.6 tp -81.59 124.32 29.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.447 -0.797 . . . . 71.13 111.133 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 374' ' ' TYR . 81.8 mt -72.91 -72.72 0.23 Allowed 'General case' 0 C--O 1.211 -0.951 0 CA-C-O 120.988 0.423 . . . . 71.31 110.179 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -148.05 -179.62 24.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.486 -1.046 . . . . 74.21 110.486 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 49.4 m-80 -130.56 152.06 50.35 Favored 'General case' 0 CA--C 1.444 -3.123 0 CA-C-N 117.021 0.41 . . . . 62.34 110.998 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.67 115.36 3.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 124.616 1.197 . . . . 74.33 109.843 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -112.03 -52.01 2.81 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.64 -0.709 . . . . 53.5 109.784 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.0 m -155.92 158.03 37.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.807 -0.633 . . . . 75.22 109.469 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.541 ' HG2' ' HG ' ' A' ' 400' ' ' LEU . 0.3 OUTLIER -137.57 117.88 13.66 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.057 -2.201 . . . . 73.35 105.057 174.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.03 119.04 19.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.797 -0.816 . . . . 74.54 108.797 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.63 -138.84 16.02 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 108.223 -1.951 . . . . 62.52 108.223 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -109.01 12.6 25.15 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 117.818 0.809 . . . . 72.22 110.366 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 85.5 t -104.23 121.25 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 71.32 110.579 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.541 ' HG ' ' HG2' ' A' ' 395' ' ' GLN . 6.0 mp -96.32 132.95 41.28 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.522 -0.763 . . . . 54.55 110.541 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.536 ' HE2' ' HB3' ' A' ' 403' ' ' GLU . 14.2 tptm -117.79 123.45 46.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.864 0.84 . . . . 72.24 112.455 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 81.8 m-85 -117.22 124.97 50.39 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.626 -1.17 . . . . 72.21 108.983 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.536 ' HB3' ' HE2' ' A' ' 401' ' ' LYS . 9.7 pt-20 -134.97 167.96 19.97 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.103 -0.373 . . . . 74.54 110.684 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 70.17 39.22 1.35 Allowed 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 124.128 0.893 . . . . 75.32 111.322 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.78 -129.3 0.89 Allowed Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.555 -0.831 . . . . 32.35 111.272 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.31 145.86 28.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.665 -1.606 . . . . 71.13 106.665 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.4 m -55.52 139.01 45.32 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.747 0.419 . . . . 74.1 110.879 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 49.7 t -69.54 -39.09 77.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.907 -0.588 . . . . 71.43 109.538 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -164.64 -66.28 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.392 -1.336 . . . . 60.44 107.392 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.5 98.72 1.13 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.72 0.771 . . . . 73.33 109.52 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.14 -79.88 0.33 Allowed Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.354 -1.098 . . . . 62.41 110.354 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -52.19 147.69 26.96 Favored 'Trans proline' 0 C--O 1.256 1.392 0 C-N-CA 122.755 2.303 . . . . 60.54 112.735 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.39 128.51 55.57 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.488 -1.233 . . . . 73.44 110.149 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -68.05 152.75 45.03 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-O 121.379 0.609 . . . . 72.43 111.611 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.3 m -147.82 165.53 30.31 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.971 -1.013 . . . . 74.42 109.665 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -144.11 130.28 19.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.636 -0.875 . . . . 72.32 108.636 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 440' ' ' LEU . 12.4 tt -121.74 120.94 63.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.139 -0.689 . . . . 74.34 109.139 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.452 HG22 HD12 ' A' ' 441' ' ' ILE . 46.4 t -99.16 113.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 C-N-CA 120.259 -0.577 . . . . 61.31 110.173 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 41.3 m -97.93 114.51 26.63 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.0 -1.481 . . . . 64.04 107.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 422' ' ' CYS . 6.6 t -112.28 134.15 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.176 -0.676 . . . . 71.53 109.176 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.62 -0.72 25.41 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.193 0.52 . . . . 72.31 110.019 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.565 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.6 t 74.35 150.97 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.504 1.122 . . . . 64.12 111.346 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.67 -156.89 8.96 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 111.438 -0.665 . . . . 25.52 111.438 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 64.6 t -94.42 -34.56 5.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.21 0.529 . . . . 72.53 110.534 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -144.27 161.08 39.84 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.081 -1.081 . . . . 64.21 108.081 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.2 OUTLIER -73.35 127.36 32.46 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.468 0.651 . . . . 64.23 110.939 178.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.92 142.57 19.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.674 -0.693 . . . . 74.14 111.094 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 45.9 mt -93.57 119.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.585 -1.265 . . . . 73.42 107.585 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.08 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.046 0.45 . . . . 62.1 110.395 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.1 m -148.62 155.51 41.17 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.898 -0.592 . . . . 73.41 110.261 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 374' ' ' TYR . 46.7 t -136.57 124.04 32.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.992 -1.114 . . . . 64.31 107.992 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.2 tp -135.91 126.29 26.67 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 121.02 -0.272 . . . . 74.31 111.255 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 38.9 tt0 -86.65 89.49 7.95 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.738 -0.838 . . . . 71.05 108.738 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.83 3.59 22.62 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.611 -0.722 . . . . 73.23 109.845 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.476 ' OE1' HD21 ' A' ' 440' ' ' LEU . 27.1 mt-30 -130.92 163.1 28.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.087 -0.961 . . . . 71.42 110.21 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.0 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.377 1.991 . . . . 73.11 116.377 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 57.0 m 59.54 22.94 11.57 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.853 0.835 . . . . 73.51 108.784 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.85 120.25 37.93 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.749 -1.114 . . . . 75.24 109.114 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -94.82 127.47 40.86 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.684 -1.144 . . . . 55.33 111.098 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 78.3 mt -83.14 115.99 22.15 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.263 -1.384 . . . . 72.42 107.263 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 443' ' ' MET . 13.9 mt -103.51 120.42 53.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.856 -1.535 . . . . 54.2 106.856 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -106.43 114.37 28.44 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.617 -1.623 . . . . 73.31 106.617 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 81.6 mtp -139.37 176.69 8.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.498 0.666 . . . . 71.43 110.867 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 25.7 pttm -150.02 145.9 26.68 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.745 -1.116 . . . . 74.34 110.993 172.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 422' ' ' CYS . 31.8 p -159.45 148.88 14.54 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.356 -0.979 . . . . 73.14 108.356 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.2 -28.86 47.74 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 122.508 2.138 . . . . 62.42 111.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.56 -12.59 61.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.56 -0.746 . . . . 71.21 111.457 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -86.79 -15.62 38.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.482 -0.326 . . . . 71.5 111.353 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 31.2 m -70.64 90.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.456 0.646 . . . . 72.23 111.378 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.128 -1.434 . . . . 70.12 107.128 177.43 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.783 -0.821 . . . . 72.01 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 65.67 90.1 0.09 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.671 0.788 . . . . 63.44 112.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -176.91 158.66 1.62 Allowed 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.809 -1.552 . . . . 44.2 106.809 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 35.4 pt -85.86 127.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 119.944 -0.702 . . . . 61.12 109.776 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 55.3 pttt -123.02 150.35 43.16 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 119.253 -0.979 . . . . 72.23 109.405 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -90.55 -72.56 1.25 Allowed Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 108.631 -1.788 . . . . 73.43 108.631 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.3 tpp -165.37 130.75 2.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.382 -1.71 . . . . 74.43 106.382 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 375' ' ' LYS . 1.4 pm0 -77.35 95.69 4.46 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.3 -0.96 . . . . 75.51 111.403 175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 11.8 m -74.59 134.62 42.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.477 -1.305 . . . . 74.44 107.477 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 95.1 mttt -123.26 138.89 54.52 Favored 'General case' 0 CA--C 1.479 -1.785 0 C-N-CA 120.327 -0.549 . . . . 61.1 110.103 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.461 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.3 tpt180 -155.41 135.7 13.15 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.045 -1.835 . . . . 74.31 106.045 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 10.2 pt-20 -102.57 111.12 23.29 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.65 -0.82 . . . . 61.23 112.018 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.465 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -107.87 128.79 62.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 73.53 108.64 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.56 22.74 64.15 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.397 0.435 . . . . 65.31 113.611 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.3 63.2 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.124 -0.56 . . . . 63.05 112.882 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.444 ' HE2' ' OH ' ' A' ' 374' ' ' TYR . 4.4 p90 -106.88 139.12 41.79 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.987 0.898 . . . . 74.1 112.614 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 25.0 m -89.4 113.98 25.37 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.497 -1.229 . . . . 65.35 111.421 -170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' CE2' HG11 ' A' ' 431' ' ' VAL . 53.0 m-85 -86.16 131.18 34.3 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.061 -0.972 . . . . 74.31 109.723 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.5 ttmt -117.81 124.1 47.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.428 -1.323 . . . . 75.22 107.428 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 58.1 t -122.34 111.51 30.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.877 -1.157 . . . . 72.31 107.877 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 21.9 t -81.15 -16.02 12.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.688 0.756 . . . . 64.21 110.21 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 13.7 t80 70.87 -1.76 2.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.219 1.408 . . . . 71.14 112.193 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.69 -31.69 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.865 0.364 . . . . 62.01 110.939 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.52 -74.71 0.38 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.48 0.548 . . . . 74.55 112.48 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 11.0 p30 -173.07 -177.28 1.54 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.582 -0.736 . . . . 70.0 111.005 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 58.7 t -129.66 136.25 59.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 123.573 0.545 . . . . 61.44 111.093 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 83.4 m-85 -125.75 161.93 26.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.994 -0.548 . . . . 73.23 110.209 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -125.23 91.42 3.42 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.217 -1.401 . . . . 70.23 107.217 167.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.16 -90.37 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.452 -1.249 . . . . 70.43 112.922 -172.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.7 m -110.29 -12.8 14.41 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.74 -0.384 . . . . 64.53 111.542 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 64.8 mt -97.36 125.41 50.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.099 0.476 . . . . 65.45 111.296 -177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.531 HD21 HD21 ' A' ' 391' ' ' ASN . 61.2 tp -81.96 120.67 25.54 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.7 -0.682 . . . . 44.32 110.237 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.473 ' HA ' ' HD2' ' A' ' 414' ' ' ARG . 89.5 mt -73.07 -45.72 55.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.51 -0.314 . . . . 71.32 111.626 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.24 48.34 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.105 -0.798 . . . . 51.31 111.105 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 50.2 m-80 -125.93 153.87 43.62 Favored 'General case' 0 CA--C 1.445 -3.094 0 CA-C-N 116.719 0.26 . . . . 63.5 110.478 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -51.96 115.22 1.58 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 124.788 1.305 . . . . 73.1 110.314 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.18 -52.19 2.69 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.535 -0.757 . . . . 65.44 110.596 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.1 t -148.88 153.77 38.52 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 116.085 -0.507 . . . . 33.4 110.473 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -130.74 119.1 21.85 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.314 -0.995 . . . . 73.45 108.314 174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.43 104.57 9.48 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.545 -0.909 . . . . 70.52 108.545 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.37 -121.59 9.06 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.681 -1.368 . . . . 75.21 109.681 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.408 HD21 ' HB1' ' A' ' 448' ' ' ALA . 66.1 t30 -107.58 13.31 26.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.015 0.912 . . . . 74.21 109.047 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 88.7 t -108.49 124.67 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.707 -0.679 . . . . 74.1 110.59 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -112.02 138.56 48.49 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.256 -0.429 . . . . 50.54 110.343 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.6 134.59 54.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.557 -1.275 . . . . 75.3 107.557 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 84.1 m-85 -117.68 123.04 45.11 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.06 -1.459 . . . . 63.33 107.06 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -124.98 158.68 33.07 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.383 -0.527 . . . . 63.12 110.861 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 51.3 t30 68.3 51.83 0.67 Allowed 'General case' 0 C--O 1.242 0.688 0 O-C-N 124.641 1.213 . . . . 51.4 112.225 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -134.56 4.15 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.852 -1.299 . . . . 73.42 109.852 176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 406' ' ' GLN . 20.6 mt-30 -83.5 146.14 28.54 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 117.293 0.546 . . . . 75.41 111.23 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 28.1 m -57.36 136.31 56.58 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.537 -0.756 . . . . 61.5 111.486 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.12 -26.51 18.24 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.016 0.912 . . . . 61.03 108.962 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 411' ' ' GLY . . . -167.19 -170.12 1.42 Allowed 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.095 -2.187 . . . . 64.33 105.095 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -77.86 22.72 0.27 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.526 0.679 . . . . 74.41 110.072 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 409' ' ' ALA . . . -139.12 -79.56 0.07 OUTLIER Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 111.798 -0.521 . . . . 31.3 111.798 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 409' ' ' ALA . 2.9 Cg_exo -71.32 148.86 56.02 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.985 1.79 . . . . 75.04 113.94 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.9 2.57 32.7 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.07 -1.423 . . . . 70.23 110.685 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 10.6 ttm180 75.32 150.51 0.11 Allowed 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.712 1.205 . . . . 64.31 110.576 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 57.4 m -149.32 159.77 43.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.949 0.404 . . . . 72.24 110.807 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -134.52 129.91 35.83 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.841 -1.17 . . . . 74.34 107.841 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 440' ' ' LEU . 0.0 OUTLIER -124.95 119.23 55.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 108.436 -0.95 . . . . 64.14 108.436 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 441' ' ' ILE . 61.9 t -101.61 117.55 47.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.109 0.481 . . . . 70.43 110.199 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -98.47 114.68 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 422' ' ' CYS . 25.8 t -114.77 127.73 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-O 121.002 0.43 . . . . 71.11 110.009 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.72 5.35 26.64 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.199 -0.455 . . . . 62.52 110.221 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.544 ' H ' HG12 ' A' ' 420' ' ' VAL . 43.1 t 70.65 157.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.948 -1.024 . . . . 72.14 110.086 -176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.31 -157.97 9.54 Favored Glycine 0 C--N 1.306 -1.131 0 C-N-CA 120.332 -0.937 . . . . 45.44 112.011 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 49.8 t -96.9 -32.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.636 0.731 . . . . 53.53 109.725 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.43 159.49 41.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.134 -1.432 . . . . 71.11 107.134 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 7.9 p30 -83.64 115.65 22.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.468 -0.938 . . . . 74.23 108.468 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.32 144.29 29.7 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.061 0.458 . . . . 73.55 110.731 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 42.9 mt -92.82 129.97 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.219 -1.771 . . . . 63.42 106.219 174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.49 -70.76 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 109.687 -0.486 . . . . 53.53 109.687 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.5 m -135.9 156.95 47.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.826 -0.625 . . . . 72.03 109.608 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 374' ' ' TYR . 48.4 t -137.74 127.22 35.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 107.655 -1.239 . . . . 64.21 107.655 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 58.7 tp -136.1 125.46 24.91 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 121.006 -0.277 . . . . 65.04 110.965 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.559 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 40.6 tt0 -82.89 89.36 6.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.62 -0.882 . . . . 65.34 108.62 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -98.4 -26.1 14.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.075 0.464 . . . . 64.24 111.248 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.523 HE21 HD21 ' A' ' 440' ' ' LEU . 48.5 mt-30 -110.49 177.73 4.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 118.881 -0.581 . . . . 74.35 110.014 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.25 0.4 OUTLIER -45.03 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.707 2.114 . . . . 75.22 116.707 -174.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.559 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 85.8 m 58.08 28.16 15.95 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.905 0.86 . . . . 72.0 109.01 -175.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 35.0 tt0 -109.3 122.24 46.91 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-N 114.666 -1.152 . . . . 65.14 109.648 -176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -95.21 118.67 32.39 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.81 -1.087 . . . . 54.42 111.93 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.523 HD21 HE21 ' A' ' 435' ' ' GLN . 76.5 mt -81.63 115.13 20.76 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.074 -1.454 . . . . 64.52 107.074 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 382' ' ' VAL . 21.4 mt -104.16 129.07 56.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.239 -1.023 . . . . 70.33 108.239 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -106.86 118.45 36.71 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.299 -1.371 . . . . 64.11 107.299 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.561 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.3 mtp -139.16 173.94 11.04 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.996 0.903 . . . . 75.41 111.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 51.9 pttt -159.49 143.79 15.06 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 113.67 -1.605 . . . . 73.1 108.025 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.1 p -158.79 143.86 11.81 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.404 -0.961 . . . . 72.31 108.404 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.74 -28.08 44.08 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 122.848 2.366 . . . . 71.11 112.051 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -70.95 -16.07 62.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.792 -0.64 . . . . 65.54 111.141 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -77.05 -29.29 55.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.069 -0.514 . . . . 64.11 111.319 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 51.9 m -61.64 102.81 0.28 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.185 0.517 . . . . 61.22 111.643 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.419 -1.997 0 N-CA-C 107.151 -1.425 . . . . 62.31 107.151 178.242 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 359' ' ' ALA . 78.8 m-85 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.824 0.345 . . . . 74.52 111.78 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -80.37 -24.28 39.89 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.853 -0.795 . . . . 72.43 108.853 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 357' ' ' TYR . . . -143.05 -166.18 2.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.26 -1.385 . . . . 70.32 107.26 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.71 136.62 51.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 109.511 -0.552 . . . . 65.34 109.511 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.8 135.15 36.41 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.831 -0.804 . . . . 63.1 108.831 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.63 -106.8 3.15 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.673 -1.251 . . . . 62.34 112.17 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -90.79 108.84 20.09 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.0 -0.741 . . . . 53.31 109.0 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.19 93.81 6.45 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.978 -0.749 . . . . 75.24 108.978 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 26.7 m -103.49 141.37 36.11 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.686 -1.228 . . . . 75.13 107.686 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 61.7 pttt -144.37 139.05 28.22 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 109.642 -0.503 . . . . 52.32 109.642 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.54 140.45 18.23 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 109.433 -0.581 . . . . 74.14 109.433 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 9.7 pt-20 -90.91 110.53 21.77 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.19 0.995 . . . . 73.21 111.232 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 54.2 mt -121.62 128.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.789 -1.55 . . . . 65.31 108.501 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.9 20.17 61.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 113.951 0.34 . . . . 52.42 113.951 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 96.53 -6.54 65.41 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.719 -0.753 . . . . 65.11 113.113 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.48 129.88 53.22 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.461 0.648 . . . . 74.21 112.541 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.1 m -72.56 110.75 7.16 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.059 -0.973 . . . . 72.3 111.182 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 28.0 m-85 -84.97 124.32 31.54 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.932 -1.136 . . . . 55.21 107.932 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.9 ttpt -119.49 124.18 45.82 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 108.608 -0.886 . . . . 73.14 108.608 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.0 115.86 50.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.148 -1.426 . . . . 74.53 107.148 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 28.1 t -92.78 -5.31 10.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.229 0 CA-C-O 122.526 1.155 . . . . 60.23 108.597 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.415 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 14.5 t80 71.3 -61.21 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.176 1.791 . . . . 65.52 111.766 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 93.3 m-85 -90.96 -4.31 56.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.886 0.374 . . . . 73.32 111.695 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 5.5 mm-40 -110.32 -68.39 0.93 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.924 0.713 . . . . 74.31 112.924 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 391' ' ' ASN . 12.6 p30 179.53 -178.84 0.39 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 123.156 0.285 . . . . 60.15 111.515 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.8 t -125.21 135.28 64.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 O-C-N 124.086 0.866 . . . . 73.14 110.269 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 92.7 m-85 -125.42 152.87 44.28 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 109.072 -0.714 . . . . 72.54 109.072 177.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.521 ' CD ' HD21 ' A' ' 389' ' ' LEU . 10.4 mt-30 -119.03 97.15 5.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.229 -1.767 . . . . 73.04 106.229 171.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.2 t70 68.24 -73.92 0.08 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 125.496 1.518 . . . . 72.31 110.013 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 24.5 t -141.13 4.14 1.82 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 115.847 -0.615 . . . . 71.42 109.538 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.93 114.72 36.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 121.081 0.467 . . . . 71.31 110.928 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.651 HD21 HD21 ' A' ' 391' ' ' ASN . 45.8 tp -74.64 115.28 14.02 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 123.834 0.854 . . . . 72.14 112.036 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.521 HD21 ' CD ' ' A' ' 384' ' ' GLN . 56.7 mt -71.92 -51.14 23.58 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.446 0.536 . . . . 70.23 112.446 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.508 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -174.1 178.8 45.82 Favored Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 109.92 -1.272 . . . . 5.44 109.92 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.651 HD21 HD21 ' A' ' 388' ' ' LEU . 45.6 m-80 -125.62 150.89 47.17 Favored 'General case' 0 CA--C 1.459 -2.522 0 CA-C-N 117.853 0.826 . . . . 64.34 112.302 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.57 115.56 3.11 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.338 1.024 . . . . 64.04 110.077 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -115.06 -52.78 2.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.956 -0.565 . . . . 43.22 110.589 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 35.7 t -145.6 143.07 29.66 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.434 -0.506 . . . . 74.52 110.292 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 400' ' ' LEU . 25.8 pt20 -121.82 126.2 48.24 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 108.487 -0.931 . . . . 73.04 108.487 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -124.66 98.13 5.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.668 -0.864 . . . . 64.1 108.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.84 -100.63 0.52 Allowed Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.407 -0.815 . . . . 54.22 112.487 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.36 -9.6 16.69 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.021 0.439 . . . . 71.15 110.617 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.0 t -110.36 132.0 59.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 72.14 111.602 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 8.1 mp -121.5 139.06 53.97 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 73.21 109.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.546 ' HG2' HD13 ' A' ' 417' ' ' ILE . 0.0 OUTLIER -118.0 134.21 55.18 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 120.083 -0.647 . . . . 74.42 109.582 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 87.3 m-85 -106.03 117.68 34.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.578 -0.737 . . . . 64.42 109.405 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 5.5 mm-40 -109.47 154.62 22.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.613 1.165 . . . . 73.41 111.668 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 61.99 51.67 3.61 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 114.419 1.266 . . . . 71.23 114.419 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.97 -165.32 22.91 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.559 -0.829 . . . . 64.43 112.8 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -75.35 145.48 41.66 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.674 -1.232 . . . . 75.32 107.674 -177.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.0 t -44.0 131.33 5.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.952 0.901 . . . . 43.32 111.169 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.55 -16.45 27.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.564 -0.744 . . . . 74.2 111.145 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.54 73.42 0.48 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.528 -0.916 . . . . 74.54 108.528 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -169.88 -43.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.292 -1.322 . . . . 61.03 108.236 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.96 -73.87 0.27 Allowed Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.656 -0.783 . . . . 61.31 111.71 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.79 179.48 3.68 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.432 2.088 . . . . 74.41 112.368 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -87.22 145.64 26.31 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.725 -0.843 . . . . 74.22 108.725 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 389' ' ' LEU . 39.3 ttm180 -75.82 145.84 40.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.08 -0.711 . . . . 74.34 109.08 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.5 p -148.64 167.91 24.22 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 116.074 -0.512 . . . . 73.41 111.093 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -138.98 134.93 33.76 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.887 -0.412 . . . . 34.52 109.887 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 401' ' ' LYS . 6.2 tp -118.71 123.44 71.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.815 . . . . 63.23 108.801 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 7.8 p -102.28 128.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 119.133 -1.027 . . . . 45.34 110.956 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 59.6 m -116.1 114.26 24.27 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.85 -1.537 . . . . 63.04 106.85 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.4 t -104.2 130.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.541 -0.911 . . . . 70.04 108.541 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.53 8.26 27.17 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.507 0.558 . . . . 70.15 112.507 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.485 ' H ' HG12 ' A' ' 420' ' ' VAL . 42.6 t 65.75 151.44 0.05 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.719 1.208 . . . . 72.51 112.866 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.05 -158.64 9.66 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.341 -1.104 . . . . 60.14 110.341 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.69 -25.26 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.58 0.705 . . . . 63.22 109.549 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.91 157.92 44.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.024 -1.102 . . . . 73.45 108.024 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.8 OUTLIER -75.91 118.85 19.12 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 109.468 -0.567 . . . . 75.24 109.468 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.76 146.03 24.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.307 -0.406 . . . . 62.12 110.309 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 25.5 mt -84.11 131.75 33.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.767 -1.197 . . . . 72.32 107.767 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.69 -63.42 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.486 -0.324 . . . . 73.33 111.262 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 t -158.31 154.71 27.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.012 -0.736 . . . . 50.41 109.012 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 47.7 t -136.01 131.01 49.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.498 -0.556 . . . . 62.32 109.498 178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.2 tp -135.99 134.24 38.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.881 0.326 . . . . 73.21 111.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 439' ' ' TYR . 38.3 tt0 -80.33 111.65 16.92 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.163 -1.421 . . . . 64.15 107.163 173.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -134.64 3.5 3.28 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.379 0.609 . . . . 63.11 110.827 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -146.44 161.48 40.33 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 106.803 -1.554 . . . . 71.51 106.803 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.915 1.82 . . . . 73.11 115.915 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 70.8 m 55.34 21.68 4.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 64.13 111.132 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.2 tt0 -109.3 119.86 40.78 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.13 108.111 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.425 ' CD2' HD22 ' A' ' 389' ' ' LEU . 95.1 m-85 -95.49 124.99 39.79 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.535 -1.211 . . . . 72.44 112.194 -172.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 74.3 mt -77.92 108.06 10.9 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.219 -1.401 . . . . 72.25 107.219 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . . . . . . . . . 65.8 mt -105.14 124.02 59.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 109.682 -0.488 . . . . 64.41 109.682 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 419' ' ' THR . 97.8 mttt -106.39 134.73 49.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.015 0.436 . . . . 72.14 111.164 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 84.5 mtp -139.53 166.89 23.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.505 -0.924 . . . . 61.22 108.505 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 56.1 pttt -143.22 139.68 30.36 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 108.974 -0.75 . . . . 72.15 108.974 173.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 422' ' ' CYS . 57.8 p -154.54 149.17 19.74 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.587 -0.894 . . . . 61.42 108.587 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.49 -27.8 46.24 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.101 1.867 . . . . 72.25 112.109 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.33 64.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.817 -0.629 . . . . 64.24 111.492 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -73.54 -28.15 61.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.766 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 33.2 m -64.96 108.68 1.86 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.23 0.538 . . . . 64.54 111.073 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.424 -1.764 0 N-CA-C 107.361 -1.348 . . . . 73.0 107.361 176.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.485 -0.561 . . . . 70.51 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -86.76 110.41 19.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 106.499 -1.667 . . . . 65.04 106.499 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.4 -168.9 2.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 110.224 -0.287 . . . . 71.44 110.224 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 360' ' ' ILE . 2.4 mp -89.54 129.44 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.812 -1.551 . . . . 61.04 106.812 176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -121.66 121.39 37.25 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.172 -1.011 . . . . 73.42 112.971 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -116.09 65.37 0.32 Allowed Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.639 -1.384 . . . . 63.32 109.639 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.467 ' HB2' HG13 ' A' ' 377' ' ' VAL . 60.5 ttp -93.0 107.3 19.11 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.008 0.523 . . . . 74.1 110.274 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -147.49 -7.55 0.45 Allowed 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.685 -0.806 . . . . 71.34 110.598 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -121.78 133.43 54.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.466 -1.293 . . . . 74.11 111.646 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -141.23 139.88 33.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.821 -0.807 . . . . 32.22 108.821 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 18.1 tpt180 -151.27 135.29 16.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.677 -1.601 . . . . 62.23 106.677 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 8.6 pt-20 -95.26 111.32 23.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.449 0.642 . . . . 71.01 111.768 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.475 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.9 mp -112.38 128.75 68.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.21 23.33 64.07 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 114.697 0.639 . . . . 62.25 114.697 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.59 -9.47 68.93 Favored Glycine 0 C--O 1.239 0.442 0 C-N-CA 120.589 -0.815 . . . . 50.01 113.048 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -113.33 141.98 46.39 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.234 0.54 . . . . 75.53 111.502 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 38.9 m -92.29 115.76 28.36 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.706 -0.679 . . . . 72.53 110.976 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 52.8 m-85 -85.84 124.77 32.7 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.916 -0.772 . . . . 71.52 108.916 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.402 ' HD2' ' SD ' ' A' ' 363' ' ' MET . 38.0 ttpt -118.58 123.22 44.52 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.487 -1.301 . . . . 63.21 107.487 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 73.1 t -106.62 108.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 120.248 -0.581 . . . . 64.13 111.144 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.513 HG11 ' OE1' ' A' ' 380' ' ' GLU . 21.5 t -106.46 101.64 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.039 -1.467 . . . . 65.45 107.039 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -55.19 132.35 47.43 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.567 0.542 . . . . 75.23 110.499 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 79.54 -12.43 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.672 1.189 . . . . 73.24 113.495 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.513 ' OE1' HG11 ' A' ' 377' ' ' VAL . 26.0 mt-10 -101.65 -76.36 0.57 Allowed 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.544 -0.462 . . . . 52.4 110.693 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.542 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.0 p30 178.45 175.51 0.56 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.637 0.775 . . . . 74.45 111.7 -174.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.44 138.39 54.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.806 -0.813 . . . . 75.23 108.806 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 69.4 m-85 -123.5 158.31 31.58 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.493 -0.322 . . . . 72.14 110.243 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -118.73 98.28 6.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.321 -0.992 . . . . 72.23 108.321 168.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.9 t70 70.93 -76.94 0.06 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.662 1.585 . . . . 72.42 109.507 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 49.2 m -135.35 -18.03 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.473 -0.785 . . . . 52.12 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 27.8 mm -83.08 122.75 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.683 0.754 . . . . 64.32 111.411 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 383' ' ' PHE . 57.8 tp -77.67 119.73 21.61 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.787 -1.097 . . . . 75.21 111.432 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.455 HD22 ' CD1' ' A' ' 439' ' ' TYR . 74.6 mt -65.44 -67.52 0.43 Allowed 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 116.11 -0.495 . . . . 74.44 110.601 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 391' ' ' ASN . . . -145.18 -177.11 19.72 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.341 -0.933 . . . . 30.21 112.048 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -121.82 142.19 50.47 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.532 -0.914 . . . . 70.24 108.532 -178.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -57.4 114.28 2.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.345 0.593 . . . . 63.24 110.56 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.39 -52.69 2.57 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.157 -0.929 . . . . 54.13 111.225 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.9 m -133.2 154.65 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.387 0.613 . . . . 73.51 112.248 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -136.62 119.32 16.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.628 -1.619 . . . . 72.34 106.628 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.22 104.65 6.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.006 -0.738 . . . . 74.33 109.006 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.11 -118.43 12.11 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.747 -0.941 . . . . 72.3 110.747 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -107.11 12.86 28.03 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.225 0.536 . . . . 74.43 110.883 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.73 128.62 62.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.049 -0.523 . . . . 65.4 110.355 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.84 138.64 50.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.282 -0.417 . . . . 33.21 110.952 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.738 ' HE2' ' HB2' ' A' ' 403' ' ' GLU . 15.7 tptm -117.67 128.7 55.16 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.856 -0.611 . . . . 71.52 112.308 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 73.4 m-85 -119.5 120.7 37.56 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 107.478 -1.304 . . . . 74.5 107.478 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 401' ' ' LYS . 16.8 tt0 -132.56 161.01 34.91 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.74 -0.784 . . . . 60.42 110.482 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 413' ' ' HIS . 48.2 m-80 71.16 50.37 0.3 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.052 1.13 . . . . 65.21 114.052 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -95.34 -140.43 10.89 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.068 -0.813 . . . . 55.33 111.068 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -62.62 147.3 49.7 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.827 0.851 . . . . 34.3 112.611 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.9 m -60.72 149.43 35.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.9 t -124.35 0.15 8.29 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.789 -0.364 . . . . 63.35 111.673 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 59.11 70.77 0.62 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.955 0.883 . . . . 75.02 109.87 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -153.25 -47.88 0.1 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.518 -1.219 . . . . 70.3 108.921 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 169.6 -80.24 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.949 -1.26 . . . . 64.4 109.949 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.88 -166.25 0.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.492 2.128 . . . . 70.33 111.241 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 404' ' ' ASN . 21.8 m-70 -88.65 165.52 14.72 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.119 -0.491 . . . . 70.33 110.058 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 389' ' ' LEU . 12.0 ttm180 -76.03 159.57 30.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 60.03 109.251 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.461 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 15.3 p -153.18 165.26 36.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 120.912 0.387 . . . . 63.31 111.606 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.71 29.42 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.119 -0.697 . . . . 75.22 109.119 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.7 tp -125.15 117.39 49.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.556 -0.905 . . . . 74.34 108.556 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 441' ' ' ILE . 89.1 t -95.2 109.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.842 -0.799 . . . . 73.04 108.842 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 23.5 m -99.48 114.34 27.25 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 107.315 -1.365 . . . . 65.42 107.315 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.3 t -112.58 134.78 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.884 -0.598 . . . . 63.54 109.989 -174.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.34 -6.44 19.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.337 -0.616 . . . . 73.13 109.337 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.619 ' H ' HG12 ' A' ' 420' ' ' VAL . 47.0 t 69.36 154.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.819 -1.082 . . . . 71.2 110.546 -177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -165.04 -157.24 9.57 Favored Glycine 0 CA--C 1.488 -1.65 0 C-N-CA 119.827 -1.178 . . . . 62.04 111.734 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.28 -20.51 5.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-O 122.049 0.928 . . . . 75.01 108.616 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.04 160.29 40.13 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.897 -1.047 . . . . 63.34 109.102 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 10.0 p30 -101.47 134.91 43.83 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.558 -0.457 . . . . 71.42 109.972 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -166.87 144.5 4.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.115 -0.698 . . . . 64.31 109.115 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.526 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 60.7 mt -87.32 114.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.683 -1.229 . . . . 53.33 107.683 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.86 -60.91 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.173 -0.677 . . . . 72.23 109.173 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.3 m -148.94 157.82 43.71 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.406 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 374' ' ' TYR . 59.7 t -132.59 131.76 59.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.565 -1.642 . . . . 73.35 106.565 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.61 130.83 35.03 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.577 -0.449 . . . . 41.32 111.35 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -90.05 98.15 11.61 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.486 -1.672 . . . . 73.5 106.486 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -126.2 3.36 7.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.823 0.82 . . . . 54.11 110.394 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 438' ' ' GLU . 8.2 tt0 -139.7 166.22 25.18 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 104.723 -2.325 . . . . 72.32 104.723 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.52 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 116.747 2.128 . . . . 63.42 116.747 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 95.4 m 56.16 26.34 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.2 0.524 . . . . 71.44 111.25 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.8 tt0 -100.04 121.15 40.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 107.788 -1.189 . . . . 63.5 107.788 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 389' ' ' LEU . 96.6 m-85 -94.43 115.64 27.86 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.872 -1.058 . . . . 74.42 111.392 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 64.2 mt -77.52 109.85 11.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.13 -1.433 . . . . 64.33 107.13 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 418' ' ' VAL . 13.7 mt -101.78 125.39 55.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.312 -0.996 . . . . 75.35 108.312 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -106.2 116.94 32.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.734 -1.21 . . . . 73.33 107.734 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.526 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 76.5 mtp -141.45 173.61 11.33 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.337 1.065 . . . . 72.42 112.205 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.711 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.9 pttt -153.69 151.63 29.87 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-N 113.354 -1.748 . . . . 72.15 106.781 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 35.2 p -165.55 147.58 6.38 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.48 -28.99 45.43 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 C-N-CA 122.542 2.161 . . . . 74.25 111.828 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.737 -0.665 . . . . 75.12 111.862 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 420' ' ' VAL . . . -76.62 -33.81 58.36 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.342 -0.39 . . . . 72.21 111.426 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.94 109.83 1.18 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 54.33 111.34 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.617 -0.883 . . . . 75.04 108.617 177.001 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 120.594 0.235 . . . . 64.52 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -130.25 73.99 1.57 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.3 -1.0 . . . . 70.22 108.3 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -170.59 113.6 0.44 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.741 0.305 . . . . 75.22 111.484 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 70.9 mt -82.37 120.02 33.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.128 -1.434 . . . . 75.43 107.128 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.576 ' HD2' ' OE2' ' A' ' 380' ' ' GLU . 20.5 pttp -79.27 136.93 37.18 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.845 -0.342 . . . . 73.44 110.687 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -99.71 -78.67 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.482 -0.866 . . . . 55.23 112.851 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 377' ' ' VAL . 12.2 tmm? 67.39 97.48 0.06 Allowed 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.689 1.196 . . . . 72.5 109.194 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.03 -35.15 0.33 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.656 -0.702 . . . . 70.43 110.586 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.542 HG22 HG13 ' A' ' 428' ' ' ILE . 3.7 m -95.17 132.79 39.73 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.477 -0.889 . . . . 73.42 110.809 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 51.2 mtmt -143.88 138.38 28.56 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 106.569 -1.641 . . . . 74.12 106.569 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 428' ' ' ILE . 68.0 ttt180 -165.04 143.44 6.41 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.153 -0.619 . . . . 73.42 109.45 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 373' ' ' THR 0.299 0.0 OUTLIER -100.2 111.29 23.56 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 113.83 1.048 . . . . 74.45 113.83 -176.722 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.449 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.0 mp -103.03 125.21 57.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.939 -1.028 . . . . 72.34 108.646 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.89 24.68 64.97 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.086 -0.506 . . . . 34.55 113.891 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.86 67.89 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.109 -0.567 . . . . 61.44 112.941 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.254 3.8 p90 -108.07 131.29 54.76 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.508 0.67 . . . . 64.41 112.508 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.2 m -84.63 116.76 23.36 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.079 -0.964 . . . . 70.14 112.434 -171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.707 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 46.3 m-85 -87.97 125.56 34.59 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.992 -1.004 . . . . 64.43 108.97 176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 39.1 ttpt -118.28 124.67 48.39 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.983 -1.117 . . . . 73.55 107.983 177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.509 HG21 ' SD ' ' A' ' 443' ' ' MET . 60.7 t -108.58 113.23 43.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.237 0.336 . . . . 70.24 110.592 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 363' ' ' MET . 39.7 t -86.07 -19.26 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.901 -0.777 . . . . 65.34 108.901 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 28.5 t80 73.33 -29.11 0.2 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.459 1.504 . . . . 72.55 112.314 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.7 -9.58 9.32 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.976 0.417 . . . . 75.33 110.98 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 361' ' ' LYS . 37.2 mt-10 -107.91 -71.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.222 0.534 . . . . 50.3 112.113 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 8.9 p30 -171.55 177.17 3.54 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.433 -0.803 . . . . 61.32 111.613 -174.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 61.3 t -130.21 133.17 64.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.427 -0.953 . . . . 71.03 108.427 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 76.9 m-85 -115.5 165.35 13.09 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.509 -0.314 . . . . 74.24 110.347 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 373' ' ' THR . 2.5 pt20 -131.23 94.06 3.49 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 124.516 1.126 . . . . 75.22 109.941 170.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.41 -78.29 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 125.059 1.344 . . . . 60.11 112.372 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 43.5 m -129.31 -15.7 4.07 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.458 -0.792 . . . . 65.04 109.276 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.409 HG23 HE21 ' A' ' 406' ' ' GLN . 65.1 mt -96.95 126.79 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.57 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.446 HD21 HD21 ' A' ' 391' ' ' ASN . 41.4 tp -79.51 134.94 36.52 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.077 -0.51 . . . . 71.5 110.458 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.512 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 96.3 mt -77.76 -79.03 0.12 Allowed 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 120.341 -0.544 . . . . 65.12 110.041 175.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.481 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -141.97 -174.39 14.64 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.134 -1.186 . . . . 72.04 110.134 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.5 m-80 -132.49 145.84 51.47 Favored 'General case' 0 CA--C 1.447 -2.996 0 CA-C-N 117.502 0.651 . . . . 74.43 110.707 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 400' ' ' LEU . 86.3 t80 -61.64 116.11 4.5 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 124.228 0.955 . . . . 53.41 111.208 -175.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.57 -53.51 3.18 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.509 -0.769 . . . . 63.5 110.252 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 m -164.49 158.9 18.79 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 108.256 -1.016 . . . . 64.34 108.256 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -114.45 139.92 49.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.02 -0.733 . . . . 73.44 109.02 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.44 102.85 6.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.352 -0.61 . . . . 54.44 109.352 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 82.76 -123.97 6.32 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 109.777 -1.329 . . . . 50.22 109.777 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.413 HD21 ' HB1' ' A' ' 448' ' ' ALA . 63.5 t30 -106.87 12.22 29.15 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.141 0.972 . . . . 73.23 108.588 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.31 137.92 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.289 -0.869 . . . . 71.2 111.213 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 392' ' ' PHE . 2.0 mm? -112.5 127.35 56.03 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 115.38 -0.827 . . . . 75.33 108.779 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -109.26 130.94 55.48 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.65 -0.82 . . . . 72.34 112.03 177.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 381' ' ' ASN . 78.9 m-85 -109.96 114.4 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.115 -0.948 . . . . 54.51 109.58 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 401' ' ' LYS . 11.9 mm-40 -117.21 158.81 23.65 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 125.236 1.414 . . . . 74.45 110.332 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 58.82 49.73 9.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.734 1.013 . . . . 65.14 113.734 173.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -85.65 -134.01 3.27 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 119.944 -1.122 . . . . 63.05 112.157 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.409 HE21 HG23 ' A' ' 387' ' ' ILE . 0.2 OUTLIER -80.81 146.34 30.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.442 -1.688 . . . . 62.21 106.442 -177.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 47.7 p -55.38 140.61 39.22 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.586 0.708 . . . . 53.23 112.74 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 53.1 t -91.12 -44.96 8.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.827 -0.624 . . . . 64.53 110.129 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -156.64 -83.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.49 -0.323 . . . . 74.52 110.487 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -146.38 12.06 1.18 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.206 0.527 . . . . 61.45 110.694 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.55 -120.73 2.27 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.148 -1.181 . . . . 63.24 110.148 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.79 167.69 13.27 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.203 1.935 . . . . 31.25 111.986 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -94.17 -175.21 3.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.546 -0.909 . . . . 73.13 108.546 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -83.04 152.25 25.46 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.281 -0.637 . . . . 65.21 109.281 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 68.4 m -135.95 162.71 32.08 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.493 -0.776 . . . . 72.14 109.452 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -141.51 130.14 22.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.513 -0.551 . . . . 60.13 109.513 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 440' ' ' LEU . 5.8 tp -114.68 108.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.164 -0.68 . . . . 75.34 109.164 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 94.6 t -93.03 114.81 30.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.757 -0.777 . . . . 75.34 110.107 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 27.9 m -97.23 114.41 26.14 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.245 -1.391 . . . . 64.11 107.245 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 444' ' ' LYS . 20.1 t -112.81 126.89 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.903 -0.59 . . . . 73.54 109.642 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.49 -1.79 21.04 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.066 -0.516 . . . . 70.31 111.241 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 51.8 t 68.4 152.35 0.09 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.15 0.98 . . . . 74.5 111.624 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -169.15 -151.68 7.38 Favored Glycine 0 C--N 1.317 -0.508 0 C-N-CA 120.14 -1.028 . . . . 75.54 112.387 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.7 -36.93 7.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.019 0.438 . . . . 75.22 110.691 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.14 159.27 42.58 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.968 -0.753 . . . . 74.23 108.968 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.3 OUTLIER -89.63 127.68 35.95 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.582 0.586 . . . . 64.2 112.582 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -145.82 144.98 30.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.337 -0.847 . . . . 73.13 108.779 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 365' ' ' THR . 50.4 mt -89.16 109.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.164 -1.791 . . . . 70.34 106.164 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.6 t -80.11 -60.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-O 120.867 0.365 . . . . 74.34 111.332 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.6 m -153.18 156.63 38.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.626 -0.509 . . . . 73.44 109.626 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 58.1 t -138.06 126.25 30.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 64.8 tp -136.27 125.16 24.13 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.657 0.265 . . . . 72.4 111.015 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 437' ' ' CYS . 39.7 tt0 -85.19 92.61 8.45 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.499 0.666 . . . . 72.21 109.401 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.42 -2.74 14.64 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.711 -0.677 . . . . 73.52 111.042 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 44.3 mt-30 -118.7 -173.81 2.56 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.131 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 81.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 114.96 1.467 . . . . 70.31 114.96 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.436 ' HA ' ' OE2' ' A' ' 433' ' ' GLU . 66.8 m 59.58 17.31 6.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.532 0.682 . . . . 71.11 110.288 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 32.1 tt0 -107.52 124.96 50.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.194 -0.912 . . . . 75.25 109.116 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -94.39 122.98 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.513 -1.222 . . . . 74.25 110.614 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 83.0 mt -76.94 110.25 11.41 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.093 -1.077 . . . . 61.33 108.093 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 16.3 mt -102.71 124.82 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.167 -1.049 . . . . 72.32 108.167 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -106.46 113.85 27.61 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.956 -1.498 . . . . 72.52 106.956 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 89.6 mtp -144.44 177.4 8.67 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.764 0.793 . . . . 64.5 112.176 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 53.8 pttt -164.4 158.26 18.32 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.303 -1.317 . . . . 44.23 109.488 173.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 44.7 t -162.59 149.95 11.28 Favored Pre-proline 0 C--N 1.312 -1.023 0 N-CA-C 107.575 -1.269 . . . . 65.21 107.575 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.85 -27.36 43.82 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 122.734 2.29 . . . . 75.53 110.434 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -71.11 -15.81 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 51.15 110.804 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.413 ' HB1' HD21 ' A' ' 398' ' ' ASN . . . -72.69 -40.98 65.79 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.624 -0.716 . . . . 75.45 110.598 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.46 110.61 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.141 -0.689 . . . . 64.33 109.141 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.415 -2.184 0 N-CA-C 108.765 -0.828 . . . . 61.55 108.765 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 109.579 -0.526 . . . . 74.4 109.579 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -88.13 82.97 7.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.11 0.957 . . . . 61.33 111.594 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -145.68 140.67 27.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.521 -1.659 . . . . 53.33 106.521 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 379' ' ' TYR . 2.4 mp -83.2 123.88 39.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.075 0.464 . . . . 71.21 110.179 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.75 121.97 42.57 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 73.41 108.914 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -110.17 50.77 0.75 Allowed Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.913 -0.66 . . . . 53.22 112.941 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.9 100.49 0.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.237 1.015 . . . . 75.01 110.535 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.11 95.42 0.4 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.814 0.816 . . . . 65.13 110.714 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 7.2 m -85.77 127.68 34.61 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.51 -1.292 . . . . 65.43 107.51 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 47.2 mtmt -124.98 135.71 53.05 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.693 0.282 . . . . 75.12 110.436 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.44 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 13.1 tpt180 -155.09 136.57 14.19 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.284 -1.006 . . . . 73.04 108.284 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.1 112.2 24.0 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-O 120.674 0.273 . . . . 54.24 110.975 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 3.1 mp -116.72 130.95 70.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.492 -0.929 . . . . 62.53 108.492 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.06 25.81 66.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 114.347 0.499 . . . . 73.24 114.347 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.2 -15.73 62.22 Favored Glycine 0 C--O 1.24 0.495 0 C-N-CA 121.171 -0.538 . . . . 50.4 113.357 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -107.69 145.79 32.93 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.164 0.507 . . . . 51.54 112.363 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 47.4 m -93.05 115.7 28.36 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.78 -0.646 . . . . 74.35 110.779 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 59.0 m-85 -86.49 128.65 34.99 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.582 -0.736 . . . . 64.43 109.963 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 37.0 ttmt -118.32 123.57 45.68 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.897 -1.149 . . . . 74.44 107.897 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.67 109.89 29.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.87 -0.789 . . . . 72.4 108.87 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 380' ' ' GLU . 19.6 t -92.91 -4.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.265 1.031 . . . . 55.25 108.717 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 15.4 t80 72.44 -57.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.622 1.569 . . . . 74.12 111.99 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' A' ' 360' ' ' ILE . 87.0 m-85 -98.36 -18.65 18.19 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.784 -0.572 . . . . 72.01 111.621 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 39.2 mt-10 -86.99 -71.96 0.53 Allowed 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.901 -0.72 . . . . 72.2 111.692 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 177.76 178.89 0.31 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.675 0.39 . . . . 75.34 110.567 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 50.3 t -127.04 137.47 57.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.289 0.368 . . . . 73.44 111.064 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 74.6 m-85 -123.29 164.69 18.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.943 -0.572 . . . . 72.13 110.429 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.1 pt20 -135.44 105.44 6.24 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.032 1.333 . . . . 71.52 108.565 169.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.83 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.745 0.818 . . . . 72.33 110.358 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.7 t -139.12 7.35 2.43 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.876 -0.787 . . . . 72.1 108.876 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 25.1 mm -102.54 123.43 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 115.602 -0.727 . . . . 64.44 110.892 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 49.4 tp -79.76 122.13 26.22 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 115.55 -0.75 . . . . 74.22 110.128 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 439' ' ' TYR . 87.6 mt -68.36 -68.24 0.41 Allowed 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 109.223 -0.658 . . . . 72.53 109.223 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.72 32.32 Favored Glycine 0 N--CA 1.421 -2.356 0 N-CA-C 109.337 -1.505 . . . . 73.43 109.337 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 47.9 m-80 -121.73 152.25 39.63 Favored 'General case' 0 CA--C 1.439 -3.292 0 CA-C-N 117.3 0.55 . . . . 72.54 110.178 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -61.94 115.5 4.1 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 124.654 1.221 . . . . 61.33 109.966 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.25 -52.89 2.57 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.2 -0.909 . . . . 72.34 110.414 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.8 m -132.44 152.69 51.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.601 -0.727 . . . . 72.21 111.894 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.58 120.86 17.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.957 -1.127 . . . . 70.23 107.957 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -132.25 97.85 4.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.428 0.632 . . . . 73.53 110.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.54 -108.84 2.62 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 114.998 -1.001 . . . . 50.24 112.405 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 420' ' ' VAL . 49.3 t30 -106.76 0.46 24.16 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.975 0.893 . . . . 73.11 110.036 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.06 122.57 68.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.869 -0.519 . . . . 74.2 110.595 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.5 ' HB2' ' CG1' ' A' ' 418' ' ' VAL . 9.4 mp -112.16 139.8 47.39 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.878 -0.601 . . . . 73.14 110.099 178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 403' ' ' GLU . 0.0 OUTLIER -118.12 132.89 56.31 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 75.24 109.459 -176.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 40.3 m-85 -116.91 129.01 55.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.706 -1.22 . . . . 72.44 107.706 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.661 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 10.3 pt-20 -135.33 167.16 21.55 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.977 0.732 . . . . 61.23 112.977 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.71 49.08 10.64 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 124.662 1.226 . . . . 72.32 114.067 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -88.93 -135.18 5.31 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 110.099 -1.201 . . . . 51.43 110.099 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -70.82 146.67 49.57 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 122.394 0.278 . . . . 55.21 110.566 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 68.2 m -55.23 137.7 46.68 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.276 0.56 . . . . 75.11 110.2 174.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.79 -45.01 25.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.437 -0.801 . . . . 70.42 109.546 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -159.78 93.67 1.1 Allowed 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.749 -1.114 . . . . 73.23 107.994 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 69.85 -49.25 0.63 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.758 1.223 . . . . 71.13 114.134 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -113.98 -97.58 2.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.476 -0.869 . . . . 65.34 114.124 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -49.95 155.98 3.82 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.522 2.815 . . . . 73.44 113.731 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 22.6 m-70 -96.28 159.44 14.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.181 -0.918 . . . . 71.22 110.934 -171.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -78.55 163.06 25.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.056 -0.975 . . . . 70.31 109.437 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 17.3 p -149.9 160.98 43.16 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.526 -0.761 . . . . 65.33 109.031 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.87 141.75 42.79 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.517 -0.549 . . . . 70.11 109.517 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -126.11 124.58 66.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.008 -0.738 . . . . 65.52 109.008 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.5 ' CG1' ' HB2' ' A' ' 400' ' ' LEU . 9.4 p -94.27 124.65 46.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.2 -1.0 . . . . 64.3 110.457 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.5 m -111.15 113.69 26.38 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.978 -1.49 . . . . 64.33 106.978 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 422' ' ' CYS . 21.6 t -108.61 133.86 52.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.685 -0.857 . . . . 61.1 108.685 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 444' ' ' LYS . 13.5 pt-20 -105.85 -0.68 25.01 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.473 -0.33 . . . . 65.43 110.468 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.571 ' H ' HG12 ' A' ' 420' ' ' VAL . 4.5 t 73.18 136.04 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.882 0.738 . . . . 70.23 111.696 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.25 -178.49 30.45 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.051 -1.22 . . . . 73.31 110.051 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.9 t -86.58 -27.36 6.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.026 0.917 . . . . 64.13 108.923 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -136.3 158.51 44.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.765 -1.107 . . . . 72.23 108.667 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 8.9 p30 -85.37 135.06 34.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.293 -0.632 . . . . 74.4 109.293 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -161.95 140.0 8.97 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.669 -0.493 . . . . 71.13 109.669 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 65.0 mt -87.03 113.71 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 106.608 -1.627 . . . . 72.31 106.608 174.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.87 -48.51 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.625 -0.879 . . . . 72.11 108.625 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 22.6 t -168.13 168.39 11.77 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.728 -0.841 . . . . 43.14 108.728 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.1 t -137.78 128.64 38.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 106.615 -1.624 . . . . 72.14 106.615 176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.9 tp -127.89 130.06 47.91 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.295 -0.562 . . . . 72.24 111.916 -175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.88 77.26 10.13 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.483 -0.932 . . . . 73.22 108.483 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -106.53 3.65 27.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.697 -0.683 . . . . 43.31 110.819 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -131.12 172.93 11.54 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.75 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.896 1.443 . . . . 75.21 114.896 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 76.3 m 59.32 20.1 8.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.63 -0.713 . . . . 54.31 110.52 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 26.5 tt0 -110.28 120.83 43.69 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.079 -1.082 . . . . 60.11 108.079 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 389' ' ' LEU . 86.0 m-85 -95.05 120.81 35.91 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.685 -1.143 . . . . 64.2 111.712 -171.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 72.0 mt -79.78 110.84 15.51 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.482 -1.303 . . . . 75.52 107.482 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 61.0 mt -96.04 121.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.024 -1.102 . . . . 74.31 108.024 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -106.64 113.97 27.8 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.202 -1.407 . . . . 72.32 107.202 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.2 mtp -141.25 177.71 7.9 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 122.079 0.942 . . . . 73.54 111.695 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 54.8 pttt -152.26 146.86 25.74 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 113.663 -1.608 . . . . 73.34 107.366 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 78.5 p -170.06 147.98 2.95 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 108.896 -0.779 . . . . 73.41 108.896 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.56 -18.76 48.85 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.238 1.959 . . . . 71.12 111.213 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.41 85.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.306 -0.861 . . . . 61.11 112.078 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.49 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -100.78 -8.08 23.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.789 0.804 . . . . 54.25 109.429 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.9 t -78.61 -13.98 59.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.679 -1.146 . . . . 75.24 110.202 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 115.57 -0.741 . . . . 73.31 109.587 -179.367 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.141 0.496 . . . . 72.12 111.848 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -95.65 95.8 8.59 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.753 -1.203 . . . . 75.52 107.753 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . 57.11 -165.52 0.15 Allowed 'General case' 0 C--O 1.256 1.417 0 O-C-N 123.859 0.724 . . . . 22.42 110.558 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.9 mp -91.14 116.16 31.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.849 -1.167 . . . . 71.0 107.849 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.475 ' HB2' ' CG1' ' A' ' 377' ' ' VAL . 21.9 pttp -117.95 155.71 29.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.368 -0.378 . . . . 64.31 110.467 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -106.42 -130.1 6.46 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 120.636 -0.793 . . . . 73.32 111.514 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 65.7 mtt -94.7 90.44 6.1 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.656 0.741 . . . . 74.03 111.09 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.94 110.79 1.27 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.938 -1.483 . . . . 73.42 111.636 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.0 m -121.94 144.83 48.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.982 -0.748 . . . . 63.31 108.982 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 55.5 mtmt -125.85 148.22 49.22 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 110.036 -0.357 . . . . 74.33 110.036 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.427 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 12.5 tpt180 -157.49 138.15 13.08 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 106.546 -1.65 . . . . 52.13 106.546 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.73 111.85 23.84 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 120.329 -0.549 . . . . 54.33 110.562 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.42 128.18 72.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.007 -0.738 . . . . 62.44 109.007 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.73 24.95 66.93 Favored Glycine 0 C--N 1.322 -0.22 0 CA-C-N 116.256 -0.429 . . . . 63.11 113.639 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 90.87 -5.95 81.96 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.645 -0.788 . . . . 72.53 113.246 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.272 3.5 p90 -117.1 143.86 45.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.829 0.823 . . . . 60.2 112.788 177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.1 m -87.83 111.28 21.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 114.585 -1.189 . . . . 74.25 111.165 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 49.1 m-85 -86.2 127.79 34.79 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.91 -0.586 . . . . 63.51 109.989 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 21.6 ttmm -117.46 124.58 49.15 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.967 -1.123 . . . . 73.13 107.967 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.89 109.5 28.73 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 N-CA-C 107.83 -1.174 . . . . 74.22 107.83 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 361' ' ' LYS . 17.7 t -88.4 -6.26 10.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.795 0.807 . . . . 71.1 109.487 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' HD2' ' CE1' ' A' ' 379' ' ' TYR . 1.7 t80 73.49 -51.0 0.7 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.567 1.547 . . . . 73.25 111.777 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.55 ' CE1' ' HD2' ' A' ' 378' ' ' PHE . 83.6 m-85 -107.07 -20.2 13.38 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 113.573 0.953 . . . . 55.34 113.573 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 377' ' ' VAL . 32.2 mt-10 -86.56 -75.05 0.4 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.477 -0.889 . . . . 71.01 111.386 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 402' ' ' TYR . 10.8 p30 -175.51 -177.21 0.97 Allowed 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.197 -0.911 . . . . 63.51 111.201 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 77.8 t -123.95 135.62 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 123.548 0.53 . . . . 71.44 110.014 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 99.0 m-85 -125.08 156.19 38.64 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.33 -0.396 . . . . 72.41 110.376 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 3.1 pt20 -117.57 91.92 3.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.137 -1.431 . . . . 74.51 107.137 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.15 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.545 -1.207 . . . . 70.43 112.692 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.6 m -125.76 -13.69 6.36 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.568 -0.287 . . . . 71.43 111.444 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.497 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 51.6 mt -93.57 131.23 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.074 0.464 . . . . 73.21 110.945 -177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 391' ' ' ASN . 61.5 tp -87.48 119.18 27.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.482 -0.781 . . . . 73.52 112.301 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.454 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 2.7 mm? -62.32 -65.86 0.62 Allowed 'General case' 0 C--O 1.202 -1.43 0 CA-C-N 114.405 -1.271 . . . . 72.42 109.881 173.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 402' ' ' TYR . . . -166.97 -178.24 39.25 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 109.529 -1.429 . . . . 73.13 109.529 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 48.8 m-80 -123.88 152.76 42.0 Favored 'General case' 0 CA--C 1.444 -3.109 0 CA-C-N 117.685 0.742 . . . . 73.25 110.523 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -54.97 114.85 1.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 124.661 1.226 . . . . 75.2 109.94 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -102.93 -52.64 3.01 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.684 -0.689 . . . . 64.13 109.168 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.1 m -163.22 156.51 19.29 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.451 -0.944 . . . . 42.21 108.451 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.29 126.54 54.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.67 -0.863 . . . . 73.22 108.67 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.97 98.1 6.96 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.214 -0.661 . . . . 70.44 109.214 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.75 -118.55 5.76 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.748 -1.341 . . . . 75.21 109.748 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 420' ' ' VAL . 62.3 t30 -106.79 11.04 30.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.358 1.075 . . . . 64.14 108.425 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.98 127.69 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.346 -0.843 . . . . 71.25 110.599 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 2.3 mm? -100.11 134.11 43.51 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.911 -0.586 . . . . 75.33 109.504 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 403' ' ' GLU . 0.1 OUTLIER -116.37 130.01 56.54 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.468 -0.938 . . . . 62.53 108.468 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASN . 77.6 m-85 -118.58 126.31 51.69 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.46 -0.941 . . . . 73.42 108.46 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 401' ' ' LYS . 13.8 tt0 -133.41 169.32 17.12 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.312 -0.625 . . . . 73.03 109.312 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.2 49.37 1.09 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.037 0.535 . . . . 61.0 111.677 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -97.48 -152.95 28.91 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.004 -1.093 . . . . 72.22 111.611 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.94 147.0 54.05 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 123.386 0.674 . . . . 74.43 112.613 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.8 m -56.43 140.16 46.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.738 -0.665 . . . . 73.42 109.989 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 44.6 t -116.78 -31.42 5.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.435 -0.348 . . . . 50.44 110.707 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 173.03 -144.28 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.403 -2.073 . . . . 62.33 105.403 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.08 -2.97 33.41 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.358 0.599 . . . . 63.24 110.053 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.13 175.79 45.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.309 -0.472 . . . . 52.31 112.366 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.55 47.52 2.54 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.511 2.807 . . . . 71.2 112.735 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 66.59 -178.44 0.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.496 1.118 . . . . 71.13 110.793 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -84.32 157.5 21.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 10.0 p -148.37 156.97 43.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.731 -0.668 . . . . 55.53 109.419 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.67 139.59 43.84 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 110.351 -0.24 . . . . 72.52 110.351 -177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 401' ' ' LYS . 8.0 tp -125.77 108.42 19.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.294 -0.632 . . . . 73.11 109.294 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 441' ' ' ILE . 98.8 t -97.09 112.42 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 121.588 -0.695 . . . . 72.11 110.497 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 30.2 m -105.92 118.53 36.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 72.02 108.046 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 443' ' ' MET . 24.4 t -102.61 132.97 47.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.874 -0.788 . . . . 74.15 108.874 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.06 16.27 15.02 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.669 0.989 . . . . 65.15 113.669 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 444' ' ' LYS . 15.0 t 69.92 140.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.224 1.194 . . . . 72.43 114.224 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -163.83 -165.53 21.17 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.367 -1.093 . . . . 65.34 110.367 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.23 -26.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.584 0.707 . . . . 53.0 109.618 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 162.34 30.94 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.741 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -86.74 106.48 17.69 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.036 -0.727 . . . . 72.35 109.036 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -141.2 143.9 34.46 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.102 -0.639 . . . . 60.12 110.094 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 41.7 mt -87.03 119.34 34.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 106.498 -1.667 . . . . 55.32 106.498 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.51 -66.15 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.558 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 36.7 m -142.24 155.8 45.26 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 121.221 -0.192 . . . . 74.12 110.66 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 59.0 t -133.78 114.69 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.986 -1.116 . . . . 74.44 107.986 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.03 128.45 48.55 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.425 0.528 . . . . 75.14 112.425 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -81.92 97.44 8.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.697 -1.223 . . . . 50.24 107.697 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -118.25 -22.64 7.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.254 0.55 . . . . 63.14 111.335 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 48.9 mt-30 -117.18 174.57 6.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.376 -0.601 . . . . 55.23 109.376 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.4 78.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.084 1.883 . . . . 70.21 116.084 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 71.4 m 56.07 25.52 9.02 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.467 0.651 . . . . 64.31 109.922 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.6 tt0 -107.62 120.35 41.96 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.082 -1.081 . . . . 63.0 108.082 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -96.28 123.86 40.07 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.564 -1.198 . . . . 72.31 111.524 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 79.0 mt -80.9 117.86 21.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.356 -1.35 . . . . 52.51 107.356 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 418' ' ' VAL . 18.1 mt -115.12 127.5 72.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.373 -0.603 . . . . 73.12 109.373 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 116.04 -0.527 . . . . 73.05 111.519 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 79.1 mtp -140.66 163.57 32.53 Favored 'General case' 0 CA--C 1.475 -1.923 0 CA-C-N 115.542 -0.754 . . . . 74.13 109.001 173.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.428 ' HB2' ' C ' ' A' ' 422' ' ' CYS . 57.5 pttt -144.25 147.96 34.26 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 106.13 -1.804 . . . . 65.24 106.13 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 72.4 p -167.14 150.88 6.28 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.879 -0.786 . . . . 63.01 108.879 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.05 -29.25 22.79 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.303 2.002 . . . . 74.23 112.413 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.47 60.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.624 0.602 . . . . 51.3 112.624 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.456 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -92.95 -2.23 55.98 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.911 0.863 . . . . 74.44 109.054 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 15.3 t -70.96 -27.94 64.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.514 -1.221 . . . . 74.1 109.0 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 108.542 -0.91 . . . . 61.2 108.542 177.755 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.138 0.018 . . . . 73.43 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 55.81 93.54 0.02 OUTLIER 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.634 1.573 . . . . 73.11 112.194 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -87.27 120.91 29.04 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.412 -0.813 . . . . 72.0 109.894 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 360' ' ' ILE . 2.2 mp -82.42 124.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.047 -1.834 . . . . 74.11 106.047 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.467 ' HD2' ' OE1' ' A' ' 380' ' ' GLU . 48.6 mtmt -104.78 156.57 17.88 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.929 0.395 . . . . 54.2 111.612 -174.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -125.49 57.49 0.69 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.812 -0.915 . . . . 64.12 110.812 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.522 ' HB2' HG13 ' A' ' 377' ' ' VAL . 56.1 ttp -79.58 81.23 5.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.931 -1.137 . . . . 63.33 107.931 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -125.11 -32.58 2.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.641 -0.708 . . . . 71.32 112.841 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.443 HG22 HG13 ' A' ' 428' ' ' ILE . 1.9 m -119.64 137.41 53.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 118.729 -1.188 . . . . 74.12 113.23 -169.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.8 145.18 31.52 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.4 -0.963 . . . . 63.25 108.4 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.464 ' CB ' ' HB ' ' A' ' 428' ' ' ILE . 21.1 tpt180 -154.61 143.41 20.86 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.422 -0.955 . . . . 60.3 108.422 -177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.1 OUTLIER -97.91 110.52 23.08 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.048 0.451 . . . . 74.22 111.076 -179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 374' ' ' TYR . 2.8 mp -112.75 125.75 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.621 -0.881 . . . . 71.03 108.621 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.53 25.57 65.39 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.451 -0.341 . . . . 61.32 113.862 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.47 62.38 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 121.018 -0.61 . . . . 72.01 113.016 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . 0.252 2.7 p90 -105.79 131.77 52.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.686 0.755 . . . . 73.52 112.001 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 59.2 m -84.85 113.51 21.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.093 -0.958 . . . . 41.41 111.782 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' PHE . 60.5 m-85 -86.0 124.71 32.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 108.32 -0.993 . . . . 72.11 108.32 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.3 ttpt -119.66 123.98 45.15 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.185 -0.672 . . . . 74.3 109.185 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.89 112.9 42.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.65 -0.5 . . . . 63.54 109.65 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.625 HG11 ' OE1' ' A' ' 380' ' ' GLU . 20.1 t -97.02 2.36 10.28 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 CA-C-O 122.344 1.068 . . . . 45.04 109.16 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.417 ' O ' HD13 ' A' ' 400' ' ' LEU . 11.3 t80 66.05 -68.95 0.12 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.731 1.613 . . . . 74.24 112.188 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.38 -16.22 33.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.887 -0.508 . . . . 73.15 111.15 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.625 ' OE1' HG11 ' A' ' 377' ' ' VAL . 40.1 mt-10 -93.06 -80.0 0.39 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.111 -0.636 . . . . 72.12 111.965 177.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.628 ' HA ' ' CE1' ' A' ' 402' ' ' TYR . 0.0 OUTLIER -174.95 172.88 2.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.79 -177.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 49.1 t -120.57 136.43 57.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 O-C-N 123.71 0.631 . . . . 73.01 110.057 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 374' ' ' TYR . 77.3 m-85 -123.34 165.0 17.73 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.755 -0.657 . . . . 72.44 109.77 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HG3' ' HB ' ' A' ' 387' ' ' ILE . 2.7 pt20 -130.42 94.93 3.77 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.341 1.056 . . . . 72.11 109.833 171.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 19.7 t70 67.11 -74.97 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.471 1.508 . . . . 74.32 111.553 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 42.5 m -135.91 -7.91 2.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.477 -0.783 . . . . 73.24 110.136 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.529 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 50.7 mm -101.25 129.33 52.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.944 -0.391 . . . . 74.3 109.944 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 40.4 tp -81.76 131.33 35.26 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.285 -0.416 . . . . 64.54 111.836 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.544 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 87.2 mt -79.01 -68.3 0.67 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.576 -0.284 . . . . 74.05 110.361 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 381' ' ' ASN . . . -154.68 -174.58 24.83 Favored Glycine 0 C--O 1.215 -1.056 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 402' ' ' TYR . 0.9 OUTLIER -128.79 139.09 52.35 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.449 0.624 . . . . 74.2 110.64 -177.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -60.28 114.09 2.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.686 -0.806 . . . . 71.44 110.363 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -116.47 -50.29 2.64 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.578 -0.737 . . . . 52.42 110.903 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.9 m -133.06 143.15 49.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.958 -0.564 . . . . 74.04 110.558 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -109.56 118.06 35.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.874 -1.528 . . . . 63.12 106.874 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.58 98.38 7.76 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.135 -1.061 . . . . 55.45 108.135 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.03 -119.36 7.99 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.299 -1.92 . . . . 71.42 108.299 -172.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -107.61 5.26 26.77 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.161 -0.681 . . . . 73.23 109.161 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.15 131.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.474 -0.785 . . . . 74.03 108.981 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 378' ' ' PHE . 72.3 mt -102.17 128.52 48.63 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.939 -0.573 . . . . 73.23 111.264 -174.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 415' ' ' SER . 12.7 tptm -109.86 122.07 46.69 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-O 121.41 0.624 . . . . 61.31 111.645 176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 381' ' ' ASN . 88.6 m-85 -104.86 115.04 29.63 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.066 -0.97 . . . . 74.13 110.442 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -109.94 157.49 19.2 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 125.281 1.432 . . . . 72.2 110.363 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 63.06 44.95 5.51 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.882 0.697 . . . . 64.44 112.882 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.22 -149.36 4.14 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 119.907 -1.139 . . . . 74.44 112.283 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -79.81 145.99 32.51 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.407 -1.701 . . . . 53.33 106.407 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 71.0 m -51.4 134.65 28.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.323 0.583 . . . . 74.35 111.774 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.0 t -73.7 -40.29 63.72 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.504 -0.771 . . . . 55.51 109.395 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . -160.79 -69.47 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.36 -1.348 . . . . 60.35 107.36 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -167.11 97.59 0.52 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.035 -0.984 . . . . 70.14 108.571 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 162.02 -116.62 0.72 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.649 -1.38 . . . . 55.23 109.649 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.65 -176.82 3.18 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.917 1.744 . . . . 55.41 110.946 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -101.68 163.78 12.08 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.378 -0.374 . . . . 75.03 110.085 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -75.76 157.93 32.89 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.187 -1.042 . . . . 75.05 108.187 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.542 ' HB3' ' HE3' ' A' ' 401' ' ' LYS . 50.0 m -144.76 164.29 31.45 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.862 0.363 . . . . 74.41 110.904 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.37 30.44 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.337 -0.616 . . . . 41.42 109.337 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.27 120.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.255 -1.017 . . . . 73.14 108.255 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.504 HG23 ' HE2' ' A' ' 402' ' ' TYR . 84.7 t -103.16 116.22 46.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.64 -0.662 . . . . 71.43 111.109 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 36.1 m -97.33 114.89 26.74 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.966 -1.124 . . . . 73.5 107.966 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 448' ' ' ALA . 21.8 t -114.01 129.85 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.886 -0.783 . . . . 53.52 108.886 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -122.97 24.52 8.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.994 0.368 . . . . 70.14 111.994 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.436 ' H ' HG12 ' A' ' 420' ' ' VAL . 22.9 t 67.82 141.45 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.266 -0.879 . . . . 70.44 113.202 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.54 179.8 30.39 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.42 -1.072 . . . . 54.54 110.42 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.1 -27.1 6.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.616 0.722 . . . . 70.14 109.242 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -146.07 152.02 38.64 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.381 -0.827 . . . . 63.2 109.125 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 9.0 p30 -85.14 128.07 34.51 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.119 0.485 . . . . 72.15 111.174 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.41 137.62 14.76 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.159 -1.052 . . . . 72.44 108.159 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 367' ' ' ARG . 69.7 mt -80.33 114.12 20.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.896 -1.15 . . . . 63.32 107.896 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.0 -59.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.562 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 57.7 m -155.43 159.3 39.73 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 110.25 -0.278 . . . . 52.54 110.25 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.52 HG11 ' CE2' ' A' ' 374' ' ' TYR . 47.7 t -139.43 121.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.114 -1.069 . . . . 65.14 108.114 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 61.9 tp -135.74 134.37 38.99 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.035 -0.266 . . . . 74.01 110.799 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -86.94 111.82 21.19 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.773 -1.195 . . . . 72.4 107.773 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -131.39 6.55 4.48 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.484 0.659 . . . . 61.2 109.649 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.47 ' HG2' ' CD ' ' A' ' 436' ' ' LYS . 23.9 tt0 -144.16 161.53 38.61 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.322 -1.362 . . . . 70.54 107.322 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.47 ' CD ' ' HG2' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -38.94 85.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.872 1.669 . . . . 74.34 115.202 -172.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 68.4 m 53.52 25.26 4.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 52.43 110.173 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 415' ' ' SER . 28.6 tt0 -111.32 123.62 50.58 Favored 'General case' 0 N--CA 1.408 -2.551 0 N-CA-C 108.752 -0.832 . . . . 72.13 108.752 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.14 124.81 39.39 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.047 -0.978 . . . . 74.23 111.793 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 56.8 mt -81.51 111.83 18.19 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.288 -1.375 . . . . 73.32 107.288 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.496 ' HB ' HG22 ' A' ' 418' ' ' VAL . 19.4 mt -101.83 125.57 55.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.913 -1.143 . . . . 72.22 107.913 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -106.17 116.42 31.91 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.156 -1.424 . . . . 60.52 107.156 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.9 mtp -139.64 173.76 11.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.091 0.948 . . . . 72.23 111.932 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 48.6 pttt -160.85 137.41 8.65 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.8 -1.545 . . . . 71.31 107.332 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.7 t -160.08 144.37 10.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 109.345 -0.613 . . . . 62.54 109.345 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.35 -28.9 39.01 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.555 2.17 . . . . 75.35 110.537 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.18 -10.22 59.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.599 -0.728 . . . . 72.13 111.403 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.495 ' HB3' HG11 ' A' ' 420' ' ' VAL . . . -116.74 -2.18 11.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.825 -0.805 . . . . 73.33 108.825 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.3 t -74.03 -31.94 63.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.827 -1.079 . . . . 64.01 108.844 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.429 -1.5 0 CA-C-N 115.573 -0.74 . . . . 39.48 110.247 179.611 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.864 -0.421 . . . . 75.3 109.864 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 358' ' ' ARG . 5.3 mpt_? 65.43 112.29 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.913 1.285 . . . . 73.14 113.164 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -106.64 112.92 26.12 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.507 -0.77 . . . . 72.41 109.894 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.47 116.01 49.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.836 -1.172 . . . . 70.52 107.836 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 361' ' ' LYS . 18.4 ptpt -86.06 136.03 33.39 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 119.418 -0.913 . . . . 64.53 111.683 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -82.37 -88.03 0.7 Allowed Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.584 -1.006 . . . . 70.33 110.584 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.13 103.02 6.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.182 -0.673 . . . . 74.31 109.182 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 376' ' ' VAL . 40.8 tt0 -79.27 106.59 11.41 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.303 -0.862 . . . . 72.33 110.2 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 18.5 m -113.18 145.73 40.48 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.913 -1.143 . . . . 43.14 107.913 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 98.9 mttt -130.38 137.85 50.09 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 110.149 -0.315 . . . . 61.33 110.149 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.445 ' HB2' ' HB ' ' A' ' 428' ' ' ILE . 17.4 tpt180 -145.08 139.33 27.3 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 107.07 -1.456 . . . . 72.12 107.07 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 368' ' ' GLU . 0.3 OUTLIER -91.84 109.78 21.11 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.174 -0.676 . . . . 71.14 109.174 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 374' ' ' TYR . 58.8 mt -125.08 127.75 72.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.428 -0.805 . . . . 74.32 109.804 -175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.72 22.46 64.18 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.218 -0.446 . . . . 52.53 113.617 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 91.87 -9.64 76.29 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.897 -0.668 . . . . 75.14 112.946 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -115.83 142.24 47.03 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.398 0.618 . . . . 71.35 112.031 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 384' ' ' GLN . 18.8 m -86.27 113.68 22.47 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.701 -0.681 . . . . 51.0 110.852 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 369' ' ' ILE . 37.7 m-85 -85.67 125.49 33.21 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.01 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.442 ' HE2' ' HE2' ' A' ' 366' ' ' LYS . 34.7 ttmt -118.38 122.89 43.92 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.623 -1.621 . . . . 75.31 106.623 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 364' ' ' GLU . 62.1 t -111.89 112.83 42.2 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 106.697 -1.594 . . . . 61.5 106.697 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -87.67 -29.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 O-C-N 123.394 0.434 . . . . 71.11 111.786 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.433 ' HA ' ' OH ' ' A' ' 402' ' ' TYR . 34.1 m-85 69.79 120.69 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 123.538 0.524 . . . . 64.02 111.501 -172.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 75.08 -14.77 0.72 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.451 1.1 . . . . 73.22 112.132 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -100.52 -76.23 0.56 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.766 -0.652 . . . . 65.21 111.264 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.557 ' HA ' ' CD2' ' A' ' 402' ' ' TYR . 9.8 p30 -178.12 -177.42 0.6 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.819 -0.628 . . . . 74.14 111.212 -175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.23 132.46 60.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 109.155 -0.683 . . . . 63.3 109.155 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.88 161.36 20.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.054 0.454 . . . . 75.34 109.8 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 373' ' ' THR . 3.2 pt20 -129.47 100.65 5.63 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.156 -0.929 . . . . 62.01 108.824 169.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.79 -77.26 0.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.044 1.338 . . . . 71.24 109.878 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 38.1 t -144.18 -1.44 0.94 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.777 -0.647 . . . . 73.34 109.462 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.512 ' HB ' ' HG3' ' A' ' 384' ' ' GLN . 55.0 mt -93.05 122.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 108.448 -0.945 . . . . 72.24 108.448 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.625 HD21 HD21 ' A' ' 391' ' ' ASN . 44.3 tp -79.42 128.5 33.42 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.872 -0.604 . . . . 71.54 112.064 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 414' ' ' ARG . 82.7 mt -76.13 -69.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.205 0.526 . . . . 62.31 110.329 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -154.88 179.14 31.17 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.341 -1.104 . . . . 74.51 110.341 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.625 HD21 HD21 ' A' ' 388' ' ' LEU . 47.5 m-80 -127.72 153.44 46.51 Favored 'General case' 0 CA--C 1.441 -3.229 0 CA-C-N 117.234 0.517 . . . . 73.33 109.941 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -56.92 113.94 1.89 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 124.417 1.073 . . . . 73.35 110.693 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.21 -46.22 2.71 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.274 -0.876 . . . . 61.13 110.893 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.6 m -134.16 152.4 51.81 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.697 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -129.08 131.81 47.34 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.972 -1.121 . . . . 70.51 107.972 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -135.02 98.59 4.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.383 -0.599 . . . . 75.14 109.383 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.39 -111.31 4.05 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.645 -0.982 . . . . 52.33 110.645 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -106.56 -0.47 23.85 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.131 0.491 . . . . 70.23 110.126 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 418' ' ' VAL . 92.4 t -97.03 139.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.754 -0.657 . . . . 75.14 110.013 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.91 139.22 53.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.624 -0.262 . . . . 74.3 110.494 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.42 127.56 55.89 Favored 'General case' 0 C--O 1.255 1.366 0 N-CA-C 108.438 -0.949 . . . . 63.43 108.438 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.557 ' CD2' ' HA ' ' A' ' 381' ' ' ASN . 79.5 m-85 -117.88 116.45 26.98 Favored 'General case' 0 C--O 1.196 -1.722 0 CA-C-N 116.143 -0.48 . . . . 73.53 111.206 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -130.33 -179.93 5.54 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 123.384 0.674 . . . . 60.51 111.044 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.67 48.57 3.28 Favored 'General case' 0 C--O 1.247 0.95 0 O-C-N 124.167 0.917 . . . . 60.24 109.53 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -98.13 -140.97 11.73 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.508 -0.853 . . . . 31.51 111.317 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 387' ' ' ILE . 0.5 OUTLIER -83.97 130.06 34.9 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.726 -1.583 . . . . 75.35 106.726 -179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 49.6 m -48.27 137.97 10.33 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.656 0.984 . . . . 51.2 113.656 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.36 -11.13 41.51 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.523 -0.762 . . . . 61.12 108.991 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . . . . . . . . . . . 75.1 118.16 0.05 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.215 1.406 . . . . 64.1 110.263 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 75.76 -38.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.456 1.103 . . . . 63.33 112.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -98.42 -159.67 30.03 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.833 -0.907 . . . . 74.41 110.833 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.74 -179.86 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.263 1.975 . . . . 64.05 111.596 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 44.7 m-70 -90.76 30.04 1.24 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.438 0.637 . . . . 61.24 110.408 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 389' ' ' LEU . 57.4 mtp180 72.3 162.44 0.26 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 126.459 1.904 . . . . 74.53 111.899 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 402' ' ' TYR . 48.4 t -151.71 150.21 29.95 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 108.275 -1.009 . . . . 54.14 108.275 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . . . -135.39 121.05 19.49 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.77 -1.196 . . . . 64.33 107.77 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.8 tp -112.42 111.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 N-CA-C 108.694 -0.854 . . . . 74.41 108.694 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.486 ' HA ' ' HB ' ' A' ' 441' ' ' ILE . 81.1 t -93.17 110.3 22.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 120.082 -0.647 . . . . 62.02 109.596 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 51.5 m -104.92 114.91 29.4 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 108.014 -1.106 . . . . 72.4 108.014 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 443' ' ' MET . 15.5 m -103.05 128.46 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 CA-C-N 115.762 -0.654 . . . . 72.33 111.422 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.08 6.54 29.03 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.852 -1.067 . . . . 75.41 110.317 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 448' ' ' ALA . 47.5 t 63.96 149.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 113.567 -1.651 . . . . 75.02 114.325 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.6 -171.82 23.23 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 110.29 -1.124 . . . . 54.42 110.29 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.74 -16.73 7.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.059 0.933 . . . . 62.23 108.79 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 445' ' ' SER . 12.7 pt-20 -134.21 160.25 38.41 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.876 -1.057 . . . . 74.41 108.917 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -87.31 121.14 29.36 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.237 -0.653 . . . . 75.41 109.237 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -156.66 143.42 18.57 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.719 -0.392 . . . . 64.21 110.238 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 63.2 mt -93.1 118.35 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.48 -1.304 . . . . 72.42 107.48 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.4 -63.15 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.845 0.355 . . . . 63.2 110.979 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 45.7 m -147.69 155.85 42.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 61.32 110.56 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 440' ' ' LEU . 62.0 t -136.49 122.04 27.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.158 -1.423 . . . . 51.13 107.158 173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.89 134.1 47.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 121.091 -0.244 . . . . 71.31 110.992 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.35 90.66 8.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.5 -18.0 15.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.85 -0.614 . . . . 55.42 110.993 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 438' ' ' GLU . 22.8 mt-30 -128.28 169.62 14.0 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.012 -0.54 . . . . 73.51 109.687 -177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.48 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.212 1.805 . . . . 53.54 114.517 -174.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.4 m 54.12 24.25 4.71 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.992 -0.549 . . . . 73.34 110.31 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 435' ' ' GLN . 39.4 tt0 -105.26 126.0 51.61 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.2 -0.667 . . . . 72.1 109.2 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.92 113.4 26.33 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.799 -1.091 . . . . 71.35 111.431 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 431' ' ' VAL . 67.7 mt -78.0 114.74 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.196 -1.409 . . . . 73.23 107.196 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 418' ' ' VAL . 18.4 mt -106.34 126.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.296 -0.562 . . . . 73.42 109.796 -177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -105.96 120.78 42.64 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 121.252 0.549 . . . . 72.11 110.982 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 420' ' ' VAL . 77.1 mtp -135.4 157.16 47.6 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.075 -0.966 . . . . 54.35 109.548 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -141.01 137.4 32.96 Favored 'General case' 0 N--CA 1.391 -3.415 0 N-CA-C 107.108 -1.442 . . . . 71.23 107.108 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 425' ' ' GLU . 60.8 p -162.63 157.5 18.72 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.289 -1.004 . . . . 54.51 108.289 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.81 -25.95 60.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.07 1.847 . . . . 63.2 110.177 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -72.56 -5.1 34.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.983 -1.008 . . . . 70.31 110.877 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 422' ' ' CYS . . . -91.36 -27.23 18.49 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.049 -0.523 . . . . 72.02 110.102 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 62.8 m -79.38 -30.13 42.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.147 -0.479 . . . . 73.43 109.922 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 109.197 -0.668 . . . . 72.43 109.197 179.128 . . . . . . . . 0 0 . 1 stop_ save_